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ABSTRACT 
Experimental Autoimmune Encephalomyelitis (EAE), a major applied model for 
Multiple Sclerosis (MS) research, is also an excellent model for studying interactions 
between the immune system and the central nervous system (CNS). The specific aims of 
this study were to ascertain how T lymphocytes (T cells), which are normally found in 
low numbers in the CNS, localise during the inflammatory response and as MS and EAE 
are both age-dependent diseases, to establish the clinical, histopathological and 
immunoregulatory changes which occur in aged animals suffering from EAE. 
In Chapter 3, using EAE in the rat as a model of CNS inflammation, activated 
and quiescent T cells with different antigen specificities were labelled with the fluorescent 
dye Hoechst 33342 and tested by fluorescence microscopy for their ability to accumulate 
in different regions of the spinal cord and in other organs at varying times post 
inoculation. With this highly sensitive assay it was found that activated myelin basic 
protein (MBP)-specific T cell lines accumulated in the spinal cord (a 1000 fold increase in 
the lumbar/sacral region by day 4) and caused clinical signs of EAE. In contrast, 
interleukin-2 (IL-2) maintained (quiescent) MBP-specific T cell lines failed to accumulate 
in the CNS and cause disease. Activated ovalbumin (OA)-specific and purified protein 
derivative of tuberculin (PPD)-specific T cell lines were also found at significantly higher 
levels in the spinal cord than non-activated cells although they failed to accumulate to a 
substantial degree when injected alone. When injected with activated MBP-specific T 
cells the activated OA-, and PPD-specific cell lines accumulated in the spinal cord 
following initial accumulation of the MBP-specific cells, demonstrating that during the 
inflammatory process there is considerable non-specific recruitment of cells into the 
inflammatory site. CNS accumulation of activated MBP-specific T cell lines occurred 1-2 
days later in irradiated animals than in non-irradiated recipients. This was consistent with 
irradiated animals also exhibiting a later onset of disease and suggests that irradiation may 
directly affect the endothelium in a way that makes it less adhesive. Preliminary 
observations also supported the view that in irradiated animals tissue repair mechanisms 
in the CNS are compromised. Considerable hemorrhage and the exposure of collagen, a 
component of the extracellular matrix, were found in irradiated recipients in this study, 
suggesting that the integrity of the vasculature had been affected. An important 
observation in this study was that astrocytic proliferation was evident in irradiated and 
non-irradiated animals exhibiting advanced clinical signs of EAE. These results suggest 
that astrocytes could be important in the development of clinical signs of EAE. In 
conclusion, the research described in Chapter 3 demonstrates that activated lymphocytes 
of any specificity enter the spinal cord, and that the neuro-antigen specific cells 
.. 
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accumulate there and lead to the recruitment of other cells. Non-activated 
cells, even 
those with neural antigen specificity, fail to enter the spinal cord. 
Chapters 4, 5 and 6 examined in detail age-related differences in EAE severity. 
In Chapter 4, EAE was induced in young (2-3 month old), middle-aged (12-13 month 
old) and geriatric (24-26 month old) Lewis (JC) rats by active immunisation with MBP in 
complete Freund's adjuvant (CFA). It was found that aged Lewis (JC) rats developed a 
more chronic form of EAE than younger rats of the same strain. Active induct
ion 
showed a slower and less vigorous response in the first instance in aged anima
ls, but the 
chronicity did not resolve suggesting there is a problem in resolving the neurol
ogical 
effects of CNS inflammation in older animals. In contrast, no significant differ
ence in 
the production of MBP-specific antibodies was found between young and aged
 animals. 
Males exhibited an increased severity and chronicity of disease compared with
 females of 
the same age. However, the sterilisation of females had no effect on the onse
t or 
severity of clinical EAE in middle-aged animals. The memory response previo
usly 
shown in young animals which had received EAE effectors postnatally was als
o evident 
in aged animals 13 months after receiving the effector cells. 
Studies described in Chapter 5, examined whether the clinical differences in EA
E 
chronicity between young and middle-aged animals could be attributed to gros
s 
differences in the histopathology of the disease. In these studies, the CNS infla
mmatory 
lesions were quantified, and the degree of fibrin deposition, demyelination and
 astrocytic 
hypertrophy was compared. Inflammatory lesions became apparent before the
 onset of 
disease, increased significantly during advanced clinical signs of EAE and wer
e still 
evident at day 22 in young animals despite the absence of clinical signs but we
re largely 
absent from middle-aged animals which still exhibited disease symptoms. At 
day 40 post 
inoculation inflammatory infiltrates were sparse in both young and middle-age
d animals 
despite 29% of middle-aged animals being symptomatic. These results sugges
t that 
disease chronicity does not correlate with the number of inflammatory lesions 
in the 
CNS. No significant differences were found in the degree of fibrin deposition
 or 
demyelination between young and middle-aged or symptomatic and asymptom
atic 
animals. However, astrocytic hypertrophy was found to correlate with disease
 chronicity 
in middle-aged animals, suggesting that astrocytic hypertrophy may play a sign
ificant role 
in the pathophysiology of the disease. 
In Chapter 6, EAE was induced in young and middle-aged naive recipients 
by 
the adoptive transfer of lymphocytes from actively immunised young dono
rs. It was 
found that middle-aged recipients developed more severe disease than young
 recipients. 
Based on these observations it was concluded that disease chronicity in m
iddle-aged 
animals is a property of the CNS mill teu rather than a property of an agei
ng immune 
system. In parallel studies the naturally occurring pro-inflammatory media
tors tumor 
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necrosis factor (TNF) and nitric oxide and anti-inflammatory mediators corticosterone 
and prostaglandin E (PGE) were examined in young and middle-aged animals using the 
actively induced model of EAE. No detectable levels of TNF-cx were evident in middle-
aged and young rats during the course of disease and no significant differences in PGE2 
levels between young and middle-aged animals or between symptomatic and 
asymptomatic animals were found. By contrast, markedly elevated corticosterone levels 
were found in both young and middle-aged animals with the development of clinical 
signs, which returned to baseline levels with the resolution of clinical symptoms. 
Elevated levels of reactive nitrogen intermediates (RNls) were evident in animals 
immediately prior to and during the early stages of symptomatic EAE. Although, these 
results suggest that nitric oxide may play a role in the pathogenesis of disease, whereas 
corticosterone may play a role in the immunoregulation of the disease, these factors 
cannot explain differences in disease chronicity evident in middle-aged animals. 
Based on the studies described in Chapters 4 to 6, it is proposed that the 
neurological deficit of chronic EAE in middle-aged animals may be caused by astrocytic 
hypertrophy with the resolution of this CNS response being a major factor contributing to 
recovery from the disease in animals of all ages. 
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CHAPTER 1: LITERATURE REVIEW 
1.1 Introduction 
Certain neurological diseases, which are characterised by inflammation and 
demyelination of the central nervous system (CNS), are a cause of morbidity and 
mortality in humans. Often, these disorders are linked etiologically by either a proven or 
suspected viral infection and pathologically by an inflammatory process resulting in 
demyelination. Multiple Sclerosis (MS) is one such disease, and is a disorder in which 
the mechanisms causing disease are not fully understood. It is a degenerative disease 
occurring when the body's immune system attacks the CNS. In this study, I will discuss 
the possibility that MS is an autoimmune disease resulting from a dysfunction in 
immunoregulation, possibly caused by a viral infection occuring during adolescence or 
early adulthood, which can subsequently be activated by age-related vascular and immune 
changes. These changes possibly cause myelin autoreactive cells, which are a direct 
result of the viral infection, to enter the CNS and cause inflammation and demyelination. 
Experimental Autoimmune Encephalomyelitis (EAE), a major applied model for MS 
research, is an excellent model to study the link between the immune and central nervous 
systems. The study of the principles of the inflammatory process within the CNS, 
particularly how the autoreactive T lymphocytes (T cells) can enter the CNS and cause 
inflammation, may lead to pharmacologic or immunoregulatory ways of manipulating the 
inflammatory process. 
The purpose of this chapter is to: 
(a) introduce the functional anatomy of the CNS and discuss the implications this 
has on neuropathology; 
(b) discuss the relationship between the immune and central nervous systems, 
considering how T cells which are normally found in low numbers in the CNS, 
localise during the inflammatory process; 
( c) consider immediate and persistent neurological damage caused by viral 
infection of the CNS; 
(d) summarise the clinical, pathological and immunological features of the human 
inflammatory disorder MS; and 
(e) characterise EAE as an experimental model considering the relative role 
inflammatory cells play in disease manifestation. 
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1.2 Functional anatomy of the central nervous system 
1.2.1 Development of Neural and Glial Cells 
There are basically two distinct types of cells in the central nervous system: the 
nerve cells and the neuroglia Both of these cell types are derived from the epithelial cells 
of the ventricular wne (Schacher, 1985). Following mitosis, these cells migrate to their 
final destinations before undergoing differentiation (Altman, 1966). The majority of the 
neuronal population loses the capacity to divide prior to their migration (Giotta and Cohn, 
1982). In rodents, the formation of neurons and their synapses is almost complete at 
birth (Altman, 1972). Although neurones are predominantly postmitotic, proliferating 
glia are evident throughout the brain. The two major classes of glial cells are the 
macroglia (astrocytes, oligodendrocytes and ependymal cells), and microglia (phagocytic 
cells that are mobilised during injury, infection, or disease) (Kandel, 1985). In the rat, 
the bulk of astrocytes are formed by the end of the third week postnatum (Raff et al., 
1983; Miller and Raff, 1984) while the majority of oligodendrocytes are formed between 
the ages of 3 weeks and 6 months (Hertz et al., 1982). However, glial cells do not 
usually divide in the adult nervous system other than in response to injury or trauma 
(Adams, 1977; Prineas, 1975). Consequently, in the CNS of the mature animal, there is 
a relatively stable population of cells which are limited in their ability to regenerate. 
1.2.2 Functional role of astrocytes 
Astrocytes are classically divided into two subclasses: fibrous and protoplasmic. 
Fibrous astrocytes abound in glial filaments and are found in areas of the CNS containing 
a predominance of axons. Protoplasmic astrocytes have shorter, stouter processes that 
contain fewer filaments, and are associated with nerve cell bcxlies, dendrites and 
particularly synapses, which they characteristically envelop (Kandel and Schwartz, 
1985). Glial fibrillary acidic protein (GFAP), an intracellular marker for astrocytes, is a 
major constituent of gliofilaments and antisera to the protein show intense 
immunohistochemical staining of the cell bodies and processes of astrocytes (Bignami et 
al., 1972; Raff et al., 1979). The functional role of astrocytes in cell-cell interactions in 
the CNS has remained largely obscure though they are thought to serve the functions set 
out in Table 1. 1. 
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Table 1.1: The functional roles attributed to astrocytes: 
1. Supporting elements: Astrocytes give firmness and structure to the brain. 
Their processes surround capillaries and synapses and form a continuous subpial 
and subependymal layer (Peters et al 1976). By wrapping areas of synaptic contact 
and presynaptic boutons on axons with their processes they segregate and 
sometimes insulate groups of neurons from each other (Miller et al, 1986). Radial 
astroglia in the developing brain have been proposed to act as guides for migrating 
neurons in the cerebellar and cerebral cortices (Schachner et al, 1982), and possibly 
direct the outgrowth of axons (Kandel and Schwartz, 1985). 
2. Nutrition: Astrocyte processes have end-feet that contact both blood capillaries 
and neurons (Kandel and Schwartz, 1985), therefore possibly providing control 
over which constituents of the blood reach the neuronal surface. 
3. Scavengers: Astrocytes remove debris and help seal-off damaged brain tissue 
after neuronal death or injury (Kandel and Schwartz, 1985). Several studies 
suggest that astrocytes proliferate in response to CNS trauma and engage in 
phagocytosis (Noske et al, 1982; Kandel and Schwartz, 1985; Eng, 1985) 
especially in those circumstances where the more active conventional phagocytes are 
not present in sufficient numbers (Noske et al, 1982). 
4. Scar tissue formation: The astrocyte response to injury of the CNS is a process 
called reactive gliosis. Scars are formed by astrocytes extending numerous 
processes that become larger and have a substantial increase in glial filaments 
(Maxwell and Kruger, 1965; Eng, 1985). 
5. Proliferation around damaged neurons: Astrocytes have been observed 
displacing presynaptic terminals along the proximal dendrites and cell lxxties of 
axotomized motor neurons. This encroachment of astrocytes results in the 
damaged neurons receiving reduced synaptic input, with the evoked excitatory 
presynaptic potentials being smaller in amplitude (Kandel and Schwartz, 1985; 
Liuzzi and Lasek, 1987; ). 
6. Regulation of K+ concentration: An established electrical property for 
astrocytes is their large negative membrane potentials, which are predominantly 
K+ diffusion potentials (Kimelberg, 1983). By taking up the excess 
extracellular K+, astrocytes are thought to buffer the extracellular K+ 
concentration, protecting the membrane potential of neurons from the 
depolarisation that might result if K + accumulated after repeated neuronal firing 
(Henn et al, 1972; Hertz, 1978; Kandel and Schwartz, 1985). 
7. Neurotransmitter uptake: Astrocytes that surround the synaptic region, have a 
high affinity for certain neurotransmitters such as gamma aminobutyric acid and 
serotonin (Bowman and Kimelberg, 1984; Kandel and Schwartz, 1985; Kimelberg 
and Katz, 1985). 
8. Interaction with hormones and cytokines: Astrocytes synthesise 
interleukin-3 like substances (Frei et al., 1985) and are targets for immune system 
cytokines and hormones (Fierz et al., 1985; Lindholm et al., 1987; Vijayan and 
Cotman, 1987). 
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1.2.3 Age-related changes and astrocytes 
As astrocytes serve many important functions, the study of these cells is critical 
when assessing age-related changes in the CNS. It has been hypothesised that age-
associated changes in neurochemistry reflect an underlying change in the cellular 
composition of the brain with an increase in astrocyte size and number and a decrease in 
the number of neurons (Finch and Morgan, 1990; Goss et al., 1991). Goss et al. (1991) 
found, as a function of age, there were increased levels of RNA for GFAP as measured 
by gel-blot analysis and by a solution hybridisation assay in the mouse cerebral cortex, 
hippocampus and cerebellum. O'Callaghan and Miller (1991), similarly found an age-
related increase in GF AP in rat brains. An increase in GF AP may reflect astrocytes 
undergoing reactive gliosis, a process by which astrocytes increase in size and the number 
of processes become larger and more numerous (de Villis et al., 1986; Eng, 1985). This 
hypertrophy may be a reaction to the degeneration of neighbouring synapses, neurites or 
entire neurons (Adams and Jones, 1985; Geinisman et al., 1978; Landfield et al., 1977). 
1.2.4 Neuronal damage 
As most neurones in the adult mammalian CNS are postmitotic, they will not 
regenerate after physical injury as would happen elsewhere in the body and functional 
recovery will depend on the site of injury. These degenerative changes will occur not 
only in the damaged neurones but also in the neurones that receive synapses from the 
damaged neurones. Termed "transneuronal degeneration", the degree of atrophy is 
related to the reduction in total input caused by the lesion. It is postulated that neurones 
require a certain amount of stimulation to survive, and in addition there is possibly a 
trophic substance released by synaptic terminals which is necessary for their survival 
(Kelly, 1985). Whatever the cause, these transneuronal changes, which may be 
anterograde (if the affected cell receives synapses from the injured neurone) or retrograde 
(if the affected cell makes synapses on the injured neurone), explain why a lesion at one 
site in the CNS can have effects on sites distant to the lesion depending on the 
connections the lesion interrupts. Consequently, neuronal damage can result in long-
lasting alterations in the structure and function of the affected areas. 
Neuronal damage activates repair mechanisms in the CNS and the axon and 
myelin sheath undergo rapid local degeneration at the sites of lesions. As lesions can 
disrupt blood vessels, macrophages are able to enter from the general circulation and 
phagocytose axonal debris. Astrocytes and microglial cells proliferate and also act as 
phagocytes. The proliferation of fibrous astrocytes leads to the formation of a glial scar 
which can block the restoration of severed synaptic connections. The term "sclerosis" 
refers to the hard scar of astrocytes that replaces phagocytosed neuronal debris and is 
often used to describe diseased states such as MS. Thus, repair mechanisms activated in 
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the CNS by neuronal injury can be both advantageous (phagocytosis) and detrimental 
(blocked regeneration) (Kelly, 1985). 
1.2.5 Myelin formation 
Large neuronal axons are surrounded by the fatty insulating sheath called myelin. 
This insulation of axons is essential for the high-speed conduction of action potentials as 
the myelin sheath shields against the capacitance and conductance of the intemode 
(Morrell and Norton, 1980). The myelin sheath is interrupted at regular intervals at nodes 
of Ran vier (Fig. 1.1 ). In myelinated axons, the action potential propagates 
discontinuously, in saltatory jumps from one node of Ranvier to the next, which is a 
faster process than the continuous propagation of unmyelinated axons (Rowland, 1985). 
The myelin sheath is formed by oligodendrocytes in the CNS (Fig. 1.2) and Schwann 
cells in the peripheral nervous system (PNS) (Peters and Vaughn, 1970). The 
oligodendrocyte is capable of producing many intemodes of myelin (Bunge, 1968) and in 
the rat optic nerve 30-50 myelinated intemodes are formed by a single oligodendrocyte 
(Peters and Proskauer, 1969). Despite different cellular origins, central and peripheral 
myelin share the same fundamental organisation as a compacted spiral of non-neuronal 
membranes (Fig. 1.3). Biochemical analysis shows that myelin has a composition similar 
to that of plasma membranes, consisting of 70% lipid and 30% protein, with a high 
concentration of cholesterol and phospholipid (Table 1. ) (Schwartz, 1985). 
Table 1.2: Composition of CNS rat myelin 
Cholesterol 
Galactolipids 
Phosphoglycerides 
Sphingomyelin 
Protein 
% dry weight (approx.) 
27.7 
27.5 
43.1 
7.9 
proteolipid protein 20.0 
myelin basic protein 10.0 
1.2.6 Demyelination 
Demyelinating diseases are the most common causes of damage to the 
corticospinal system and the principle disabling lesions in MS are in the corticospinal 
tracts and cerebellar pathways (Traugott and Raine, 1984). Corticospinal axons extend 
from the cerebral cortex through the brainstem to the spinal cord, and can be damaged by 
lesions at any one of these locations. Weakness can be accounted for by either lesions in 
the upper motor neurones (pathways in the cerebral cortex, brainstem or spinal cord), 
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Fig. 1.1: Typical neuron illustrating the major regions. Many axons are 
insulated by the myelin sheath, which are interrupted at the nodes of Ranvier. 
As there are many points of contact from other nerve cells, the excitory 
presynaptic terminals are shown as white triangles and the inhibitory terminals 
as black triangles (Kandel and Schwartz, 1985). 
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Fig. 1.2: Illustration of how the myelin sheaths of many axons are formed by an 
oligodendrocyte in the CNS (Morrell, 1984 ). 
Jl' 
' 
.,, 
f 
~,) .,. 
;t, a>, 
",· 0 . 
4ft. 
Fig. 1.3: Typical transverse section of myelin sheaths in the mature central nervous system of 
a dog illustrates how the 1nyelin sheath is a c01npacted spiral of non-neuronal membranes 
(Morrell, 1984). 
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lower motor neurones (motor neurones in the ventral horns) or the neuromuscular 
junction or the muscle (Bannister, 1985). The most caudal section of the CNS is the 
spinal cord which receives information from the skin, joints and muscles in the trunk and 
limbs, and issues the final commands for movement. Consequently, weakness or 
flaccidity in the limbs can be related to specific lesion(s) in the CNS. 
1.2.7 The Blood Brain Barrier 
The blood brain barrier (BBB) is a system of permeability barriers which 
preserve homeostasis in the CNS by facilitating the entry of necessary metabolites and, 
blocking entry or facilitating removal of unnecessary metabolites and toxins (Fishman, 
1975). The brain must be kept rigorously isolated from fluctuations in the blood 
composition of hormones, amino acids and ion levels, as these are capable of influencing 
the firing of the nerve cells. The ability of molecules to exchange across the BBB 
depends on their size and physical characteristics and also on the presence of specialized 
transport mechanisms for some substances. For instance, small molecules like sucrose 
enter at a relatively rapid rate; high lipid solubility of compounds enhances transport 
(Banks and Kastin, 1985); and nutrients (Crone, 1965; Cornford and Cornford, 1986), 
hormones (Banks et al., 1985) and precursors of neurotransmitters (Cornford and 
Oldendorf, 1975; Cornford et al., 1978) are able to cross the BBB due to specialized 
transport mechanisms. 
The barrier function is achieved because the brain capillaries differ from vessels 
in other organs in that they have tight junctions between the endothelial cells. 
Ultrastructurally, tight junctions are where the outer leaflets of adjoining cells merge and 
become physically joined (Goldstein and Betz, 1986). In addition, the capillaries are 
surrounded by and encased in the glial foot processes of astrocytes (Rowland, 1985) 
(Fig. 1.4). These "foot processes" are not sealed by intercellular tight junctions and are 
therefore not thought to serve a barrier function. However, astrocytes may be important 
in maintaining the differentiation of the CNS endothelial cell (Schmidley and Maas, 
1990). The basement membrane of the CNS vessels is similar to the basement membrane 
of other regions of the body though the structure is more compact (Schmidley and Maas, 
1990). The structural characteristics of the CNS vessels consequently ensure the 
preservation of homeostasis within the CNS. 
1.2.8 Age related changes to the BBB 
Ageing is associated with a variety of degenerative diseases involving the CNS. 
The degree of CNS function deterioration is variable and probably dependent on genetic, 
constitutional and nutritional factors (Goodwin et al., 1983; Albalan, 1984), as well as the 
presence of environmental toxins (Michaelson and Bradbury, 1982; Crapper et al., 1982; 
----~· j,--- · 
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Fig. 1.4: The BBB is achieved because the endothelial cells have tight 
junctions and the capillary is almost completely ensheathed by astrocytic foot 
processes. The basement membrane supports the endothelium, enabling it to 
maintain its tubular form (Goldstein and Betz, 1986) 
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Banks and Kastin, 1983). As the BBB is a major determinant in the delivery of nutrients 
or environmental toxins to the CNS, it is of extreme importance to know what happens 
when the. functional integrity of the-BBB declines. The. age~related decline. in CNS 
function may actually be secondary to age-related alterations in BBB function. These 
alterations may allow the entrance of circulating toxic agents or CNS directed antibodies 
to gain access to the CNS tissue and impair the transport of nutrients into the brain. 
Subtle changes to the BBB are associated with ageing. Alterations such as 
gliofibrillar proliferation (Ravens, 1978), loss of endothelial cells (Barr et al., 1978) 
increases in basement membrane thickness (Donahue and Pappas, 1961; Barr, 1978; 
Burns et al., 1981) and thinning of capillary walls (Burns et al., 1979) particularly in the 
white matter of humans (Stewart et al., 1987) and changes in capillary lumen size (Burns 
et al., 1981; Hicks, 1983) are all age-related changes in the CNS. These age-related 
changes are region and species-specific and would result in significant alterations in the 
functional integrity of the BBB. Age associated diseases such as hypertension 
(Johansson et al., 1970; Westergaard et al., 1977; Hatzinikolaou et al., 1981) and 
cerebrovascular ischemia (Klatzo, 1983; Sage et al., 1984) would further aggravate the 
alterations in BBB function (reviewed by Mooradian, 1988). 
Hypertension is common with advancing age, and its complication, 
arteriosclerosis appears to be an accelerated form of the ageing process (Ooshima and 
Y amori, 1980). As hypertension acts as a physical insult or injury to the vessel wall, it is 
the most obvious physical factor which compromises the endothelial cell barrier 
(Hazzard, 1989). With advancing age, the blood vessels lose their elasticity and become 
stiff (Ooshima and Y amori, 1980). Particularly, the intracranial arteries become 
increasingly stiff with age and show marked thickening of the vessel walls (Nagasawa et 
al., 1982) whereas, in humans under 40 years of age, the extracranial arteries are 
relatively distensible with little change in wall stiffness (Nagasawa et al., 1982). This 
feature of intracranial arteries corresponds with the common occurrence of cerebral 
aneurysm in the middle-aged and elderly person (Locksley, 1966). 
In some studies a correlation has been found between arteriosclerosis and 
demyelination (Goto et al., 1981; Lotz et al., 1986; van Swieten et al., 1991). Using 
magnetic resonance imaging (MRI), van Swieten et al. (1991) found the presence of 
demyelination and gliosis accompanied by arteriolosclerosis in brain specimens. In 
contrast, normal arterioles were always found in conjunction with normal white matter. 
These findings are in favour of the notion that demyelination and/or gliosis is the 
pathological correlate of periventricular white matter lesions seen on MRI. It was also 
suggested that arteriolosclerosis precedes and probably causes the demyelination and loss 
of axons (van Swieten et al., 1991). 
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There is some evidence to suggest that astrocytes undergo structural changes 
during ageing and disease which results in partial loss of the BBB. During cerebral 
infarction or severe head trauma, there is an increase in the levels of extracellular K +, 
which is taken up by astrocytes. The cellular oedema that developes is confined to 
astrocytes (Schmidley and Maas, 1990). In Reye's syndrome, a disorder which usually 
follows a viral infection and is characterised by encephalopathy with severe brain oedema, 
there is swelling of astrocytes and focal expansions of the myelin sheath (Schmidley and 
Maas, 1990). 
Under normal conditions the BBB is assumed to impede the entry of 
immunoglobulins and immunocompetent cells from the peripheral circulation to the CNS 
(Rappoport, 1976). The diffusion of immune elements such as brain-reactive antibodies 
(antilxxlies which can react with brain antigens), which are found in increased numbers as 
a function of age (Nandy, 1972a; Feden et al., 1979; Baldinger and Blumenthal, 1983; 
Blumenthal, 1988; Blumenthal et al., 1984; reviewed by Forster and Lal, 1991 ), may be 
possible when the function of the BBB is disrupted. For instance, lg binding to CNS 
neurons was demonstrated in aged mice, which had circulating brain-reactive antibodies 
but not in young mice where these circulating antibodies were not present (N andy, 
1972b ). The age-related increase in permeability of the BBB (reviewed by Mooradian, 
1988) may permit the diffussion of brain-reactive antibcxlies into CNS tissue (Nandy, 
1975; Forster and Lal, 1991). 
Brain oedema can occur in patients during infectious, vascular, metabolic, 
neoplastic, toxic and traumatic brain disorders, although the most common is vasogenic 
brain oedema (Schmidley and Maas, 1990). During vasogenic brain oedema, the 
disrupted tight junctions which normally allow very little protein to enter the CNS, break 
down and the extracellular fluid is found to be high in plasma protein (including 
immunoglobulins). Vasogenic oedema also shows a predilection for white matter and it is 
believed that the parallel bundles of myelinated axons making up the white matter offer 
less resistance to the flow of extracellular fluid than the densely packed neuronal and glial 
processes of the gray matter (Schmidley and Maas, 1990). Consequently, there is a 
mechanism suggesting that neuropathology can be attributed to pathologic changes to the 
BBB associated with the ageing process. 
1.3 Link between the immune and central nervous systems 
The relationship between the immune and central nervous systems is complex 
and despite the endeavours of many researchers is poorly understood (Ader, 1981, 1991; 
Leibowitz and Hughes, 1983; Behan and Spreafico, 1984 ). The central nervous and 
immune systems are physically separated as the CNS lacks an extensive lymphatic system 
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and is protected by the BBB which is thought to be impermeable to immunoglobulins and 
lymphoid cells. It has been found in many species, that under normal conditions 
lymphocytes are found in low numbers in the CNS (Hauser et al., 1983; Hickey et al., 
1983; Booss et al., 1983; Lassmann et al., 1986; Raine and Mcfarlin, 1985) and it is 
only when disease occurs that components of the immune system become apparent 
(reviewed by Hickey, 1991). How their entry is achieved in the absence of gross damage 
to the vascular endothelium is unknown and is one of the subjects of investigation in 
Chapter 3 of this report. The ability of glial cells to synthesise a variety of lymphokines 
and cytokines within the CNS, which influence the growth and function of lymphoid cells 
(reviewed by Benveniste, 1988), may be important in the development of intracerebral 
immune responses. Two questions which need to be answered are: is the CNS an 
immunologically privileged site and if so, how then do lymphocytes become apparent in 
an organ from which they are normally excluded? 
1.3.1 Immunological surveillance of body tissues 
The generalised immunological surveillance of body tissues is achieved by the 
constant recirculation of lymphocytes between the bloodstream and lymphoid tissue 
(Gowans, 1957, 1959a, 1959b; Gowans and Knight, 1964). This process maximises 
exposure of a captured antigen in a particular lymphoid organ to migrating lymphocytes, 
only a few of which can respond to it (reviewed by Kieran et al., 1989; Yednock and 
Rosen, 1989). Although lymphocytes have the potential for universal migration, they 
display migratory preference for particular lymphoid tissues (Butcher et al., 1980; 
Stevens et al., 1982; Chin and Hay, 1984) and sites within those tissues (de Sousa, 1981). 
Extensive reviews have been published demonstrating these selective lymphocyte 
migratory patterns (Jalkanen et al., 1986b; Butcher, 1986; Woodruff and Clarke, 1987; 
Berg et al., 1989; Duijvestijn and Hamann, 1989; Hamann and Thiele, 1989; Pals et al. , 
1989; Y ednock and Rosen, 1989). 
1.3.2 Antigen presentation in the central nervous system 
Unlike antibody, T cells cannot recognise free antigen but are dependent on 
antigen presentation by accessory cells. Antigens have to be seen in association with 
glycoproteins encoded by genes of the major histocompatibility complex (MHC) 
(Zinkemagel and Doherty, 1976; Doherty et al., 1977). There are two different types of 
MHC glycoproteins designated class I and class II found on the cell surface which are 
thought to target functionally different types of T cells. Helper (CD4+) T cells are 
targeted onto the class II MHC antigens while cytotoxic (CD8+) T cells interact with the 
class I MHC antigens (Steinmetz and Hood, 1983; Doherty et al., 1984). 
10 
CNS cells usually display low or virtually undetectable levels of WIC 
glycoproteins compared with other cells in the body (Williams et al., 1980; Ting et al., 
1981; Hauser et al., 1983; Wong et al., 1984; Sobel et al., 1984; Hickey et al., 1985; 
Lampson and Hickey, 1986; Lassmann et al., 1986; Fontana et al., 1987) although WIC 
molecules play a fundamental role in the induction and regulation of immune responses. 
Gamma-interferon (IFN-y), a lymphok:ine produced by activated T cells (Morris et al., 
1982; Sethi et al., 1983) induces an increase in the expression of class I WIC on 
astrocytes, oligodendrocytes, microglia and neurones in rat, mice and humans (Wong et 
al., 1984, 1985; Suzumura et al., 1986; Hirayama et al., 1986). Class II MHC antigens 
may be expressed at low levels due to the local production of prostaglandins (PGs). 
Alternatively, the stimulus for class II MHC antigen expression may be lacking, eg. by 
the failure of substances such as IFN-y to enter the brain due to the existence of the BBB 
(Fontana and Fierz, 1985). Class II MHC antigen expression can be enhanced by viral 
infection (Massa et al., 1987) or by the addition of IFN-y (Wong et al., 1984; Fontana et 
al., 1984). Although, the primary function of IFN-y in the CNS is thought to be the 
enhancement of class I and II MHC antigen expression on various brain cell types, IFN-y 
also activates macrophage killing, enhances the function of natural killer (NK) and 
cytotoxic T cells, and modulates antibody production (Wong et al., 1985). Thus IFN-y 
may render brain cells competent to initiate and participate in both immunoprotective and 
immunopathological responses in the brain. 
1.3.2.1 Astrocytes Act as Immune Accessory Cells 
Previous research suggests that astrocytes may form the active contact between 
the immune system and the brain. There is intense contact between astrocytes and brain 
vascular tissue at the site of the BBB (Peters et al., 1976); astrocytes are capable of 
expressing class II MHC molecules and presenting antigen to T cells (Fierz et al., 1985; 
Fontana et al., 1984, 1987; Wekerle, 1986; Wekerle et al., 1987); class II MHC antigen 
expression is enhanced on astrocytes by IFN-y (Hirsch et al., 1983; Wong et al., 1984) 
or by virus particles of murine hepatitis virus (JHM) (Massa and Ter Meulen, 1987); this 
IFN-y-induced expression is further enhanced by tumour necrosis factor-a. (TNF-a.) 
(Benveniste et al., 1989; Vidovic et al., 1990); astrocytes can be stimulated to secrete 
interleukin-1 (IL-1) (Fontana et al., 1982), interleukin-3 (IL-3) (Frei et al., 1985), 
interleukin-6 (IL-6) (Frei et al., 1989; Benveniste et al., 1990), PGs (Fontana et al., 
1982) and TNF-a. (Robbins et al., 1987; Lieberman et al., 1989; Chung and Benveniste, 
1990); astrocytes can be stimulated to proliferate by lymphok:ines released by T cells 
(Fontana et al., 1981; Merrill et al., 1983) and it has been suggested that IL-3 released by 
astrocytes could act locally as a growth factor for the proliferation of microglial cells and 
macrophages (Benveniste, 1988). 
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Fontana and Fierz ( 1985) put forward the following hypothesis to explain the 
way in which astrocytes may interact with endothelial cells to determine the immune 
reactivity of the CNS. Initially, astrocytes could be involved in the bi-directional 
transport of antigens between endothelial cells (which have access to the circulation) and 
brain tissue. Lymphocytes passing through brain vessels would recognise the antigen on 
endothelial cell surf aces and interact with the endothelial cells to disrupt the endothelial 
tight junctions by a mechanism not yet established. This would allow T cells to enter the 
brain and astrocytes would then support the intracerebral T cell activation process. The 
capacity of astrocytes to present antigen would be enhanced by increased class II MHC 
expression due to T cell signals such as IFN-y and T cell activation would be further 
developed. The extent of intracerebral T cell activation may be limited by prostaglandin E 
(PGE) which is released by activated astrocytes and can lead to inhibition of class II MHC 
expression (Fontana and Fierz, 1985). Thus, there is evidence of a communication 
between astrocytes and immune cells which is mediated by cytokines. 
1.3.2.2 Microglial cells as Immune Accessory Cells 
It has also been suggested that the microglial cell is the principle antigen 
presenting cell in the CNS, responding to stimuli ranging from trauma to degenerative 
diseases (Vass et al., 1986; Woodroofe et al., 1986; Hayes et al.,1987; Hickey and 
Kimura, 1987, 1988; Hickey et al., 1987; McGeer et al., 1987,1988; Cruzner et al., 
1988; Graeber et al., 1989; reviewed by Hickey, 1990). The origin of microglial cells is 
unknown, though they have been shown to be related to the macrophage/monocyte family 
(Giulian and Baker, 1985; Matsumoto et al., 1986; Baker et al., 1986; Giulian, 1987; 
Perry and Gordon, 1987,1988; Frei et al., 1987, 1988; Graeber et al., 1988; Giulian and 
Ingeman, 1988; Hickey and Kimura, 1988). Microglial cells have been shown to express 
MHC antigens and to synthesise immunoregulatory molecules such as IL-1, IL-6, TNF-a 
andPGE2 (Giulian et al., 1986; Frei et al., 1987, 1988, 1989; Giulian, 1987; Northoffet 
al., 1989; Gebicke-Haerter et al., 1989) as well as secreting substances which stimulate 
astrocytes to become reactive (Giulian and Baker, 1985; Giulian, 1987; Graeber et al., 
1988). Microglial MHC expression (class! and class II) is induced in vivo within 48 
hours of intravenous injection of TNF and IFN-yin rats (Male and Pryce, 1988; Steiniger 
and van der Meide, 1988). Microglial cells can also become phagocytic (Mori and 
Leblond, 1969), express gamma globulin (IgG) receptors and function as antigen 
presenting cells in vitro (Giulian et al., 1986; Giulian, 1987; Frei et al., 1987, 1988,; 
Graeber et al., 1988; Northoff et al., 1989). 
Microglial cells are generally thought to act as scavenger cells during injury or 
inflammation of the CNS as they become activated, undergo rapid proliferation and 
migrate towards the inflammatory site. It has been proposed by Giulian et al.(1986) that 
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microglial cells are the first brain cells to appear in increased nwn bers at inflammatory 
sites and that the release of IL-1 from microglial cells stimulates the proliferation of 
nearby astrocytes. IL-1 has been demonstrated to have a stimulatory effect on astrocytes 
(Giulian and Lachman, 1985). As both astrocytes and microglial cells release 
immunoregulatory molecules as well as express class II MHC upon stimulation with IFN-
y, they could both be important immune accessory cells. 
1.3.2.3 Endothelial cells as Immune Accessory Cells 
The vascular endotheliwn may also play an important role in inflammation. The 
endothelial cells line the vessels and therefore provide the barrier between circulating T 
cells and the extravascular sites of antigen. Endothelial cells can also be induced by IFN-
y to express class II MHC (Colson et al., 1987; Markus et al., 1987) and increase the 
expression of cell adhesion molecules such as lymphocyte function-associated antigen-1 
(LFA-1) and intercellular adhesion molecule-1 (ICAM-1) (Dustin and Springer, 1988). 
Freshly isolated human endothelial cells have been found to be as effective as 
macrophages in antigen presentation (Burger et al., 1981). Thus, it is possible that 
lymphokines may increase the adhesiveness of leukocytes to endotheliwn at sites of 
inflammation. 
1.3.2.4 Shared antigens on nervous system and lymphoid cells 
There is considerable evidence for shared antigenic determinants between 
nervous system and lymphoid cells (Fuchs et al., 1980; Oger et al., 1982; Garson et al., 
1982). Antigenic structures which are shared on nervous system and lymphoid cells are 
the IL-2 receptor (Hofman et al., 1986), CD4 antigen (Funke et al., 1987; Dewhurst et 
al., 1987), IFN-y and IL-6 receptors (Benveniste et al., 1990) and class I and II MHC 
antigens (Wong et al., 1984; Fierz et al., 1985). The shared antigenic determinants 
between nervous system and lymphoid cells may be relevant in the pathogenesis of 
hwnan inflammatory disorders of the CNS. 
1.3.3 T cell entry into the central nervous system 
In order to enter the CNS parenchyma, lymphocytes must first adhere to and 
then migrate through the CNS endotheliwn and the subendothelial extracellular matrix. 
The mechanism of this initial entry into the CNS is unknown. 
1.3.3.1 Antigen specificity 
Could T cell entry into the CNS be dependent on antigen specificity? If only T 
cells specific for CNS antigens were permitted to enter the CNS, then all the T cells in the 
cerebro-spinal fluid (CSF) would need to be specific to CNS antigens. This is not the 
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case (Clark et al., 1984). It has been found that lymphocytes which have specificities 
which are non-specific to the CNS are able to move from the circulation to the CNS 
(Wekerle et al., 1986, 1987; Hickey et al., 1989; Meyermann et al., 1986) implying that 
any T cell regardless of antigen specificity can gain access to the CNS. Consequently, 
antigen specificity is not thought to be a mechanism of initial entry of lymphocytes into 
the CNS though specific cell surface molecules are thought to play an important role in 
these interactions. 
1.3.3.2 Adhesion molecules implicated in lymphocyte migration 
LFA-1 and ICAM-1 interactions have also been strongly implicated in 
lymphocyte migration and cell-mediated immune reactions such as antigen presentation 
(Bierer and Burakoff, 1988; Maio et al 1989; Altmann et al 1989). LFA-1 is a member of 
the integrin family and is expressed virtually on all lymphocytes (Hynes, 1987). LFA-1 
has been identified as a facilitator of T cell recognition and as a T cell adhesion molecule 
(Kishimoto et al., 1989; Shaw et al., 1986 and 1990; Shaw and Luce, 1987). Studies by 
Hamann et al. (1988) revealed that antibcxlies to LFA-1 inhibit lymphocyte attachment to 
specialised postcapillary venules, termed high endothelial venules (HEVs) in vitro and 
decrease the migration of normal lymphocytes into lymph nodes and Peyer's patch by 40-
60% in vivo. It has been suggested that LF A-1 acts as an accessory molecule supporting 
weak interactions between cells, as cells containing high levels of murine peripheral 
lymph node homing receptor (MEL-14, an antigen associated with mature, recirculating, 
unstimulated lymphocytes) are less susceptible to inhibition by anti-LFA-1 than those 
with low levels (Harder and Heinz-Gunther, 1988). 
ICAM-1 was initially identified as a B lymphocyte (B cell) activation marker 
(Clark et al., 1986) and a ligand for LFA-1 (Rothlein et al., 1986; Simmons et al., 1988). 
ICAM-1 is expressed on many cell types (Shimizu and Shaw, 1990) and is induced on 
others in inflammation following exposure to lymphokines such as IL-1, TNF-a, IFN-y 
and lipopolysaccharide (LPS) (Boyd et al., 1988; Dustin et al., 1988; Dustin and 
Springer, 1988; Marlin and Springer, 1987; Simmons et al., 1988; Rothlein et al., 1988; 
Staunton et al., 1988). ICAM-1 is a member of the immunoglobulin (lg) supergene 
family (Wawryk et al., 1989) and shares sequence homology with N-CAM and MAG 
(myelin-associated glycoprotein) (Simmons et al., 1988; Staunton et al., 1988). 
The expression of ICAM-1 on CNS endothelial cells and glia in sites of active 
inflammation could relate to their hypothesised immune functions within MS plaques 
(Traugott et al., 1985; Male et al., 1987; Fontana et al., 1984; Hayes et al., 1987) and in 
other lesions. Sobel et al. (1990) immune-stained postmortem CNS tissues from patients 
with CNS inflammatory and noninflammatory conditions with antibodies to ICAM-1 and 
LFA-1. Their findings suggest that vascular ICAM-1 may be upregulated early and 
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focally in inflammatory lesions in the CNS and possibly participate in the regulation of the 
focal accumulation of leukocytes in CNS immune reactions through interaction with LFA-
1. 
1.3.3.3 The role of sulphated polysaccharides in lymphocyte mimtion 
Recent studies have suggested that sulphated polysaccharide (SPS) recognition 
may also play a key role in the migration and positioning of lymphocytes within lymphoid 
tissues and in a range of cell-adhesion systems including neuronal cell-cell adhesion ( Cole 
et al., 1986). Receptors for SPSs are present on a wide variety of cell types including 
lymphocytes (Bradbury and Parish, 1989; Parish and Snowden, 1985; Parish et al., 
1984, 1988; Thurn and Underhill, 1986), macrophages (Bleiberg et al., 1983; Chong and 
Parish, 1986), endothelial cells (Glimelius et al., 1978; Glabe et al., 1983b) and rat 
sympathetic neurones (Vidovic et al., 1986). Certain SPSs, such as dextran sulfate and 
heparin, cause leucocytosis and inhibit lymphocyte recirculation when injected into 
animals (Bradfield and Born, 1974; Jansen et al., 1962; Sasaki and Suchi, 1967) whereas 
fucoidan inhibits lymphocyte adhesion to HEVs in vitro (Stoolman et al., 1987; Stoolman 
and Rosen, 1983). The most conclusive in vivo evidence for SPS involvement in 
lymphocyte recirculation comes from the work of Brenan and Parish ( 1986) which 
demonstrated the selective effects of SPS on entry, displacement and subsequent 
positioning of lymphocytes within lymphoid organs. SPSs appeared to block SPS 
receptors on the surface of endothelial cells and decrease lymphocyte entry. Lymphocytes 
were also displaced from their normal positions in the red and white pulp of the spleen by 
fucoidan and dextran sulfate. 
SPSs are also capable of inhibiting EAE (Willenborg and Parish, 1988; Lider et 
al., 1989) by preventing entry of lymphocytes into sites of inflammation in the CNS. 
Since encephalitogenic cells when stimulated with antigen produce elevated levels of 
heparan sulphate endoglycosidase (Naparstek et al., 1984; Lider et al., 1989), a critical 
enzyme in the passage of leukocytes through the vascular extracellular matrix, it is 
thought that SPSs inhibit this enzyme and thus prevent development of EAE (Willenborg 
and Parish, 1988; Lider et al., 1989). Furthermore, although the mechanism of entry of 
lymphocytes into the CNS is unknown, entry is thought to be dependent upon the 
activation state of the lymphocytes (Naparstek et al., 1983, 1984; Meyermann et al., 
1986; Wekerle et al., 1987; Hickey et al., 1989). Wekerle et al. (1986) have proposed 
that initial emigration of lymphocytes into the CNS is not immunologically specific and 
that activated T cells of any specificity can and will emigrate through CNS endothelium 
into the parenchyma of the CNS. They suggest that the process acts as an immune 
surveillance mechanism. If the activated cells entering the CNS encounter an antigen for 
which they have a specificity, they remain, otherwise they may die or move back out of 
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the CNS. Activation is thought to result in the expression of enzymes, such as heparan 
sulphate endoglycosidase, on the cell surface that enable these lymphocytes to migrate 
through vascular endothelium by degrading the vascular extracellular matrix. 
1.3.4 Immune Responses to Viruses in the CNS 
In addition to causing acute and chronic inflammatory disease, viral infections of 
the CNS in humans and animals have been associated with malformation, degenerative 
disease, demyelinating disease, neoplasms and vascular disease (Wolinsky and Johnson, 
1980). This extraordinary diversity of pathological reactions can be explained by the 
vulnerability of CNS cells to different types of viruses. During infection, CNS cells 
differ enormously in their response to viral infection and range from high susceptibility to 
complete resistance (Johnson, 1980). For instance, poliovirus infection appears to 
involve only motor neurons resulting in flaccid paralysis without sensory abnormalities 
(W olinsky and Johnson, 1980) whereas the JHM strain of mouse hepatitis virus causes 
acute demyelination in mice by the selective infection of oligcxlendrocytes (Lampert et al., 
1973; Johnson, 1980). 
The mature CNS represents an organ of extraordinarily high metabolic activity 
composed of a stable cell population that has only limited capacity to regenerate and little 
normal turnover of cells (Wolinsky and Johnson, 1980). This results in very different 
clinical features developing from viral infections initiated at different developmental 
periods. For instance, cytomegalovirus, which in adults is fairly common and usually 
innocuous may lead to deafness and subnormal intelligence when it infects the foetal 
brain. Likewise the transmission of rubella from mother to foetus in the first trimester of 
pregnancy, can cause mental retardation and infantile autism (Kety, 1979). Thus acute 
infections, although of limited duration, can have permanent effects on CNS cells. 
1.3.4.1 Demyelination in viral infections of the CNS 
Watanabe et al. (1983) suggested that a viral infection of glial cells could initiate 
an autoimmune response causing exacerbating demyelinating disease. Myelin breakdown 
can be accounted for by increased proteolytic activity at the edges of MS plaques (Einstein 
et al., 1972) which could be caused by an immune response to a non-myelin component. 
Wisniewski (1977) decribed this as the "bystander" effect where the expression of a viral 
antigen at the surface of a glial cell could stimulate an immune response with resultant 
release of proteolytic enzymes. Myelin has a high susceptibility to enzymic digestion and 
the release of the proteolytic enzymes could result in breakdown of adjacent myelin. 
Thieler's murine encephalomyelitis virus, an immunologically mediated, MHC influenced 
disease which results in demyelination (Clatch et al., 1986; Melvold et al., 1987) could be 
an example of this type of "bystander" demyelination. The extent of demyelination in 
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Thieler's disease actually correlates best with the presence of macrophages rather than the 
amount of virus (Lipton and Dal Canto, 1979). Demyelination caused by macrophages 
has also been illustrated in a variety of viral infections (Lampert et al., 1973; Dal Canto 
and Lipton, 1975; Lampert, 1978). The macrophages penetrate the sheaths where the 
myelin lamellae have dissolved or at nodes of Ranvier and insinuate themselves either 
within or between the myelin sheaths (Lampert, 1967). Infection of Lewis rats with a 
neurotropic measles virus results in subacute encephalomyelitis which is associated with a 
cell mediated autoimmune response to myelin basic protein (MBP) (Liebert et al., 1990). 
It is evident from these results that demyelination in the CNS similar to that found in MS 
can occur as a result of a viral infection. 
1.3.4.2 Viral persistence in the CNS 
As a consequence of the BBB, the CNS is partially sequestered from the immune 
system and under normal conditions the brain is relatively devoid of immunocompetent or 
phagocytic cells. Consequently, a foreign particle such as a virus in the CNS will not be 
phagocytozed and processed by scavenger cells as it would in other areas of the body 
(Wolinsky and Johnson, 1980; Johnson, 1982). High molecular weight constituents of 
blood such as antibody and complement are relatively excluded by the BBB (Norrby, 
1978). Immunity may be provided by immunoglobulins that do transfer across the BBB 
or by immunoglobulins produced locally by a restricted number of antibody-producing 
cells harboured in the CNS (Vandvik and Norrby, 1973; Kristensson and Norrby, 1986). 
After infection is established, mononuclear cells appear to enter the CNS, clonal 
expansion of these cells is stimulated (Kristensson and Norrby, 1986) and the 
inflammatory response develops. As tissue destruction and inflammatory reactions 
proceed, these barriers to the diffusion of large molecules into and within the brain 
become less substantial (W olinsky and Johnson, 1980). 
The physical nature of the BBB deters virus invasion of the CNS, yet once 
invaded these same barriers form an impediment to clearance of infection (W olinsky and 
Johnson, 1980). Viruses can persist and cause chronic disease during immune responses 
if latency is established, if replication and spread of the virus is restricted or if the virus is 
non-antigenic and fails to incite host responses (Wolinsky and Johnson, 1980). For 
instance, several of the herpes viruses (varicella-wster, herpes simplex virus types 1 and 
2) move centripetally along sensory axons and establish latency in the sensory ganglia 
(Stevens, 1978; Johnson, 1984). The viral genome is apparently either integrated into 
neuronal DNA or sequestered within the episome. The static cell provides a life-long 
repository for viral genetic information which can subsequently be reactivated to cause 
disease (Johnson, 1984). 
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1.3.4.3 Viral latency in the CNS 
In subacute sclerosing panencephalitis, an uncommon complication of measles 
virus infection, virus appears to be adequately cleared during the initial infection. 
However a late disease develops and is associated with anti-viral antibody in both sera 
and the CNS (Aganarsdottir, 1977). The viral antigens remaining on the surface of 
infected cells are not fully enveloped. The virions are defective in the brain, but once 
established in culture are capable of replicating in permissive cells to yield infectious virus 
(Kipps, 1983). This defect may lead to slow cell-to-cell spread of virus and to lack of 
efficient clearance despite a strong immune response (Wolinsky and Johnson, 1980). 
Oldstone and colleagues (1984) also found that a virus can cause injury by 
altering the normal functions of cells without destroying the cells. Pituitaries from 
lymphocytic choriomeningitis virus (LCM) infected mice were found to contain viral 
antigens but demonstrated no evidence of altered morphology by low power or high 
resolution microscopy. Despite this the animals were abnormal and it was found that 
synthesis of a hormone needed for growth and glucose regulation was absent It was 
found that viral replication had occurred in the specialised cells making the hormone 
although morphology was normal (Oldstone et al, 1984). 
Cross-reactivity between viral and host antigens may occur due to similarity of 
viral and host epitopes or alternatively, when a virus buds through the host cell membrane 
it is possible that host cell membrane proteins are included in the envelope of lipid-
enveloped viruses. It is consequently natural to ask whether demyelinating disorders 
could be caused by previous viral infections. Waksman and Reingold (1986) have 
postulated that this autoimmune mechanism could cause MS. Autoimmune demyelination 
could arise through molecular mimicry (Fujinami and Oldstone, 1985; Janke et al., 1985; 
Oldstone, 1987; Shaweif)(,ihvc.e l987) and it is plausible that demyelination may result from 
vascular changes causing increased BBB permeability with the resultant entry of 
autoreactive T cells directed against myelin, which were initially caused by a viral 
infection. 
1.3.5 Age related changes in the immune system 
There is a drastic decline in immune competence with age (reviewed by 
Gottesman and Walford, 1982). Two functional changes in the immune system which 
are evident with age are the decline in the immune response to exogenous stimuli and a 
loss of self tolerance. These changes are thought to be associated with the increased 
incidence of infectious and autoimmune diseases observed in the elderly (Ackerman et al., 
1991). 
Autoimmune diseases are characterised by the failure of the immune system to 
distinguish self and non-self. Taguchi et al. (1990) suggested that every organ in the 
1 8 
body produces tissue-specific antigens, which may be released into the blood stream and 
encounter the immune system. Possible explanations of why the normal immune system 
does not react to these antigens are that: 
a) T cell clones reactive to self antigens are positively eliminated in the 
thymus (clonal deletion theory); 
b) self-reactive clones are in a long-term state of unresponsiveness (clonal anergy 
theory); and 
c) peripheral auto-reactive T cells are controlled by specifically organised T cells 
(suppressor T cell theory) (Schwartz, 1989; Taguchi et al., 1990). 
The appearance of cells with non-self characteristics could be accounted for by 
the error-autoimmune theory where it is suggested that cells can be incorrectly specified 
(Blumenthal and Berns, 1964; Blumenthal and Probstein, 1968; reviewed by Blumenthal, 
1976). The immune system normally provides an adaptive mechanism which removes 
cells which are specified incorrectly but with ageing this function is decreased and cells 
acquiring "non-self' characteristics may evoke an immune response. 
The decline in immune responsiveness with age has been demonstrated most 
prominantly in T-cell-mediated immunity (reviews by Kay, 1980; Kay and Makinodan, 
1981; Nagel, 1983; and Ackerman et al., 1991). Age-related alterations in lymphocyte 
function include: a decrease in T-helper, cytotoxic T cell and NK-cell activity; a decrease 
in T cell response to mitogens and antigens and a decrease in the production of 
lymphokines including IL-2 (reviewed by Ackerman et al., 1991). Age-related changes 
in macrophages and B cell function (Heidrick and Makinodan, 1972; Gardner and 
Remington, 1978; Becker et al., 1981; Goidl et al., 1983; reviewed by Ackerman et al., 
1991) may also indirectly influence T-cell-mediated responses. 
On the basis of the suppressor T cell theory, the normal immune system would 
be involved in the maintenance of self-tolerance by suppressor T cells which are 
stimulated by tissue-specific antigens and inhibit the activation of tissue-specific 
autoreactive T cells. A dysfunction of organ-specific suppressor T cells in the immune 
system would be a risk factor for the development of organ-specific autoimmune 
diseases. For instance, thymic dysfunction may cause the elimination of suppressor T 
cells from the immune system (Tauchi and Nishizuka, 1987; Taguchi et al., 1986; 
Taguchi et al., 1990) and result in autoimmunity. One of the anatomically most 
prominant age-related changes is the decline in size of the thymus (Boyd, 1932). There is 
evidence to suggest that the loss of the ability to discriminate self from nonself is also 
impaired with age (Zinkemagel, 1978) and could contribute to the increase in 
autoimmunity with age. 
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With increasing age beyond 65, progressively greater percentages of otherwise 
healthy individuals show abnormal neurological signs. Both in humans and animals the 
brain shrinks with advancing age with decrements occuring in brain weight, cortical 
thickness and white matter volume, the major loss in volume being attributed to shrinkage 
of neurons (reviewed by Berg and Morris, 1990). It is hypothesised that with ageing the 
immune system loses its ability to recognise elements of the host's body and that antibrain 
antibodies may be causes of neuronal degeneration (Reisberg, 1983). One of the changes 
associated with increasing age noted in the human CNS is a decrease in neuronal 
numbers. This neuronal loss results in astrocytic gliosis and spongiosis (loosening of the 
basic structure of the cortex due to the appearance of vacuoles of the cortex) (Rosenberg, 
1983). Aged individuals demonstrate an increase in the incidence of serum 
autoantibodies, although this increase does not necessarily correlate with the presence of 
autoimmune disease (reviewed by Nagel, 1983). Brain-reactive antibodies could interact 
with myelin components (McFarland, 1988; Waksman, 1988) or glial elements (Allerand 
and Y ahr, 1964 ). This interaction could result in neuronal death, demyelination, and 
membrane changes resulting in changes in permeability of the BBB (Jankovic, 1985; 
Jankovic et al., 1987; Forster and Lal, 1991). 
1.3.5.1 Neuroendocrine-immune network in ageing 
With advancing age, there is a reduction in the concentration of membrane 
receptors for glucocorticoids (Roth, 1975) and catecholamines (Schocken and Roth, 
1977). The altered functional responsiveness of old cells to glucocorticoid action may 
actually be due to this defect in cell receptors (Roth, 1979). Alterations in the 
neuroendocrine system may also cause functional modifications of immune reactivity 
(Fabris, 1981) as lymphoid cells have receptor sites for hormones (Gavin, 1977; Melmon 
et al., 1977). 
Noradrenergic sympathetic innervation is found in all primary and secondary 
lymphoid organs of the immune system (Felten et al., 1987; reviewed by Felten and 
Felten, 1991 and Ackerman et al., 1991). Noradrenergic sympathetic nerves, through the 
direct innervation of cells in lymphoid tissue, may provide a link between the central 
nervous and immune systems throughout ontogeny, maturation and senescence. 
Coutinho et al. ( 1991) demonstrated that MHC class II expression on bovine brain 
endothelial cells was inducible by IFN-y and further stimulated by catecholamines through 
activation of ~-adrenergic receptors. Because the brain endothelial cells are strategically 
located at the interface between the circulation and the CNS, they could be involved in the 
initiation of the immune response. A role for noradrenergic sympathetic innervation has 
also been suggested in immune senescence due to the similarity between the alterations in 
immune responses with age and the effect of acute sympathetic denervation in young 
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adults (Ackerman et al., 1991). For example, ageing and noradrenergic sympathetic 
denervation both result in diminished T cell responses and primary responses to T-
dependent antigens and increased immunoglobulin secretion in response to polyclonal B 
cell stimulation. They concluded that the decreased availability of norepinephrine in 
secondary lymphoid organs may result in immune senescence with ageing (Ackerman et 
al., 1991). Possibly the noradrenergic central neurones directly control the immunologic 
activity of the BBB endothelium. It was suggested by Fabris (1982) that the reduced 
catecholamine receptor density may represent an adaptive phenomena toward the 
increased plasma levels of noradrenaline which increases with age (Ziegler et al., 1976). 
The thymus may also exert a widespread influence on the neuroendocrine system. 
Sex steroid hormones influence normal immune mechanisms (Cohn, 1979) and 
development of autoimmune disease (Talal et al., 1984). There is a marked predominance 
of autoimmune diseases in females and in autoimmune mcxiels, androgens have been 
found to suppress and estrogens to accelerate disease severity (Roubinian et al., 1978; 
Ahmed and Penhale, 1982). In murine lupus, a model for systemic lupus erythematosus 
(SLE), females have a more severe form of the disease (Roubinian et al., 1977). 
Castrated males develop an accelerated autoimmune disease indistinguishable from 
females (Roubinian et al., 1978). However, castration of females fails to improve disease 
severity (Raveche et al., 1979) suggesting that it is androgen which is causing the 
immunosuppressive effect in this model of autoimmunity. 
rThere are four naturally occuring animal models for neurological disease which all have a viral 
etiology: canine distemper encephalomyelitis (Wieniewski et al., 1972; Raine, 1976b), 
visna (Georgsson et al., 1982), mouse hepatitis (JHM) virus encephalomyelitis (Lampert 
et al., 1973; Fleury et al., 1980) and Thieler's virus encephalomyelitis (Dal Canto and 
Lipton, 1975). It is evident so far that demyelination can occur as a result of a viral 
infection and possibly the age-related or disease-associated breakdown of the BBB further 
results in subsequent inflammation with demyelination. In the next section, I will give an 
overview of MS and discuss different possible causes. 
1.4 Multiple Sclerosis, an inflammatory, demyelinating disease 
1.4.1 Historical Note 
Jean-Martin Charcot (1825-1893) is given credit for establishing MS as a 
pathologic and clinical entity, referring to the disease as "la sclerose en plaques 
disseminees" in his 1868 lectures at la Salpetriere in Paris. Charcot viewed the disease as 
predominantly of the white matter of the CNS, with lesions of varying age and size 
distributed throughout the neuroaxis from the cerebrum to the spinal cord. Charcot 
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recognised complete and partial remissions as well as a chronic progressive phase with 
clinical features referring to the different lesions occurring at different times in the course 
of the illness (Kurtzke, 1988). 
1.4.2 Clinical Aspects of Multiple Sclerosis 
There are no laboratory tests that are diagnostic of MS and the clinical diagnosis 
is dependent on history and neurological examination (Traugott and Raine, 1984 ). The 
safest diagnostic criteria is considered to be that of the Schumacher Panel prepared in 
1965 (Schumacher et al., 1965). Certain tests of the CSF and electrophysiological tests 
may strengthen the clinical diagnosis. For instance, protein content, type of lymphocytes 
present and the amount of IgG are important determinants in the CSF in MS. 
Electrophysiological tests of visual, brainstem and sensory pathways (Chiappa, 1980; 
Kjaer, 1980), computerised tomographic (CT) scanning (Sears et al., 1978; Mastaglia and 
Cala, 1980) and MRI may also demonstrate multiple lesions indicative of MS. 
MS affects young adults with the majority of cases occuring between the ages of 
20 and 40 (Kurtzke, 1970; Mc Alpine et al., 1972) and showing a fem ale to male ratio of 
1: 1.5 (McAlpine et al., 1972). MS usually occurs as a series of attacks separated by 
pericxis of partial or complete remission and frequently followed by a phase of chronic 
progression. Alternatively the disease may progress inexorably from the start (McAlpine 
et al., 1972). Many MS patients have a relapsing/remitting course during the first year of 
the disease and then switch to a progressive one (Amason et al., 1988). 
MS primarily manifests as impaired sensory or motor performance due to the 
demyelination of motor axons which interferes with impulse conduction and therefore 
with perception and proper motor coordination (Traugott and Raine, 1984). Although 
each skeletal muscle fiber from mature mammals are innervated by only one motor 
neuron, each motor neurone innervates more than one muscle fiber. Consequently, the 
term "motor unit" refers to a motor neurone in the spinal cord and the muscle fibers that it 
innervates. Most diseases of the motor unit cause weakness and wasting of skeletal 
muscles (Rowland, 1985). The clinical features of MS refer to the different lesions 
occuring at different times in the course of the illness. Disturbances in balance are a 
composite complaint due to cerebellar or sensory changes as well as brainstem, auditory 
or visual involvement; sensory loss, weakness, micturition impairment and motor 
symptoms such as heaviness or dragging of the legs, undue fatigue, tripping, parapesis, 
quadripesis all denote spinal cord damage (Traugott and Raine, 1984 ). 
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1.4.3 Pathology of Multiple Sclerosis 
In MS, there is an initial accumulation of leukocytes (inflammation) and fluid 
(oedema) around the blood vessels that lie within the CNS. Demyelination subsequently 
occurs in these areas of inflammation. 
1.4.3.1 Inflammation 
MS is an inflammatory disease where there is a localized immune response in the 
CNS with perivascular lymphocytic infiltrates and macrophages associated with focal 
zones of demyelination. MHC class II positive activated macrophages and T cells are the 
predominant immune cells (Traugott et al., 1983). There are immunoregulatory defects in 
T cell function associated with T and B cell hyperactivity with these defects accompanied 
by migration of activated T cells from the peripheral blood to the CNS (Hafler and 
Weiner, 1989). Total lymphoid irradiation of the peripheral immune compartment 
ameliorates progressive MS supporting the argument for the CNS inflammatory response 
being closely linked to the peripheral immune compartment (Hafler and Weiner, 1989). 
1.4.3.2 Demyelination 
The resulting myelin breakdown with the preservation of axis cylinders is the 
hallmark of MS (Waksman, 1984 ). The impaired sensory or motor performance 
experienced by MS patients is due to the demyelination of motor axons. Demyelination 
ultimately interferes with impulse conduction and therefore with perception and proper 
motor co-ordination. Some remyelination occurs, though if damage is severe, astrocytes 
proliferate (gliosis) and lay down glial fibers, ultimately forming a dense scar in the area 
of demyelination (Raine, 1978a; Soffer and Raine, 1980). Hence, the name multiple 
sclerosis, which literally means many damaged areas filled with sclerotic (scar) tissue. 
Glial fibrillary acidic protein (GF AP), a component of glial filaments and a useful index 
of astrocytic reactions and gliosis in pathological tissue (Raine, 1985) is present in MS 
plaques (Eng et al., 1971; Eng, 1980). 
Oligodendrocytes disappear in the MS plaque (Lumsden, 1951) and it is possible 
that the target of the disease process is the oligodendrocytes which produce and maintain 
myelin, rather than the myelin itself. The relatively tenuous connection with the 
oligodendrocyte cell body, together with the fact that numerous myelin sheaths are 
produced by one glial cell in the CNS, have been invoked as possible explanations for the 
relative paucity of remyelination following damage to CNS myelin. The possible attempt 
by oligodendrocytes to remyelinate is evidenced by the "shadow plaques" which are 
found at the edge of MS lesions. These are composed of thinly remyelinated axons 
(Powell and Lampert, 1983). It was once presumed that mature oligodendrocytes in the 
CNS were postmitotic and therefore unable to proliferate in response to trauma. Ludwin 
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(1984) has shown by the in vivo incorporation of tritiated thymidine (a marker of cell 
division) that mature oligcxlendrocytes do actually proliferate in response to trauma 
Although oligodendrocytes are able to divide in response to injury (Aranella and 
Herndon, 1983) their ability to achieve remyelination would be dependent on many 
factors. 
1.4.3.3 Role of T cells 
A small number of lymphocytes are usually found throughout the normal 
appearing white matter in MS (Traugott, 1983; Woodroofe, 1986; Hayes, 1987). 
Studies using monoclonal antibodies directed against T cell subsets and class II MHC-
positive cells indicate that the predominant immune cells at the plaque site in MS are 
activated macrophages and CD4+ T cells (Pettinelli and McFarlin, 1981; Bernard and 
McKay, 1983; Holda and Swanborg, 1982; Traugott et al., 1983; Ben-Nun et al., 1981; 
Hauser et al., 1984b; Sobel et al., 1988). The number of cells increases during the acute 
phase with T cells predominating with phenotypic analysis showing increased ratios of 
CD4+ to CD8+ T cells (Hauser et al., 1983). There is considerable fluctuation of 
peripheral blood T cell subset concentrations seen in longtitudinal studies of MS patients 
and their close relatives (Massman Rose et al., 1985; Hughes, 1986). Whatever the 
etiology of MS, T cells and macrophages contribute significantly to the pathophysiology 
of the disease. 
1.4.3.4 Immunoglobulin Concentrations 
There is an increase in the concentrations of all the immunoglobulin isotypes, 
and in particular IgG in the CSF (Waksman, 1984; McFarlin et al., 1987) in at least 80 
percent of patients with MS (Kabat et al., 1950; Tourtellotte, 1971 ). These 
immunoglobulins are generally oligoclonal (Ebers, 1984) and the continual synthesis of 
oligoclonal bands in the CSF of MS patients may be explained by the presence of plasma 
cells in MS plaques. As the disease progresses, plasma cells are found in increased 
numbers in normal appearing white matter (Prineas, 1985). As the antigens related to the 
restricted bands of antibody have not been identified it may be that the IgG is the product 
of a non-specific response by non-specific B cells attracted into the CNS and is a 
reflection of antibody production against antigen(s) residing within the CNS. 
In many neurodegenerative disorders, a higher concentration of MBP, or its 
fragmented peptide are also found in the CSF compared to the blood (Cohen et al., 1980; 
Gupta, 1987). In MS, levels of MBP and its antibody in the CSF correlate with the 
course of demyelination, suggesting a localised sensitisation of lymphocytes to MBP 
within the CNS compartment (Patterson et al., 1981 ). MBP-reactive T cell clones and 
lines have been raised from the CSF of MS patients (Richert et al., 1983; Tournier-
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Lasserve et al., 1986). However, whether or not the MBP-specific T cells are a 
secondary phenomenon that result from myelin breakdown prcxiucts being released, 
remains unclear as MBP or MBP fragments have also been found in the sera of clinically 
well humans (Paterson et al., 1981). 
1.4.3.5 The Role of Cytokines 
The increased number of leukocytes in demyelinating regions provides the CNS 
with a potential source of cytokines. The production of cytokines is significantly 
increased during an immune response (Arai et al., 1990) and these polypeptides may 
orchestrate the complex processes of inflammation and immune reaction. 
Abnormalities in the prcxiuction of IL-2, in vitro inducibility of IL-2 secretion, 
expression of IL-2 receptors, or IL-2 responsiveness have been reported in a variety of 
disorders and age-associated immune dysfunctions (reviewed by Kroemer et al., 1990). 
IL-2 induces the prcxiuction of IFN-y, TNF-a and IL-6 in vitro and in vivo (Heslop et 
al., 1989; Kasid et al., 1989; Jablons et al., 1989) all of which are implicated in the 
pathogenesis of inflammation. In MS, elevated levels of circulating IL-2 have been found 
during relapse (Adachi et al., 1989) and in the CSF (Trotter et al., 1988). The 
immunosuppressive effect of cyclosporin A (CsA) is possibly related to its capacity to 
inhibit IL-2 and IFN-y gene expression in vitro and in vivo (Kronke et al., 1984; 
Granelli-Pipemo, 1990; Kroemer et al., 1990). Although IL-2 may have a predominantly 
immunostimulatory function, it may also be involved in inhibitory effects related to its 
actions on different populations of (suppressor, helper and effector) immune cells. 
There is an increase in the number of episodic MS attacks suffered by patients 
being treated intravenously with IFN-y (Panitch et al., 1987). Previous research has 
shown increased levels of TNF-a in the blood and spinal fluid of MS patients (Merrill et 
al., 1989) with TNF-a+ cells present in MS plaques (Hofman et al., 1989). The majority 
of these TNF-a+ cells are morphologically identified as reactive fibrous astrocytes. 
TNF-a is suggested to exert cytotoxic effects on oligodendrocytes resulting in 
demyelination (Robbins et al., 1987; Lieberman et al., 1989). It is possible that TNF-a 
secreted by astrocytes and macrophages may activate an array of immune defences and 
cause the initiation of inflammation and disease progression. 
1.4.3.6 The role of astrocytes 
MS is a disease in which intense fibrous astrogliosis is a prominant feature 
(Raine, 1983, 1984) and it is possible that astrocytes contribute to tissue damage by 
acting as either auxiliary or effector cells. Active and replicating astrocytes are prominant 
in the MS lesion (Adams, 1983) where they fill areas formerly occupied by myelinated 
axons (Raine, 1985). The presence of myelin fragments or myelin degradation products 
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in astrocytes suggests that they can also act as scavenger cells (Raine, 1982). Class II 
MHC antigens are expressed in the brains of patients with MS (Traugott et al., 1985). 
However, the nature of the antigen-presenting cell has been suggested by some 
researchers to be macrophages (Hauser et al., 1986; Boyle and McGeer, 1990) while 
others suggest astrocytes (Traugott and Raine, 1985; Woodroofe et al., 1986). Traugott 
(1988) hypothesised that early in MS lesion formation, lymphokines released by 
infiltrating activated T cells lead to astrocytic proliferation and hypertrophy. In addition, 
locally produced y-IFN induces Class II MHC antigen expression on astrocytes and thus 
contributes to local antigen presentation. Subsequently, hypertrophic astrocytes being 
rich in hydrolytic enzymes can participate in demyelination. In support of this 
hypothesis, one of the most striking features of the MS plaque is the presence of fibrillary 
gliosis in the areas of myelin loss (Raine, 1985). 
1.4.4 Epidemiology of Multiple Sclerosis 
The cause of MS is still unknown, however, epidemiologic studies strongly 
support the hypothesis that the MS process is triggered in genetically predisposed 
individuals by exogenous factors. Genetically, MS is strongly associated with products 
of genes that code for the human leukocyte antigen (HLA) of the MHC (Bertrams et al., 
1972; Maito et al., 1972; Jersild et al., 1975 · ; reviewed in Compston et al., 1986). 
The higher concordance rate for MS in monozygotic compared with dizygotic twins 
provides strong evidence for a genetically determined susceptibility (Mackay and 
Myrianthopoulos, 1966; Kuwert, 1977). In support of the hypothesis for exogenous 
factors, it has been found that MS prevalence varies with latitude (Kurtzke, 1977; 
Hallpike , 1983) and migrants between low-and-high prevalence areas carry their 
prevalence with them if they migrate after puberty (Kurtzke et al., 1970; Dean and 
Kurtzke, 1971; McAlpine et al., 1972; Alter et al., 1978). Also, there was an epidemic of 
MS in the Faeroe Islands after the arrival of British troops in 1940 suggesting a 
contagious factor (Kurtzke et al., 1986; Currier et al., 1982). 
1.4.S Possible Role of Viral Infections in Multiple Sclerosis 
It has been suggested that MS may be caused by either a "slow virus" or one or 
more of the common viral infections of childhood. Waksman (1988) suggests that 
infection with common viruses probably initiates both the primary MS process and most 
exacerbations. Viral infections followed by demyelinative disease have been thought to 
induce autoimmunisation to myelin antigens. In human subjects with postinfectious 
encephalomyelitis after measles, rubella and varicella, the disease process correlates with 
lymphocytic sensitisation to MBP (Johnson et al., 1981). These results may testify to 
past infection and a possible role in autoimmunisation. Alternatively, a persistent 
26 
infection of the nervous system with an associated immune response to the pathogen may 
be the cause. Measles, herpes simplex, cytomegalovirus, rubella, coronavirus and 
lymphocytic choriomeningitis have been isolated from the brains of MS patients (Bauer et 
al., 1980; Boese, 1980) but no common etiology has emerged from these studies. 
Despite the fact that neither a virus nor antigen have been found many still support the 
viral model (Wege et al., 1984; Tardieu et al., 1984). 
1.4.5.1 Similarities between poliomyelitis and Multiple Sclerosis 
The pattern of epidemologic findings in MS is reminiscent of the pattern of 
poliomyelitis in the early part of the 19th Century (Poskanzer et al., 1980; Nathanson et 
al., 1979, reviewed by Waksman, 1988). When polio infection occurs in early 
childhood, gastrointestinal disease develops, usually without CNS involvement. 
However, polio infection occuring in adolescence or early adult life frequently results in 
neurological dysfunction as well. The probability of viral transmission in early childhood 
diminished as domestic hygiene improved in developed countries and with the decrease in 
the number of children in each family. This resulted in an increase of poliovirus 
infections occurring with neurologic involvement, particularly in countries in the 
temperate wne (latitude effect) and in higher socioeconomic groups within the affected 
populations. These features are also seen in MS. The latitude effect is evident (Kurtzke, 
1977; Hallpike , 1983) with an increased incidence among higher socioeconomic 
groups. In the Faroe Islands epidemic, possibly an infectious agent was carried in by 
British troops. There has been a link made between severe viral infections of Faroe 
Island adolescents between the ages of 13 to 26 in this period and susceptibility to MS 
(Currier et al., 1982; Kurtzke et al., 1986) 
MS patients have been found to experience infection with common exanthematic 
and other viruses significantly later in life, eg. during late childhood or early adolescence 
than matched controls (Sullivan et al., 1984; Anderson et al., 1985; Compston et al., 
1986). Since children in the tropics are regularly infected with measles, mumps and 
rubella before one year of age, it seems likely that both the low incidence of MS in the 
tropics and the resistence to MS of migrants from the tropics may be directly related to the 
early age of infection with such world-wide agents (Alvord, 1988). Thus, this data 
suggests that a combination of genetic predisposition and environmental factors (possibly 
a viral infection) experienced in adolescent life leads to the development of MS. 
1.4.6 Abnormalities in the vascular system 
Lesions of MS are associated with small blood vessels (Adams, 1972) and it was 
at one time proposed platelet changes in vivo may cause venular occlusion and contribute 
to plaque formation (Putnam, 1935, 1937; Fog et al., 1955) with early lesions of MS due 
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to clots in small veins or a result of paralysis or spasm of small vessels. Alterations of the 
clotting mechanism have been reported in MS patients in in vitro studies (Nathanson and 
Savitsky, 1952; Caspary et al., 1965; Wright et al., 1965; Millar et al., 1966) and 
experimental work in animals prcxiucing blockage of small veins supported this idea. 
However, the notion of venular thrombosis as the pathogenic factor in MS plaque 
formation has been discarded (Putnam, 1935, 1937; Fog et al, 1955). Anti-coagulants 
such as dicoumarol, heparin and atromid, vasodilators such as histamine, 
tetraethylammonium chloride and hydergine and circulatory stimulants such as ephedrine, 
caffeine, alcohol, adrenal cortical extract and deoxycorticosteroneacetate have been tested 
and appear to be ineffective in the treatment of MS ( Aronson et al.1 1982). 
1.4. 7 Age related factors in MS 
MS is an age dependent disease. It is rare for children or adults over the age of 
50 to develop MS (Kurland, 1952). Ageing is associated with marked deterioration of the 
immune system (Gardner, 1980; reviewed by Talor and Rose, 1991) and a significant 
increase in the incidence of autoimmune diseases (Talor and Rose, 1991 ). Mechanisms to 
explain the increase in autoimmunity have been: a repeated or prolonged insult by 
endogenous autoantigen; molecular mimicry with environmental antigens; or a decrease in 
immune suppression with age (Talor and Rose, 1991). 
Dore-Duff et al. (1987) found age-related changes in lymphocyte adherence to 
myelinated cerebellar tissue in MS patients with adherence levels to myelin being 
significantly higher than in controls at most ages tested Maximum adherence to myelin 
was found in both MS and control cells during the ages of 20 to 45 years which 
corresponds to the peak age of onset of MS. These findings could be explained by a 
number of possibilities: age-related differences in human myelin, possibly the receptor for 
T cells on myelin is altered with ageing; there could be an increase in the number of cells 
that recognise myelin; or a decline in immunoregulatory mechanisms governing adherence 
of lymphocytes. There is subsequently a decrease in the adherence levels of lymphocytes 
to myelin from elderly donors. This also correlates with the decrease in the incidence of 
MS in older patients (Kurland, 1952) and the abating of disease activity in some older 
patients. 
1.4.8 MS Drug Therapy 
Many attempts have been made to mcxiify the course of MS. Some drug 
therapies have been directed at controlling the associated side effects of this disease 
whereas others have been palliative in nature and design (Mertin, 1985). With an 
increasing understanding of cellular immunology, more recent treatments have 
concentrated on immunomcxiulation and/or anti-inflammatory actions (Mertin, 1985). 
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Adrenocorticotropic hormone (ACTII), prednisone and its derivatives 
az.athioprine and cyclophosphamide are the most widely used immunosuppressive drugs 
(Ellison and Myers, 1980). Unfortunately, no treatment has been shown to alter the 
progressive tissue damage of MS in the nervous system although it is possible to 
moderate the severity of attacks. Short-term high-dose therapy with ACTII or prednisone 
can shorten the duration and diminish the severity of acute attacks, however long-term 
moderate dose therapy is ineffective in modifying the disease (Traugott and Raine, 1984 ). 
ACTII is extracted from beef pituitary glands whereas adrenal corticosteroid hormones 
are extracted from beef adrenal glands. These act pharmacologically like the 
corresponding human hormones. Physiologically, ACTII acts by stimulating the adrenal 
gland to release II glucocorticoid II hormones. They reduce oedema and other aspects of 
inflammation, cause destruction of some types of lymphocytes and improve conduction of 
nerve impulses in demyelinated nerve fibres. Both drugs have adverse side effects and 
cannot be used chronically. The complications of ACTII and glucocorticoid therapy are 
generalised puffiness, psychosis, ulcer, general infections, acne, abnormalities of sodium 
and potassium levels, softening of bone and pathologic fractures, cataracts, hypertension, 
diabetes and adrenal exhaustion (Wilkinson, 1988). 
Although corticosteroids are effective in treating acute exacerbations, they do not 
influence the progression of disease, whereas high dose short-term cyclophosphamide 
may be of some benefit in slowing progression. MS can be arrested in the majority of 
patients tested for a year or more by this powerful immunosuppressive agent (Hauser et 
al., 1983). Cyclophosphamide interferes with nucleic acid metabolism and at high doses 
kills lymphocytes. Consequently, a combination of ACTII or corticosteroid (used both 
for anti-inflammatory and immunosuppressive actions) and a longer term 
immunosuppressive (azathioprine, cyclophosphamide) is often used to treat the disease 
(Dau et al., 1980). 
Currently, anti-inflammatory drugs or general immune system suppressants such 
as steroids or cyclosporin A are commonly used in MS. These drugs are expensive and 
have severe side effects. For these reasons, physicians are reluctant to prescribe them in 
the early stages of autoimmune disease when they might do the most good. Experimental 
models such as EAE have been used to study neuroimmunological relationships in the 
CNS and to test anti-inflammatory and immunosuppressive agents which may be useful 
in the treatment of MS. In the next section I will characterise EAE as an experimental 
model considering the relative role inflammatory cells play in disease manifestation. 
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1.5 Experimental Autoimmune Encephalomyelitis - an 
experimental model of inflammation of the CNS 
Experimental Autoimmune Encephalomyelitis (EAE) is an inflammatory disease 
of the CNS produced in laboratory animals by the injection of neural tissue in adjuvant 
(Hashim et al., 1980; Raine, 1984). It is an autoimmune condition in which the host 
animal is induced to mount an immune attack on constituents of myelin (Paterson, 1976, 
1981; Paterson et al., 1981). In some respects, EAE immunologically, pathologically and 
clinically resembles the human demyelinating disease MS (reviewed by Raine, 1985) and 
it has since become the principal animal model for the disorder. 
1.5.1 Historical Note 
With the introduction of the anti-rabies vaccine by Pasteur in 1885, there 
appeared reports of "neuroparalytic accidents" in some of the patients vaccinated. These 
patients exhibited weakness and sensory disturbance in the limbs, sphincter dysfunction 
and perivascular inflammation and demyelination in the CNS (Bassoe and Grinker, 
1930). The Pasteur vaccine consisted of repeated subcutaneoufjnjections of desiccated 
spinal cords removed from rabbits which had been infected with living fixed rabies virus 
(Harvey and Acton, 1923). Many investigators studied the effect of injections of nervous 
tissue into experimental animals (reviewed by Hurst, 1932) and it was suggested that the 
"neuroparalytic accidents" following the rabies vaccination were due to neural 
contamination of the vaccine (Koritschoner and Schweinburg, 1925). 
In 1933, Rivers et al. induced the disease in monkeys by the repeated 
intramuscular injection of brain extracts. Diseased animals clinically exhibited ataxia and 
weakness and were found to have perivascular inflammatory and demyelinated lesions in 
the CNS. The induction of disease was facilitated with the introduction of adjuvants into 
the inoculum. Induction of EAE without adjuvant requires multiple injections of CNS 
material. For instance, Rivers et al. (1933) injected normal rabbit brain 94 times into 8 
monkeys to achieve clinical and histological evidence of EAE in only 2 monkeys. Using 
complete Freund's adjuvant (CFA) supplemented with mycobacterium (Freund and 
McDermott, 1942), EAE symptoms were evident in monkeys within 2 weeks (Morgan, 
1947; Kabat et al., 1947) and EAE became a practical laboratory disease model to study 
demyelinating diseases. Subsequently, the disease has been induced in a variety of 
animals (reviewed by Waksman, 1959) with several different forms of EAE being 
distinguished by pathological findings and clinical profiles. 
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1.5.2 Clinical aspects of EAE 
The chief clinical manifestation of EAE is an ascending paralysis. In susceptible 
animals, EAE is generally characterised by transient ataxia, hindlimb weakness or 
paralysis and urinary and fecal incontinence due to autonomic nervous system 
dysfunction from spinal cord injury (Paterson, 1959, 1966, 1971). Specifically, in the 
monkey, clinical features consist of ataxia, limb weakness and paralysis, tremour, 
spasticity, visual loss, ptosis, facial weakness and nystagmus (Rivers et al., 1933; Rivers 
and Schwentker, 1935; Ferraro and Jervis, 1940; Morgan, 1947; Kabat et al., 1947) 
whereas weight loss, transient ataxia, limb weakness and paralysis, and incontinence 
have been described as the main clinical features of rabbits (Morrison, 1947; Waksman 
and Adams, 1955; Waksman and Adams, 1956), rats, mice and guinea-pigs (Freund et 
al., 1947; Lipton and Freund, 1953; Waksman and Ada1ns, 1956) 
1.5.3 Genetic variations in EAE 
An association between MHC compatibility and susceptibility to EAE has been 
reported in guinea pigs (Kies et al., 1975; Lisak et al., 1975; Webb et al., 1973) and rats 
(Gasser et al., 1973, 1975; 1Williams and Moore, 1973; Gunther et al. , 1978; Wettstein et 
al., 1981). Survival rates of monkeys treated with antibodies to class II MHC molecules 
is significantly higher than controls after induction of EAE (Jonker et al., 1988). 
Administration of anti-class II MHC antibodies at the onset of clinical signs of EAE in 
mice prevents the homing of radio-labelled neurospecific T cells to the brain (Sriram and 
Carroll, 1991). Konno et al. (1990) demonstrated that if class II MHC positive microglia 
are induced in recipient rats by corticol cryoinjury or eyeball enucleation prior to induction 
of EAE, the lesions which are similar to lesions found normally in EAE develop in accord 
with the class II Ml-IC-positive microglia. This suggests that class II MI-IC-positive cell 
clusters can serve as a target for autoimmune CNS lesions. This class II MHC 
association is also noted in many autoimmune diseases and indicates that CD4 T cells 
recognising antigen in association with class II MHC products are involved in the disease 
pathogenesis. 
1.5.4 Pathology of EAE 
Generally, the disease is characterized by leukocyte infiltration of the brain and 
spinal cord, oedema (Raine, 1984; Kerbro de Rosbo et al., 1985; Vanderbark et al., 
1985; Sedgewick et al., 1986; Simmons et al., 1987) and astrocytic hypertrophy (Bubis 
and Luse, 1964; Lampert, 1965; Hirano et al., 1970; Raine et al., 1980; Blakemore, 
1979). There is some demyelination of the spinal roots (Pender, 1987), with little 
demyelination of central axons (Kerbro de Rosbo et al., 1985; Vanderbark et al., 1985; 
Pender, 1987). Although, typically perivascular inflammatory lesions are disseminated 
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throughout the CNS affecting the white matter more than the grey matter (Paterson, 1966; 
Alvord, 1970; Palmer and Dawson, 1969), this distribution varies in different species. In 
the rat, mouse and guinea-pig, lesions are evident in both the brain and the spinal cord. 
The spinal cord of the rabbit is more severely damaged than the brain, whereas, in the 
monkey, lesions are predominantly found in the brain, brainstem and cerebellum 
(reviewed by Waksman, 1959). 
EAE can be actively induced in genetically susceptible species by immunisation 
with neural tissue derived antigens emulsified in adjuvant (Paterson, 1981; Paterson et 
al., 1981; Hickey et al., 1983) or by the transfer of lymphoid cells from actively 
immunised donors into naive syngeneic recipients (Paterson, 1960; Richert et al., 1979; 
Ben-Nun et al., 1981; Hickey et al., 1987; Holda et al., 1980; Panitch, 1980) (Fig. 1.5). 
1.5.5 Active induction of EAE 
EAE is actively induced in susceptible animals by the inoculation of 
encephalitogen such as MBP in CF A. The usual inoculum consists of brain and spinal 
cord white matter, whole spinal cord or purified MBP (50µg/animal) homogenised in 
saline and emulsified 1:1 in CFA to which Mycobacterium butyricum has been added 
(400µg/animal). Induction of EAE can be by subcutaneous or intracutaneous inoculation 
(Raine, 1984) and is usually in the footpads (Raine, 1985). 
MBP is an 18,000 1nolecular weight molecule made up of 170 residues 
(Carnegie and Lumsden, 1966, 1967) and different segments of the molecule are 
encephalitogenic in different species (Raine, 1976). The encephalolitogenic sequences are 
known for the rat (Dunkley and Carnegie, 1974) with two peptides being active, one 
small (sequence 44-48) and one large (sequence 71-85) (Martenson et al. , 1972). Lewis 
rats only respond to sequence 75-84 (Hashim et al., 1978). Guinea pig MBP (GPMBP) 
is the most encephalitogenic for Lewis rats, being 25 times more active than bovine, 
human or rabbit MBP and 10 times 1nore active than rat MBP (McFarlin et al., 1973). 
CFA is thought to result in better antigen presentation because it acts as a "depot" 
to slowly administer the antigen (Raine, 1985), which would otherwise disperse quickly 
and lose its ability to stimulate and to boost both delayed type hypersensitivity and 
antibcxly responses. In addition, bacterial prcxiucts would further activate an effective 
immune response. The addition of Bordetella pertusis in adjuvants results in increases in 
the number of lymphocytes as well as activating macrophages which results in a marked 
increase in the antibody response (World Health Organisation, 1976). EAE can be 
induced in rats with MBP without the use of adjuvant or pertussis vaccine if rats are 
pretreated with a peritoneal irritant and by subsequently injecting MBP into pre-enlarged 
popliteal lymph nodes (Levine et al., 1990). 
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Fig. 1.5: EAE can be actively induced in susceptible species by immunisation with MBP 
emulsified in adjuvant or by the transfer of lymph node derived cell lines, or spleen cells from 
actively immunised donors into naive syngeneic recipients. 
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Encephalitogenicity varies with the species of neural antigen used, the amount of 
neural antigen and mycobacterium used, and the proportions of water and oil in the 
adjuvant emulsion (Lee and Sneider, 1962; Paterson and Bell, 1962; Shaw et al., 1962). 
The expression of disease is also dependent on the strain of animals and their age at the 
time of inoculation (Lassmann, 1983). 
1.5.5.1 Acute EAE 
MBP is mostly found to produce an acute, monophasic, self-limiting 
experimental disease in animals with a pathology similar to acute human inflammatory 
CNS diseases. Lewis rats are highly susceptible to the disease (Levine and Wenk, 1963). 
The disease course is usually acute and monophasic (Paterson et al., 1970). Initial signs 
appear 9 to 10 days after sensitisation, with animals progressing rapidly to acute paralysis 
by day 12 (Fig. 1.6). They usually survive the acute phase and recover rapidly by day 17 
to 19. The clinical symptoms of EAE progress rostrally (namely a flaccid tail, followed 
by hindlimb weakness and then paralysis) whereas recovery occurs in the opposite 
direction. In approximately 10% of animals there is a second episode of clinical signs 
between days 19-25 post inoculation (McFarlin et al., 1974). Rechallenge of 
convalescent rats shortly after recovery leads to the reinduction of a mild, brief clinical 
episode (Willenborg, 1979) but with increasing time after primary sensitization, rats 
exhibit long-term resistance to active reinduction of disease but are susceptible to passive 
induction of disease (Swierkosz and Swanborg, 1975; Welch et al., 1980; Ben-Nun and 
Cohen, 1981). 
1.5.5.2 Hyperacute EAE 
In rats, the addition of Bordetella pertussis to guinea-pig spinal cord and CF A 
results in a hyperacute form of the disease (HEAE) (Levine and Wenk, 1965; Lennon et 
al., 1976). HEAE has a shorter latent period, a more rapidly progressive course and 
higher mortality (Levine and Wenk, 1965). Bordetella pertussis is thought to increase 
BBB permeability because it increases vascular permeability, causes lymphocytosis and 
sensitivity to vasoactive amines (Bergman et al., 1978) and augments the immune 
response to antigen (Kalpaktsoglou et al., 1969; Maillard and Bloom; 1972) by increasing 
antibody formation by B cells (Maillard and Bloom; 1972). The addition of pertussigen 
in adjuvant also results in the induction of EAE in genetically resistant strains of mice 
(Levine and Sowinski, 1973; Bernard and Carnegie, 1975; Raine et al., 1980a; Munoz 
and McKay, 1984). Serotonin is thought to play a role in the induction phase as 
methysergide, a serotonin antagonist blocks the effect of the pertussigen (Linthicum et al., 
1982). 
Fig. 1.6: Lewis(JC) rat exhibiting signs of EAE 16 days post inoculation with spinal cord 
homogenised in complete Freund's adjuvant. There are obvious signs of a flaccid tail and 
hindlimb paralysis (Photograph taken by N. Bowem). 
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1.5.5.3 Chronic relapsing forms of EAE 
The neuropathological changes and disease course observed in the chronic 
relapsing forms of EAE (CREAE) found in Strain 13 guinea-pig (Stone and Lerner, 1965; 
Wisnewski and Leith, 1977), SJL/J mice (Brown and McFarlin, 1981; Lublin et al., 
1981) and more recently in monkeys (Shaw et al., 1988) are more typical of MS (McKay, 
et al., 1973; Raine, 1976; reviewed by Lassman, 1983). The features of CREAE are 
inflammatory lesions, demyelination, gliosis and oligodendrocyte loss (Lassmann and 
Wisniewski, 1979a; Shaw et al., 1988). The demyelinated plaques are often found 
around small veins and usually show recent demyelinative activity with some axonal 
degeneration (Lassmann and Wisniewski, 1979a). CREAE is induced by whole myelin 
rather than MBP alone (Raine et al., 1977; Lassman et al., 1979) and overcomes the 
problem where EAE has an acute, monophasic and self limiting course, whereas MS has 
a relapsing/remitting nature. 
1.5 .5 .4 Inflammatory infiltrate 
Studies using monoclonal antibcxlies directed against T cell subsets and class II 
MI-IC-positive cells indicate that the predominant immune cells in EAE lesions are CD4+ 
(helper) and CD8+ (cytotoxic/suppressor) lymphocytes. Macrophages and lg+ B cells 
are also evident in EAE lesions (Hickey et al., 1983; Traugott et al., 1985). Inflammatory 
cell composition also depends on the mode of immunisation (Levine, 1974) as the general 
pattern of cellular distribution in CNS lesions is similar for all models of EAE except 
where pertussis has been used (Traugott et al., 1981, 1982a, 1982b; Sriram et al., 1982; 
Hickey et al., 1983; Hickey and Gonatas, 1984). Animals inoculated with MBP in CFA 
containing Mycobacterium tuberculosis or Mycobacterium butyricum exhibit a monocytic 
infiltration (Traugott, 1989) whereas the use of Bordetella pertussis vaccine produces 
HEAE with neutrophilia (Levine and Wenk, 1964). Neutrophils are recognised as having 
the greatest oxidative capacity of all the phagocytes (Klebanoff, 1988). 
1.5.6 Passive induction of EAE 
EAE can be passively induced by intravenous transfer of lymphocytes from 
actively immunised donors to naive syngeneic recipients (Paterson, 1960; Astrom and 
Waksman, 1962). Passive EAE can be induced using either spleen cells from donors 
immunised 10 to 12 days previously with 50µg MBP in CFA and incubated with either 
MBP or concanavalin A (ConA) for 72 hours (method of Panitch and McFarlin, 1977) or 
a cell line derived from the lymph ncxles of donors immunised 10 to 12 days previously 
with 50µg MBP in CFA. The cell line is alternately stimulated with MBP antigen and IL-
2 (method of Ben-Nun et al., 1981). Activated cells are transferred into the tail vein of 
rats at a dose of 30 to 50x10 6 cells/recipient Without activation by incubation with MBP 
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or ConA before injection into syngeneic recipients these cell populations will inefficiently 
transfer EAE (Richert et al., 1979). Although both ConA and MBP activated cells 
transfer disease, they may be effective via different mechanisms as MBP stimulation is 
more efficient. Only 1()6 viable cells activated by MBP are necessary for the transfer of 
disease, whereas 107 ConA activated viable cells are required (Panitch, 1980; Richert et 
al., 1981). 
The T cell population responsible for disease transfer has been shown to be the 
CD4+ T cell subset in both mice and rats (Hickey et al., 1983; Traugott et al., 1985). 
Initial recognition of autoantigen in association with class II MHC, followed by the clonal 
expansion of MBP-specific CD4+ cells, represents the primary events in EAE induction 
(Paterson and Swanborg, 1988). Development of disease after the transfer of T cells 
which have already been sensitised to MBP into recipient animals is a model of the 
effector stage of EAE (Paterson, 1960). The earlier onset of disease possibly occurs as 
the initial recognition and proliferative events have already taken place. The disease 
produced is clinically and histologically similar to that of active induction, however 
passively sensitised rats develop disease in 4 to 5 days. The animals subsequently 
recover, but remain susceptible to both active and passive reinduction of disease. The 
passively induced EAE model is useful in that it is free of the "antigen depot" effects 
which are present in the actively induced disease. 
1.5. 7 Immunisation with CNS endothelial membrane fractions 
Guinea-pigs and monkeys immunised with CNS endothelial membrane fractions 
uncontaminated with myelin proteins can cause an EAE-like disease consisting of 
paralysis and demyelination (Tsukada et al., 1987). This result suggests that an immune 
disturbance of the BBB is sufficient to cause EAE with specificity to a parenchymal target 
(eg., myelin). 
1.5.8 T cell mediated disease 
EAE is a T cell mediated disease, as demonstrated by an inability of genetically 
susceptible animals depleted of T cell precursors by neonatal thymectom y (Wick, 1972; 
Bernard et al., 1976), thoracic duct drainage (Gonatas and Howard, 1974), or anti-
thymocyte serum (Ortiz-Ortiz and Wiegle, 1976) to manifest symptoms. Injection of 
normal thymocytes restores susceptibility to disease (Amason et al., 1962; Lennon and 
Byrd, 1973; Ortiz-Ortiz and Wiegle, 1976; Gonatas and Howard, 1979). The important 
role played by T cells in this process is further illustrated by the adoptive transfer of 
sensitised T cells from an EAE donor (Paterson, 1960; Stone, 1961; Astrom and 
Waksman, 1962; Levine et al., 1970; Bernard et al., 197 6) or introduction of 
encephalitogenic T cell clones into naive, syngeneic recipients causing disease symptoms 
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(Ben-Nun et al., 1981; Hauser et al., 1984b; Raine, 1984). The course of the disease can 
also be mcxlified by immunosuppressive medication (reviewed by Raine, 1985), such as 
treatment with anti-class II :Ml-IC antibodies or treatment with anti-CD4 antibodies. Thus 
it is clearly established that EAE is mediated by MHC class II antigen-restricted T cells 
(Pettinelli and McFarlin, 1981; Zamvil et al., 1985). However, the actual mechanisms 
initiating the entry of T cells and the subsequent damage remain unclear. 
1.5.9 T cell entry into the CNS in EAE 
As mentioned previously, lymphocytes are normally found in low numbers in 
the CNS. A critical feature in the pathogenesis of EAE is the entry of T cells into the 
parenchyma of the CNS. This is the case whether EAE is induced actively by 
immunisation with MBP emulsified in CFA or passively with activated MBP-specific 
CD4+ T cells (Smith and Waksman, 1969; Raine, 1976; Hickey et al., 1983; Fontana et 
al., 1984; Traugott et al., 1986; Zamvil and Steinman, 1990). As early as 5 days after the 
injection of neural antigen, T cells have entered the perivascular space in the CNS 
(W ak:sman and Adams, 1962; Traugott et al., 1978, 1981) and at the height of clinical 
signs, the typical EAE lesion contains approximately 60-80% T cells, 30-50% 
macrophages and 10-12% B cells (Sriram et al., 1982). The mechanism of this initial 
entry into the CNS is not known, and the concept that antigen recognition at the 
endothelial cell surface triggers migration would seem no longer tenable (Lassman et al., 
1986; Hinrichs et al., 1987). 
Hickey et al. (1983) found that the majority of the T cells in the CNS lesions are 
activated. Wekerle et al. (1986) have proposed that the initial emigration of lymphocytes 
in the CNS is not immunologically specific. They hypothesise that "activated" T cells of 
any specificity migrate across the CNS endothelium into the parenchyma of the CNS and 
that this random migration acts as an immune surveillance mechanism. If the activated 
cells entering the CNS encounter an antigen for which they have a specificity, they 
remain, otherwise they may die or move back out of the CNS. 
Willenborg and Parish (1988) expanded the hypothesis that "activated" T cells of 
any specificity migrate acros& the CNS endothelium into the parenchyma of the CNS by 
suggesting that "activation" translated to the expression of enzymes on the lymphocyte 
surface. These enzymes assisted the cells in degrading the sub-endothelial basement 
membrane and the extracellular matrix, thus facilitating movement through interendothelial 
junctions and the subendothelial extracellular matrix into the parenchyma. Both direct and 
indirect evidence has been provided to support this hypothesis. Activated lymphocytes 
prcxluce elevated levels of a heparan sulphate-specific endoglycosidase (Naparstek et al., 
1984; Lider et al., 1989) which specifically degrades the heparan sulphate side chains of 
the proteoglycan scaffold of the extracellular matrix. Inhibitors of this enzyme also 
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prevent EAE development (Naparstek et al., 1984; Lider et al., 1989; Willenborg and 
Parish, 1988). Non-activated cells which lack the elevated levels of heparan sulphate 
endoglycosidase (Naparstek et al., 1984; Lider et al., 1989) do not cause disease (Panitch 
et al., 1981; Ben-Nun et al., 1981; Holda et al., 1980; Peters and Hinrichs, 1982). 
Neurospecific cells do not need to be stimulated by their specific antigen in order 
to cause disease, but can also be activated in a non-antigen-specific way using the lectin 
ConA (Panitch, 1980; Hinrichs et al., 1981; Peters , 1982). However, activation with all 
T cell mitogens does not result in the ability of cells to transfer disease. 
Phytohaemagglutinin (PHA) is a T cell mitogen able to produce large, dividing, blast-like 
cells in culture (Nowell, 1960). However PHA does not enable immune cells to transfer 
EAE (Peters and Hinrichs, 1982; Jones et al., 1989). This may be due to the effects these 
lectins have on lymphocyte migration. Schlesinger and Israel (1974) tested a range of 
lectins for their ability to affect lymphocyte migration. Radiolabelled murine lymphocytes 
were exposed to ConA and PHA, and then injected intravenously into syngeneic 
recipients. It was found that ConA inhibited lymphocyte migration to lymph nodes to a 
greater degree than entry into spleen, whereas PHA inhibited migration to each of these 
organs to a similar degree. These results suggest that the ability of lectins to cause the 
transfer of disease could be related to their effects on lymphocyte migration. 
The ability of the T cell to enter the CNS is not related to the antigen specificity 
of the cell, the phenotype of the cell, the MHC restriction element used by the cell, or 
even MHC compatibility with the host (Hickey et al., 1991). T cells not in blast phase 
were excluded from entry into the rat CNS whereas T-lymphoblasts entered the CNS in 
an apparently random manner (Hickey et al., 1991). Their results suggest that entrance 
was primarily dependent upon the activation state of the cells. It is hypothesised that in 
the process of activation, the T cell acquires new enzymatic and cell surface properties 
which enable it to enter the CNS. If they encounter an antigen in MHC context they 
persist to elicit an inflammatory response or otherwise exit 
In passive transfer, the fate of the activated cells following transfer to recipient 
animals is unknown. There is a latent period of 4 to 6 days between the injection of cells 
and the development of clinical signs. There may be a need for cell replication, 
differentiation or recruitment of recipient non-specific reactive cells. Results using 
gliotoxin treated lymphocytes appears to rule out a need for replication of donor cells 
upon transfer (Willenborg et al., 1988). Activated MBP-specific cells have been found to 
rapidly enter the CNS within a few hours after intravenous injection (Hickey et al., 1989; 
Meyermann et al., 1986; Wekerle, 1986; Wekerle and Fierz, 1985; Wekerle et al., 1986; 
Wekerle et al., 1987). Subsequently, it has been reported by some researchers that the 
numbers of activated MBP-specific cells progressively diminish until the opening of the 
BBB and the onset of EAE on approximately day 4 post inoculation (Hickey et al., 1989; 
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Meyermann et al., 1986; Wekerle et al., 1986) whereas, in contrast, Naparstek et al. 
(1983) reported that MBP-specific cells selectively and progressively accumulated in the 
CNS over the 72 hours post injection before the onset of EAE. 
1.5.10 Recruitment of non-specific lymphocytes 
Although it appears that neuroantigen-specific T cells initiate EAE, the majority 
of lymphocytes in established CNS lesions are not neuro-antigen-specific (McClusky et 
al., 1963; Dresser et al., 1970; Werdelin et al., 1971; Werdelin and McClusky, 1971; 
Sriram et al., 1982; Cross et al., 1990) and the recruitment of non-specific lymphocytes 
may be the most salient aspect of lesion formation during EAE. Ninety percent of the 
inflammatory cells comprising the lesions of EAE represent cells which are not specific 
for neuroantigen (Kosunen et al., 1963; Werdelin and McCluskey, 1971; Cross et al., 
1990). MBP-specific cells are found to "home" to the CNS 24 hrs prior to and during 
initial clinical disease and despite massive parenchymal inflammatory cell infiltration 
almost invariably remain within the perivascular area (Cross et al., 1990). Hickey et al. 
( 1991) also found peak concentrations of T cells predominantly around the meninges and 
blocxl vessels throughout the study. The fact that lesions of EAE begin around capillaries 
of the CNS suggests that events on the vascular endothelium are responsible for the 
cellular infiltrate. Sensitised lymphocytes are thought to enter the CNS, recognise 
specific antigen triggering the release of soluble mediators which attract and activate other 
inflammatory cells. Thus, MBP-specific cells are proposed to orchestrate the influx of 
inflammatory cells, which are mostly of recipient derivation, from the perivascular 
location. 
1.5.10.1 Adhesion molecules in EAE 
Cannella et al. (1990) examined the expression of two molecules associated with 
cell adhesion, a murine HEV marker (MECA-325) (Duijvestijn et al., 1986) and a murine 
homologue of ICAM-1 (Takei, 1985; Horley et al., 1989) on CNS vessels during chronic 
relapsing EAE in the mouse. Increased expression of adhesion molecules corresponded 
with clinical relapses and they suggested that the expression of MECA-325, ICAM-1 and 
MHC class II appear to be important in leukocyte homing and adhesion to the BBB 
during active stages of autoimmune demyelination. Subsequently, it was shown that 
MECA-325 is absent from normal CNS tissue but rises to maximal levels during acute 
disease as does ICAM-1 and MHC class II (Cannella et al., 1991). LFA-1 and CD4 
receptor molecules on inflammatory cells also fluctuated in parallel with MECA-325, 
whereas CD8 receptor molecule was absent during the preclinical stage but was 
upregulated in inflammatory cells and astrocytes with acute disease activity and during 
relapses (Cannella et al., 1991). They suggested that cellular entry into the CNS is related 
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to the fluctuations of adhesion molecules. Similarly, Raine et al. ( 1990) in a study using 
monoclonal antibodies directed against different adhesion molecules on frozen sections in 
combination with the avidin-biotin-complex technique, found that the attachment and 
infiltration of MBP-specific lymph ncxle cells and T cell lines correlated with the onset of 
signs and the appearance of MECA-325 and ICAM-1 on vessels and the appearance of 
cellular infiltrates which were also largely LFA-1 + lymphocytes. Wilcox et al. (1990) 
also found cells of the perivascular infiltrate in acute EAE and CREAE in guinea-pigs 
expressed increased levels of ICAM-1. Hence in EAE, several distinct adhesion-related 
molecules appear to be involved in the regulation of the cellular traffic to and from the 
CNS. 
1.5.11 Antigen presentation in EAE 
In EAE, antigen is presented in the context of class II MHC molecules to CD4+, 
CD8-, IL-2 dependent lymphocytes (Ben-Nun et al., 1981~ Fritz et al., 1985; Happ et al., 
1988; Hickey and Kimura, 1988; Holda and Swanborg, 1982; Sakai et al., 1985; 
Takenaka et al., 1986; V andenbark et al., 1985). Class II MHC antigen appears to play a 
role in the pathogenesis of EAE, as treatment of antigen presenting cells with anti-class II 
MHC antibody blocks T-cell proliferation to MBP in vitro and prevents relapses in mice 
in vivo (Steinman et al., 1981; Sriram and Steinman, 1983). Increased endothelial cell 
class II MHC expression correlates with the development of increased permeability of the 
BBB (Weigler, 1980) facilitating cellular infiltration into the CNS. The antigen 
presenting cell is unknown and the astrocyte, oligodendrocyte, microglial and endothelial 
cells have all been suggested. 
1.5 .11.1 The role of microgial cells 
Hickey ( 1991) suggests that the vasogenicity of the inflammatory infiltrate could 
be explained if activated T cells entering the CNS, produce a wide spectrum of cytokines 
including IFN-y and thus induce MHC expression on perivascular microglial cells. T 
cells can induce MHC expression (Pober et al., 1983) and this could also explain the 
phenomenon where activated encephalitogenic T cells could induce EAE if injected 
intravenously but not if given intrathecally. The need for activated cells to cross the BBB 
to induce disease could be explained by the necessity for perivascular antigen 
presentation. Allen et al. ( 1987) also suggested that a macrophage/monocytic antigen 
presenting cell was necessary for the development of lymphocytic choriomeningitis in 
. 
mice. 
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1.5.11.2 The role of astrocytes 
Although the T cell derived lymphokine y-IFN induces astrocytes to express 
class II molecules (Fierz et al., 1985; Hirsch et al., 1983; Wong et al., 1985) and 
astrocytes are capable of presenting MBP to appropriately sensitised T cell lines in vitro 
(Fontana et al., 1984, 1987; Wekerle, 1986; Wekerle et al., 1987), researchers using in 
vivo methods have found that astrocytes expressing class II MHC are either very rare or 
unable to be detected in animals developing EAE (Sobel et al., 1984~Sobel and Colvin, 
1985; Craggs and Webster, 1985; Hickey et al., 1985; Lassmann et al., 1986; Matsumoto 
and Fujiwara, 1986; Matsumoto et al., 1986; Vass et al., 1986). These results suggest it 
is unlikely that astrocytes play an important role in MBP antigen presentation in the CNS. 
1.5 .11.3 The role of oligodendrocytes 
Oligodendrocytes have also been found to express substantial amounts of class II 
MHC molecules in vivo (Suzimura et al., 1986), in situ (Ting et al., 1981) and during 
virus infection (Rodriguez et al., 1987). Despite this, immunohistochemical studies have 
not detected class II MHC molecules on oligodendrocytes in developing EAE, in the 
normal human CNS, or in patients suffering from MS (Craggs and Webster, 1985; Hayes 
et al., 1987; Matsumoto and Fujiwara, 1986; Matsumoto et al., 1986; Traugott et al., 
1985; Vass et al., 1986), again suggesting that these cells do not play a significant role in 
antigen presentation in EAE. 
1.5 .11.4 The role of endothelial cells 
Despite its interaction with lymphocytes during their entry into the CNS, there is 
no evidence to suggest that the endothelial cell is the antigen presenting cell in the 
development of CNS inflammation and studies using rat bone marrow chimeras have 
demonstrated that the endothelial cell cannot be the antigen presenting cell in rodents 
(Hickey and Kimura, 1988; Hinrichs et al., 1987; Hickey, 1990). Although some reports 
have been unable to find class II MHC positive endothelial cells in EAE and MS (Hayes et 
al., 1987; Matsumoto and Fujiwara, 1986; Matsumoto et al., 1986; Lassmann et al., 
1986; Vass et al., 1986) there have been some reports where CNS endothelium has 
become class II MHC positive in EAE and MS (Hickey and Kimura, 1987; Hickey et al., 
1985; Lampson and Hickey, 1986; Sobel et al., 1984f Sobel and Colvin, 1985; Traugott 
et al., 1985; Hickey, 1990). In addition, in vitro studies have shown that endothelial 
cells can present antigen to MBP-specific lymphocytes in a class II MHC restricted way 
(Male and Pryce, 1988,1989; Male et al., 1987; McCarthy et al., 1985; Pober et al., 
1983; Wagner et al., 1985). Thus, although endothelial cells may be an important antigen 
presenting cell during the latter stages of an inflammatory episode, they appear to play 
little or no role in the initiation of CNS lesions in EAE. 
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1.5.12 The role of macrophages in EAE 
The induction of EAE appears to require an antigen-processing cell and an 
immune cell. Some authors have suggested that demyelination occurs when there is 
intimate contact between inflammatory cells and myelin (Kosunen et al., 1963; Bubis and 
Luse, 1964; Lampert, 1965) and ultrastructural analysis has shown macrophages 
apparently "stripping" myelin lamellae from the axon by insertion of processes under the 
sheath (Lampert and Carpenter, 1965; Lampert, 1967). Activated macrophages secrete 
phospholipases (Trotter et al., 1982) and proteinases (Cammer et al., 1978) which may 
result in the breakdown of acidic proteins. MBP and the acidic proteins which are buried 
in the lipid bi-layer are particularly susceptible to protease activity (Einstein and Czejtey, 
1968; Brosnan et al., 1981 ). Phospholipases may cause the exposure of these proteins to 
proteolytic attack. In support of this notion, depletion of either donor or recipient 
macrophages results in the failure of induction of EAE (Panitch and Ciccone, 1981; 
Brosnan et al., 1981; Killen and Swanborg, 1982a). 
1.5.13 The Role of Antibody in EAE 
The role of antibody in EAE is still unclear although a role for circulating factors 
has been suggested (Bornstein and Appel, 1961; Brosnan et al., 1983). MBP-specific 
antibody can be detected in serum by day 6 after antigenic challenge (Gonatas et al., 
1974). Serum from recovered animals can protect against active induction of disease if 
administered during the first 8 days post inoculation (Hughes, 197 4) although it will not 
prevent cellular transfer of disease in rats (Richert et al., 1982). Heat-inactivated sera 
from rabbits with acute EAE has been demonstrated to induce demyelination in myelinated 
cultures of rat cerebellum (Bornstein and Appel, 1961) suggesting that anti-myelin 
antibodies may be responsible for this effect (Bornstein and Raine, 1976; Raine et al., 
1978). Although intravenous injection of EAE sera fails to induce CNS damage 
(Paterson, 1971) possibly due to the BBB, when EAE sera is injected into the lateral 
ventricles of guinea-pigs demyelination is evident (Jankovic et al., 1965). These studies 
demonstrate a potential demy~linating activity of EAE sera. 
There is no direct evidence suggesting that antibody plays a role in the 
pathogenesis of EAE. However, B cell and immunoglobulin-deficient rats fail to develop 
clinical or histological evidence of EAE when sensitized with whole spinal cord or MBP. 
The T cells were found to be unaltered as they responded normally to PHA and could 
reject tissue allografts (Willenborg, 1983). The transfer of anti-MBP antibody containing 
serum to MBP-sensitized lg deficient rats resulted in the subsequent development of EAE 
(Willenborg, 1986). Cells producing antibody to MBP have been detected in EAE lesions 
(Lennon et al., 1972). Treatment of neonatal rats with antiserum to IgM inhibits both 
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clinical and histological EAE (Willenborg and Prowse, 1983). MBP sensitized lg 
deficient rats, which do not develop disease, generate lymphocytes capable of transferring 
disease to naive rats and also disease develops in these animals after induction with EAE 
effector cells (Willenborg, 1986). However, the transfer of purified T cells into mice 
induces disease without detectable antibody production (Bernard et al., 1976). Antibody 
production doesn't correlate with onset, severity or relapse of EAE (Lisak et al., 1969; 
Lennon et al., 1971; Tabira and Endoh, 1985) and serum does not transfer disease to 
normal animals (Kabat et al., 1947; Chase, 1959; Bernard et al., 1976). It is possible that 
antibody may play a role in demyelination within inflammatory lesions, and in recovery 
and resistance to re-induction of EAE (Paterson and Harwin, 1963; Willenborg, 1979, 
1980). 
1.5.14 The Role of Cytokines in EAE 
Several investigators have claimed to have found a strong correlation between 
differential cytokine secretion and encephalitogenicity (Powell et al., 1990; Tokuchi et al., 
1990) and immunomodulators such as TNF-a, IFN-y and IL-6 have been implicated in 
the pathogenesis of demyelinating diseases such as EAE and experimental autoimmune 
neuritis (EAN) (Gijbels et al., 1990; Hartung et al., 1990; Ruddle et al., 1990; Selmaj et 
al., 1991; Chung et al.,1991). 
1.5.14.1 Gamma interferon 
IFN-y, a lymphokine which has wide ranging effects on many cells is produced 
mainly by activated T cells (Morris et al., 1982: Sethi et al., 1983). Its primary function 
in the CNS is thought to be the induction of expression of class II MHC on various cell 
types. Thus, these IFN-yresponsive cells become active in antigen presentation. In 
addition, IFN-ymcxiulates antibody production (Wong et al., 1984). In EAE, systemic 
(Billiau et al., 1988) and intravenous (Voorthuis et al., 1990) administration of IFN-y 
exhibits immunosuppressive properties. Despite this IFN-y upregulates astrocytic class II 
MHC expression and superoxide production by microglia, processes relevant to the 
development of disease (Woodroofe et al., 1989; Voorthuis et al., 1990). Consequently 
this cytokine is viewed as proinflammatory at the local level (ie. brain and spinal cord), 
while exerting anti-inflammatory effects systemically (Billiau et al., 1988). Possibly the 
latter is related to the induction of T suppressor cells, which have been suggested to 
inactivate T helper subsets (Noma and Dorf, 1985). 
1.5.14.2 Tumour Necrosis Factor 
The immunopathological significance of TNF-a is unclear. TNF induces IFN-y 
and IL-2 secretion (Kohase et al 1986; Naworth et al 1986), enhances T and B cell 
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proliferation and differentiation (Schenrich et al 1987, Jelinek and Lipsky 1987) and 
when incubated with IFN-y, TNF-a enhances astrocyte class II MHC mRNA expression 
(Vidovic et al., 1990). TNF causes the endothelial cell surface, which is usually an 
anticoagulant, to become a procoagulant (Bevilagua et al 1986) increasing its 
adhesiveness for different leukocytes (Bevilacqua et al 1985), alters the immunologic 
properties of vascular endothelium (01~ 1986) by increasing their permeability (Stem and 
Naworth, 1986) and :Ml-IC expression (Collins et al 1986) and TNF also stimulates rat 
macrophages and human vascular endothelium to release platelet-activating-factor (PAF) 
(Camussi et al, 1977) which alters the vascular tone and increases vascular permeability 
(Camussi, 1986; Bussolini et al, 1987; Camussi et al., 1991). TNF may also cause 
myelin damage as it has been shown that TNF produces myelin swelling and 
oligodendrocyte death in vitro (Selmaj and Raine 1988). 
Chung et al. (1991) demonstrated that EAE resistant (Brown-Norway) rat astrocytes 
do not express appreciable TNF-a in response to IFN-y whereas EAE susceptible 
(Lewis) rat astrocytes do. However, experiments employing neutralising anti-TNF-a 
antibodies have yielded conflicting results. Actively induced EAE is unaffected by 
antibody administration (Teuscher et al., 1990), whereas in a murine passive transfer 
model, symptoms of EAE were markedly reduced (Ruddle et al., 1990; Selmaj et al., 
1991 ). Preincubation of MBP-sensitised T cells with anti-TNF-a antibodies in vitro prior 
to injection had no effect on the ability of these cells to transfer EAE (Selmaj et al., 1991). 
1.5.14.3 Interleukins 
IL-1 may initiate or promote inflammation within the CNS. IL-1 causes the 
endothelial cell surface to become procoagulant and suppresses cell surface anti-coagulant 
activity (Nawroth et al., 1986). Treatment of cultured human endothelial cells with IL-1 
results in a concomitant decrease in the production of tissue plasminogen activator (t-PA), 
the moiety responsible for endogenous thrombolysis and an increase in plasminogen 
activator inhibitor by suppressing net fibrinolytic activity (Bevilacqua et al., 1986). 
Treatment with IL-1-a for 15 days following immunisation with MBP+CF A resulted in a 
longer duration and greater severity of disease with increased weight loss in Lewis rats. 
An IL-1 antagonist significantly delayed the onset of EAE, reduced the severity of 
paralysis and weight loss and shortened the duration of disease (Jacobs et al., 1991). In 
related studies, local elevations in IL-6 correlated with disease severity in mice (Gijbels et 
al., 1990) and treatment of Lewis rats with anti-IL-2 receptor antibody protected 
recipients from passive transfer of EAE (Engelhardt et al., 1989). 
In summary, both TNF-a and IFN-y have paradoxical effects on autoaggressive 
processes depending on the administration schedule and the experimental system. During 
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an immune response, the production of cytokines is significantly increased and may play 
a significant role in the pathophysiology of disease. 
1.5.15 Cause of clinical symptoms 
The correlation between the number of lesions in the CNS and flaccid paralysis 
is poor (Hoffman et al., 1973; Raine, 1980; Simmons et al., 1982, 1984) and other 
mechanisms have been proposed to explain the loss of nerve transmission which results 
in paralysis. Slowing of internodal conduction or conduction block of selected fibers 
(Pender and Sears, 1982, 1984; Pender, 1986; Raine, 1976; Amon, 1981) and the extent 
of oedema in the spinal cord (Leibowitz and Kennedy, 1972; Levine et al., 1966; 
Simmons et al., 1982) have been suggested as mechanisms of dysfunction. 
One of the features of the clinical progression of EAE is the ascending nature of 
weakness and sensory loss (Williams and Moore, 1973; Simmons et al., 1982). 
Ascending impairment of tail nociception occurs in both MBP-induced EAE and in whole 
spinal cord-induced EAE (Pender, 1986b). This can be accounted for by the caudally 
increasing length of the spinal roots (Waibl, 1973) which increases the probability of 
lesion formation progressively in a caudal direction. Thus, the probability of 
demyelination (Pender, 1986b) or oedema (Simmons et al., 1982) induced conduction 
block increases caudally and can anatomically account for the ascending weakness of 
EAE. Daniel et al. (1983) found that permeability to mannitol was evident in the lower 
spinal cord of rats developing EAE. This permeability reached its highest level during the 
acute phase of disease and slowly returned to normal from 15 days post inoculation 
starting from the caudal end of the spinal cord. Pender ( 1986b) further suggests that 
caudal roots show more extensive demyelination. 
1.5.15.1 Oedema 
Clinical signs correlate best with the extent of oedematous changes in the spinal 
cord (Blakemore et al., 1989). It has been suggested that BBB permeability changes 
which result in oedema are responsible for clinical symptoms (Leibowitz and Kennedy, 
1972; Daniel, 1981; Simmons et al., 1981, 1982, 1984; Kerlero de Rosbo et al., 1985). 
Vascular permeability changes are evident in the rat by day 6 post immunisation (Oldstone 
and Dixon, 1968; Daniel et al., 1981 and 1983; Suckling et al., 1983; Sobel et al., 1984). 
However, CFA alone can cause increases in vascular permeability (Suckling, 1984). 
Lymphocyte migration and vascular permeability are not interdependent as vascular 
permeability is a serotonin-dependent phenomenon (Schwartz et al., 1977) whereas 
lymphocyte migration is not (Rose and Parrot, 1977). Inflammatory cells may contribute 
to BBB dysfunction and associated oedema formation in EAE (Claudio et al., 1990). 
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Hawkins et al. ( 1991) found that BBB permeability as measured by MRI and gadolinium 
leakage was associated with duration of clinical relapse in CREAE. 
There is considerable swelling of the spinal cord during EAE (Levine et al., 
1966) and oedema associated with fibrin deposition in EAE lesions has been implicated in 
the loss of conduction of impulses down nerve fibres (Paterson, 1976; Kristensen and 
Wisniewski, 1977). Effector lymphocytes enter the CNS, recognise MBP in a class II 
MHC restricted way (Steinman et al., 1981). The recognition results in the release of 
lymphokines which attract monocytes and macrophages to the CNS. This accumulation 
of inflammatory cells initiates oedema formation. The oedema is associated with fibrin 
deposition in the lesions (Paterson, 197 6) and results in a loss of conduction of nerve 
impulses. More recently, oedema has also been proposed as the mechanism for 
neurological signs in passively transferred acute EAE (Sedgewick et al., 1987) and 
CREAE (Butter et al., 1989). 
1.5.15.2 Fibrin deposition 
Fibrin is deposited in lesions of EAE (Oldstone and Dixon, 1968; Paterson, 
1976; Rauch et al., 1978) and has been suggested as a cause of paralysis in EAE 
(Paterson, 1976). Fibrinogen-depleted rats do not develop paralysis although the extent 
of cellular infiltration is the same as controls (Paterson, 197 6). Vascular permeability 
allows extravasation of plasma proteins into the perivascular space where fibrinogen is 
converted to insoluble fibrin and deposited (Colvin and Dvorak, 1975). Neural cells are 
also a rich source of thromboplastin and any damage in the CNS can lead to the release of 
thromboplastin and additional fibrin formation (Graebar and Stuart, 1978). In 
histological sections of spinal cord from Lewis rats with acute EAE, Ackerman et al. 
( 1981) found fibrinogen was restricted to vessels containing cellular infiltrates suggesting 
that fibrin deposition does not occur as a result of general vascular permeability, leading 
to plasma protein extravasation, but is produced by infiltrating cells. As fibrinogen is a 
large molecule (340,000 daltons) it can possibly only enter lesions when vascular damage 
has occurred Although the fibrin deposition in EAE has been attributed to vascular 
leakage, the possibility exists that neural cells are the source of inducible procoagulant 
activity and may contribute to fibrin deposition in EAE lesions. However, treatment with 
two platelet-activating factor antagonists had no effect on the development of disease 
(Velna et al., 1991). 
1.5.15.3 Demyelination 
There is evidence to suggest that it is demyelination which produces the clinical 
signs of EAE (Pender, 1987; Pender et al., 1990). Demyelination causes conduction 
block with refractory periods of transmission (McDonald and Sears, 1970; Smith et al., 
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1979,1981; Bostock and Grafe, 1985; Kaji et al., 1988). Motor conduction abnormalities 
have been found in the region of the spinal cord ventral roots in acute EAE in Lewis rats 
(Pender, 1988b). The clinical form and amount of demyelination are different among 
species and antigen used. Guinea-pigs show the greatest amount of demyelination and 
the least axonal damage. More demyelination is seen in animals with a more chronic 
disease process (Tabira and Sakai, 1987). Chronic relapsing EAE, like MS, is 
characterised by extensive demyelination associated with lesions. Guy et al. (1991) 
measured myelin sheath thickness and axon diameter of optic nerves in guinea-pigs 
suffering from EAE. Both myelin sheath thickness and axonal diameter of animals with 
EAE were significantly lower than normal animals. Jones et al. (1990) found that 
prominant perivascular demyelination associated with mononuclear inflammation was 
evident in passively induced EAE in Buffalo rats and that demyelination occurred without 
the addition of demyelinating antibcxlies or subsequent clinical relapses. In contrast, there 
is very little demyelination in EAE which is MBP-induced (Lampert, 1965). Although 
MBP is necessary for the induction of the inflammatory response, demyelination may be 
caused by an additional immune response against other lipid myelin surface antigens 
(Moore et al., 1984 ). Demyelination occurs in cerebellar cultures if EAE sera from 
animals immunised with whole CNS tissue is used (Bornstein and Appel, 1961) but not if 
MBP as the immunogen is used (Seil et al., 1968). Some authors have suggested that 
demyelination occurs when there is intimate contact between inflammatory cells and 
myelin (Kosunen et al., 1963; Bubis and Luse, 1964; Lampert, 1965) and ultrastructural 
analysis has shown macrophages apparently "stripping" myelin lamellae from the axon by 
the insertion of processes under the sheath (Lampert and Carpenter, 1965; Lampert, 
1967). However, others claim that demyelination cannot be the cause of neurological 
signs of acute EAE as demyelination is reported to be sparse or absent in these models, 
particularly if MBP is the inoculum (Hoffman et al., 1973; Lassman and Wisniewski, 
1979; Panitch and Ciccone, 1981; Raine et al., 1981; Simmons et al., 1981, 1983; White, 
1984; Kerlero de Rosbo et al., 1985) and that recovery occurs too rapidly to be attributed 
to remyelination (Panitch and Ciccone, 1981; Simmons et al., 1981). 
1.5.15.4 Astrocytic gliosis 
Astrocytes fonn scar tissue in response to injury to the nervous system (reactive 
gliosis) (Miller et al., 1986) and may be involved in the pathogenesis of EAE. Fibrillary 
astrogliosis is one of the preclinical changes evident in EAE (Field, 1961 ; Bubis and 
Luse, 1964; Lampert, 1967). Gliosis is a prominant feature in the chronic model of EAE 
in the guinea-pig and mouse (Linington et al., 1984; Raine, 1983; Smith et al., 1984, 
1985). Smith et al. (1983) have shown that in acute EAE in the Lewis rat enhanced 
immunocytochemical staining of GFAP is evident 10 to 12 days post inoculation. The 
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intensity of staining increased with time post inoculation. Reactive astrocytes were 
distributed throughout the tissue and persisted until clinically evident disease had 
subsided, with the increased staining correlating with an increased permeability of the 
BBB. Cammer et al. (1990) found the increased GFAP staining evident in the spinal cord 
in acute EAE in Lewis rats occurred primarily in the white matter tracts and was not 
restricted to areas of inflammation. Goldmuntz et al. (1986) also showed increased 
staining for GFAP of Lewis rats with acute EAE commencing 10 days post inoculation 
and increasing with time. These reults suggest that astrocytes may play an important role 
in the pathogenesis of EAE. 
In a study on CREAE in the SJUJ mouse, Smith et al. (1988) found astrocytic 
hypertrophy near demyelinating lesions which eventually resulted in the formation of 
gliotic plaques in the affected mouse. Astrocytes may perpetuate myelinolysis within the 
lesion as they contain lysosomal enzymes which are activated in EAE lesions and are 
capable of degrading myelin (Arstila et al., 1973; Allen, 1983). Demyelinated axons are 
associated with astrocytic processes (Black et al., 198.7) and gliosis has been shown to 
inhibit remyelination in vitro (Raine and Bornstein, 1970) and impede regenerating axons 
in the dorsal roots of the spinal cord (Liuzzi and Lasek, 1987). Clinical and histological 
EAE can also be induced in guinea-pigs and monkeys by the injection of human 
glioblastoma, suggesting that glial cells are associated with the symptoms of EAE (Bigner 
et al., 1981). Thus, astrocytic gliosis may contribute to the clinical symptoms of EAE, 
particularly if demyelination is a major cause of disease symptoms. 
1.5.15.5 Axonal degeneration 
Axonal damage and degeneration is probably an important pathophysiological 
mechanism in CREAE (White et al., 1989; Pender et al., 1990; Stanley and Pender, 
1991), HEAE (Lampert, 1967; Hansen and Pender, 1989) and acute EAE in rats (White 
and Bowker, 1988) and mice (Tabira and Sakai, 1987). During the acute paralytic phase 
of EAE in rats, large numbers of the bulbospinal axons that contain the monoamine 
neurotransmitters, serotonin and noradrenalin appear to be damaged (White et al., 1985). 
Axonal dysfunction can also occur as a result of the action of inflammatory mediators 
such as lymphokines without detectable morphological changes (Arezzo et al., 1988). 
White et al. (1990) found that axonal damage was equally pronounced whether EAE is 
induced by MBP or whole spinal cord homogenate which suggests that the damage is not 
a result of immune attack directed against monoaminergic or peptidergic antigens present 
in the inoculum. Axonal degeneration probably contributes to persistent neurological 
dysfunction of CREAE and HEAE. 
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1.5.15.6 Neurotransmitters 
Neurological signs of EAE have been attributed to impairment of monoaminergic 
neurotransmission (Carnegie, 1971; White, 1984). Interference with neurotransmission 
due to decreases in noradrenaline and serotonin in the lumbar-sacral region (Lycke and 
Roos, 1973; Honeggar and Isler, 1984), an area rich in serotonin terminals, may account 
for the localisation of clinical symptoms of EAE (Lennon and Carnegie, 1971). Guinea-
pigs showing symptoms of EAE show depletion of receptors (Weinstock et al., 1977; 
White, 1979). MBP binds serotonin (Weinstock et al., 1977) and this may be the cause 
of the decreased levels in EAE. However there are increased levels of monoamine 
oxidase activity in guinea-pigs with EAE (Saregea et al., 1965), reflecting increased levels 
of serotonin, and this may partially account for the reduction in serotonin levels. 
Rabbits injected with neural tissue in adjuvant have shown disturbances of 
neuro-electrical transmission (Feldman et al., 1969). The MBP antigen has also been 
found to cause a long-lasting depolarisation of neurones leading to a loss of transmission 
in frog spinal cord (Honeggar et al., 1977; Gahwiler and Honeggar, 1979; Isler and 
Honeggar, 1983) and the intraneural electrical activity of mammalian brain cultures is 
blocked by the addition of sera from animals with EAE or patients with MS (Ross and 
Bornstein, 1969). There is considerable depletion of serotonin and noradrenaline in the 
lumbo-sacral region of the spinal cord during clinical episodes and recovery phases in 
Lewis rats with CREAE (Krenger et al., 1986). 
1.5.15.7 Oxidative damage 
The action of oxygen radicals can result in substantial damage in the nervous 
system (reviewed by Halliwell and Gutteridge, 1985a). Oxidative damage of the CNS is 
suggested to be one of the mechanisms underlying the pathogenesis of EAE. Kassabova 
et al. ( 1990) found oxidative damage in the lumbar spinal cord of guinea-pigs with clinical 
signs of EAE, whereas injection of animals with vitamins C and B2 during the disease 
latent pericxi suppressed EAE development. Disruption of the lipid layer by the prcxiucts 
of superoxide or hydrogen peroxide could expose MBP and proteolipid protein to 
proteolytic attack with demyelination reflecting a combination of oxidative damage by 
macrophages and a protein generated immune response. Damage to myelin appears to 
result from contact with macrophages (Lampert, 1968) and macrophages activated by 
lymphokine prcxiuce superoxide and hydrogen peroxide (Freund and Pick, 1985). 
Another explanation for the loss of serotonin is that free radicals are scavenged by 
serotonin. Possibly lymphoid cells liberating superoxide or hydrogen peroxide could 
cause initial damage to myelin membrane in EAE and exposure of myelin proteins may 
perpetuate the specific immune rsponse. 
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1.5.16 Recovery from disease 
The immunoregulatory events determining recovery and subsequent resistence 
have not been clearly defined. It seems most likely that the resolution of oedema is the 
initial factor contributing to the rapid recovery of disease; whereas longterm changes may 
involve remyelination, axonal regeneration and synaptic re-organisation. 
1.5.16.1 Resolution of oedema 
McDonald ( 197 4 ) suggested that the dispersal of oedema in optic neuritis in 
humans may allow conduction to return to demyelinated fibres. The study by Jacobson et 
al. (1979) on optic pathways of cat demyelinated by diphtheria toxin injection supported 
this hypothesis. Early recovery was suggested to be due to the dispersal of oedema at the 
site of the lesion, with later recovery involving more complex re-organisation of synapses 
(Jacobson et al., 1979). However, resolution of axonal dysfunction caused by the toxin 
could also result in early recovery. 
1.5.16.2 Remyelination 
Remyelination is evident in EAE (Lampert, 1965; Wisniewski et al., 1969; 
Lassman et al., 1980b) although it has generally been considered to be a late feature of 
demyelinated chronic lesions (Prineas et al., 1969). In contrast, Lassman et al. (1980b) 
demonstrated that the capacity for remyelination in the CNS differs at various stages of 
disease. They suggested that the decrease in remyelination in later stages of disease is due 
to a more destructive demyelination occuring at later stages, the unavailability of 
oligodendrocytes, and to the pronounced astrocytic gliosis which possibly affects 
remyelination. 
As remyelination occurs, conduction is restored resulting in a return to 
transmission (Smith et al., 1979, 1981). Koles and Rasminsky (1972) found that as little 
as 3% of normal myelin thickness could be sufficient to ensure saltatory conduction. 
Pender (1988) performed histological and electrophysiological studies and found that the 
functional recovery from acute EAE in Lewis rats was due to the remyelination achieved 
by Schwann cells in the PNS and oligodendrocytes in the CNS. Shrager ( 1988) also 
found by measuring ionic currents in remyelinating frog nerve fibres, that conduction can 
be improved by remyelination via the aggregation of existing sodium channels at new 
nodes of Ranvier. Can clinical recovery be due to the repair of the myelin sheath? Raine 
and Traugott (1983) found that animals treated with a combination of MBP and 
galactocerebroside during chronic relapsing EAE displayed widespread remyelination and 
oligcxiendroglial proliferation. On the other hand, some researchers believe that 
remyelination occurs too slowly in demyelinating lesions to contribute effectively to 
clinical recovery (McDonald, 197 4 ) . 
49 
1.5.16.3 Axonal regeneration 
Recent studies suggest that even after axonal regeneration, abnormal 
physiological properties still persist in synaptic connections (Kierstead et al., 1989) and 
conduction velocities (Cragg and Thomas, 1964a; Feasby et al., 1981; Bowe et al., 
1989). With increasing axonal diameter and myelin sheath thickness, conduction 
velocities do improve but may never return to normal values (Cragg and Thomas, 1964a). 
These persistent changes would limit recovery and more possibly contribute to 
neurological deficit. 
1.5.16.4 Neuroendocrine-mediated immunoregulation 
Several investigators have suggested that the production of cytokines during an 
immune response induces endocrine-mediated suppression of the immune response 
(Munck et al., 1984; Besedovsky et al., 1986; Salpolsky et al., 1987; Kroemer et al., 
1988) and neuroendocrine-mediated immunoregulation could be relevant in the recovery 
phase of EAE. Exogenous stress has been found to suppress EAE in Lewis rats (Levine 
et al., 1962) and Mason et al. (1990) have proposed that the resistance to EAE seen in 
some strains is due to corticosterone-mediated suppression. In the susceptible Lewis 
strain, recovery from paralysis correlates with increased levels of corticosterone. If 
susceptible Lewis rats are adrenalectomised, they are unable to recover and the disease 
becomes uniformly fatal, an effect which can be reversed by steroid replacement therapy 
(Mac Phee et al., 1989). The critical time for adrenalectomy was found to be 24 to 48 
hours before paralysis occurred (Mason et al., 1990). Adrenalectomy petformed 12 to 14 
days post inoculation does not result in the development of disease suggesting that the 
long-term refractory period found in recovered rats does not depend on corticosterone-
mediated suppression (MacPhee et al., 1989). The PVG strain which is not susceptible to 
EAE, develops severe disease after adrenalectomy with steroid replacement therapy 
preventing the fatal progression of disease. PVG rats were also found to have 
significantly higher basal levels of corticosterone than those in Lewis rats and to produce 
a more vigorous response to stress (Mason et al., 1990). These results suggest that 
possibly an exaggerated adrenal response may result in recovery from disease but not the 
long-term resistance to active reinduction. 
1.5.17 Resist4nce to reinduction of disease 
In addition to recovery, animals become resistant to further attempts of active 
induction of disease (Vandenbark and Hinrichs, 1974). The events determining this 
subsequent resistance are unknown. The immune system becomes tolerant of the body's 
molecules because mechanisms either suppress (suppression), eliminate self reactive cells 
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(deletion) or turn them off (anergy). Although resistant to active induction of EAE, 
animals remain fully susceptible to the passive transfer of disease (Willenborg, 1979) 
suggesting that an active suppressor mechanism is either overwhelmed by the number of 
effector cells injected with passive transfer or suppressive mechanisms act at an early 
stage of disease development before T cells are primed to neural antigen (Hinrichs, 1984 ). 
Suppression was also demonstrated to be expressed systemically rather than just locally 
as resistQnce to reinduction is independent of the site of primary and sensory sensitisation 
(Willenborg, 1981 ). Whatever the mechanism of resistence, total body irradiation 
(Willenborg, 1982), pertussigen (Waxman et al.,1982) and cyclophosphamide (Miyazaki 
et al., 1985) allow reinduction of disease in convalescent rats. 
1.5.18 Inhibition and Treatment of EAE 
1.5.18.1 Hormonal regulation of EAE 
Steroids have been shown to have an immunosuppressive effect on EAE 
(reviewed by Komarek and Dietrich, 1971). ACTH and glucococorticosteroids, which 
includes both endogenously produced steroids (eg. cortisol or hydrocortisone) and the 
more potent synthetic analogues such as prednisone, prednisolone, methylprednisolone 
and dexamethasone, are the more commonly used immunosuppressive agents (Mertin, 
1985). High methylprednisolone dose given prior to EAE induction, significantly 
increases disease duration. In contrast, when given after the onset of clinical disease this 
drug has a marked beneficial effect (Steiner et al., 1991). Steroids act at a variety of 
stages in the immuno-inflammatory cascade. For instance, they cause an inhibition of the 
T cell growth factor IL-2 (Pinkston, 1987), prevention of neutrophil chemotaxis (Cupps 
and Fauchi, 1982), lowering of monocyte superoxide production (Bell, 1986) and 
arachidonic acid release (Flower, 1984) and diminished local antibody production 
resulting from inhibition of granuloma formation by cortisone (Kabat et al., 1952). In 
addition, MacPhee et al. ( 1989) reported that adrenalectomised rats with EAE were unable 
to recover from an acute episode of the disease. Steroid replacement therapy prevented 
death in these rats. Unfortunately, there are a number of adverse side effects that can be 
attributed to the use of steroids, including renal insufficiency, peptic ulceration, 
osteoporosis and hyperglycaemia (Marble et al., 1980) and the possibility of increased 
susceptibility to infections as the bactericidal and antimicrobial capacities of the immune 
system are compromised. 
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1.5.18.2 Irradiation 
Radiation has been reported to have varying effects on the induction of EAE 
(Levine et al., 1969) with variations probably being related to the species studied, the 
dose, the timing and the type of radiation. Some investigators found that irradiation of 
recipients completely inhibited cellular transfer of inflammatory disease (Levine et al., 
1969; Werdelin and McCluskey, 1971) and when recipients were restored with bone 
marrow cells inflammation developed (Werdelin and McCluskey, 1971), whereas others 
found low dose irradiation (350rads) facilitated induction of EAE with MBP-reactive T 
cell lines (Zamvil et al., 1985). Sedgewick et al. (1987) reported that regardless of the 
status of the recipient (irradiated or not), clinical signs were induced when animals 
received MBP-reactive cells although the number of infiltrating leukocytes was reduced in 
irradiated animals. The augmenting influence of irradiation on EAE could be due to 
irradiation increasing the permeability of the CNS and the interaction of sensitised cells or 
antibody with CNS antigen. 
1.5.18.3 Cyclosporin-A 
Cyclosporin-A (CsA) is effective in inhibiting EAE and rejection of tissue grafts 
as well as other models of immunologically mediated disease. A daily oral dose of 
15mg/kg or more prevents the induction of the disease in Lewis rats and histological 
analysis demonstrates that the average number of inflammatory lesions in the CNS is 
substantially reduced (reviewed by Nussenblatt et al., 1986). The immunosuppressive 
effect of CsA is possibly related to its capacity to inhibit the sensitisation of T cells to 
specific antigen (Klaus and Chisholm, 1986; Benson et al., 1989). CsA inhibits the 
expression of MHC antigens (Autenried et al., 1985), T cell proliferation (Kumagai et al., 
1988) and IL-2 and IFN-yexpression (Kronke et al., 1984; Granelli-Piperno, 1990; 
Kroemer et al., 1990). However, low dose CsA administered immediately after 
immunisation until day 22 post immunisation does not prevent a first attack of EAE 
(Polman et al., 1988). CsA in fact contributes to the pathology of EAE, by inducing 
clinical relapses in 100% of Lewis rats examined, with the relapses in general being 
clinically severe and long-lasting or even continuous. Pender et al. (1990) investigated 
the neuropathology of CREAE induced by inoculating female Lewis rats with guinea-pig 
spinal cord and adjuvants and treated with low dose CsA and found that severity and 
chronicity of neurological signs were increased. These results are consistent with the 
known inhibitory effect of CsA on the initial steps in the sensitisation of cells to specific 
antigen and on T cell proliferation but not progression (Kumagai et al., 1988). 
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1.5.18.4 Inhibitory effect of neural tissue homogenates 
It was first observed by Ferraro and Cazzulo (1949) that repeated injections of 
nervous tissue homogenates interfered with the development of EAE. Many researchers 
have subsequently found that injections with relatively large amounts of CNS tissue 
diminish or abolish development of disease (Paterson, 1958; Waksman, 1959; 
Kornblum, 1968) and it is thought that these large doses inhibit immunologic responses 
to CNS tissue or antigen in adjuvant. Oral administration of MBP also suppresses EAE 
in Lewis rats immunised with MBP in adjuvant with antibody responses to MBP also 
being suppressed (Khoury et al., 1990). 
1.5.18.5 T cell vaccination 
If rats were inoculated with subencephalitogenic doses of activated MBP-reactive 
cells, animals not only did not develop disease but were protected from subsequent EAE 
induction (Beraud et al., 1989). MBP-reactive clones, rendered harmless by chemicals or 
radiation, and reinjected into animals also suppress EAE, possibly by sensitising the 
animals to the myelin-destroying T cells (Cohen, 1988). Whether this approach is viable 
as a general therapy for autoreactive T cells requires further investigation. 
1.5.18.6 Sulphated polysaccharides in EAE 
Heparin and fucoidan, two anti-coagulants, are potent inhibitors of passively 
induced EAE (Willenborg and Parish, 1988). Clinical signs are abrogated, but with 
heparin there are no inflammatory lesions seen in numerous histologic sections taken from 
treated rats. Heparin and fucoidan have been shown to stop lymphocytes from 
recirculating (Bren an and Parish, 1986) causing a three-fold and six-fold increase in 
blood lymphocytes, respectively. This result suggests that the inflammatory cells have 
failed to enter the CNS. Heparin also inhibits actively induced disease (Lider et al., 
1989). Rats usually develop disease after 10 to 11 days but when given an initial dose of 
heparin disease is delayed by 6 days. Heparin and possibly fucoidan may inhibit disease 
by blocking the migration of activated lymphocytes by binding to heparanases on the 
surface of activated lymphocytes as non-cleaveable substrates that occupy and block the 
active site of the enzyme. Chemically mcxtified heparins lacking anti-coagulant activity 
are anti-inflammatory and this correlates with the ability of the modified heparins to inhibit 
heparanase. As sulphated polysaccharides are inhibitors of inflammation in the CNS, 
these compounds may be used as potent, non-toxic anti-inflammatory agent useful in the 
treatment of inflammation of the CNS. Furthermore, the lack of toxicity may enable them 
to be used chronically to prevent further exacerbations. 
Finally, it should be noted that agents effective in suppressing EAE, ie. anti-
lymphocyte serum, MBP (Eylar et al., 1972; Levine et al., 1972; Driscoll et al., 1974; 
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Raine et al., 1977), 6-mercaptopurine, glucocorticosteroids, phytohaemagglutinin 
(reviewed by Amason, 1972), linoleic acid (Meade et al., 1978) and proteinase inhibitors 
(Smith, 1980), have not been successful in treating MS. 
1.5.19 Age Related Factors in EAE 
EAE is an age dependent disease which requires the presence of a mature 
lymphoid system (Paterson et al., 1970). Neonatal rats are resistent to EAE and become 
susceptible at approximately 8 weeks of age. The encephalitogenic activity of the CNS 
material parallels the ontogenic development of myelin, which is poorly developed at 
birth, reaching sufficient quantities by 2 weeks of age to induce EAE in guinea-pigs 
(Schwenkter and Rivers, 1934). CREAE in GPs is most readily achieved at weaning. 
Earlier animals lack effective T cell response to produce disease. Later EAE tends to be 
monophasic (Amon, 1981). Probably weaning (and adolescence in humans) is 
associated with maturation of the system of suppressor cells and immune regulation 
(Waksman, 1988). 
Neonatal rats are apparently resistQnt to passive induction of EAE as they do not 
show clinical or histopathological evidence of disease after the transfer of cells. 
However, these rats are thought to be asymptomatic carriers of the disease, as at 10 to 12 
weeks of age, they can be actively sensitised with MBP in CF A and they will develop 
disease significantly earlier than control animals (7 to 8 days compared with 10 to 11 
days). The earlier onset of disease in rats that are neonatally induced is thought to be a 
memory response due to the persistence of transferred cells. Animals not only develop 
disease earlier but MBP antibody levels increase at Day 5 rather than Day 7. These rats 
might appropriately be considered asymptomatic carriers of the autoimmune disease. An 
early etiological event may set up an autoimmune carrier state and the MS patient may in 
effect be a reservoir of autoimmune effector cells which are periodically activated by one 
or more unknown stimuli. 
With advancing age the lymphoid system undergoes atrophy and has a decreased 
ability to mount a T cell immune response (Walford, 1969; Roberts-Thomson et al., 1974). 
Levine and Sowinski (1976) demonstrated an age related decline in susceptibility to EAE. 
They found that with intense immunisation (MBP+CFA+pertussis vaccine) of rats (inbred 
Fischer 344 males) aged 2, 6 and 12 months, EAE developed at a similar rate and severity. 
There was a lesser response in 18 and 24 month olds with a more protracted incubation period 
and milder or absent signs. However, with less intense immunisation (without pertussis or 
lµg MBP) almost all 6 month olds developed disease but not a single 24 month old developed 
EAE under these conditions. In their passive transfer model, Levine and Sowinski (1976) 
found that only 2 out of 4 of the 24 month olds developed EAE. The data indicated an age 
related decline in susceptibility to EAE although histologic examination of inoculated feet and 
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draining lymph nodes revealed no deficiencies in the processing of the antigenic inoculum. 
However, none of their rats seemed to be free of disease and extensive leukemic infiltration of 
lymphoid organs might have immunosuppressed recipients. Due to the array of pathologic 
lesions found in aged F344 rats (Sass et al., 1975; Levine and Sowinski, 1976), it was 
suggested that this was not a good model for assessing age related factors and possibly a 
strain with a longer life-span would be a better model. In old mice, susceptibility to EAE 
induced with bovine proteolipid apoprotein (PLP) and MBP is reduced significantly although 
some old mice develop histologic EAE without clinical signs. Lymphocyte proliferative 
response to mitogens and antigens, and IL-2 production were also decreased in aged mice 
(Endoh et al., 1990). It was subsequently found that the reduced susceptibility of old mice to 
EAE and the decreased T cell functions cannot be restored by the treatment of old mice with 
thymic hormones (Endoh and Tabira, 1990). In contrast, Mc Farlin et al. ( 197 4) reported 
recurrent EAE in aged (6 months old) female Lewis rats, whereas young rats of the same 
strain exhibited a monophasic course of disease and Ben-Nun et al. (1981) found Lewis rats 
developed recurrent or chronic EAE when sensitised with MBP at an advanced age. 
1.5.20 EAE as an experimental model 
MS and EAE are both diseases characterised by considerable infiltration of 
leukocytes into the CNS. As alterations in the ratios of T cell subsets during clinical 
relapses are evident (Reinherz et al., 1980; Brinkman et al., 1983; Weiner and Hauser, 
1983; Antel et al., 1984) much research has focused on immune regulation in EAE and 
MS. Similar to MS, it is the myelin sheath which is destroyed with the axon being 
spared. For this reason it was hypothesised that the "antigen" for EAE and MS was 
residing in myelin. 
However, there are clinical, pathological and immunological differences between 
acute EAE and MS (Adams, 1959; Field, 1967; Paterson; 1971; Raine; 1976) resulting in 
major criticisms of its use as a model for MS. Acute EAE has a monophasic disease with 
a high mortality rate, whereas MS usually has a chronic relapsing or chronic progressive 
course. In acute EAE, the lesions are of the same age and demyelination and gliosis are 
often absent whereas in MS there are both old and recent lesions, extensive demyelination 
and gliosis. Pender (1988) makes the point that one possible major difference between 
EAE and MS is that the neurological signs of EAE may be attributed to peripheral nervous 
system (PNS) involvement whereas MS is diagnosed on the presence of neurological 
signs in the CNS. PNS involvement has been described in EAE in the rabbit (Waksman 
and Adams, 1955; Wisniewski et al., 1969), mouse (Waksman and Adams, 1956), 
guinea-pig, rats and mice with chronic relapsing EAE (Madrid and Wisniewski, 1978; 
Lassman et al., 1980; Brown et al., 1982) and the monkey (Ferraro and Roizin, 1954). 
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Acute EAE is considered to be a satisfactory model for the human disease acute 
disseminated encephalomyelitis (Adams, 1959; Levine, 1971; Lisak et al., 1974) whereas 
chronic relapsing forms of EAE are a more appropriate mcxiel for MS. Chronic relapsing 
forms of EAE in the immature strain 13 and Hartley guinea-pigs are clinicopathologically 
similar to MS. Both diseases have a relapsing clinical course, inflammatory lesions, 
primary perivenous demyelinated plaques, gliosis, loss of oligodendrocytes with some 
axonal loss within the plaques in the later stages of disease (Lassman and Wisniewski, 
1979). Although there are dissimilarities between MS and EAE, EAE is a useful model to 
study neuroimmunological relationships in the CNS. Abberations in immune regulation 
may be a result of disease rather than a cause and it is important to establish the site and 
nature of the lesions responsible for neurological signs. 
1~6 Aims of the present study 
1.6.1 T cell entry into the CNS 
Lymphocytes are normally found in low numbers in the CNS. Migration of T 
cells to the CNS and their cellular distribution in EAE lesions is well documented. How 
their entry is achieved during EAE in the absence of gross damage to the vascular 
endothelium is unknown. This study addresses the hypothesis that "activated" 
lymphocytes of any specificity enter the CNS but only those with neuro-antigen 
specificity persist and cause pathology. 
The host contribution to passively induced EAE was also examined by assessing 
whether the entrance and accumulation of neurospecific cells was altered by irradiation of 
the recipients. 
1.6.2 Age related changes in EAE 
The development of EAE requires an intact lymphoid system and with advancing 
age the lymphoid system undergoes atrophy and has a decreased ability to mount a T cell 
immune response. MS and its animal model EAE are both age dependent diseases. It is 
rare for children to develop MS. Similarly, neonatal rats are resistant to EAE and become 
susceptible at approximately 8 weeks of age. Lesions of MS begin in relation to small 
blood vessels and alterations of the clotting mechanism have been reported in MS patients 
and in ageing. Lack of the endothelial smooth muscle cell relaxing hormone (nitric oxide) 
seems to be involved in the occurrence of spasm of blood vessels and differences in the 
production of this hormone may possibly be involved in the pathogenesis of MS and 
EAE. Previous research also suggests that aberrations in immunoendocrinological 
communication may be the cause of immune dysfunction in both autoimmunity and 
ageing, corticosterone playing an important role in the recovery of animals from EAE. 
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The immunoregulation of EAE was investigated by specifically looking at age related 
differences and testing for differences in immunoregulatory factors such as the prcxluction 
of cytokines and the effects of hormone levels on the disease state. 
A combined clinical, biochemical and histopathological study of acute EAE in 
Lewis(JC) rats of differing ages was performed to understand the clinical manifestations 
of this neurological disease. The specific aims of the study were: 
1) to ascertain the functional significance of antigen specificity and state of activation of 
lymphocytes in entry and accumulation in the CNS; 
2) to establish clinical and histopathological changes in disease of aged animals and to 
determine the mechanisms of recovery; 
3) to correlate the clinical, histological changes and recovery with the prcxluction of 
corticosteroids, TNF, nitric oxide, prostaglandins and MBP antibody. 
The study of the principles of the inflammatory process within the CNS may lead 
to pharmacologic or immunoregulatory ways of manipulating the inflammatory process. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Animals 
Lewis (JC) rats were bred under specific pathogen free conditions at the Animal 
Breeding Establishment, John Curtin School of Medical Research (JCSMR), Canberra. 
Lewis (JC) rats bred at the JCSMR carry the AA allelle whereas most other Lewis rats are aa. 
This strain is fully susceptible to EAE although the disease is not as severe and deaths are 
infrequent. In lymphocy e labelling studies, only male rats between the ages of 9 and 12 
weeks were used as recipients of cell populations. In all experiments, control and 
experimental animals were age and sex matched. Sterilisation of females by ovariectomy was 
performed at four days postnatally by Dr. Andrew Hughes, a veterinarian. 
2.2 Irradiation 
Rats were given total bcxiy irradiation with a lOOCi 60co gamma source one day 
before receiving cultured cells. Groups of four rats were placed in plastic containers on a 
revolving stage 15 ems from the source. The dose rate was 60 rads/min with 1000 rads being 
the total dose delivered. Peripheral blood leukocyte levels were assessed using white cell 
counting fluid. 
2.3 Antigens 
MBP was isolated from frozen guinea pig CNS tissue using the methcxi of Deibler et 
al. (1972). The entire procedure was carried out at 4oC. Spinal cords and brains were 
weighed and then homogenised in 19 volumes of chloroform/methanol (2:1, v/v) and stirred 
overnight. The mixture was filtered (Whatman filter paper No. 1) by vacuum and the filtrate 
discarded. The tissue residue was resuspended in 10 volumes of acetone, stirred for 15 mins 
and filtered again. The acetone-treated residue was resuspended in 20 volumes ddH2O (pH 
2.1) and stirred overnight. After vacuum filtration (Whatman filter paper No. 54) the residue 
cto<..!ole.c.. 1~1111ed aO 
was resuspend in 5 volumes(dd.H2 The stirred H2O suspension was slowly adjusted to pH 
3.0 by dropwise addition of lN HCL and stirred for lh with the pH being maintained at 3.0, 
filtered again and the residue discarded. 33.3mls purified 8M urea per lOOmls of the pH3 
extract was added, and stirred for 10 mins. 
Purified MBP was then obtained by ion-exchange chromatography on CM-52 resin 
(Carboxymethylcellulose, Whatman). Equal volumes of CM-52 to the original weight of 
spinal cord was added and by dropwise addition of lN NaOH, the suspension was adjusted 
to pH 11.6 and stirred for 30 mins. The alkaline suspension was vacuum filtered (Whatman 
filter paper No. 54). The solid was resuspended in 2 volumes 2M urea - 0.02M NaCL - 0.2 
M scxiium glycinate solution (pH 11.6), stirred and vacuum filtered. This step was repeated 
with the same volume of urea-salt-buffer solution and 4 volumes of H2O was added, stirred 
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and filtered (repeated twice). The residue was resuspended in 2 volumes H2O (pH 2.5) with 
1 M HCl, stirred for 5 mins and filtered. Resuspended in 2 volumes 0.1 M HCl and stirred 
for 10 mins. After filtering, the filtrate was dialysed for 2 days in ddH2O before being freeze 
dried (Dynavac Model FD12, Australia). The yield of MBP from 50g of original spinal cord 
material was approximately 50mg. The purified MBP was stored at -4oC. 
Grade V ovalbumin (QA) with an electrophoretic purity of approximately 99% was 
used (Sigma Chemical Co., St. Louis, MO, USA). Purified protein derivative of tuberculin 
(PPD) was obtained from CSL, Parkville, Vic, Australia. 
2.4 Blastogenesis assay 
The cross reactivity of MBP- and PPD-specific cell lines was assessed using a 
lymphocyte proliferative assay. MBP- and PPD-specific cell lines were cultured in 
quadruplicate in 96-well Linbro culture plates (Linbro Chemical Co., New Haven, Conn.) at 
concentrations of 105/ml or Io6/ml in 0.2ml RPMI (Flow, McLean, VA) containing 5% foetal 
calf serum (FCS; Flow Labs. Stanmore, NSW, Australia), 2mM L-glutamine, 5xIQ-5M 2-
mercaptoethanol (2ME), antibiotics and antigens (either MBP or PPD at concentrations of 
25µg/ml and 50µg/ml). Irradiated (2000rads) normal thymocytes were used as accessory 
cells (5xI05 or lxl06) and the plates were incubated for 72h at 37°C in an atmosphere of 
10% CO2, 7% 02 with the balance N2. Five hours before harvesting, cultures were pulsed 
with 5µCi (methyI-3H) thymidine (specific activity 5Ci/mmole, Amersham, 
Buckinghamshire, England). Cultures were harvested on glass fiber filters (Whatman, 
Clifton, NJ) with a multiple automated sample harvester (Skatron Titertek, Lierbyen, 
Norway) and 7 mis PPO (2,5-Diphenyloxazole) was added. Dried filters were transferred to 
counting vials and the proliferative response was determined by measuring the radioactivity on 
a Packard Liquid Scintillation Counter (Packard Instrument Co., Downers Grove, ILL). 
2.5 Immunisation 
The appropriate antigen was dissolved in saline and emulsified in an equal volume of 
CFA (Difeo Laboratories, Detroit, Ml) containing 4mg/ml heat killed Mycobacterium 
butyricum (Difeo Laboratories, Detroit, MI). Rats were immunised subcutaneously with a 
volume of 100 µl of the antigen/adjuvant emulsion into each hind footpad. The total dose 
received per rat was 50 µg antigen plus 400 µg M. butyricum. 
2.6 Passive transfer of EAE with MBP reactive splenocytes 
Single cell suspensions were prepared from the spleens of donor rats sensitired with 
50µg MBP emulsified in CFA 10-12 days previously. Cells were cultured at 2x106/ml in 
RPMI containing 5%FCS, 5x 10-SM 2ME, 2mM L-glutamine and antibiotics. Cells were 
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activated in vitro with 2µg/ml Concanavalin-A (Con A) for 3 days at 37°C in an atmosphere 
of 10% CO2, 7 % 02 and the balance N 2. Cells were harvested, washed in serum free 
medium and transferred via the lateral tail vein. Transfer populations contained 5xl07 viable 
cells (method of Panitch and Mcfarlin, 1977). 
2. 7 Generation of antigen-specific T cell lines 
Activated MBP-, OA- and PPD-specific cell lines were derived from the lymph ncxle 
cells of animals immunised with the appropriate antigen using the method of Ben-Nun et al. , 
(1981) (Fig. 2.1). Draining lymph nodes (LNs) (popliteal and inguinal) were removed 10 
days after immunization with protein antigens and single cell suspensions were prepared by 
gently pressing the LN s through a 400-mesh wire screen into RPMI (Flow, McLean, VA). 
Cells were washed once and resuspended at a concentration of 2xl06/ml in Eagle's medium 
(Grand Island Biological Co., Grand Is., NY) containing 1 % fresh autologous serum, 5xl0-
5M 2-ME, 2mM L-glutamine, lmM sodium pyruvate, antibiotics and 50 µg/ml of the 
appropriate antigen and incubated at 37°C in an atmosphere of 8% CO2, 7% 02 and the 
balance N2. Following activation, cells were depleted of dead lymphocytes by density 
separation using Isopaque-ficoll as previously described by Davidson and Parish (1975). The 
cells collecting at the interface were found to be highly enriched for lymphoblasts. The cell 
lines were maintained in medium with a 15 % content of interleukin-2 (IL-2) containing 
medium (see below) and 10% FCS in the absence of specific antigen or accessory cells. The 
lines were alternately (every 3-4 days) stimulated with specific antigen (20µg/ml MBP, 
50µg/ml OA, 50µg/ml PPD) in the presence of syngeneic irradiated (2000rads) normal 
thymus cells (5xl06/ml) as accessory cells. 
2.8 Interleukin-2 (IL-2) preparation 
IL-2 containing culture supematants were prepared based on the method of 
Rosenberg et al. (1978) and were used as a T cell growth factor for the maintenance of the cell 
lines. Single cell suspensions were prepared by gently pressing rat spleens through a 400-
mesh wire screen into RPMI. Cells were washed once and resuspended at a concentration of 
107 /ml in RPMI containing 5%FCS, 5x1Q-5M 2ME, 2mM L-glutamine, antibiotics and 
5µg/ml ConA and incubated for 4-6h at 37°C in an atmosphere of 8% CO2, 7% 02 and the 
balance N2. Cells were washed twice by centrifugation (300g, 5mins, 4°C) to remove lectin 
and serum and resuspended at 5xl06/ml in serum free medium containing lOOµg/ml bovine 
serum albumin (BSA). Cells were incubated for 40h at 37°C, then IL-2 enriched medium 
was harvested by centrifugation and sterile filtered. 
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Fig. 2.1: Activated MBP-, OA- and PPD-specific cell lines were derived from the lymph 
node cells of animals immunised with appropriate antigen. Draining lymph nodes (popliteal 
and inguinal) were removed 10-12 days after immunization and single cell suspensions were 
prepared. The cell lines were maintained in medium with interleukin-2 and were alternately 
stimulated with specific antigen in the presence of accessory cells. Subsequently the lymph 
node derived cells lines were labelled with H33342 and injected via the tail vein into naive 
syngeneic recipients. 
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2.9 Immunofluorescence and flow cytometry 
The surface phenotype of the MBP-specific T cell line was assessed by 
immunofluorescent flow cytometry using anti-CD4 (clone W3/25) and anti-CD8 (clone OX8, 
both kindly provided by Dr. Donald Mason, Oxford) monoclonal antibodies (mAb). MBP-
specific cells (106) were resuspended in 200µ1 RPMI containing 5% FCS, 0.02% NaN 3, and 
the appropriate mAb dilution ( 1 :50). Following incubation on ice for 60 mins the cells were 
underlayed with FCS, pelleted by centrifugation and incubated with 200 µl of 1:30 dilution of 
fluoresceinated sheep F(ab')2 anti-mouse IgG (Silenus, Dandenong, Vic, Australia) for 30 
mins on ice followed by a final wash through a layer of FCS. Secondary fluoresceinated 
antibody without primary antibody was used as a control for background staining. 
The level of fluorescent staining was analysed on a Becton Dickinson FACS 440 
equipped with a Spectra physics 2025 laser. Fluorescein was excited at 488nm, triggering on 
forward scatter through a number 1 neutral density filter and fluorescence emission detected 
through a 560 dichroic filter and 535/15 nm bandpass filter. Uncorrelated data was collected 
using log amplification with a base of 1 and multiplier of 0.5. 
2.10 Clinical assessment of EAE 
The animals were examined daily for clinical signs of EAE and scored on an arbitrary 
scale of severity ranging from Oto 5 where: 0 = asymptomatic; 1 = flaccid distal half of tail; 
2 = entire tail flaccid; 3 = ataxia, difficulty with righting reflex; 4 = hindlimb weakness; 5 = 
hindlimb paralysis. Animals suffering from hindlimb paralysis were given supportive care in 
that they were watered by hand, turned twice daily and dry bedding was maintained. 
2.11 Histologic examination 
Rats were selected for histological examination at various times post-immunisation 
with MBP in CFA or injection of effector cells. Rats were anaesthetized, the chest cavity was 
opened and a small incision was made in the right auricle. Rats were perfused with 10% 
neutral buffered formalin under pressure via the left ventricle. Brains and spinal cords were 
removed and the spinal cord was divided into lumbar, thoracic and cervical areas. Tissues 
were fixed in 10% neutral buffered formalin. The subsequent sectioning and staining was 
performed by Ms Wendy Hughes, Histology Section, JCSMR. Sections were embedded in 
paraffin, sectioned longitudinally and stained with either hematoxylin and eosin (Culling, 
1974) to demonstrate cellular infiltrates in lesions, MSB Fibrin (method of Lendrum et al., 
1962 as shown in Culling, 1974) to ascertain the degree of fibrin and collagen deposition, a 
mercuric chloride staining method (Naoumenko and Feigin's modification of Cajal's methcxi 
as shown by Ralis et al., 1973) to demonstrate astrocytic hypertrophy throughout the CNS or 
chromoxane cyanine R (method of Pearse, 1957 as amended by Clark, 1981) which is a 
myelin sheath stain to observe demyelination (see below for the methods). A minimum of 10 
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sections from each area and at different levels was prepared from each animal for each staining 
methcxl. 
2.11.1 Hematoxylin and eosin stain 
Sections of 4µms were: 
1) deparaffinised and brought to water through xylene and graded alcohols; 
2) stained with Gill's Hematoxylin (3mins); 
3) washed in water, 
4) treated with Scott's tap water substitute (0.2% scxlium bicarbonate and 1.0% magnesium 
sulphate in distilled water) for 1 min; 
5) washed in water, 
6) stained in alcoholic eosin for 2 mins; 
7) differentiated in 2 changes of 90% alcohol; 
8) dehydrated and mounted. 
Using a conventional microscope (Nikon Optiphot), the number and distribution of 
inflammatory lesions were assessed in five fields per section. 
Stained sections were photographed under a conventional microscope (Nikon 
Optiphot) (Fig. 2.2a) and a laser scanning confocal microscope (Biorad MRC 500) (Fig. 
2.2b). 
2.11.2 MSB Fibrin stain 
Sections of 4µms were: 
1) placed in Zenker's solution overnight; 
2) washed in running water for 1-2 hrs; 
3) treated with a alcoholic iodine and sodium thiosulphate sequence to remove the mercury 
pigment; 
4) washed in water, 
5) stained with celestin blue (5mins); 
6) rinsed in water, 
7) stained with Gill's Hematoxylin (3mins); 
8) washed in water, 
9) treated with Scott's tap water substitute for 1 min; 
10) washed in water, 
11) rinsed in 95% alcohol; 
12) stained with Martius yellow solution (2mins); 
13) rinsed in distilled water; 
14) stained in 1 % brilliant crystal scarlet in 2.5% acetic acid for 10 mins; 
15) rinsed in distilled water; 
a) 
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Fig. 2.2: Brain and spinal cord sections were stained using hematoxylin and eosin to 
demonstrate cellular infiltrates in lesions throughout the CNS. Stained sections were 
photographed under a conventional microscope (a) (x225, scale bar corresponds to 50µms) 
and a laser scanni11g confocal ·microscope (b) (x600, scale bar corresponds to 25µms) . 
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16) treated with 1 % phosphotungstic for 5 mins; 
17) rinsed in water; 
18) stained in 0.5% aniline blue in 1 % acetic acid 10mins; 
19) rinsed in 1 % acetic acid; 
20) dehydrated and mounted. 
Using this methcxl the nuclei were stained blue black, fibrin was red, red cells were 
yellow and collagen was stained blue. Differences in fibrin deposition was determined using 
a conventional microscope (Nikon Optiphot). Stained sections were photographed under a 
conventional microscope (Nikon Optiphot) using the black and white video (Fig. 2.3a) or 
colour video (Fig. 2.3b) and a laser scanning confocal microscope (Biorad MRC 500) (Fig. 
2.3c). 
In addition, fibrin deposition was assessed by transmission electron microscopy in 
one animal from each group at each time point. Approximately four segments throughout the 
lumbar spinal cord were selected from each parraffin wax embedded specimen. 
Subsequently, the segments were prepared for electron microscopy by Ms Sue Bell 
(Histology Section, JCSMR) using the following procedure: 
1) the wax was removed from the tissue using 2 changes of xylene for a total of 30 mins; 
2) the tissue was rehydrated 3 times using a graded series of ethanols (absolute alcohol, 95%, 
90%, 70%, 50%, 30%) for 10-15 mins each; 
3) rinsed in distilled water for 1-2 mins; 
4) immersed in 0.lM caccxlylate buffer pH 7.4 for 1 hour; 
5) and 2% osmium tetroxide solution for 1.5 hours; 
6) washed 2 times with 0. lM caccxlylate buffer (5 mins); 
7) rinsed in distilled water; 
8) stained with 2% uranyl acetate for 1 hour; 
9) washed 2 times in distilled water (5 mins); 
10) dehydrated 3 times in a graded series of ethanols (30%, 50%, 70%, 90%, 95%, absolute 
alcohol) for 10-15 mins each; 
11) immersed in 1.1 mixture Spurr's resin/absolute alcohol for 2 hours; 
12) and absolute Spurr's resin for 2 hours; 
13) embedded in Spurr's resin and polymerised for 8 hours at 800C; 
14) cut on a Reichert-Jung Ultracut ultramicrotome; 
15) stained with uranyl acetate and Reynold's lead citrate; 
16) examined and photographed on a Philips 301 Transmision Electron Microscope. 
c) 
Fig. 2.3: Brain and spinal cord sections were stained using the MSB Fibrin 
technique to detect the degree of fibrin and collagen deposition. Using this 
method the nuclei were stained blue black, fibrin was red, red cells were 
yellow and collagen was stained blue. Stained sections were photographed 
under a conventional microscope using the black and white video (a) (x450, 
scale bar corresponds to 25µms) and colour video (b) (x450, scale bar 
corresponds to 25µms) and a laser scanning confocal microscope (c) (x200 
scale bar corresponds to 100 µms). 
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2 .11.3 Astrocyte Stain 
Sections of 20µms were: 
1) taken down to water and placed in a solution of 0.6g ammonium bromide and 14mls 
formalin in 1 OOmls distilled water for 3 days at room temperature (RT); 
2) rinsed briefly in distilled water, 
3) placed in 8mls 1 % gold chloride in 40 mis distilled water and 6.4mls of 5% aqueous 
mercuric chloride was added immediately and mixed well. Sections were kept in the dark for 
12 hours at room temperature; 
4) after rinsing for 2-5 mins, sections were fixed in 5% sodium thiosulphate for 5mins and 
rinsed again in distilled water for 5 mins; 
5) dehydrated and mounted in Histoclad. 
It has been found using this method that fibrous astrocytes of the white matter stain 
better than the grey matter and pathological astrocytes stain intensively while resting astrocytes 
are inconspicuous (Ralis et al., 1973). The astrocytes were stained dark purple with the 
background a pale pink colour. Using a conventional microscope (Nikon Optiphot), the 
changes in astrocyte staining patterns were assessed in five fields per section. Stained 
sections were photographed under a conventional microscope (Nikon Optiphot) (Fig. 2.4 ). 
2.11.4 Chromoxane Cyanine R stain 
Sections of 4µms were: 
1) deparaffinised and brought to water through xylene and graded alcohols; 
2) stained with chromoxane cyanine R solution (0.2% chromoxane cyanine R in 1 OOmls 
0.5% aqueous sulphuric acid, boiled for 5 mins) for 10 mins; 
3) washed in water, 
4) differentiated for 1 min in 1 % aqueous ammonium hydroxide (NI-4OH); 
5) washed in water, 
6) counterstained 15 mins in 1 % aqueous neutral red; 
7) rinsed quickly in distilled water, 
8) dipped 1 sec in copper sulphate-chrome alum solution (0.5gm CuSO4.5H2O, 0.5gm 
CrK(SO4)3.12H2O, 3.0mls 10% acetic acid and 250mls distilled water); 
9) rinsed quickly in distilled water, 
10) dehydrated quickly and clear in xylene; 
11) mounted. 
Using this method the nuclei and nissl bodies were stained red and myelin was 
stained blue. Changes in myelin staining patterns were assessed using a conventional 
microscope (Nikon Optiphot) in five fields per section. Stained sections were photographed 
under a conventional microscope (Nikon Optiphot) using the colour video (Fig. 2.5a) and 
black and white video (Fig. 2.5b,c ). 
Fig. 2.4: Brain and spinal cord sections were stained with a mercuric chloride 
technique to detect proliferating astrocytes. The astrocytes were stained dark purple 
with the background a pale pink colour. Stained sections were photographed under a 
conventional microscope (a) (x225, scale bar con-esponds to 50µms) and (b) (x450, 
scale bar con-esponds to 25µms). 
a) 
b) 
c) 
Fig. 2.5: Brain and spinal cord sections were stained using the chromoxane 
cyanine R staining technique to detect the degree of demyelination. Using this 
method the nuclei and nissl bodies were stained red and myelin was stained 
blue. Stained sections were photographed under a conventional microscope 
using the colour video (a) (x90) and black and white video (b) (x90, scale bar 
corresponds to l00µms) and (c) (x1350, scale bar corresponds to 10 µms, 
large arrows point to one myelinated axon). 
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2.12 Analysis of in vivo lymphocyte migration 
The migration of lymphocytes was monitored in vivo by labelling cells with the DNA 
binding fluorescent dye Hoechst 33342 (H33342, Sigma, St. Louis, USA) as previously 
described by Brenan and Parish (1984). H33342 is an intensely fluorescent dye taken up by 
all cells, which remains intracellular, being diluted only by division (Brenan and Parish, 1984; 
Brenan et al., 1985; Weston and Parish, 1990). 
In a pilot study, using a standard transfer population of 30 x 106 EAE cell lines, 
H33342 labelled cells were found to be as equally encephalitogenic as unlabelled cells. This 
was evidenced by identical disease critera of day of onset, severity and duration of symptoms 
(Willenborg, unpublished data). 
Antigen-activated T cell lines were isolated 4 days after antigen stimulation in vitro. 
Non-activated cell populations were antigen-specific cell lines taken after 3 days culture in IL-
2 containing medium. Lymphocytes were resuspended at 5xl07 cells/ml in RPMI containing 
1 %FCS to which was added 12µg/ml of H33342. The cells were incubated for 15 mins in a 
37°C waterbath, being shaken after 10 mins. Labelling was stopped by adding cold medium, 
cells were washed twice by centrifugation (300g, 5 mins, 4°C) and resuspended in serum-
free medium. Prior to injection the lymphocyte cell suspensions were examined for 
fluorescent intensity and uniformity of labelling. H33342 was found to have an intense 
fluorescence evenly distributed throughout the entire cell population. The cells were counted 
on a fluorescent microscope using a haemocytometer to ensure that the number of labelled 
cells to be injected was accurate and also checked for viability by their ability to exclude the 
dye trypan blue. 
The H33342 labelled cells (108 viable cells) were then injected into a lateral tail vein 
of either irradiated or non-irradiated syngeneic rats. At specified time intervals the animals 
were observed for clinical signs of EAE, then anaesthetised with ether and 2.5 mis of blood 
collected by cardiac puncture and peripheral blood lymphocytes isolated by centrifuging the 
blood on Isopaque-ficoll. Subsequently, animals were killed and the lungs, spleen, 
mesenteric lymph nodes and spinal cord removed. The spinal cord was divided into three 
20mm sections relating to the lower (lumbar 1-6, sacral 1), middle (thoracic 3-9) and the 
upper (cervical 1-7) regions (Fig. 2.6). Sections were weighed and single cell suspensions 
were then prepared by gently pressing tissue through a 400-mesh screen into 2 mls of 
medium. The content of H33342-labelled cells was quantified in the cell suspensions by 
fluorescence microscopy using an Olympus fluorescence microscope (BH series) and a HBO 
(100W) mercury vapour lamp for epi-illumination and appropriate barrier and filter 
combinations for H33342 (364nm excitation and >435nm emission). Labelling cells with 
H33342 resulted in an intensely fluorescent nuclear staining pattern which allowed cells to be 
easily observed against background autofluorescence at low magnification on a fluorescence 
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Fig. 2.6: Schematic diagram of the adult rat spinal cord showing the different 
regions of the spinal cord. In this study the spinal cord was divided into three 
sections relating to the lower (lumbar 1-6, sacral 1 ), middle (thoracic 3-9) and 
the upper (cervical 1-7) regions (Adapted from Waibl, 1973). 
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microscope. Positively stained cells could be accurately counted up to 4 days post 
inoculation. 
The total number of labelled cells present in the organs or per 100mg spinal cord was 
then calculated. Determinations represent the mean of five animals for each group at each time 
point except in the case of the IL-2 maintained MBP-specific cells where data from only 3 
animals was obtained per time point due to the difficulty in obtaining large numbers of these 
cells. To increase the accuracy of the method when the number of fluorescent cells in a 
sample was very low, 5 samples for each specimen were counted on the haemocytometer and 
the mean of these results was used. The sensitivity of this assay was such that at least 100 
labelled cells was necessary per tissue sample before the fluorescent cells could be detected. 
In order to estimate the content of blood borne lymphocytes in spinal cord cell 
suspensions, the blood content of samples was determined spectrophotometrically based on 
haemoglobin absorbance. The procedure involved lysing red cells by the addition of 1.9 
volumes of distilled water to 0.1 volume of peripheral blood or spinal cord cell suspension, 
spinning out debris (12000g, 10 mins) and measuring haemoglobin absorbance at 540nm on a 
microplate reader (Model MR600; Dynatech Laboratories, Alexandria, VA) with a reference 
wavelength set at 630nm. Based on peripheral blood haemoglobin absorbance the content of 
blood in spinal cord samples was then calculated. 
2.13 Anti-MBP antibody assay 
At specified time intervals the animals were observed for clinical signs of EAE, 
anaesthetised with ether and bled from a cut in the tail and the levels of anti-MBP antibody in 
the serum was assessed. Dynatech microELISA plates (Dynatech, Switzerland) were coated 
with MBP at a concentration of l0µg/ml in phosphate-buffered saline (PBS). 200µ1 of MBP 
was added to each well and the plates incubated overnight at 4oC. The MBP was removed 
and the plates washed 3 times with PBS. To reduce the amount of non-specific binding, 
200µ1 of 2% BSA in PBS was added to each well and the plates then incubated for 30min at 
RT. Plates were washed 3 times with buffer (0.2% gelatine, 0.5% Tween 20 
(polyoxythlylene sorbitan monolaurate) in PBS) and 100µ1 of 2-fold dilutions (in buffer) of 
serum added to the wells. After a 90min incubation at RT the plates were washed 5 times 
with buffer and 100µ1 of peroxidase labelled rabbit anti-rat lg (Dakopats, Copenhagen, diluted 
1: 1500 in buffer) was added to each well. Plates were incubated for 1 hr at RT, washed 5 
times in buffer and 100µ1 substrate added to each well. The substrate was made fresh and 
consisted of 30mg O-phenylenediamine, 4µ1 hydrogen peroxide, in 10ml citrate-phosphate 
buffer pH 5.4. After 15-20min the reaction was stopped by the addition of 50µ12M HCl to 
each well. Plates were read on a Dynatech microELISA plate reader at optical density 
(OD)492nm- A panel of normal rat serum was run in each assay and the mean OD plus 3 
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standard deviations of this panel calculated. Any serum dilution higher than this value was 
considered positive. Titers are expressed as log2 serum dilution. 
2.14 Measurement of TNF production 
Detection of TNF in spinal cord and spleen tissue homogenates and biological fluids 
such as CSF and plasma was assessed. At specified time intervals the animals were observed 
for clinical signs of EAE, then anaesthetised with ether and 2mls of blood collected by cardiac 
puncture. Subsequently, animals were killed, CSF was removed with a 75mm micro-
hematocrit tubes (Clay Adams) and the lumbar spinal cord removed. The blood was allowed 
to clot, serum removed and heat inactivated at 56°C for 30mins. Spinal cord sections were 
weighed and single cell suspensions were then prepared by gently pressing tissue through a 
400-mesh screen into 2 mls of medium with 10% FCS added CSF was diluted 1 in 25 with 
10% FCS media. 
Two different methods were performed to measure the production of TNF in the 
tissue homogenate and biological fluid samples of animals from different time points post 
inoculation. 
2.14.1 Method 1 
TNF levels were initially assessed using the MIT tetrazolium cytotoxicity assay 
(method of Mosmann, 1983 as shown in Espevik and Nissen-Meyer, 1986). Basically, target 
cells were seeded in 96 well flat-bottomed plates (Dynatech, Switzerland) at a concentration of 
2xlo4 cells/well (WEHI 164) in 100µ1 H16 medium containing 10% FCS, Sxl0-5 2ME and 
2µg/ml actinomycin D. Different dilutions of TNF (r-Mu TNF, Genzyme, Boston, MA) in 
H16 were added to the target cells. After 20h of incubation at 37°C in CQi, 10 µl MTT at a 
concentration of 5mg/ml in PBS was added and further incubated for 4-6 h at 37oC in C{)i. 
100µ1 of isopropanol with 0.01 M HCL was added to all wells and incubated overnight. The 
plates were read on a Dynatech MR 600 microplate reader, using a test wavelength of 600nm 
and a reference wavelength of 630nm. The percentage of dead cells was determined as the 
OD in wells with TNF divided by the OD in control wells multiplied by 100. 
2.14.2 Method 2 
TNF-a levels in the tissue homogenates and biological fluids from two different 
experiments were determined using the ELISA method based on the method of Sheehan 
(1989) (Wheeler et al., 1991) by Sue Fordham (Division of Cell Biology, JCSMR) and 
Elizabeth Rockett (Dept. of Biochemistry and Molecular Biology, ANU). Briefly, 96 well 
flat-bottomed plates (Immulon II, Dynatech Labs, Alexandria, VA) were coated by overnight 
incubation at 4°C with 0.2µg per well of TNF319:12, a TNF-specific mAb, which had been 
made up in carbonate buffer (pH 9.6). The plates were washed 6 times with PBS containing 
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0.05% Tween 20, and again between each subsequent treatment. They were then incubated 
overnight at 4oC with 100µ1 of a 1 in 5 dilution of the test samples per well in RPMI 1640 
supplemented with 10% FCS, lOmM penicillin and streptomycin, and lOmM HEPES, (RIO). 
A standard curve of recombinant murine TNF-a. (Genzyme, Boston, MA) starting at 25nglml 
and followed by 8 doubling dilutions, was used. Rabbit anti-murine TNF-a. (100µ1, 
Genzyme) in RIO at 1 in 750 dilution was added to each well for 2 hours at 25°C. The same 
volume of goat anti-rabbit alkaline phosphatase (Silenus, Victoria, Australia) at a dilution of 1 
in 1000 in Rl0 was then added for 2 hours at 25°C. Colour development was achieved using 
100µ1 per well of phosphatase substrate tablets (Sigma, St. Louis, MO) dissolved in substrate 
buffer to a concentration of lmg/ml. The plates were then read with a Titertek Multiskan MC 
ELISA reader (Flow Labs, McLean, VA) at a wavelength of 450nm with a reference of 
620nm, and the TNF-a. in the test samples calculated from the standard curve. 
2.15 Determination of blood glucose levels 
Glucose levels in the blocxi were determined by the method of Simeonovic et al. 
(1990). At specified time intervals the animals were observed for clinical signs of EAE, then 
anaesthetised with ether and a sample of blocxi (10µ1) was taken from the tail vein and diluted 
in 40µ1 of 0.66M perchloric acid. After centrifugation at 15,000 rpm for 2.5 mins (Beckman 
microcentrifuge), the plasma glucose levels (mmol/1) was measured in a Beckman Glucose 
Analyser 2 (Beckman Instruments, Inc., Fullerton, CA). The instrument was calibrated using 
the manufacturer's standard and each sample was measured in duplicate. 
2.16 Determination of glucocorticosteroid levels 
Middle aged (12-14mths) and young (2-3mths) male animals were caged in pairs. 
Between the hours of 9:00 and 10:00 a.m. both animals were anesthetised simultaneously and 
bled from a cut in the tail within 2 min. This procedure does not elevate blood steroid levels 
significantly within this time interval (Cook et al., 1973; MacPhee et al., 1989). Blood was 
allowed to clot, kept at 4°C for 24 hrs, and then centrifuged (15,000rpm, 10mins) on a 
Beckman microcentrifuge. The serum was removed and stored at -200C until assayed. The 
level of corticosterone in the _serum was determined by a radioimmunoassay (RIA) using the 
RSL (125!) corticosterone assay system (ICN Biomedicals, Inc., Costa Mesa, CA). 
2.17 Determination of prostaglandin E levels 
2.17.1 The removal of spinal cord tissue 
The techniques employed in the preparation of spinal cords of normal and sensitised 
rats for PGs extraction were based on the method of Bolton et al. (1984a). At specified time 
intervals the animals were observed for clinical signs of EAE, then killed with COi and the 
lumbar spinal cord exposed and washed in situ with a chilled solution of PBS containing 5% 
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(w/v) sodium bicarbonate and l0µg/ml of the PG synthetase inhibitor, indomethacin (Sigma, 
St. Louis, MO). The drug was employed to minimise the extracellular synthesis of PGs 
which are released by physical disruption (Samuelsson et al., 1975; Vapaatalo and 
Parantainen, 1978) during the dissection procedure. Each spinal cord section was weighed 
and then transferred to glass universals containing 2 mls of chilled PBS/indomethacin 
solution. Samples were homogenised at 4°C for 5 mins, and the resulting homogenates were 
centrifuged (3000rpm, 15 mins at 4°C). Supernatants were aliquoted, gassed with nitrogen 
for 30 secs and stored at -7(1)C. 
2.17.2 Extraction of PGs from supernatants 
In glass universals, supernatant volumes of 0.5ml were diluted 1 in 2 with PBS, 
adjusted to pH3.0 with lN HCl (tested on litmus paper) and extracted 3 times with diethyl 
ether. The ether was removed by evaporation using nitrogen gas and the dried extracts were 
stored under nitrogen at -700C until assayed. 
2.17.3 Radioimmunoassay (RIA) of extracted supernatants 
Dried supernatant extracts were solubilised in 1 ml of 0.lM tricine-buffered saline 
containing 0.1 % gelatine and 0.1 % sodium azide. RIA was undertaken using a PGE2 (125J) 
assay system (Code RPA 530, Amersham, England). 
2.18 Determination of reactive nitrogen intermediate levels 
At specified time intervals the animals were observed for clinical signs of EAE, then 
anaesthetised with ether and 2mls of blood collected by cardiac puncture. Subsequently, 
animals were killed, CSF was removed with a 75mm micro-hematocrit tubes (Clay Adams) 
and the lumbar spinal cord removed. Blood was allowed to clot, serum removed and heat 
inactivated at 56oC for 30mins. Spinal cord sections were weighed and single cell 
suspensions were then prepared by gently pressing tissue through a 400-mesh screen into 2 
mls of medium with 10% FCS added. CSF was diluted 1 in 25 with 10% FCS media. 
The measurement of reactive nitrogen intermediates (RNI) on tissue homogenates 
and biological fluids was performed by Melissa Awbum (Division of Cell Biology, JCSMR). 
The assay was based on the reduction of nitrate by a Cd-Cu complex (Davidson and Woof, 
1978; Rockett et al., 1991) and coupled to the Griess reagent for azochromaphoretic detection. 
Basically, 30µ1 volumes of plasma, cell suspensions or CSF were dispensed into 1.5ml 
plastic tubes (Elkay Products Inc., Shrewsbury, MA) in duplicate. Sodium nitrite (Sigma 
Chemical Co., St. Louis, MO) and sodium nitrate (Sigma) standards (concentration range: 
lµM to lmM) were set up separately in 30µ1 volumes of pooled normal mouse serum. 
Control tubes contained 30µ1 of normal mouse plasma or 30µ1 of phosphate buffered saline 
(pH7.2) (blank). Twenty microlitres of catalyst buffer was added to one set of samples and 
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the nitrite standard curve, while the other set and the nitrate standard curve received 20µ1 of 
catalyst. All the tubes were incubated at room temperature for 5 mins, after which the tubes 
containing the catalyst were centrifuged at 15,000rpm for 1 min (Beckman microcentrifuge) 
and the supematants were transferred to clean tubes. Griess reagent (100µ1) and 10% 
trichloroacetic acid (100µ1) were added to all tubes and mixed thoroughly before centrifuging 
for 15 mins at 15,000rpm (Beckman microcentrifuge). Two 100µ1 samples of the supernatant 
from each tube were transferred to a 96-well flat-bottom plate (Nunc, Denmark) and the 
absorbance was read on a microplate reader (Dynatech MR 600, Dynatech Scientific, Inc., 
Cambridge, MA), using a test wavelength of 540nm and a reference wavelength of 630nm. 
Plasma nitrite was calculated by reading the absorbance directly from the nitrite 
standard curve, whereas reading plasm nitrate from the nitrate standard curve first required the 
absorbance of the sample (without catalyst) to be subtracted from the absorbance of the 
sample (with catalyst). The results are expressed as micromolar concentrations of total RNI 
(the sum of nitrite and nitrate) concentrations. 
2.19 Statistical Analysis 
Statistical analysis was carried out using the Student t-test. The means of various 
treannents were considered to be significantly different when P<0.05. 
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CHAPTER 3: SELECTIVE LOCALISATION OF NEURO-
SPECIFIC T LYMPHOCYTES IN THE CNS 
3.1 Introduction 
A critical feature in the pathogenesis of EAE is the entry of T lymphocytes into the 
parenchyma of the CNS. This is the case whether EAE is induced actively by immunisation 
with MBP emulsified in CFA or passively with activated MBP-specific CD4+ T cells (Smith 
and Waksman, 1969; Raine, 1976; Hickey et al., 1983; Fontana et al., 1984; Traugott et al., 
1986; Zamvil and Steinman, 1990). The mechanism of this initial entry into the CNS is not 
known, and the concept that antigen recognition at the endothelial cell surface triggers 
migration would seem no longer tenable (Lassman et al., 1986 ; Hinrichs et al., 1987). 
Wekerle et al. (1986) have proposed that the initial emigration of lymphocytes in 
the CNS is not immunologically specific. They hypothesise that "activated" T lymphocytes 
of any specificity migrate across the CNS endothelium into the parenchyma of the CNS and 
that this random migration acts as an immune surveillance mechanism. If cells entering the 
CNS encounter an antigen for which they have a specificity, they respond accordingly, 
otherwise they either die or move back out of the CNS. Willenborg and Parish (1988) 
expanded this hypothesis to suggest that "activation" translated to the expression of enzymes 
on the lymphocyte surface which assisted the cells in degrading the sub-endothelial 
basement membrane and the extracellular matrix, thus facilitating movement through 
interendothelial junctions and the subendothelial extracellular matrix into the parenchyma. 
Both direct and indirect evidence has been provided to support this hypothesis. Activated 
lymphocytes produce elevated levels of a heparan sulphate-specific endoglycosidase 
(Naparstek et al., 1984; Lider et al., 1989) which specifically degrades the heparan sulphate 
side chains of the proteoglycan scaffold of the extracellular matrix. Inhibitors of this 
enzyme also prevent EAE development (Naparstek et al., 1984; Lider et al., 1989; 
Willenborg and Parish, 1988). Non-activated cells which lack the elevated levels of heparan 
sulphate endoglycosidase (Naparstek et al., 1984; Lider et al., 1989) do not cause disease 
(Panitch and Ciccone, 1981; Ben-Nun et al., 1981; Holda et al., 1980; Peters and Hinrichs, 
1982). 
The study described in this chapter explores further the pathogenesis of EAE by 
quantifying the accumulation and localisation of Hoechst 33342 (H33342)-labelled 
lymphocytes of different specificities in different regions of the spinal cord. H33342 is a 
highly fluorescent dye which binds specifically to DNA (Brenan and Parish, 1984; Brenan 
et al., 1985; Weston and Parish, 1990) and individual fluorescent cells can be quantified by 
7 1 
fluorescence microscopy. The hypothesis that "activated" lymphocytes of any specificity 
enter the CNS but only those with neuro-antigen specificity persist and cause pathology was 
addressed in this study. The data presented in this chapter strongly support the hypothesis 
as T cell lines specific for MBP, purified protein derivative of tuberculin (PPD), or 
ovalbumin (QA) all enter the spinal cord, if first activated with their specific antigen, but 
only MBP-specific cell lines accumulate. QA- and PPD-specific cell lines were used 
because the antigen-specificities of these lines are non-specific to the CNS and cause no 
known illness or inflammation in syngeneic rats. Furthermore, IL-2 maintained (non-
activated) MBP-specific cell lines fail to enter the CNS and cause disease. The host 
contribution to passively induced EAE has also been examined by assessing whether the 
entrance and accumulation of activated MBP-specific cells is altered by irradiation of the 
recipients. 
3.2 Results 
3.2.1 Characterisation of cell lines 
A number of cell lines were established which were MBP-specific or specific for 
the non-neural antigens QA and PPD. A consistent feature of all cell lines was that they 
remained viable when cultured in IL-2 containing medium, although there was usually no 
increase in cell numbers, whereas it was usual to expect a 4-10 fold increase in cell numbers 
following activation with specific antigen. Immunofluorescent flow cytometry revealed that 
after two to three months of alternately culturing with specific antigen or IL-2 the cell lines 
were predominantly T cells with approximately 85-95% of the cells being CD4+ and CD8-
(Fig. 3.1 ). 
It was found using a blastogenesis assay that our PPD cell line responded 
marginally to MBP (at 25µg/ml of MBP, the PPD-specific cell line had a stimulation index 
of 2.3±0.21, compared with the MBP-specific cell line stimulation index of 10.25+1.17). 
Cross-reactivity between PPD and MBP has also been described previously by V andenbark 
etal. (1975). 
3.2.2 Ability of cell lines to induce EAE 
To assess the ability of various cell lines to induce EAE, the antigen-activated 
MBP-specific cell line, the IL-2 maintained MBP-specific cell line and the antigen-activated 
QA-specific cell line were all labelled with H33342 and then transfered at 108 cells per rat 
into naive recipients. As can be seen in Fig. 3.2 the non-specific T cell line (QA) and the 
IL-2 maintained (non-activated) MBP cell line failed to induce disease whereas the activated 
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Fig. 3.1: Fluorescence profiles measured by flow cytometry of MBP-specific 
cell line labelled with (a) W3/25 (a marker for CD4+ T cells) and (b) OX8 
(a marker for CDS+ T cells) monoclonal antibodies. 
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Fig. 3.2: Ability of different T cell populations to induce EAE in recipient rats. The animals 
received either 108 H33342-labelled antigen-activated MBP-specific T cells(•), antigen-
activated OA-s~c T cells (~), IL-2 maintained MBP-specific T cells (FA) or 5xl07 ConA 
activated T cells from MBP-immunised rats (II). Animals were assessed for clinical signs of 
EAE before being culled for quantification of labelled cells present in the different organs and 
regions of the spinal cord (see Figs. 3.3, 3.4, 3.5). An arbitrary scale of disease severity 
ranging from O to 5 was used where: 0 = asymptomatic; 1 = flaccid distal half of tail; 2 = 
entire tail flaccid; 3 = ataxia, difficulty with righting reflex; 4 = hind.limb weakness; 5 = 
hind.limb paralysis. 
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MBP cell line caused disease be inning as early as day 2 after cell transfer The disease 
mBP JI Ile <.:.el I wC\s J"Y)vC,f) more seve ,re. ;1-'}c1.r, t't')(,t 
prcxiuced by 108Acaused by the standard dose of ConA activated EAE spleen cells as would 
be expected of a cell line. This large number of cells was chosen in order to increase the 
chances of detecting migration of small numbers of cells. 
3.2.3 Tissue localisation of fluorescently labelled cells 
The localisation of the H33342 labelled cell populations in different organs of 
recipient rats was assessed at various times post inoculation by fluorescence microscopy of 
cell suspensions. Fig. 3.3 shows the localisation pattern of H33342-labelled antigen-
activated MBP-specific, QA-specific, PPD-specific and IL-2 maintained MBP-specific T cell 
lines in the lower spinal cord up to 4 days post injection of labelled cells. At 24 hours post 
inoculation antigen-activated MBP-, QA- and PPD-specific cell lines could be found in the 
spinal cord. In contrast, non-activated MBP-specific cells were not detected in the lower 
spinal cord until day four after injection. Assessment of the blocxl content of spinal cord 
specimens, based on haemoglobin absorbance, revealed that <30 fluorescent T cells/100mg 
of spinal cord was due to blood contamination, a cell number well below the detection limits 
of the assay used. Thus spinal cord accumulation of the antigen-activated QA- and PPD-
specific T cells cannot be explained by blood contamination and is clearly due to localisation 
of activated T cells in the cord. 
The localisation of H33342 labelled MBP-, PPD- and QA-specific T cell lines was 
examined in other organs over the same time pericxl (Fig. 3.4). It was found that antigen-
activated MBP-, PPD- and QA-specific cells were at approximately the same levels in the 
lung, spleen, blocxi and mesenteric lymph ncxles of recipient animals at all time points. 
Similar numbers of IL-2 maintained MBP-specific T cells were also detected in the 
circulation (data not shown). Thus, differences in spinal cord accumulation was not due to 
the various cell lines being selectively removed from the blood and sequestered elsewhere, 
so that fewer cells were available in the circulation. 
The MBP activated cell line showed a dramatic increase in spinal cord accumulation 
with time. At day 2, one day before the appearance of clinical signs (Fig. 3.2), there was a 
30 fold increase in the number of labelled MBP-specific T cells in the lower spinal cord with 
further increases occurring at days 3 and 4 (Fig. 3.3). In fact, at 4 days post injection there 
was up to a 1000 fold greater number of MBP-specific T cells in the CNS than QA-specific 
T cells. 
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Fig. 3.3: The time dependent accumulation of 108 H33342 labelled antigen-activated MBP-
specific ( • ), QA-specific ( • ), PPD-specific ( •) or IL-2 maintained MBP-specific ( 0) T 
cells in the lower spinal cord (lumbar segments 1-6, sacral segment 1) of recipient rats. Each 
data point represents the mean and standard error of 5 animals except with the IL-2 maintained 
MBP-specific cell population where each data point represents the mean of 3 animals. 
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3.2.4 Accumulation of cells at various levels of the spinal cord 
As EAE clinically presents as an ascending paralysis, the question whether 
accumulation of MBP-specific T cells differed between the upper and lower spinal cord 
during development of the disease was addressed. It was found that accumulation of 
antigen-activated MBP-specific cells was the same at all three levels of the cord with the 
exception that there was no further increase in the number of cells in the cervical cord 
between days 3 and 4 compared to that observed at the other two levels (Fig. 3.5). 
Histologically lesions were apparent throughout the spinal cord and there was marked 
perivascular inflammation evident in the three regions of the cord (Fig. 3.6). It was also 
clear that IL-2 maintained MBP-specific T cells failed to enter all spinal cord regions up to 3 
days post injection whereas antigen-activated QA- and PPD-specific T cells exhibited 
significant accumulation in all regions of the cord (Fig. 3.5). 
3.2.5 Spinal cord recruitment of MBP specific cells 
The dramatic increase in accumulation of antigen-activated MBP-specific cells is 
certainly more than could be explained by additive random entrance over time. Although 
some cell replication may occur, it is unlikely that such a substantial increase ( 1000 fold) 
could be due to in situ replication of the cells. In this study, under the best in vitro 
conditions, only a 10 fold increase in cell numbers was found to occur over three days. The 
most likely explanation for this dramatic increase is that the inflammatory response set up 
following the initial entrance of the MBP-reactive cells recruits not only non-specific cells 
but also MBP-specific cells in a random fashion. To test this, 108 H33342 labelled 
activated QA-specific cells were injected with 108 unlabelled activated MBP-specific cells. 
The results. (Table 3~1) showed that H33342 labelled antigen-activated QA-specific T cells~ 
when injected with unlabelled, antigen-activated, MBP-specific T cells, accumulated in the 
spinal cord, although the accumulation of these cells was less than when the MBP-specific T 
cell line was injected alone. In the converse situation, injection of a mixture of H33342 
labelled MBP-specific T cells and unlabelled QA-specific T cells resulted in a reduced 
accumulation of the MBP-specific cells in the CNS. This phenomenon was parallelled by a 
later onset of disease (data not shown) and presumably is due to non-specific cell crowding 
effects in vivo. 
3.2.6 Host contribution to cell accumulation 
To evaluate the host contribution to passively induced EAE, non-irradiated and 
irradiated rats were given 108 antigen-activated MBP-specific effectors. Non-irradiated 
animals exhibited approximately a 2-day earlier onset of disease than irradiated animals (Fig. 
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Fig. 3.5: The time dependent accumulation of 108 H33342 labelled antigen-activated MBP-specific ( • ), QA-
specific ( • ), PPD-specific ( A ) or IL-2 maintained MBP-specific ( • ) T cells in the spinal cord of recipient rats . 
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where each data point represents the mean of 3 animals. 
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Fig. 3.6: Hematoxylin and eosin stained histological sections from rat spinal cord where 
recipients received 108 H33342 labelled antigen-activated MBP-specific T cells. Perivascular 
lesions are depicted in sections from the lumbar ((a) and (b)); thoracic ((c) and (d)) and the 
cervical ((e) and (f)) regions of the spinal cord by conventional light microscopy in (a), (c) 
and (e) at x225 and by confocal imaging in (b), (d) and (f) at x600. Scale bar corresponds to 
25µms. 
TABLE 3.1 
CELL LINE ACCUMULATION IN 'l'BB LONER SPINAL CORD 
Cell line 
Injected 
108 fluorescent 
MBP-specific 
108 fluorescent 
QA-specific 
108 fluorescent 
QA-specific+ 
108 MBP-specific 
108 fluorescent 
MB&-specific + 
10 QA-specific 
108 fluorescent 
MBP-specific 
108 fluorescent 
QA-specific 
Recipient 
Normal 
Normal 
Normal 
Normal 
Irradiated 
Irradiated 
Day 3 
Cell 
accumulation 
120.0 ± 23.oa 
0.3 ± 0.2 
4.7 ± 1.8 
27.0 ± 1.2 
5.3 ± 4.4 
0.5 ±0.2 
Clinical 
score 
I 
2.7 ± 0.3b 
oc 
0.2 ± 0.2 
0.3 ± 0.3 
0 
0 
Day 4 
Cell 
accumulation 
470.0 ± 330.0 
0.3 ± 0.2 
7.0 ± 0.5 
70.0 ± 36.0 
16.0 ± 4.3 
NDd 
a 
b 
C 
d 
represents the number of labelled cells per 100mg wet tissue x103 + se 
represents the severity of disease on a scale ranging from Oto 5 + se 
disease was not evident 
not determined 
Clinical 
score 
4.7 ± 0.2 
0 
1.5 ± 1.5 
1.3 ± 0.3 
1.5 ± 0.3 
ND 
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3.7). It was found that an irradiation dose of 1000 rads induced considerable leukopenia, 
the peripheral blood leukocyte level of irradiated rats being 5-10% and 2-3% of untreated 
rats when measured at 2 and 3 days post irradiation. The CNS localisation of T cells lines 
in irradiated animals is shown in Table 3.1. MBP-specific T cell accumulation was less 
pronounced and occurred 1-2 days later in irradiated than in non-irradiated animals, an 
observation consistent with the later onset of disease (Table 3.1). Antigen-activated OA-
specific T cells did not accumulate in the CNS of irradiated animals (Table 3.1), thus ruling 
out the possibility of extensive radiation-induced damage to the blood brain barrier allowing 
non-specific entry of T cells. 
As activated MBP-specific cells were found to accumulate to a lesser extent in the 
spinal cord of irradiated rats than in non-irradiated recipients, an interesting question was 
whether there were any differences in the size and distribution of inflammatory lesions in the 
irradiated and non-irradiated animals. To assess histological differences, 3 irradiated and 3 
non-irradiated animals were passively transferred with 108 MBP-specific cells. Due to the 
small number of animals observed over two time points, only general observations can be 
made. One animal from each group was sacrificed when animals were exhibiting the clinical 
symptom of a flaccid tail. Inflammatory cells were evident in the meningeal (Fig. 3.8 a,b) 
and perivascular regions (Fig. 3.9 a,b) of the non-irradiated animal. In contrast, in the 
irradiated animal, lesions were not apparent, but considerable haemorrhage was evident 
throughout both regions (Figs. 3.8 c,d and 3.9 c,d). In non-irradiated animals, marked 
perivascular inflammation was evident throughout the spinal cord when animals were 
exhibiting the symptom of ataxia (Fig. 3.10 a,b,c), whereas in irradiated animals exhibiting 
similar symptoms, the inflammatory cells which were evident were found to be less 
organised around the blood vessels (Fig. 3.10 d,e,f) but showed a marked presence of 
collagen (a component of the extracellular matrix) (Fig. 3.10 e) compared with lesions 
found in non-irradiated animals (Fig. 3.10 b). Sections from animals exhibiting early signs 
of EAE (flaccid tail) in the irradiated and non-irradiated groups did not show evidence of 
astrocytic proliferation (Fig. 3.11 a,c) whereas animals exhibiting more advanced symptoms 
of disease (ataxia) from both groups showed marked astrocytic proliferation (Fig. 3.11 
b,d). 
3.3 Discussion 
The results presented in this chapter support the hypothesis, originally put forward 
by Wekerle et al. (1986), that "activated" lymphocytes of any specificity can migrate into the 
CNS, but that only those cells with specificity for antigens found within the parenchyma of 
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Fig. 3.7: Ability of MBP-specific T cells to cause EAE in irradiated rats. 108 H33342 
labelled antigen-activated MBP-specific T cells were injected into irradiated (fa) or non-
irradiated ( • ) recipients. Animals were assessed for clinical signs of EAE before being 
culled for quantification of labelled cells present in the lower spinal cord (Table 3.1). 
Arbitrary scale of disease severity ranging from O to 5 as in Fig. 3.2. 
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Fig. 3.8: Hematoxylin and eosin stained histological sections of the meningeal regions of rat 
spinal cord where either non-irradiated (a,b) or irradiated (c,d) recipients received 108 
H33342 labelled antigen-activated MBP-specific T cells and exhibited early clinical signs of 
EAE (flaccid tail). Sections were viewed using video imaging at x225 (a,c) (scale bar 
corresponds to 50µms) and confocal imaging at x200 (b,d) (scale bar corresponds to 
l00µms). Inflammatory cells (large arrows) are evident in meningeal regions of the spinal 
cord by light microscopy in a non-irradiated recipient (a), whereas areas of hemorrhage (c, 
small arrows) are clearly evident in confocal images of an irradiated recipient (d). 
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Fig. 3.9: Hematoxylin and eosin stained histological sections of the parenchymal regions of 
rat spinal cord where either non-irradiated (a,b) or irradiated (c,d) recipients received 108 
H33342 labelled antigen-activated MBP-specific T cells and exhibited early clinical signs of 
EAE (flaccid tail). Sections were viewed using video imaging at x225 (a,c) (scale bar 
corresponds to 50µms) and confocal imaging at x200 (b,d) (scale bar corresponds to 
l00µms). Inflammatory cells (large arrows) are evident in perivascular regions of the spinal 
cord by light microscopy in a non-irradiated recipient (a), whereas haemorrhage (c, small 
arrows) are clearly evident in confocal images of an irradiated recipient (d) . 
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Fig. 3.10: MSB fibrin stained histological sections from rat spinal cord 
where non-irradiated (a,b,c) and irradiated (d,e,f) recipients received 108 
H33342 labelled antigen-activated MBP-"8pecific T cells and exhibited 
advanced clinical signs of EAE (ataxia). Inflammatory cells, presence of 
collagen (blure area in panel e) and fibrin deposition (fluorescent areas inc 
and f) are evident in perivascular regions of the spinal cord by light 
microscopy using black and white (a,d) and colour (b,e) video imaging at 
x225 (scale bar corresponds to 50µms) and confocal imaging at x600 (c,f) 
(scale bar corresponds to 25µms). 
a 
b) 
, 
. " 
.. 
' 
. \ 
. . 
. 
.s 
c) 
•.-
d) 
Fig. 3.11: Mercuric chloride (stain for astrocytes) stained histological sections from rat 
spinal cord where recipients received 108 H33342 labelled antigen-activated MBP-
specific T cells. Astrocytic proliferation was not evident in the spinal cord of non-
irradiated (a) and irradiated (c) recipients exhibiting early signs of EAE (flaccid tail), but 
was evident (arrows) in non-irradiated (b) and irradiated (d) recipients exhibiting more 
advanced signs of EAE (ataxia) using video imaging at x450 (scale bar corresponds to 
25µms). 
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the CNS will accumulate. In this study, antigen-activated MBP-, PPD- and QA-specific cell 
lines all accumulated in the spinal cord to a significant level. The MBP-specific cell line 
accumulated in an almost exponential fashion whereas the other cell lines although detectable 
in the CNS for four days did not accumulate. This constant level of cells in the CNS may 
represent the random ingress and egress of activated CNS and non-CNS antigen specific 
cells, as suggested by the hypothesis. This view was supported by the observation that IL-
2 maintained (non-activated) MBP-specific cells were undetectable in the spinal cord up to 3 
days after transfer. 
The state of activation of the MBP-specific cells was critical for the induction of 
disease. Non-activated MBP-specific T cells failed to accumulate in the spinal cord to a 
substantial degree (Fig. 3.5) and did not cause clinical signs of EAE (Fig. 3.2). These 
results are consistent with the earlier finding that quiescent cells do not cause disease 
(Panitch and Ciccone, 1981; Ben-Nun et al., 1981; Holda et al., 1980; Peters and Hinrichs, 
1982; Naparstek et al., 1983) and lack the elevated levels of heparanases (Naparstek et al., 
1984) which facilitate penetration of the cells through the CNS endothelium and into the 
inflammatory site (Willenborg and Parish, 1988; Willenborg et al., 1989a, 1989b ). 
Although the non-activated MBP-specific cell line was undetectable in the lower spinal cord 
on days 1-3 post injection, it did increase to over 103 cells per 100 mg tissue on day 4 (Fig. 
3.5). This increase on day 4 was also seen in the middle and upper spinal cord, but not to 
the same extent (Fig. 3.5). This late entrance of non-activated cells could indicate the in 
vivo activation of the cell line by endogenous systemic antigen. Where the antigen is, or in 
what form is only conjecture, but Day et al. (1978) have reported the existence of a MBP-
like serum factor in the serum of normal rats, which could conceivably activate the cells. 
Hickey et al. (1991), using immunohistochemical methods, also showed that T 
lymphoblasts enter the CNS in an apparent random manner while T cells not in an activated 
state are excluded. While confirming some of these results, the data presented in this 
chapter differ significantly in two ways. First, activated but non-MBP specific cell lines 
remained at a constant level in the spinal cord throughout the 4 days period of observation, 
whereas Hickey et al. ( 1991) reported that activated non-MBP specific cells left the cord by 
approximately 2 days. Why the level of activated non-specific cells in the cord returned so 
rapidly to baseline is unknown. If the number of activated cells in the circulation remained 
constant (as in the present study) then it would be expected that the cells would be available 
to move in and out of the spinal cord at an equal rate. Thus, an equilibrium would be 
maintained, until the cells lost their state of activation. Hickey et al. ( 1991) did not quantify 
the number of cells in the blood and other tissues. It is possible that their use of ConA for 
activation (in contrast to the use of specific antigen in this study) altered the cell surface 
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properties in such a way so as to ensure their diversion out of the circulation into other 
tissues. Consequently, the cells would not be available for continual movement in and out 
of the spinal cord Secondly, we found that the activated MBP-specific cells accumulated to 
high levels in the cord with time, while Hickey et al. ( 1991) showed a peak concentration 
between 9 and 12 hours after injection with a subsequent decrease and no further 
accumulation. These results could also be explained by the suggestion that ConA-activated 
cells are not available in the circulation and therefore unable to accumulate in the spinal cord 
Naparstek et al. (1983) reported that only activated MBP cell lines migrated into the 
brain and spinal cord. Using 51cr labelled cells, these investigators found (as in the present 
study) that the activated MBP specific cells accumulated in the brain and spinal cord with 
time. Naparstek et al. (1983) reported the disappearance of activated MBP-specific cells 
from the blood within 1 to 2 days of injection, whereas blood levels remained constant for 
up to four days post injection in this study. They also reported that significant accumulation 
in the brain did not occur until day 4, one day before the onset of clinical signs. However, 
in this study, there was a highly significant accumulation by day two. Further, Naparstek et 
al. (1983) did not detect the presence of activated non-neurospecific cells in the brain or 
spinal cord at any time whereas in this study and in that of Hickey et al. (1991) activated 
non-neurospecific cells were evident in the brain and spinal cord. These differences may 
reflect the fact that both in this study and in that of Hickey et al. (1991) many more cells 
(108) were used than in the study of Naparstek et al. (1983) (5 x 106). 
MBP-specific cellular accumulation was found to be similar throughout the 
different regions of the spinal cord during the first 3 days post inoculation (Fig. 3.5). This 
is an unusual finding as EAE is a disease consisting of an ascending paralysis with clinical 
signs attributed to disturbances of the lumbar-sacral areas of the cord. In this study, it was 
only at day 4 that there were significantly lower levels of labelled cells in the upper spinal 
cord than in the other regions (Fig. 3.5). Histologically, however, lesions were apparent 
throughout the spinal cord at days 4 and 7 post inoculation and there was marked 
perivascular inflammation evident in all regions of the cord (Fig. 3.6). Possibly lower 
spinal cord nerve damage is more likely to result in the clinical signs of disease. 
The substantial increase in accumulation of the antigen-activated MBP-specific T 
cells between days one and four is much more than could be accounted for by either random 
entrance of activated cells or by the replication of the cells in situ once they had entered the 
parenchyma. One possible explanation is that the MBP-specific cell line is being recruited in 
a non-specific fashion following the initial entrance of specific cells and their subsequent 
interaction with antigen. If this is the case then one would expect that antigen-activated, 
non-neuroantigen specific T cells could be recruited into the CNS if injected along with 
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activated MBP-specific cells. This is indeed what happened (Table 3.1). The CNS 
accumulation of an OA-activate4 QA-specific T cell line increased 15-20 fold when injected 
simultaneously with a MBP-activated MBP-specific T cell line. However, there was a delay 
in CNS accumulation of the QA-specific cells (data not shown), suggesting the need to first 
establish an inflammatory response, and the CNS entry by the QA-specific cells was 
significantly less than that observed when the MBP-specific T cells were injected alone 
(Table 3.1). This latter effect may be partly due to a crowding effect as 108 non-labelled 
QA-specific cells added to 108 labelled MBP-specific cells had the effect of decreasing the 
number of labelled cells accumulating in the spinal cord at days 3 and 4 (Table 3.1). 
Whereas the results of this study show that the non-specific recruitment of non-
neurospecific cells does occur, Naparstek et al., (1983) reported an inability to detect CNS 
accumulation of non-neuroantigen specific (anti-PPD) T cell lines when they were injected 
into recipients simultaneously with anti-MBP T cell lines. I have no explanation for this 
discrepency other than the way the two experiments were done. As stated earlier, in these 
studies many more cells were used than in the studies by Naparstek et al. (108 vs 5x106 ). 
Furthermore, donor cell accumulation was assessed, not only in the brain, but in all regions 
of the spinal cord, where the majority of inflammatory lesions occur. There is no doubt that 
under these experimental conditions there is significant recruitment of activated non-
neurospecific cells into the spinal cord by antigen-activated MBP-specific T cells. 
To examine the host contribution to passively induced EAE, the entrance and 
accumulation of activated MBP-specific cells was assessed in irradiated recipients. 
Radiation has been reported to have varying effects on the induction of EAE (Levine et al., 
1969) with variations probably being related to the species studied, the dose, the timing and 
the type of radiation. Some investigators found that irradiation of recipients completely 
inhibited cellular transfer of inflammatory disease (Levine et al., 1969; Werdelin and 
McCluskey, 1971) and when recipients were restored with bone marrow cells inflammation 
developed (Werdelin and McCluskey, 1971), whereas others found low dose irradiation 
(350rads) facilitated induction of EAE with MBP-reactive T cell lines (Zamvil et al., 1985). 
Sedgewick et al. (1987) reported that regardless of the status of the recipient (irradiated or 
not), clinical signs were induced when animals received MBP-reactive cells although the 
number of infiltrating leukocytes was reduced in irradiated animals. This finding may in 
fact be due to the delayed CNS entry of MBP-specifc T cells. In the present study, 
activated MBP-specific cells accumulated in the spinal cord of irradiated rats but to a lesser 
extent than in non-irradiated recipients. There was also a delay in the kinetics of 
accumulation by about two days which agrees with the altered kinetics of clinical signs (Fig 
3.7). Two possible explanations for these results would be that irradiation may directly 
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affect the endothelium in a way that makes it less adhesive or alternatively the recruitment of 
"non-specific" host cells may in turn act as recruiting cells in further promotion of the 
inflammatory response. In this study, the failure of non-specific T cells to accumulate in the 
CNS rules out the possibility of extensive radiation-induced changes in the vasculature 
allowing non-specific cellular infiltration. 
Differences in the size and distribution of inflammatory lesions in irradiated and 
non-irradiated recipients were observed by histological methods using spinal cord sections. 
(Fig. 3.8 to 3.10). In this study, as in that of Sedgewick et al. (1987), the number of 
inflammatory cells in the spinal cord of irradiated animals was reduced compared to non-
irradiated recipient animals. The correlation between the number of lesions in the CNS and 
flaccid paralysis has been found to be poor (Hoffman et al., 1973; Raine, 1980; Simmons et 
al., 1982, 1984 ), and possibly other mechanisms of dysfunction cause clinical symptoms of 
EAE. Considerable hemorrhage and the exposure of collagen, a component of the 
extracellular matrix, were found in irradiated recipients in this study, suggesting that the 
integrity of the vasculature had been affected. Sedgewick et al. (1987) also found that 
disease in irradiated recipients was associated with substantial hemorrhagic lesions in the 
spinal cord and brain stem. In addition, a complete absence of hemorrhagic lesions was 
reported in irradiated recipients receiving QA-reactive cells, suggesting that the vascular 
damage was caused by the MBP-reactive cells. In support of this hypothesis, the clinical 
signs of EAE and hemorrhage were preventable by the administration of mAbs specific for 
the CD4 antigen, leading to the conclusion that the ability to repair damage has been 
compromised in irradiated animals. In support of this conclusion, it is known that CD4+ 
cells are cytotoxic to MBP-presenting astrocytes in vitro (Sun and Wekerle, 1986) and 
possibly CD4+ cells cause damage to the blood vessels within the CNS, resulting in the 
fonnation of local oedema and astrocytic hypertrophy and consequently in nerve conduction 
defects and clinical symptoms of EAE. 
An important observation in this study was that astrocytic proliferation was evident 
in irradiated and non-irradiated animals exhibiting advanced clinical signs of EAE (Fig. 
3.11). The astrocytic response to injury of the CNS is a process called reactive gliosis 
(Miller et al., 1986). Scars are fonned by astrocytes extending numerous processes that 
become larger and have a substantial increase in glial filaments (Maxwell and Kruger, 1965; 
Eng, 1985). The proliferating astrocytes engage in phagocytosis (Neske et al., 1982; 
Kandel, 1985; Eng, 1985), and consequently astrocytes remove debris and help seal-off 
damaged brain tissue after neuronal death or injury (Kandel, 1985). This encroachment of 
astrocytes displaces presynaptic terminals and results in the damaged neurons receiving 
reduced synaptic input, with the evoked excitatory presynaptic potentials being smaller in 
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amplitude (Kandel, 1985). Clinical and histological EAE can also be induced in guinea pigs 
and monkeys by the injection of human glioblastoma (Bigner et al., 1981 ). These results 
suggest that astrocytes could be important in the development of clinical signs of EAE with 
the loss of nerve transmission which results in paralysis possibly being due to astrocytic 
proliferation slowing the conduction of fibers. The role of astrocytes in EAE will be 
examined further in Chapter 5. 
The question of whether antigen specific lymphocytes accumulate at sites of antigen 
presence is very important when considering approaches to inhibit autoimmune 
inflammation. This question has therefore been asked in systems other than EAE. 
Lightman et al. (1987) reported that T cell lines directed against retinal S antigen (ThS) did 
not accumulate in the eye of naive recipients to any greater extent than did T cell lines against 
PPD. This was the case even though recipients of ThS developed autoimmune 
uveoretinitis. When comparing the studies of Naparstek et al. (1983), Hickey et al. (1991), 
Lightman et al. (1987) and my own (all of which used T cell lines in a rat model) it is 
evident that where accumulation of antigen specific cells is reported, the cell lines were 
activated with specific antigen, but when ConA was used to activate cell lines antigen 
specific cells did not accumulate. An exception to this is seen in a study of EAE in the 
mouse by Cross et al. (1990) where MBP activated MBP-specific T cell lines were reported 
not to accumulate. These investigators used (14C)thymidine-labelled cells and 
autoradiography to identify and localize cells. This technique would seem to be less 
sensitive as no cells were seen until day 5 post transfer, and thus it is difficult to compare 
our results with theirs. The question of whether the type of activation (specific antigen vs 
ConA) influences the ability of neurospecific cell lines to accumulate needs to be addressed. 
Both activated non-neurospecific cell lines (QA- and PPD-specific) enter the lower 
spinal cord and persist at a low level. There was a difference in the absolute numbers of 
cells observed for the two cell lines, with the PPD-specific cells being more numerous. One 
possible explanation for this difference is that PPD-specific T cells show some cross 
reaction with MBP and the cell line is therefore behaving as a neuroantigen-specific cell line. 
Cross-reactivity between PPD and MBP has been described previously by V andenbark et 
al., (1975). This explanation would seem unlikely, however, because if the cells were 
reacting with antigen, a higher level of PPD cells in the spinal cord with accumulation with 
time would be expected. This is clearly not the case. Furthermore, PPD-specific cells were 
not more numerous than QA-specific cells in other regions of the spinal cord (Fig. 3.5). 
Another possibility is that the two cell lines differed in their degree of "activation" and hence 
their ability to enter the CNS parenchyma. This brings up the question of what exactly 
"activation" represents. This is currently unknown but it has been suggested that activation 
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translates to the expression of enzymes on the lymphocyte surface that facilitate the 
degradation of the sub-endothelial basement membrane and extracellular matrix thus 
promoting emigration (Willenborg and Parish, 1988; Willenborg et al., 1989a, 1989b). 
There are of course a number of other interpretations of what "activation" represents such as 
the up-regulation of lymphocyte function associated antigens (LFA-1) with increased 
adhesion to endothelial cells (Cannella et al., 1990; Sobel et al., 1990), or the ability of 
activated but not non-activated cells to produce a given range of cytokines (Powell et al., 
1990). Comparing specific antigen-activated with ConA-activated cells with respect to their 
ability to express enzymes, adhesion molecules or various cytokines may provide valuable 
inf onnation. 
In conclusion, this study demonstrates that activated lymphocytes of any specificity 
enter the spinal cord whereas only neuro-antigen specific cells accumulate, initiating an 
inflammatory response with resultant non-specific recruitment of mononuclear cells and 
associated vascular damage. Non-activated cells, even those with neural antigen specificity 
fail to enter the cord. Understanding the nature of what an "activated" lymphocyte is will 
possibly enable the design of strategies to inhibit such immune-mediated inflammation. 
3.4 Summary 
Using EAE in the rat as a model of CNS inflammation, activated and quiescent T 
lymphocytes with different antigen specificities were labelled with the fluorescent dye 
Hoechst 33342 and tested by fluorescence microscopy for their ability to accumulate in 
different regions of the spinal cord and in other organs at varying times post inoculation. 
With this highly sensitive assay it was found that activated MBP-specific T cell lines 
accumulated in the spinal cord (a lOOOfold increase in the lumbar/sacral region by day 4) 
and caused clinical signs of EAE. In contrast, IL-2 maintained (quiescent) MBP-specific T 
cell lines failed to accumulate in the CNS and cause disease. Activated QA-specific and 
PPD-specific T cell lines were also found at significantly higher levels in the spinal cord 
than non-activated cells although they failed to accumulate to a substantial degree when 
injected alone. When injected with activated MBP-specific T cells the activated OA-, and 
PPD-specific cell lines accumulated in the spinal cord following initial accumulation of the 
MBP-specific cells, demonstrating that during the inflammatory process there is 
considerable non-specific recruitment of cells into the inflammatory site. CNS accumulation 
of activated MBP-specific T cell lines occurred 1-2 days later in irradiated animals than in 
non-irradiated recipients. This was consistent with irradiated animals also exhibiting a later 
onset of disease and suggests that irradiation may directly affect the endothelium in a way 
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that makes it less adhesive. Preliminary observations also supported the view that in 
irradiated animals tissue repair mechanisms in the CNS are compromised. Considerable 
hemorrhage and the exposure of collagen, a component of the extracellular matrix, were 
found in irradiated recipients in this study, suggesting that the integrity of the vasculature 
had been affected. An important observation in this study was that astrocytic proliferation 
was evident in irradiated and non-irradiated animals exhibiting advanced clinical signs of 
EAE. These results suggest that astrocytes could be important in the development of clinical 
signs of EAE. In conclusion, this study demonstrates that activated lymphocytes of any 
specificity enter the spinal cord, and that the neuro-antigen specific cells accumulate there 
and lead to the recruitment of other cells. Non-activated cells, even those with neural 
antigen specificity fail to enter the spinal cord. Understanding the nature of what an 
"activated" lymphocyte is may allow the design of strategies to inhibit such immune 
mediated inflammation. 
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CHAPTER 4: AGE RELATED CHANGES IN THE SEVERITY 
AND CHRONICITY OF EAE 
4.1 Introduction 
Ageing is associated with a marked deterioration of the immune system (Gardner, 
1980; reviewed by Talor and Rose, 1991) and a significant increase in the incidence of 
autoimmune diseases (Talor and Rose, 1991). Two functional changes in the immune system 
which are thought to be associated with the increased incidence of infectious and autoimmune 
diseases observed in the elderly are the decline in the immune response to exogenous stimuli 
and a loss of self tolerance (Ackerman et al., 1991). 
One of the anatomically most prominant age-related changes is the decline in size of 
the thymus (Boyd, 1932) and the decline in immune responsiveness with age has been 
demonstrated most prominantly in T-cell-mediated immunity (reviews by Kay, 1980; Kay and 
Makinodan, 1981; Nagel, 1983; and Ackerman et al., 1991). Age-related alterations in 
lymphocyte function include a decrease in CD4+ and CD8+ T cell activity, a decrease in T cell 
response to mitogens and antigens and a decrease in the production of lymphokines including 
IL-2 (reviewed by Ackerman et al., 1991). Age-related changes in macrophages and B cell 
function (Heidrick and Makinodan, 1972; Gardner and Remington, 1978; Becker et al., 1981; 
Goidl et al., 1983; reviewed by Ackerman et al., 1991) may also indirectly influence T-cell-
mediated responses. 
MS and its animal model EAE are both age dependent diseases. It is rare for 
children, or adults after the age of 50, to develop MS (Kurland, 1952). The presence of a 
mature lymphoid system is necessary for the development of EAE (Paterson et al., 1970) as 
neonatal rats are resistent to EAE and become susceptible at approximately 8 weeks of age. 
EAE is also a T cell mediated disease, as demonstrated by an inability of genetically 
susceptible animals depleted of T cell precursors by neonatal thymectomy (Wick, 1972; 
Bernard et al., 1976), thoracic duct drainage (Gonatas and Howard, 1974), or anti-thymocyte 
serum (Ortiz-Ortiz and Wiegle, 197 6) to manifest symptoms. Injection of normal thymocytes 
restores susceptibility to disease (Amason et al., 1962; Lennon and Byrd, 1973; Ortiz-Ortiz 
and Wiegle, 197 6; Gonatas and Howard, 1979). The important role played by T cells in this 
process is further illustrated by the demonstration that the adoptive transfer of sensitised T 
cells from an EAE donor (Paterson, 1960; Stone, 1961; Astrom and Waksman, 1962; Levine 
et al., 1970; Bernard et al.,1976) or the introduction of encephalitogenic T cell clones into 
naive syngeneic recipients, cause disease symptoms (Ben-Nun et al., 1981; Hauser et al., 
1984b; Raine, 1984). The course of the disease can also be modified by immunosuppressive 
medication (reviewed by Raine, 1985), such as treatment with anti-class II antibodies or 
treatment with anti-CD4 antibcxties. Thus, it is clearly established that EAE is mediated by 
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:MI-IC class II antigen-restricted T cells (Pettinelli and McFarlin, 1981; Zamvil et al., 1985). 
However, the actual mechanisms initiating the CNS entry of T cells and the subsequent CNS 
damage produced by the ensu ,11j· inflammatory response remain unclear. In this context, it is 
of considerable interest to determine whether advanced age, which is associated with a decline 
in T cell-mediated immunity, protects against EAE, a T cell mediated disease. 
Conflicting results have been found in previous studies on EAE development in aged 
animals. Mc Farlin et al. (1974) reported recurrent EAE in aged (6 months old) female Lewis 
rats, whereas young rats of the same strain exhibited a monophasic course of disease. Ben-
Nun et al. (1981) found Lewis rats developed recurrent or chronic EAE when sensitised with 
MBP at an advanced age. In old mice, susceptibility to EAE induced with bovine proteolipid 
apoprotein (PLP) and MBP was found to be reduced significantly although some old mice 
develop histologic EAE without clinical signs. Lymphocyte proliferative response to 
mitogens and antigens, and IL-2 production were also decreased in aged mice (Endoh et al., 
1990). It was subsequently found that the reduced susceptibility of old mice to EAE and the 
decreased T cell functions cannot be restored by the treatment of old mice with thymic 
hormones (Endoh and Tabira, 1990). However, Endoh et al. (1990) found that clinical signs 
and histological lesions were more severe in the small number of aged mice which did develop 
disease, indicating that although there was a decrease in susceptibility to EAE with age, when 
disease was apparent in aged animals it was severe. Levine and Sowinski (1976) 
demonstrated an age related decline in susceptibility to EAE in rats. They found that with 
intense immunisation (MBP+CF A +pertussis vaccine) of rats (inbred Fischer 344 (F344) 
males) aged 2, 6 and 12 months, EAE developed at a similar rate and severity. There was a 
lesser response in 18 and 24 month olds with a more protracted incubation period and milder 
or absent signs. However, with less intense immunisation (without pertussis or lµg MBP) 
almost all 6 month olds developed disease but not a single 24 month old developed EAE under 
these conditions. The data indicated an age related decline in susceptibility to EAE although 
histologic examination of inoculated feet and draining lymph nodes revealed no deficiencies in 
the processing of the antigenic inoculum. However, none of their aged rats seemed to be free 
of illness and extensive leukemic infiltration of lymphoid organs might have 
immunosuppressed recipients. Levine and Sowinski (1976) suggested that because of the 
multiplicity of specific illness found in F344 rats (Sass et al., 1975), that this was not a good 
model for assessing age related factors and possibly a strain with a longer life-span would be 
a better model. 
In this study, the pathogenesis and immunoregulation of EAE was investigated by 
specifically looking at age related differences in Lewis (JC) rats, a rat strain which does not 
suffer from a multiplicity of age-related illnesses. In a preliminary experiment, old rats (over 
one year old) were found to have an increased chronicity of the disease compared to young 
rats when actively induced with EAE. Consequently, a combined clinical, histopathological 
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and biochemical study of EAE in Lewis (JC) rats of differing ages was performed to 
understand the clinical manifestations of this neurological disease. The specific aims of the 
study were: 
1) to establish clinical and histopathological changes in the disease of aged animals, 
to examine sex-related differences in disease severity in aged animals and to 
determine the mechanisms of recovery; 
2) to determine whether advanced age protects against EAE as it does against MS in 
humans; 
3) to correlate the clinical and histological changes and disease recovery with the 
production of MBP-specific antibody, corticosteroids, TNF, nitric oxide and 
prostaglandins (see Chapter 6). 
4.2 Results 
4.2.1 Age-related differences in clinical profiles 
EAE was actively induced by immunisation with MBP in CFA in rats of different 
ages to determine the age-related differences in the development of disease. Representative 
clinical disease profiles of male geriatric (24-26 months old), middle-aged (12-13 months old) 
and young (2-3 months old) rats are shown in Fig. 4.1. The clinical course of the disease 
was typical for this model of EAE, namely animals initially developed a flaccid tail followed 
by hindlimb weakness and then paralysis. The severity of disease was similar in that 
paralysis was evident in all age groups, however the disease chronicity in older animals was 
significantly higher. The number of deaths was high in geriatric rats and a chronic relapsing 
course with a high number of deaths also occurred in middle-aged rats (Fig. 4.1). It is 
evident in Table 4.1 that young animals exhibited a short monophasic episode of hindlimb 
paralysis (1.7 days), they recovered from this episode of paralysis with no obvious deficit, 
had a low death rate (10% ), a short length of disease (7.4 days) and only 11 % of animals 
exhibited a mild second episode of disease. In comparison, there was a slower and less 
vigorous response initially in middle-aged and geriatric rats which have a mean day of onset 2 
to 3 days later than young recipients. Middle-aged animals had a high death rate (35%) and 
high relapse rate (62%) with significantly more days paralysed (4.6) and a protracted length of 
disease was also evident (18.6 days). In geriatric rats, there was a higher death rate (54%) 
but, animals that didn't die had less chronic disease (2.9 days with hindlimb paralysis and 
length of disease of 12.3 days) with no evidence of relapses. These data clearly indicate an 
age-related increase in the disease chronicity of EAE in middle-aged and geriatric rats with 
significantly more deaths evident in both middle-aged and geriatric animals than in young 
animals. 
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Fig. 4.1: Effect of age on actively induced EAE. Representative clinical profiles of male 
geriatric (a), middle-aged (b) and young (c) rats inoculated with 50µg MBP in CFA 
containing 400µg M. butyricum~ Animals were assessed for clinical signs of EAE daily and 
an arbitrary scale of disease severity ranging from Oto 5 was used as in Fig. 3.2. Eac.h 
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TABLE 4.1 
AGE RELATED CHANGES IN THE CBRONICITY AND SEVERITY OF EAE IN MALE RATS . 
Number of 
animals 
Mean day 
of onset 
Number of 
deaths 
Number with 
relapses 
Number of days 
with hindlimb 
paralysis 
Mean lengthC 
of disease 
Young 
(2-3 months) 
20 
10.5 ± O.la 
2/20(10%) 
2/18(11%) 
1.7 ± 0 . 4 
7 . 4 + 0 . 7 
Middle Aged 
(12-14 months) 
20 
12.0 ± 0.3 
7/20(35%) 
8/13(62%) 
4.6 + 0 . 8 
18 . 6 ± 2 . 2 
Geriatric 
(24-26 months) 
13 
13.5 ± 0 . 5 
7/13(54%) 
0/6(0%) 
2.9 ± 0 . 7 
12.3 + 1 . 3 
a + se (Resultswere derived from three experiments) 
b relapse is defined as a second episode of disease where clinical signs 
were evident for 2 or more days 
c the number of days clinical signs of EAE were evident 
85 
A general observation made during these experiments was that there were slight 
variations found in the course of disease between experiments. In Fig. 4.2, it is evident that 
in one experiment, middle-aged (a) and young (c) rats had more relapses than in a second 
experiment where middle-aged (b) and young rats (d) received a different batch of MBP, 
although the MBP had been prepared using the same method. However, in this second 
experiment middle-aged rats exhibited a higher death rate. It has been suggested previously 
(Mc Farlin et al., 1973; Martenson et al., 1974) that the initial attack of EAE may be prcxiuced 
by one encephalitogenic determinant of MBP whereas the second attack is related to a different 
determinant. These results are consistent with this hypothesis and consequently one 
substantial batch of MBP was prepared and used for the remainder of the experiments. Minor 
variations may also be attributed to seasonal and individual differences. 
4.2.2 Sex-related differences in clinical profiles 
EAE was actively induced by immunisation with MBP in CF A in male and female 
rats of different ages to determine the sex-related differences in the development of disease. 
In Fig. 4.3, representative clinical profiles of geriatric male (a) and female (b ), middle-aged 
male (c) and female (d) and young male (e) and female (t) rats are shown. Disease severity 
and the number of deaths was highest in geriatric rats of both sexes (a,b ), a chronic relapsing 
course with significant deaths occurred in both male and female middle-aged rats (c,d), 
whereas a typically monophasic disease was evident in both male and female young rats (e,t). 
It is evident from Fig. 4.3 and pooled data in Table 4.2, that males generally exhibited 
increased severity and chronicity compared with fem ales of the same age. Thus, it was found 
that at all ages, females had a mean day of onset approximately 2 days after males of the same 
age, and fewer deaths, less numbers of days with paralysis with generally a shorter duration 
of disease. 
To test whether hormonal levels were contributing to the generally less severe and 
less chronic form of the disease found in females, middle-aged sterilised females were 
compared with non-sterilised females of the same age using both actively and passively 
induced disease models of EAE. In Table 4.3, it is evident that no significant differences 
between sterilised and control animals were found in these experiments. The sterilisation of 
fem ales had no detrimental effect on the onset or severity of clinical EAE in middle-aged 
animals using either active or passive induction of the disease. 
4.2.3 The Role of MBP-specific antibody 
To assess whether MBP-specific antibody production correlated with the onset, 
severity or chronicity of EAE, the serum anti-MBP antibcxly titres of young and middle aged 
male rats were determined up to 80 days post inoculation with MBP in CF A (Fig. 4.4 ). In 
this study, anti-MBP antibody levels were found to reach a peak by day 30 post inoculation 
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Fig. 4.3: Relationship of age and sex on actively induced EAE. Representative clinical 
profiles of geriatric male (a) and female (b), middle-aged male (c) and female (d) and young 
male (e) and female (f) rats inoculated with 50µg MBP in CFA containing 400µg M. 
butyricum. Animals were assessed for clinical signs of EAE daily and an arbitrary scale of 
disease severity ranging from O to 5 was used as in Fig. 3.2. 
TABLE 4.2 
SEX RELATED CHANGES IN TSE CBRONICITY AND SEVERITY OF EAE IN RECIPIENTS OF 
DIFFERENT AGES 
Number of 
Animals 
Mean day 
o~ onset 
Number of 
deaths 
Number ot, 
relapses 
Number of 
days with 
hindlimb 
Young 
(2-3 months) 
Male Female 
24 23 
9.5 ± O.la 11.3 ± 0.3 
5/24(21%) 0/23(0%) 
3/19(16%) 2/23(9%) 
paralysis 1.8 ± 0.3 0.4 ± 0.2 
Mean lengthc 
of disease 7.7 ± 0.5 6.2 ± 0.3 
Middle aged 
(12-13 months) 
Male Female 
20 6 
11.9 ± 0.3 13.0 ± 0.5 
14/20(70%) 2/6(33%) 
0/6(0%) 2/4(50%) 
5.2 ± 0.8 3.8 ± 0.4 
12.0 ± 1.6 13.3 ± 1.4 
Geriatric 
(24-26 months) 
Male Female 
10 8 
13.8 ± 0.5 16.1 ± 0.8 
5/10(50%) 2/8(25%) 
0/5(0%) 0/6 (0%) 
1.9 + 0.6 0.75 + 0.5 
12.4 + 1.6 9.5 + 1.3 
a + se 
b relapse is defined as a second episode of disease where clinical signs 
were evident for 2 or more days 
c the number of days clinical signs of EAE were evident 
.... 
TABLE 4.3 
CHRONICITY AND SEVERITY or EAi: IN STERILISED AND NON-STERILISED MIDDLE 
AGED FEMALE RECIPIENTS 
Number of 
Animals 
Mean day 
of onset 
Number of 
deaths 
Number of 
relapsesc 
Number of 
days with 
hindlimb 
paralysis 
Mean lengthd 
of disease 
Actively Induced EAE 
(MBA+ CFA) 
Sterilised Non-Sterilised 
5 5 
12.0 ± 0.3a 12.0 ± 0.3 
0/5(0%) 0/5(0%) 
2/5(40%) 0/5(0%) 
5.3 ± 0.3 7.7 ± 0.3 
18.3 + 6.5 23.3 + 4.7 
Passivlly Induced EAE 
(50x10 ConA-activated 
effector cells) 
Sterilised Non-Sterilised 
4 5 
4.0 ± 0.4 4.6 ± 0.2 
0/4(0%) 0/5(0%) 
0/4(0%) 0/5(0%) 
0.8 ± 0.3 0.2 + 0.2 
14 + 1.8 11.8 + 1.9 
a memory animals received 50x106 ConA activated effector cells 4 days postnatally 
b ± se 
c relapse is defined as a second episode of disease where clinical signs were 
evident for 2 or more days 
d the number of days clinical signs of EAE were evident 
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Fig. 4.4: Serum anti-MBP antibody titres of young (•) and middle aged ( 0) male rats 
inoculated with 50µg MBP in CFA containing 400µg M. butyricum. Antibody titres are 
expressed as the reciprocal of the sen1m dilution. Each data point represents the mean and 
standard error of 10 animals. 
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and when measured at 80 days post inoculation were found to be still at the same high level. 
No significant differences were found between the anti-MBP antibody titres of young and 
middle-aged animals. 
4.2.4 Memory response in aged animals 
Neonatal rats, passively transferred with ConA-activated spleen cells from MBP-
immunised rats do not show clinical or histopathological evidence of disease after the transfer 
of cells. If these animals are actively sensitised with MBP in CFA at 10 to 12 weeks of age, 
they will develop disease significantly earlier than control animals (Willenborg, 1986). The 
earlier onset of disease in rats that were neonatally injected with MBP sensitised lymphocytes 
is thought to be a memory response due to the persistence of transferred cells. To ascertain 
the persistence of the memory response, rats that had neonatally received 50x106 ConA-
activated spleen cells from MBP sensitised rats were immunised with MBP in CFA at 13 
months of age. In this study, the EAE memory response was also evident in aged animals 
(Table 4.4). The day of disease onset was approximately 2 days earlier in animals which had 
received EAE effector cells neonatally than in controls of the same age and sex, suggesting the 
memory response is a long-term phenomenon lastly for more than one year. However, no 
significant differences were found in the length and severity of disease between the naive and 
neonatally inoculated male animals. However, an increased severity and chronicity was found 
when males were compared to female rats of the same age. One hundred percent of the naive 
male rats died and a large number of the neonatally inoculated male rats died (67%) or had 
relapses (30%). In contrast, naive female rats had no deaths or relapses. These results 
confirm once again the sex differences in disease manifestations. However, neonatally 
inoculated female rats had a higher number of deaths (23%) and relapses (50%) than naive 
females suggesting an earlier and more vigorous response in these animals. 
4.3 Discussion 
The results presented in this chapter show that aged Lewis (JC) rats develop a more 
chronic form of EAE with significantly more deaths than younger rats of the same strain. 
Although there was a slower and less vigorous response initially in aged animals, the disease 
chronicity in middle-aged and geriatric rats was significantly higher. Young animals exhibited 
a short monophasic episode of disease, had a low death rate and only a few animals exhibited 
a mild second episode of disease. These results suggest there is a deficit in the resolution of 
paralysis resulting from CNS inflammatory lesions in older animals. The study also revealed 
that male rats exhibited increased severity and chronicity of disease compared with females of 
the same age. However, sterilisation off em ales did not have a significant effect on disease 
profiles. 
TABLE 4.4 
DAY OF ONSET, CHRONICITY AND SEVERITY OF EAi: IN MIDDLE-AGED NAIVE AND 
PREVIOUSLY INOCULATED RECIPIENTS. 
Number of 
Animals 
Mean day 
of onset 
Number of 
deaths 
Number of 
ralapsesc 
Number of 
days with 
hindlimb 
paralysis 
Mean lengthd 
of disease 
Naive 
Mala Female 
10 9 
10.6 ± 0.3b 11.6 ± 0.2 
10/10(100%) 0/9(0%) 
0/0(0%) 0/9(0%) 
6.7 ± 0.8 2.7 ± 1.0 
10.1 ± 1.1 12.7 + 1.0 
Mamorya 
Male Female 
9 13 
8.4 ± 0.2 8.9 ± 0.2 
6/9(67%) 3/13(23%) 
1/3(33%) 5/10(50%) 
6.3 ± 1.1 3.1 ± 0.9 
11.0 + 1.8 11.8 + 1.9 
a memory animals received 50x106 ConA activated effector cells 4 days postnatally b + se 
c relapse is defined as a second episode of disease where clinical signs were 
evident for 2 or more days 
d the number of days clinical signs of EAE were evident 
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Although EAE is usually a monophasic self-limiting disease in rats, recurrent EAE 
has been previously reported in aged (6 months old, Mc Farlin et al., 1974 and 13 months 
old, Ben-Nun et al., 1980) female Lewis rats. Kallen and Logdberg (1982) also reported 
there was an age-effect on the susceptibility of Lew/Mol (a nearly EAE resistant Lewis 
substrain) rats. In contrast, an age related decline in susceptibility to EAE has been 
demonstrated by some researchers (Levine and Sowinski, 1976; Endoh et al., 1990). Levine 
and Sowinski (1976) found that with intense immunisation (MBP+CFA+pertussis vaccine) of 
rats (inbred Fischer 344 males) aged 2, 6 and 12 months, EAE developed at a similar rate and 
severity. However, there was a lesser response in 18 and 24 month olds with a more 
protracted incubation period and milder or absent signs. With less intense immunisation 
(without pertussis or lµg MBP) almost all 6 month old animals developed disease but not a 
single 24 month old animal developed EAE under these conditions. They concluded that this 
indicates a deficit in the recipient and possibly in the non-specific components of the 
inflammatory response in the CNS. However, none of their rats seemed to be free of disease 
and extensive leukemic infiltration of lymphoid organs might have immunosuppressed 
recipients. In the study reported in this chapter, two Lewis (JC) rats which had very 
extensive abdominal swelling were refractory to EAE and were discarded from the 
experiment. Due to the array of pathologic lesions found in aged F344 rats (Sass et al., 1975; 
Levine and Sowinski, 1976), it appears that F344 rats are not a good model for assessing age 
related factors whereas Lewis (JC) rats, due to being a healthy and more long-lived strain, are 
a more appropriate model. 
Sex steroid hormones have previously been found to influence normal immune 
mechanisms (Cohn, 1979) and the development of autoimmune disease (Talal et al., 1984). 
In this study, females generally showed a less severe and less chronic form of the disease. In 
contrast, generally there is a marked predominance of autoimmune diseases in females and in 
autoimmune models, androgens have been found to suppress and estrogens to accelerate 
disease severity (Roubinian et al., 1978; Ahmed and Penhale, 1982). For instance, in murine 
lupus, a model for systemic lupus erythematosus (SLE), females have a more severe form of 
the disease (Roubinian et al., 1977). Castrated males develop an accelerated autoimmune 
disease indistinguishable from females (Roubinian et al., 1978). However, sterilisation of 
females fails to improve disease severity (Raveche et al., 1979) suggesting that it is androgen 
which is causing the immunosuppressive effect in this model of autoimmunity. Keith (1978a) 
reported a sex-related difference in the incidence of spontaneous recurrent EAE. Although the 
mean onset and the severity of disease was similar in both males and females, 45% of females 
had a recurrent episode as severe as the initial attack. In contrast, no males exhibited a second 
episode of disease. However, 15% of males died whereas all females survived both episodes 
of disease. Hormonal changes due to pregnancy have also been shown to have an 
immunosuppressive effect on the course of EAE in rats and guinea pigs (Keith, 1978b). 
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Although the clinical signs of EAE were found to be considerably delayed in the pregnant 
animals, if disease did occur, it was of a similar severity in pregnant and non-pregnant 
animals. However, histologically pregnant animals exhibited more severe lesions, suggesting 
that pregnancy only has a delaying effect on the onset of the disease and does not reduce the 
severity of disease (Keith, 1978b). In the study described in this chapter, middle-aged 
sterilised females were compared with non-sterilised females of the same age using both 
actively and passively induced disease models of EAE to test whether hormonal levels were 
contributing to the chronicity of disease evident in older animals. The sterilisation of females 
had no detrimental effect on the onset or severity of clinical EAE in middle-aged animals, 
however, it may be appropriate to test young sterilised animals as well. 
In this study, MBP-specific antibody production did not correlate with onset, 
severity or relapse of EAE. These are similar results to those found in previous studies where 
MBP-specific antibody levels were determined in young animals (Lisak et al., 1969; Lennon 
et al., 1971; Tabira and Endoh, 1985). Anti-MBP antibody levels were found to reach a peak 
by day 30 post inoculation and when measured at 80 days post inoculation were found to be 
still at a high level. No significant differences were found between young and aged animals in 
the production of MBP-specific antibody. Although there is no direct evidence suggesting 
that antibody plays a role in the pathogenesis of EAE, a role for circulating factors has been 
suggested in EAE (Bornstein and Appel, 1961; Brosnan et al., 1983). B cell and 
immunoglobulin-deficient rats fail to develop clinical or histological evidence of EAE when 
sensitized with whole spinal cord or MBP (Willenborg, 1983). MBP-specific antibcxiy can be 
detected in serum by day 6 after antigenic challenge (Gonatas et al., 1974) and MBP is found 
in the antigen depot for at least a year after injection (Tabira et al, 1984 ). As suggested by 
some researchers (Paterson and Harwin, 1963; Willenborg, 1979, 1980), it is possible that 
antibcxly may play a role in demyelination within inflammatory lesions, and in the recovery 
and resistance to re-induction of EAE. 
Neonatal rats do not show clinical or histopathological evidence of disease after the 
transfer of EAE effector cells. However, these rats are thought to be asymptomatic carriers of 
the disease as previous studies (Willenborg, 1986) have shown that if these animals are 
actively sensitised with MBP in CFA at 10 to 12 weeks of age, they will develop disease 
significantly earlier than control animals (7 to 8 days compared with 10 to 11 days). Animals 
which had received effector cells neonatally were found to not only develop disease earlier but 
MBP antibody levels also increased at Day 5 rather than Day 7. The earlier onset of disease in 
rats that are neonatally induced is thought to be a memory response due to the persistence of 
transferred cells (Willenborg et al., 1986). In this study, this memory response was also 
evident in aged animals 13 months after receiving the effector cells, suggesting that an early 
etiological event may set up an autoimmune carrier state which can persist even into middle-
age. These results support the hypothesis put fof\1/ard by many researchers that MS is caused 
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by a viral infection occurring in childhood or adolescence which induces prolonged 
immunological memory to CNS antigens (Wege et al., 1984; Tardieu et al., 1984; Waksman, 
1988). Coupled with the observation in this chapter that EAE is more severe in aged animals, 
in MS an early etiological event may set up an autoimmune carrier state which can persist even 
into middle-age and be reactivated with chronic disease resulting due to the aged persons 
inability to resolve inflammation effectively. 
In conclusion, the results presented in this chapter suggest that age-related factors can 
cause a shift in EAE in Lewis (JC) rats from a self-limiting disease to a chronic or relapsing 
disease of the CNS. The age-related mechanisms affecting EAE may be complex as age 
modifies both the immune and endocrine systems. Subsequent chapters will examine in detail 
factors that may explain the differences in EAE chronicity between young and aged animals. 
4.4 Summary 
EAE was produced in young (2-3 month old), middle-aged (12-13 month old) and geriatric 
(24-26 month old) Lewis (JC) rats by active immunisation with MBP in CFA. It was found 
that aged Lewis (JC) rats develop a more chronic form of EAE than younger rats of the same 
strain. Active induction shows a slower and less vigorous response in the first instance in 
aged animals, but the chronicity does not resolve suggesting there is a problem in the 
resolution of the immune response at the inflammatory site in older animals. In contrast, no 
significant difference in the production of MBP-specific antibodies was found between young 
and aged animals. Males exhibited an increased severity and chronicity of disease compared 
with females of the same age. It was found that at all ages, females had a mean day of onset 
approximately 2 days after males of the same age, fewer deaths, less numbers of days with 
paralysis with generally a shorter duration of disease. However, the sterilisation of females 
had no detrimental effect on the onset or severity of clinical EAE in middle-aged animals. The 
memory response previously shown in young animals which had received EAE effectors 
postnatally was also evident in aged animals 13 months after receiving the effector cells. In 
terms of MS, these results suggest that an early etiological event may set up an autoimmune 
carrier state which can persist even into middle-age and be reactivated with chronic disease 
resulting due to the aged persons inability to resolve inflammation effectively. 
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CHAPTER 5: AGE-RELATED CHANGES IN EAE-INDUCED 
INFLAMMATION OF THE CNS 
5.1 Introduction 
As discussed in Chapter 4, the chronicity of actively induced EAE was significantly 
increased in aged rats ( over one year old). The study presented in this chapter aimed to 
determine whether these clinical differences could be attributed to gross differences in the 
histopathology of the disease in aged animals. 
In EAE, the correlation between the number of inflammatory lesions in the CNS 
and flaccid paralysis is poor (Hoffman et al., 1973; Raine, 1980; Simmons et al., 1982, 
1984). A number of hypotheses have been proposed to explain this apparent paradox. 
The extent of oedema in the spinal cord has been one of the suggested mechanisms of 
neurological dysfunction (Levine et al., 1966; Leibowitz and Kennedy, 1972; Simmons et 
al., 1982; Sedgewick et al., 1987; Butter et al., 1989). The accumulation of 
inflammatory cells is thought to initiate oedema formation and result in fibrin deposition 
as vascular permeability allows extravasation of plasma proteins into the perivascular 
space where fibrinogen is converted to insoluble fibrin and deposited (Colvin and 
Dvorak, 1975). Fibrin is deposited in lesions of EAE (Oldstone and Dixon, 1968; 
Paterson, 1976; Rauch et al., 1978) and in histological sections of spinal cord from Lewis 
rats with acute EAE, Ackerman et al. (1981) found that fibrinogen was restricted to 
vessels containing cellular infiltrates. These results suggested that fibrin deposition does 
not occur as a result of general vascular permeability, but is produced by infiltrating cells. 
As fibrinogen is a large molecule (340,000 daltons) it can possibly only enter lesions 
when vascular damage has occurred. Neural cells are also a rich source of thromboplastin 
and any damage in the CNS can lead to the release of thromboplastin and additional fibrin 
formation (Graebar and Stuart, 1978). These results suggest that oedema associated with 
fibrin deposition may cause a loss of conduction of impulses down nerve fibres which 
results in paralysis in EAE. The subsequent resolution of oedema may be the initial factor 
contributing to the recovery from disease. 
In contrast, it has been suggested by others that it is demyelination which 
produces the clinical signs ofEAE (Pender, 1987; Pender et al., 1990). The insulation of 
axons with myelin is essential for the high-speed conduction of action potentials as the 
myelin sheath shields against the capacitance and conductance of the intemcxle (Morrell 
and Norton, 1980). In myelinated axons, the action potential propagates discontinuously, 
in saltatory jumps from one node of Ran vier to the next, which is a faster process than the 
continuous propagation of unmyelinated axons (Rowland, 1985). Demyelination causes 
conduction block with refractory periods of transmission (McDonald and Sears, 1970; 
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Smith et al., 1979,1981; Bostock and Grafe, 1985; Kaji et al., 1988). Motor conduction 
abnormalities have been found in the region of the spinal cord ventral roots in acute EAE 
in Lewis rats (Pender, 1988b). However, the clinical form and amount of demyelination 
are different depending upon the species and antigens used Chronic relapsing EAE, like 
MS, is characterised by extensive demyelination associated with lesions. Guinea pigs 
show the greatest amount of demyelination and the least axonal damage with more 
demyelination seen in animals with a more chronic disease process (Tabira and Sakai, 
1987). Guy et al. (1991) measured myelin sheath thickness and axon diameter of optic 
nerves in guinea pigs suffering from EAE. Both myelin sheath thickness and axonal 
diameter of animals with EAE were significantly lower than normal animals. Jones et al. 
( 1990) found that prom in ant peri vascular demyelination associated with mononuclear 
inflammation was evident in passively induced EAE in Buffalo rats and that demyelination 
occurred without the addition of demyelinating antibodies or subsequent clinical relapses. 
In contrast, there are numerous claims that demyelination cannot be the cause of 
neurological signs of acute EAE as demyelination is reported to be sparse or absent in 
these models, particularly if MBP is the inoculum (Lampert, 1965; Hoffman et al., 1973; 
Lassman and Wisniewski, 1979; Panitch and Ciccone, 1981; Raine et al., 1981; 
Simmons et al., 1981, 1983; White, 1984; Kerlero de Rosbo et al., 1985). Although 
MBP is necessary for the induction of the inflammatory response, demyelination may be 
caused by an additional immune response against other lipid myelin surface antigens 
(Moore et al., 1984). In addition, demyelination occurs in cerebellar cultures if EAE sera 
from animals immunised with whole CNS tissue is used (Bornstein and Appel, 1961) but 
not if MBP is used as the immunogen (Seil et al., 1968). 
Remyelination is also evident in EAE (Lampert, 1965; Wisniewski et al., 1969; 
Lassman et al., 1980b) and has been proposed to play a role in disease recovery although 
it has generally been considered to be a late feature of demyelinated chronic lesions 
(Prineas et al., 1969). As remyelination occurs, conduction is restored resulting in a 
return to transmission (Smith et al., 1979, 1981). Koles and Rasminsky (1972) found 
that as little as 3% of normal myelin thickness could be sufficient to ensure saltatory 
conduction. Pender (1988) performed histological and electrophysiological studies and 
found that the functional recovery from acute EAE in Lewis rats was due to the 
remyelination achieved by Schwann cells in the PNS and oligcxlendrocytes in the CNS. 
Raine and Traugott (1983) found that animals treated with a combination of MBP and 
galactocerebroside during chronic relapsing EAE displayed widespread remyelination and 
oligodendroglial proliferation. Others propose that disease recovery occurs too rapidly to 
be attributed to remyelination (McDonald, 1974a,b; Panitch and Ciccone, 1981; Simmons 
etal., 1981). 
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Finally, astrocytes which form scar tissue in response to injury to the nervous system 
(reactive gliosis) (Miller et al., 1986) may also be involved in the pathogenesis of EAE. Scars 
are formed by astrocytes extending numerous processes that become larger and have a 
substantial increase in glial filaments (Maxwell and Kruger, 1965; Eng, 1985). The 
proliferating astrocytes engage in phagocytosis (N oske et al., 1982; Kandel, 1985; Eng, 
1985), and consequently astrocytes remove debris and help seal-off damaged brain tissue after 
neuronal death or injury (Kandel, 1985). This encroachment of astrocytes displaces 
presynaptic terminals and results in the damaged neurons receiving reduced synaptic input 
(Kandel, 1985). Fibrillary astrogliosis is one of the preclinical changes evident in EAE 
(Field, 1961; Bubis and Luse, 1964; Lampert, 1967). Gliosis is a prominant feature in the 
chronic model of EAE in the guinea pig and mouse (Linington et al., 1984; Raine, 1983; 
Smith et al., 1984, 1985). Smith et al. (1983) have shown that in acute EAE in the Lewis rat 
enhanced immunocytochemical staining of GFAP is evident 10 to 12 days post inoculation. 
This intensity of staining increased with time post inoculation. Reactive astrocytes were 
distributed throughout the tissue and persisted until clinically evident disease had subsided, 
with the increased staining correlating with an increased permeability of the BBB. An 
important observation in the study presented in Chapter 3 was that astrocytic proliferation was 
evident in irradiated and non-irradiated animals exhibiting advanced clinical signs of EAE. 
These results suggest that astrocytes may play an important role in the pathogenesis of EAE. 
The specific aims of the study presented in this chapter were to establish whether 
there were age-related differences in histopathological features of EAE such as lesion 
formation, fibrin deposition, demyelination and astrocytic hypertrophy. 
5.2 Results 
5.2.1 Accumulation of inflammatory cells in the spinal cord 
As EAE histologically presents with the accumulation of inflammatory cells in the 
CNS, the question whether lesion formation differed in young and middle-aged animals 
during the development of the disease was addressed. Inflammatory lesions became 
apparent in young and middle-aged animals during the onset of disease (Fig. 5 .1 ). 
Histological examination revealed meningeal and subpial infiltrates and perivascular cuffs 
and infiltrates of mononuclear cells evident in the spinal cord by day 14 post inoculation 
in both young (Fig. 5.lb) and middle-aged (Fig. 5.lf) animals. Inflammatory lesions 
were not evident in naive animals (Fig. 5.la,e). Inflammatory lesions were considerably 
resolved by day 22 post inoculation in middle-aged animals (Fig. 5. lg) whereas young 
animals (Fig. 5.lc) still exhibited considerable inflammatory infiltrates. By day 40 post 
inoculation, there was little evidence of inflammatory infiltrates in young or middle-aged 
animals (Fig. 5.ld,h). Quantification of histological sections verified the impression 
Fig. 5.1: Hematoxylin and eosin stained histological sections of parenchymal 
regions of spinal cord from male rats inoculated with 50µ.g MBP in CFA containing 
400µg M. butyricwn. Representative photographs of the presence or absence of 
inflammatory lesions found in young animals at days O (a), 14 (b), 22 (c) and 40 
(d) and middle-aged animals at days O (e), 14 (t), 22 (g) and 40 (h). Sections were 
viewed using video imaging at x225 (scale bar corresponds to 50µms). 
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gained from microscopic examination (Table 5.1). Lesions were virtually absent in 
animals at day 7, prior to the onset of disease but were nwnerous in all regions of the 
spinal cord by day 14 in young and middle-aged animals, which correlated with an 
increase in disease severity (clinical scores of 4.6 + 0.2 and 3.9 ± 0.6 respectively). 
However, despite the absence of clinical signs in young animals at day 22 post 
inoculation, these animals had a considerable number of lesions (eg., 19.4 + 0.5 lesions 
in the lwnbar spinal region), whereas middle-aged animals despite a mean clinical score of 
2.5 + 0.5 had few lesions (eg., 0.7 + 0.3 lesions in the lumbar spinal cord). By day 40 
post inoculation, inflammatory lesions were almost totally resolved in both young and 
middle-aged animals, despite the presence of clinical signs in 29% of middle-aged 
animals. These results suggest that although the peak of disease correlated with a 
substantial number of inflammatory lesions, the chronicity of disease in middle-aged 
animals was not due to the persistence of large numbers of inflammatory lesions in the 
spinal cord. 
5.2.2 Fibrin deposition 
To assess whether the significant increase in severity and chronicity of disease in 
middle-aged animals was due to increased fibrin deposition, lumbar spinal cord regions 
were sectioned and stained with MSB fibrin and examined by light microscopy. It was 
evident that fibrin deposition was not significantly increased above background during the 
course of disease. Representative photographs of the presence of fibrin are shown in 
young (Fig. 5.2a,b,c,d) and middle-aged (Fig. 5.2e,f,g,h) animals. A·s an additional 
methcxi for the detection of fibrin deposition, electron microscopy was performed on 
lumbar spinal cord sections (data not shown) and again no increase in fibrin deposition 
above background were observed, suggesting that fibrin deposition does not play a major 
role in the clinical signs of disease in this model of EAE. 
5.2.3 Demyelination 
To assess whether the significant increase in severity and chronicity of disease in 
middle-aged animals was due to increased demyelination, lumbar spinal cord regions 
were sectioned and stained with chromoxane cyanine R and examined by light 
microscopy. Demyelination was not evident during the course of disease. Representative 
photographs of myelinated areas are shown in young (Fig. 5.3a,b,c,d) and middle-aged 
(Fig. 5.3e,f,g,h) animals. These results suggest that demyelination does not cause the 
clinical signs of disease in this model of EAE. 
TABLE 5.1 
NUMBER OF INFLAMMATORY LESIONS IN SPINAL CORD SECTIONS OF YOUNG AND MIDDLE-AGED MALE RECIPIENTS 
D.P.I.a 
0 
7 
14 
22 
40 
N 
Clinical 
Score Lumbar 
YOUNG 
No. of lesions 
Thoracic Cervical 
4 0 0 0 0 
2 0 0.4 ± O.lb 0.2 ± 0.1 0.1 ± 0.1 
7 4.6 ± 0.2 54.8 ± 3.1 48.4 ± 3.5 50.9 ± 3.9 
2 0 19.4 ± 0.5 15.5 ± 3.7 18.2 ± 1.0 
4 0 0.3 ± 0.0 0.2 ± 0.1 0.1 ± 0.1 
a Days post inoculation 
b ± sa 
N 
Clinical 
Score 
MIDDLE-AGED 
Lumbar 
No. of lesions 
Thoracic Cervical 
4 0 0 0 0 
2 0 0.2 ± 0.1 0 0.1 ± 0.1 
7 3.9 ± 0.6 47.3 ± 3.0 38.0 ± 5.9 30.6 ± 4.7 
2 2.5 ± 0.5 0.7 ± 0.3 1.5 ± 0.5 1.3 ± 0.9 
7 0.8 ± 0.5 1.4 ± 0.6 2.7 ± 1.5 0.6 ± 0.3 
Fig. 5 .2: MSB fibrin stained histological sections of parenchymal regions of spinal 
cord from male rats inoculated with 50µg MBP in CF A containing 400µg M. 
butyricum. Representative photographs of the presence or absence of fibrin 
deposition found in young animals at days O (a), 14 (b), 22 (c) and 40 (d) and 
middle-aged animals at days O (e), 14 (t), 22 (g) and 40 (h). Sections were viewed 
using confocal fluorescence imaging at x200 (scale bar corresponds to lOOµms). 
Fluorescent areas represent fibrin deposition. 
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Fig. 5.3: Chromoxane cyanine R (stain for myelin) stained histological sections of 
parenchymal regions of spinal cord from male rats inoculated with 50µg MBP in 
CFA containing 400µg M. butyricum. Representative photographs of myelinated 
areas found in young animals at days 0 (a), 14 (b), 22 (c) and 40 (d) and middle-
aged animals at days 0 (e), 14 (t), 22 (g) and 40 (h). Sections were viewed using 
video imaging at x90 (scale bar corresponds to lOOµms). 
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5.2.4 Astrocytic hypertrophy 
The hypertrophy of astrocytes, which consists of the extension of numerous 
processes that become larger and have a substantial increase in glial filaments, is the 
astrocytic response to CNS damage (Maxwell and Kruger, 1965; Eng, 1985). To assess 
whether the significant increase in chronicity of disease in middle-aged animals was due 
to increased astrocytic hypertrophy, lumbar spinal cord regions were sectioned and 
stained with mercuric chloride and examined by light microscopy. By using this 
modification of Cajal's (1913) methcxi (Ralls et al., 1973), it was found that reactive 
astrocytes and their processes stained intensely, while resting astrocytes were 
inconspicuous. It was evident that the presence of reactive astrocytes increased during the 
course of disease (Table 5.2). Reactive astrocytes were absent in naive animals, however 
by day 14 post inoculation were found distributed throughout the tissue in young (1.9 + 
0.3) and middle-aged (1.6 + 0.2) animals. In Fig. 5.4, representative photographs of the 
presence of astrocytic hypertrophy are shown in young (Fig. 5.4a,b,c,d) and middle-aged 
(Fig. 5.4e,f,g,h) animals. At day 22 post inoculation, although reactive astrocytes were 
still evident in young animals (1.7 + 0.3), these astrocytes were faintly staining and only 
14.6% had long processes (Fig. 5.4c). In contrast, reactive astrocytes were clearly 
evident in middle-aged animals (3.0 + 0.0) with 77% of reactive astrocytes with long 
intensely staining astrocytic processes (Fig. 5.4g). At day 40 post inoculation, the 
presence of reactive astrocytes was considerably resolved in young animals (0.4 + 0.2) 
with only 1.1 % of these astrocytes exhibiting evidence of hypertrophy. In contrast, 
reactive astrocytes were evident in middle-aged animals (2.1 + 0.3) with 42% with long 
processes (Fig. 5.4h). In addition, at 40 days post inoculation, sections from middle-
aged animals exhibiting signs of EAE showed the presence of intensely staining 
astrocytes (2.9 + 0.1 ) with 74% + 9.0 with long processes, whereas in asymptomatic 
animals although reactive astrocytes were still present (1.6 + 0.3), there were significantly 
fewer and these were less intensely stained with shorter processes (only 13.0% + 7.9 had 
long processes). Representative photographs of an asymptomatic (Fig. 5.5a) and an 
animal exhibiting clinical signs of EAE (Fig. 5.5b) show the considerable difference 
found in the degree of astrocytic hypertrophy. These results suggest that astrocytes play a 
major role in the chronicity of disease shown in middle-aged animals in this mcxiel of 
EAE. 
5.3 Discussion 
In Chapter 4, middle-aged rats were found to develop a more chronic form of 
EAE than younger rats of the same strain. In order to determine whether the clinical 
differences could be attributed to gross differences in the histopathology of the disease in 
middle-aged animals, the inflammatory lesions were quantified, and the degree of fibrin 
TABLE 5.2 
PRESENCE OF ASTROCYTIC HYPERTROPHY IN SPINAL CORD SECTIONS OF YOUNG AND MIDDLE-AGED MALE 
RECIPIENTS 
YOUNG MIDDLE-AGED 
Presence or Percentage Presence or 
Clinical activated with long Clinical activated 
D.P.I.a N Score astroc1tesh processes N Score astrocytes 
0 4 0 0 0 4 0 0 
14 7 4.6 ± 0.2 1.9 ± 0.3 27.6 ± 10.1 7 3.9 ± 0.6 1.6 ± 0.2 
22 2 0 1.7 ± 0.3 14.6 ± 5.7 2 2.5 ± 0.5 3.0 ± 0.0 
40 4 0 0.4 ± 0.2 1.1 ± 0.7 5 1.1 ± 0.6 2.1 ± 0.3 
a Days post inoculation 
Percentage 
with long 
processes 
0 
32.0 ± 7.0 
77.0 ± 13.9 
42.0 ± 16.6 
b The presence of astrocytes in the spinal cord sections were scored on a scale from Oto 3, where O = no astrocytes; 1 = <5 astrocytes per field; 2 = 5 to 9 astrocytes 
per field; 3 = 10 or more astrocytes per field 
Fig. 5.4: Mercuric chloride stained astrocytes in histological sections of 
parenchymal regions of spinal cord from male rats inoculated with 50µg MBP in 
CFA containing 400µg M. butyricum. Representative photographs of the presence 
or absence of reactive astrocytes found in young animals at days 0 (a), 14 (b), 22 
(c) and 40 (d) and middle-aged animals at days 0 (e), 14 (f), 22 (g) and 40 (h). 
Sections were viewed using video imaging at x225 (scale bar corresponds to 
50µms). 
a) e) 
b) f) 
c) g) 
d) h) 
a) 
b) 
' 
Fig. 5.5: Mercuric chloride stained astrocytes in histological sections of 
parenchymal regions of spinal cord from middle-aged male rats inoculated 
with 50µg MBP in CFA containing 400µg M. butyricum. Representative 
photographs of the presence of reactive astrocytes found in an 
asymptomatic animal (a) and an animal exhibiting clinical signs of EAE (b) 
at day 40 post inoculation. Sections were viewed using video imaging at 
x225 (scale bar corresponds to 50µms). 
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deposition, demyelination and astrocytic hypertrophy was compared. Inflammatory 
lesions became apparent before the onset of disease, increased significantly during 
advanced clinical signs of EAE and were still evident at day 22 in young animals despite 
the absence of clinical signs but were largely absent from middle-aged animals which still 
exhibited disease symptoms. At day 40 post inoculation inflammatory infiltrates were 
sparse in both young and middle-aged animals despite 29% of middle-aged animals being 
symptomatic. These results suggest that disease chronicity does not correlate with the 
number of inflammatory lesions. No significant differences were found in the degree of 
fibrin deposition or demyelination between young and middle-aged or symptomatic and 
asymptomatic animals. However, astrocytic hypertrophy was found to correlate with 
disease chronicity, suggesting that astrocytic hypertrophy may play a significant role in 
the pathophysiology of the disease. 
It has previously been found in EAE, that the correlation between the number of 
lesions in the CNS and flaccid paralysis is poor (Hoffman et al., 1973; Raine, 1980; 
Simmons et al., 1982, 1984). Similarly, in the study presented in this chapter, it was 
evident that the persistence of inflammatory lesions found in young animals at day 22 did 
not cause chronicity of disease. In addition, the resolution of lesions apparent in middle-
aged animals at days 22 and 40 post inoculation suggest that the persistence of the 
neurological deficit found in middle-aged animals is not due to inflammatory lesions. 
Although fibrin has previously been found to be deposited in lesions of EAE 
(Oldstone and Dixon, 1968; Paterson, 1976 ) and has been suggested 
as a cause of paralysis in EAE (Paterson, 1976), no significant fibrin deposition above 
background was found in this model ofEAE in young and middle-aged or symptomatic 
and asymptomatic animals using both light and electron microscopic methods for the 
detection of fibrin. The reason for this discrepancy with earlier studies is unclear. 
However the results clearly indicate that fibrin deposition does not cause the chronicity of 
the neurological deficit found in middle-aged animals using this particular model of EAE. 
In this model of EAE, demyelination was not apparent in young and middle-
aged, or symptomatic and asymptomatic animals. Demyelination has previously been 
reported to be sparse or absent in acute models of EAE, particularly if MBP is the 
inoculum (Hoffman et al., 1973; Lassman and Wisniewski, 1979; Panitch and Ciccone, 
1981; Raine et al., 1981; Simmons et al., 1981, 1983; White, 1984; Kerlero de Rosbo et 
al., 1985). It has also been suggested that recovery occurs too rapidly to be attributed to 
remyelination (McDonald, 1974a,b; Panitch and Ciccone, 1981; Simmons et al., 1981). 
More demyelination has usually been found in animals with a more chronic disease 
process (Tabira and Sakai, 1987) and it was hypothesised that the more chronic form of 
disease in middle-aged animals may be due to demyelination. However, this was clearly 
not the case. The results presented in this chapter suggest that demyelination is not the 
cause of the persistent neurological deficit found in middle-aged animals in this model of 
--- -------
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EAE, although electron microscopic studies would be necessary to discount 
demyelination evident in the spinal cord ventral roots as suggested by Pender (1988b). 
In this study astrocytic hypertrophy was found to increase during the 
development of disease and persist in symptomatic middle-aged animals. Astrocytic 
proliferation was also found in irradiated and non-irradiated animals exhibiting advanced 
clinical signs of EAE (refer to Chapter 3). These results suggest that astrocytes may play 
an important role in the pathogenesis of EAE. Fibrillary astrogliosis has previously been 
found to be one of the preclinical changes evident in EAE (Field, 1961; Bubis and Luse, 
1964; Lampert, 1967). Gliosis is also a prominant feature in the chronic model of EAE in 
the guinea pig and mouse (Linington et al., 1984; Raine, 1983; Smith et al., 1984, 1985). 
In the study presented in this chapter, the intensity of staining increased with time post 
inocul_ation with reactive astrocytes being distributed throughout the tissue and decreasing 
in the intensity of staining as clinically evident disease subsided. Similarly, other 
investigators have also shown that in acute EAE in the Lewis rat enhanced 
immunocytochemical staining of GFAP is evident 10 to 12 days post inoculation with 
staining for GFAP increasing with time (Smith et al., 1983; Goldmuntz et al., 1986; 
Cammer et al., 1990). Clinical and histological EAE can also be induced in guinea pigs 
and monkeys by the injection of human glioblastoma, further suggesting that glial cells 
are associated with the symptoms of EAE (Bigner et al., 1981). 
Astrocytes are found in "white and grey matter" areas of the CNS where they are 
associated with myelinated regions, nerve cell bodies, dendrites and synapses, which they 
characteristically envelop (Ffrench-Constant and Raff, 1986). It has been suggested that 
astrocytic gliosis may contribute to the clinical symptoms of EAE if demyelination is a 
major cause of disease symptoms. In a study on CREAE in the SJL/J mouse, Smith et al. 
(1988) found astrocytic hypertrophy near demyelinating lesions which eventually resulted 
in the formation of gliotic plaques in the affected mouse. Astrocytes contain lysosomal 
enzymes which are activated in EAE lesions and are capable of degrading myelin (Arstila 
et al., 1973; Allen, 1983). Demyelinated axons are associated with astrocytic processes 
(Black et al., 1987) and gliosis has been shown to inhibit remyelination in vitro (Raine 
and Bornstein, 1970) and impede regenerating axons in the dorsal roots of the spinal cord 
(Liuzzi and Lasek, 1987). However, although astrocytic hypertrophy was evident in the 
study presented in this chapter, demyelination was not and other mechanisms of 
dysfunction are suggested. 
It is known that CD4+ cells are cytotoxic to MBP-presenting astrocytes in vitro 
(Sun and Wekerle, 1986) and possibly CD4+ cells in inflammatory lesions cause damage 
to astrocytes within the CNS, resulting in the formation of astrocytic hypertrophy and 
consequently in nerve conduction defects and clinical symptoms of EAE. Kandel (1985) 
has found that encroachment of proliferating astrocytes can displace presynaptic terminals 
and result in the damaged neurons receiving reduced synaptic input, with the evoked 
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excitatory presynaptic potentials being smaller in amplitude. The proliferation of fibrous 
astrocytes leads to the formation of a glial scar which can subsequently block the 
restoration of severed synaptic connections (Kelly, 1985). It is possible that the 
astrocytic hypertrophy evident in middle-aged animals results in chronicity of disease by 
the long astrocytic processes interfering with synaptic input. 
Astrocytes that surround the synaptic region, also have a high affinity for certain 
neurotransmitters such as gamma aminobutyric acid and serotonin (Bowman and 
Kimelberg, 1984; Kandel and Schwartz, 1985; Kimelberg and Katz, 1985). Serotonin is 
thought to play a role in the induction phase of EAE disease as methysergide, a serotonin 
antagonist, blocks the effect of the pertussigen (Linthicum et al., 1982). The addition of 
pertussigen in adjuvant results in the induction of EAE in genetically resistant strains of 
mice (Levine and Sowinski, 1973; Bernard and Carnegie, 1975; Raine et al., 1980a; 
Munoz and McKay, 1984). Neurological signs of EAE have been attributed to 
impairment of monoaminergic neurotransmission (Carnegie, 1971; White, 1984 ). During 
the acute paralytic phase of EAE in rats, large numbers of the bulbospinal axons that 
contain the monoamine neurotransmitters, serotonin and noradrenalin appear to be 
damaged (White et al., 1985). Interference with neurotransmission due to decreases in 
noradrenaline and serotonin in the lumbar-sacral region (Lycke and Roos, 1973; 
Honeggar and Isler, 1984), an area rich in serotonin terminals, may account for the 
localisation of clinical symptoms of EAE (Lennon and Carnegie, 1971). Possibly, 
astrocytes, by their ability to bind and internalise neurotransmitters, may reduce local 
concentrations of specific neurotransmitters and consequently interfere with the 
conduction of impulses. 
Astrocytic hypertrophy may be a reaction to the degeneration of neighbouring 
synapses, neurites or entire neurons (Adams and Jones, 1985; Geinisman et al., 1978; 
Landfield et al., 1977). As most neurones in the adult mammalian CNS are postmitotic, 
they will not regenerate after physical injury as would happen elsewhere in the body and 
functional recovery will depend on the site of injury. It is postulated that neurones require 
a certain amount of stimulation to survive (Kelly, 1985). Thus, repair mechanisms 
activated in the CNS by neuronal injury may be detrimental and lead to blocked 
regeneration of neurones (Kelly, 1985). Consequently, the motor conduction 
abnormalities previously found in the region of the spinal cord ventral roots in acute EAE 
in Lewis rats (Pender, 1988b) may be due to astrocytes slowing the conduction of fibers 
and resulting in clinical signs of EAE. These changes would limit recovery and possibly 
contribute to neurological deficit 
The immunoregulatory events determining the induction of disease and the 
subsequent recovery from EAE have not been clearly defined. From the results presented 
in this study, it seems most likely that astrocytic hypertrophy causes the chronic 
neurological deficit of EAE seen in middle-aged animals and that the resolution of 
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astrocytic hypertrophy is one of the factors contributing to the recovery of disease in this 
particular mcxiel of EAE. Possible mechanisms of dysfunction can be attributed to the 
encroachment of proliferating astrocytes displacing presynaptic terminals which results in 
the damaged neurons receiving reduced synaptic input; the formation of astrocytic scar 
tissue blocking the restoration of severed synaptic connections and by their ability to bind 
and internalise neurotransmitters, astrocytes may reduce local concentrations of specific 
neurotransmitters and consequently interfere with the conduction of impulses. MS is also 
a disease in which intense fibrous astrogliosis is a prominant feature (Raine, 1983, 1984) 
and it is possible that astrocytes contribute to tissue damage by acting as either auxiliary or 
effector cells in this human disease and its animal model EAE. 
5.4 Summary 
In Chapter 4, middle-aged rats were found to develop a more chronic f onn of 
EAE than younger rats of the same strain. In order to determine whether the clinical 
differences could be attributed to gross differences in the histopathology of the disease in 
middle-aged animals, the inflammatory lesions were quantified, and the degree of fibrin 
deposition, demyelination and astrocytic hypertrophy was compared. Inflammatory 
lesions became apparent before the onset of disease, increased significantly during 
advanced clinical signs of EAE and were still evident at day 22 in young animals despite 
the absence of clinical signs but were largely absent from middle-aged animals which still 
exhibited disease symptoms. At day 40 post inoculation inflammatory infiltrates were 
sparse in both young and middle-aged animals despite 29% of middle-aged animals being 
symptomatic. These results suggest that disease chronicity does not correlate with the 
number of inflammatory lesions. No significant differences were found in the degree of 
fibrin deposition or demyelination between young and middle-aged or symptomatic and 
asymptomatic animals. However, astrocytic hypertrophy was found to correlate with 
disease chronicity, suggesting that astrocytic hypertrophy may play a significant role in 
the pathophysiology of the disease. Based on these studies, it is proposed that the 
neurological deficit of chronic EAE in middle-aged animals may be caused by astrocytic 
hypertrophy with the resolution of this CNS response being a major factor contributing to 
recovery from the disease. 
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CHAPTER 6: ANALYSIS OF THE MECHANISMS 
CONTROLLING AGE-RELATED DIFFERENCES IN EAE 
SEVERITY AND CHRONICITY 
6.1 Introduction 
In Chapters 4 and 5 of this study, the pathogenesis of EAE was investigated by 
specifically looking at age-related differences in the clinical and histological manifestations 
of disease in Lewis (JC) rats. Although in old rats (over one year old), there was initially 
a slower and less vigorous onset of disease, aged rats developed a more chronic form of 
EAE with significantly more deaths than younger rats (Table 4.1). These results suggest 
that age-related factors can cause a shift in EAE in Lewis (JC) rats from a self-limiting 
disease to a chronic or relapsing disease of the CNS (refer to Chapter 4). Subsequent 
studies outlined in Chapter 5 suggested that astrocytic hypertrophy may induce prolonged 
paralysis in aged animals. Since the observations of disease chronicity in aged animals 
were obtained from whole animal experiments, EAE chronicity could result from either a 
mcxlified immune response in aged animals or an inability of the ageing CNS to resolve 
paralysis resulting from localised inflammatory lesions. In order to distinguish between 
these two possibilities, this chapter describes experiments where EAE was induced in 
either young or middle-aged naive recipients by the adoptive transfer of lymphocytes from 
actively immunised donors. By using such an experimental approach it was hoped to 
resolve whether disease chronicity in aged animals was a property of the immune system 
or the CNS mill i'eu, 
The production of cytokines is significantly increased during an immune 
response (Arai et al., 1990) and the infiltration of the CNS by leukocytes in EAE provides 
a potential source of cytokines. These polypeptides play an important role in the 
interaction between cells in the immune response and may substantially affect the 
pathophysiology of the disease. Several investigators claimed to have found a strong 
correlation between differential cytokine secretion and encephalitogenicity (Powell et al., 
1990; Tokuchi et al., 1990), and immunomodulators such as TNF-a, IFN-y and IL-6 
have been implicated in the pathogenesis of demyelinating diseases such as EAE and EAN 
(Gijbels et al., 1990; Hartung et al., 1990; Ruddle et al., 1990; Selmaj et al., 1991; 
Chung et al.,1991). Chung et al. (1991) demonstrated that EAE resistant (Brown-
Norway) rat astrocytes do not secrete appreciable TNF-a in response to IFN-y when 
compared to EAE susceptible (Lewis) rat astrocytes. In Chapter 5, astrocytic hypertrophy 
was evident in animals exhibiting clinical signs of EAE and it is possible that TNF 
secreted by cells in the CNS may cause the inflammatory response and initiate disease 
progression. Enhanced production of TNF may explain the chronic nature of EAE. 
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The production of cytokines during an immune response has been suggested to 
induce endocrine-mediated suppression of the inflammatory process (Munck et al., 1984; 
Besedovsky et al., 1986; Salpolsky et al., 1987; Kroemer et al., 1988) and 
neuroendocrine-mediated immunoregulation could be relevant in the recovery phase of 
inflammation in the CNS. With advancing age, the altered functional responsiveness of 
old cells to glucocorticoid action (Roth, 1979) may be due to a reduction in the numbers 
of membrane receptors for glucocorticoids (Roth, 1975). Alterations in the 
neuroendocrine system may also cause functional modifications of immune reactivity 
(Fabris, 1981) through lymphoid cells which have receptors for hormones (Gavin, 1977; 
Melmon et al., 1977). For example, steroids have an immunosuppressive effect on EAE 
(reviewed by Komarek and Dietrich, 1971). Exogenous stress has also been found to 
suppress EAE in Lewis rats (Levine et al., 1962) and Mason et al. (1990) have proposed 
that the resistance to EAE seen in some rat strains is due to corticosterone-mediated 
suppression. In the susceptible Lewis strain, recovery from paralysis correlates with 
increased levels of corticosterone, and if these rats are adrenalectomised, they are then 
unable to recover and the disease becomes uniformly fatal, an effect which can be 
reversed by steroid replacement therapy (Mac Phee et al., 1989). The results of these 
studies suggest that possibly an exaggerated adrenal response may result in recovery from 
EAE and differences in the production of corticosterone between young and aged animals 
may explain differences in disease chronicity. 
The anti-inflammatory and immunosuppressive effects of steroids may also be 
related to their ability to inhibit the prcxiuction of nitric oxide in inflammatory cells. 
Conversely, the ability of TNF and related cytokines to cause cell-mediated pathology in 
CNS diseases may be related to the ability of such cytokines to generate nitric oxide 
prcxiuction. Nitric oxide and other nitrogen oxides such as nitrogen dioxide (NO2), 
nitrite (NO2-) and nitrate (NO3-) are collectively known as reactive nitrogen intermediates 
(RNls) (Ding et al., 1988). RNis may cause tissue damage in host immunopathology 
(Ding et al., 1988) and are potently anti-microbal and anti-parasitic (Wagner et al., 1988; 
Green et al., 1990) and have been shown to inhibit protein synthesis (Curran et al., 1991) 
and mitochondrial respiration (Stehr and Nathan, 1989). RNis also act as vasodilators 
(lgnarro, 1987) and have been implicated in microvascular permeability changes (Del 
Maestro et al., 1981), especially within the CNS (Wei et al., 1985). RNis, by making 
the BBB more permeable, may allow other factors into the CNS which contribute to the 
disease state. RNI production can be augmented by the action of cytokines including 
TNF-a, IFN-y, IL-1 and lymphotoxin (Rockett et al., in press) and may be critical in 
amplifying the cellular response in inflammation (Akira et al., 1990). Nitric oxide is 
released by both central (Garthwaite et al., 1988) and peripheral (Gillespie et al., 1989; 
Bulte et al., 1990) neurones and may act as neurotransmitters. It has been suggested that 
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nitric oxide from extraneural sources could diffuse to nearby neurons and be 
misinterpreted by the brain as being of synaptic origin and consequently interfere with 
orderly neuronal transmission (Clark et al., 199)J). It is possible that the enhanced 
prcxiuction of nitric oxide by CNS cells may initiate inflammation and induce disease 
chronicity in aged animals. 
Another important group of hormones which regulates the immune response are 
the PGs which suppress immune responses (Goodwin and Webb, 1980). For example, 
PGE secreted by astrocytes inhibits the ConA response of murine thymocytes (Fontana et 
al., 1982). Similarly, treatment with precursors of PGs can inhibit the clinical and 
histological manifestations of EAE in guinea-pigs (Meade et al., 1978) whereas an 
aggravation of clinical signs of EAE follows indomethacin (an inhibitor of PG synthesis) 
treatment in rats (Levine and Sowinski, 1977, 1980; Ovadia and Paterson, 1982) or 
guinea-pigs (Bolton and Cuzner, 1980). Since PGE is immunosuppressive, differences 
in PGE prcxluction could be a causative factor in the age-related differences evident in 
EAE. 
It is clear that the age-related mechanisms affecting EAE may be complex since 
age modifies both the immune and endocrine systems. The heightened disease state 
found in middle-aged Lewis (JC) rats ensures that it is an appropriate system to test for 
differences in immunoregulatory factors such as the prcxiuction of cytokines and the 
effects of hormone levels on the disease state. The specific aims of this study were: 
1) to examine the role of the immune response and the CNS miUieu in mediating 
age-related differences in disease severity and chronicity using the passively 
transfered disease model of EAE; and 
2) in parallel studies to correlate the clinical changes and disease recovery in young 
and middle-aged animals with the prcxiuction of the naturally occurring pro-
inflammatory mediators TNF and nitric oxide and anti-inflammatory mediators 
corticosterone and PGE. 
6.2 Results 
6.2.1 Passive transfer model of EAE 
To determine whether the increased chronicity of disease observed in aged 
animals during active induction of EAE (refer to Chapter 4) was due to a property of the 
immune response or an inability to resolve CNS paralysis, EAE was passively transferred 
to naive rats of different ages by intravenous injection of lymphocytes from actively 
immunised syngeneic donors. Initially, it was found that ConA activated spleen cells 
from immunised middle-aged rats failed to induce disease in young or middle-aged 
animals (50x106 ConA activated spleen cells from immunised middle-aged animals were 
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tranferred into 5 young and 5 middle-aged animals and none of these animals exhibited 
clinical signs of EAE). The reasons for this failure were unclear but it may be due to the 
fact that there was also a 50% reduction in the proliferative response to ConA of spleen 
cells from aged donors when compared to cells from young donors. Consequently, 
young animals were used as donors for the passive transfer of disease. 
There are substantial differences in the mean weights of young and middle-aged, 
and male and female rats (Table 6.1), with middle-aged males weighing 35% more than 
young male rats. A dose response experiment was performed to determine the optimum 
number of immune spleen cells required to transfer disease to middle-aged male animals. 
A dose-dependent increase in severity and chronicity was evident in middle-aged rats 
(Fig. 6.1 ). When 30x 1 ()6 cells were transferred, a very mild form of disease was 
evident. The severity and chronicity of disease increased using higher numbers of cells. 
As paralysis and a substantial length of disease (7 .6 days) was evident in middle-aged 
animals receiving 50x106 cells, this number of cells was subsequently used to passively 
transfer disease to young and middle-aged recipients. It was evident that the severity and 
chronicity of disease using the adoptive transfer model was reduced when compared with 
active induction of EAE (refer to Chapter 4). 
TABLE 6.1: AGE- AND SEX-RELATED DIFFERENCES IN THE MEAN 
WEIGHTS OF RATS 
Young 
(2-3 mths) 
Middle-aged 
(12-13 mths) 
'" 
a Weight in grams + SE 
Male Female 
250 + 7.73 151 + 0.9 
387 + 18.6 209 + 4.6 
The results from two experiments which examined the age-related differences in 
severity and chronicity of passively transfered EAE are given in Table 6.2. No significant 
differences were found for the day of onset of disease in either experiment, with all 
animals exhibiting clinical signs between 4 to 7 days post inoculation. In experiment one, 
young animals exhibited a short monophasic episode of disease (lasting 6.7 days) with no 
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Fig. 6.1: Dose-dependent differences in the chronicity of adoptively transferred EAE in 
middle-aged male recipients. Animals were assessed for clinical signs of EAE daily and an 
arbitrary scale of disease severity ranging from Oto 5 was used as in Fig. 3.2. The length of 
disease was determined as the number of days clinical signs of EAE were evident. Each data 
point represents the mean and standard error of 7 animals. 
TABLE 6.2 
AGE-RELATED DIFFERENCES IN THE CHRONICITY AND SEVERITY OF ADOPTIVELY TRANSFERRED EAE 
IN MALE RECIPIENTS USING sox106 CON-A EFFECTORS FROM YOUNG DONORS 
Number of 
Animals 
Mean day 
of onset 
Number of 
deaths 
Mean maximum 
clinical score 
Number of 
relapsesh 
Number of days 
with hindlimb 
paralysis 
Mean lengthd 
of disease 
a ± se 
Experiment 1 
Young Middle-aged 
14 15 
4.6 ± 0.18 4.6 ± 0.1 
0/14 (0%) 2/15 (13%) 
2.7 ± 0.1 4.6 ± 0.1 
0/14 (0%) 2/13 (15%) 
0 0. 7 ± 0.2 (9/l 5)C 
6.7 ± 0.3 7.6 ± 0.9 
b relapse is defined as a second episode of disease where clinical signs were evident for 2 or more days 
c number of animals with hindlimb paralysis 
d number of days clinical signs of EAE were evident 
Experiment 2 
Young Middle-aged 
5 5 
6.6 ± 0.6 5.8 ± 0.2 
0/5 (0%) 0/5 (0%) 
2.2 ± 0.2 2.2 ± 0.2 
0/5 (0%) 2/5 (40%) 
0 0 
3.6 ± 0.7 9.6 ± 0.9 
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young animals progressing to hind.limb weakness or paralysis, the highest clinical score 
observed was 3 (ataxia). In contrast, 60% of middle-aged males became paralysed 
(although paralysis generally only lasted for one day), 13% died and 15% had relapses. 
In a second experiment, the chronicity of disease was significantly higher in middle-aged 
rats than in young rats (the mean length of disease was 9.6 days compared with 3.6 days 
in young animals). Forty percent of middle-aged rats also had relapses in this experiment 
whereas no young rats exhibited a second episcxle of disease. These data clearly indicate 
an age-related increase in the disease severity and/or chronicity of EAE in middle-aged 
rats when compared with young animals. 
As the severity and chronicity of disease was found to be significantly lower in 
the passive transfer model, active induction was considered the more appropriate mcxiel of 
EAE to assess the relevance of cytokine and hormone levels in the progression of disease. 
6.2.2 Measurement of TNF levels 
To assess whether the production o )TNF correlates with the severity of disease, 
( blo d, c.,SF) C ~pleeti, .&P.,,)cd cor 
circulating,,an local"concentrations of TNF were measured by both an ELISA method 
and a bioassay using MTI to measure cell viability. In this particular model of EAE, no 
detectable levels of TNF were evident in old and young animals using either of the above 
methods for the detection of TNF (the limit of detection was lOOpg/ml). 
TNF and related cytokines are known to cause hypoglycaemia (Clark et al., 
1989; Clark et al., 1992), therefore serum glucose levels were determined as an indirect 
measure of these cytokines. It is evident from Fig. 6.2 that there were no significant 
differences in glucose levels between young and middle-aged animals or between animals 
exhibiting clinical signs of EAE and asymptomatic animals at different time intervals 
during the course of the disease. These results are consistent with no detectable levels of 
TNF in animals exhibiting clinical signs of EAE and also suggest that other 
hypoglycaemia-inducing cytokines may not be significantly raised 
6.2.3 Measurement of corticosterone and RNI levels 
To assess whether the significant increase in the severity and chronicity of 
disease in old animals was due to a lack of the production of corticosterone or differences 
in the production of nitric oxide after active induction, samples were taken at different 
time intervals from young and middle-aged actively immunised males for the 
determination of corticosterone and RNI levels. In a preliminary experiment, RNI levels 
were measured in the blood, CSF and spinal cord of middle-aged male rats at different 
times after active induction to assess which of these tissues were the best specimens for 
showing changes in RNI levels. Increased levels of RNI were found in all blood and 
CSF specimens by day 15 post inoculation, whereas this increase was not observed in 
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Fig. 6.2: The effect of age on plasma glucose levels during actively induced EAE. Plasma 
glucose levels (mmol/1) were measured on a Beckman Glucose Analyser in middle-aged (•) 
and young (FJ) male rats inoculated with 50µg MBP in CF A containing 400µg M. butyricum 
or middle-aged (Iii) and young (W male rats inoculated with normal saline in CFA 
containing 400µg M. butyricwn. Each bar represents the mean and standard error of 10 
animals in the MBP in CFA groups and 5 animals in the normal saline in CFA groups. At da 
24, 3 aged animals had died in the MBP in CF A group. 
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control animals receiving normal saline in CF A which were measured at day 11 post 
inoculation (Table 6.3). As blood samples showed significant increases in RN1 and these 
samples can be taken easily without sacrificing the animal, blood was analysed to measure 
both RNI and corticosterone levels at different times during EAE development. Elevated 
corticosterone levels were found in the blood of both young and middle-aged animals 
with the development of clinical signs (Fig. 6.3b). These increased levels returned to 
baseline levels with the resolution of clinical symptoms (Fig. 6.3a,b). Elevated levels of 
serum RNI were evident in animals immediately prior to and during the early stages of 
symptomatic EAE (Fig. 6.3a,c ). The reduction in RNI to baseline levels occurred in 
conjunction with the increase in corticosterone levels in middle-aged animals. However, 
additional time points between days 10 and 20 would have given more information on the 
exact peak of RNI and corticosterone production in relation to clinical signs of EAE. 
6.2 .4 Measurement of prostaglandin levels 
To assess whether the reduction in the severity and chronicity of disease in 
young animals was associated with increased production of prostaglandins, spinal cord 
homogenates were prepared at different time intervals from young and middle-aged 
actively immunised females for the determination of PGE2 levels. It is evident from Fig. 
6.4 that there were no significant differences in PGE2 levels between young and midqle-
aged animals or between animals exhibiting clinical signs of EAE and asymptomatic 
animals at different time intervals during the course of the disease. 
6.3 Discussion 
In Chapter 4, middle-aged rats were found to develop a more severe and chronic 
form of EAE than younger rats of the same strain. In order to determine whether the 
chronicity results from a modified immune response in aged animals or an inability of an 
ageing CNS to resolve paralysis due to localised inflammatory lesions, EAE was induced 
in young and middle-aged naive recipients by the adoptive transfer of lymphocytes from 
actively immunised donors. The data clearly demonstrated increased disease severity 
and/or chronicity of EAE in middle-aged rats when compared with young animals. These 
results suggested that disease chronicity in middle-aged animals was a property of the 
CNS mill ,eu rather than a property of an ageing immune system. 
In parallel studies the naturally occurring pro-inflammatory mediators TNF and 
nitric oxide and anti-inflammatory mediators corticosterone and PGE were examined in 
young and middle-aged animals. TNF-a was not detected in young or middle-aged rats 
throughout the course of the disease and no significant differences were found for PGE2 
levels between young and middle-aged animals or between symptomatic or asymptomatic 
TABLE 6.3 
CIRCULATING AND LOCAL REACTIVE NITROGEN INTERMEDIATE LEVELS IN MIDDLE-
AGED MALE RATS DURING THE COURSE OF EAE 
DPI 3 
0 
1 1 
15 
Control 
NS+CFA 
Day 11 
N 
6 
3 
6 
6 
a Days post inoculation 
b+ SE 
Blood 
(µM) 
2.2 + 0.5b 
1.6 +0.4 
19.6 + 5.8 
1.9 + 0.4 
N 
3 
3 
2 
3 
CSF 
(µM) 
41.6 + 8.9 
103.9 + 26.3 
272.0 + 49 .4 
63.5 +3_3 
N 
6 
3 
6 
6 
Spinal 
Cord 
(µM) 
2.2 + 0.5 
4.8 + 2.3 
3.1 + 0.9 
2.2 + 0.3 
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Fig. 6.3: The effect of age on serum corticosterone and reactive nitrogen intermediate levels 
during actively induced EAE. Clinical profiles (a), and changes in serum corticosterone (b) 
and reactive nitrogen intermediate ( c) levels of young ( •) and middle aged ( O) male rats 
inoculated with 50µg MBP in CF A containing 400µ.g M. bu.tyricwn. Animals were assessed 
for clinical signs of EAE daily and an arbitrary scale of disease severity ranging from O to 5 
was used as in Fig. 3.2. Corticosterone levels were measured by RIA and reactive nitrogen 
intermediate levels were determined by an assay based on the reduction of nitrate by a Cd Cu 
complex coupled to Griess reagent for azochromaphoretic detection. The results are 
expressed as micromolar concentrations of total RNI (the sum of nitrite and nitrate) 
concentrations. Each data point represents the mean and standard error of 12 animals. At day 
21, 5 aged animals had died. 
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Fig. 6.4: The effect of age on prostaglandin levels during actively induced EAE. Clinical 
profiles (a) and prostaglandin-E2 levels (b) of young(•) and middle aged (O) male rats 
inoculated with 50µg MBP in CFA containing 400µg M. butyricwn. Animals were assessed 
for clinical signs of EAE daily and an arbitrary scale of disease severity ranging from O to 5 
was used as in Fig. 3.2. Prostaglandin levels were measured by RIA using a PGE2 (125I) 
assay system. Each data point represents the mean and standard error of 3 animals. 
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animals. By contrast, markedly elevated corticosterone levels were found in both young 
and middle-aged animals with the development of clinical signs which returned to 
baseline levels upon resolution of clinical symptoms. Elevated levels of RNI were found 
in animals immediately prior to and during the early stages of symptomatic EAE. 
Although, these results suggest that nitric oxide may play a role in the pathogenesis of 
disease whereas corticosterone may play a role in the immunoregulation of EAE, these 
factors clearly do not explain the differences in disease chronicity evident in middle-aged 
animals. 
There have been few previous studies where age-related effects on passively 
transfered EAE have been examined. Levine and Sowinski (1976) found that with the 
passive transfer of potent encephalitogenic cells from young donors to 24 month old F344 
rats, only 2 out of 4 of these animals developed EAE. In contrast, Endoh et al. (1990) 
found that PLP-sensitised spleen cells from young mice transfered EAE to both young 
and aged mice and that there were no significant differences in the severity of disease 
between young and aged mice. However they noted an earlier day of onset of clinical 
signs in the young animals. Unlike these data, the study presented in this chapter 
demonstrates a considerable age-related difference in the susceptibility of Lewis (JC) rats 
using the passively transfered model of EAE with middle-aged rats developing a more 
severe and/or chronic disease than young rats. 
Spleen cells from immunised middle-aged animals were found to have a reduced 
ability to proliferate after induction with ConA and were unable to transfer disease. It is 
known that there is a reduced in vitro response to ConA-induced proliferation (Abraham 
et al., 1977) or specific antigen (PLP)-induced proliferation (Endoh et al., 1990) in aged 
mice. In addition, Endoh et al. ( 1990) found that PLP-sensitised spleen cells from young 
mice, but not from old mice, could transfer EAE to both young and aged mice. This age-
related alteration in lymphocyte function could be explained by a decrease in the T cell 
response to mitogens and antigens associated with a decrease in the production of 
lymphokines including IL-2 (Miller and Stutman, 1981; Thoman and Wiegle, 1981, 
1982; reviewed by Ackerman et al., 1991). 
Despite no TNF-a being detected in animals with EAE in this study, TNF-a has 
been implicated in the pathogenesis of EAE (Ruddle et al., 1990; Selmaj et al., 1991; 
Chung et al.,1991). TNF has been found to have a paradoxical effect on autoaggressive 
processes depending on the administration schedule and the experimental system 
(Teuscher et al., 1990; Ruddle et al., 1990; Selmaj et al., 1991). TNF production may 
possibly be involved in other models of disease where an enhanced immune response is 
evident, eg. in a model where pertussis is added to the inoculum. 
Since PGE is immunosuppressive, it was hypothesised that its production could 
be a causative factor in some of the age-and sex-related differences evident in EAE. The 
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regulatory role of PGs in EAE was suggested by studies in which guinea-pigs fed on 
large amounts of dietary polyunsaturated fatty acids (which are precursors of PGs) did 
not develop clinical or histological manifestations of EAE (Meade et al., 1978). This 
inhibitory effect of polyunsaturated fatty acids can be reversed by in vivo administration 
of indomethacin (an inhibitor of PG synthesis) (Hughes et al., 1980). However, in the 
study reported in this chapter, there were no significant differences in PGE2 levels 
between young and middle-aged animals or between symptomatic and asymptomatic 
animals at different time intervals during the course of the disease. In contrast, significant 
changes in the PGE content of CNS tissue during the induction and progression of EAE 
has been found in guinea-pigs (Bolton et al., 1984a) and Lewis rats (Bolton et al., 
1984b ). PGE was found in these studies to increase before the appearance of clinical 
signs and to rise until approximately 12 days post inoculation when they returned to 
normal levels. One explanation for the drop in PGE observed in these studies could be 
that glucocorticoid hormones secreted from the adrenal cortex or administered as a drug 
curtail the availability of arachidonic acid (Claman, 1983) and possibly exogenously block 
PG production. However, in this model of EAE, no increase in PGE2 levels were found. 
The explanation for these differences is unclear. 
Elevated corticosterone levels were found in both young and middle-aged 
animals with the development of clinical signs. These increased levels returned to 
baseline levels with the resolution of clinical symptoms (Fig. 6.3a,b). It has been 
suggested that recovery from EAE results from an exaggerated adrenal response (Levine 
et al., 1962; MacPhee et al., 1989; Mason et al., 1990). For example, stress which has 
been shown to cause an increase in the production of adrenocortical hormones, was found 
to suppress EAE in Lewis rats (Levine et al., 1962). Subsequently, it was found that if 
Lewis rats were adrenalectomised, they were unable to recover and the disease became 
lethal, an effect which was reversed by steroid replacement therapy (Mac Phee et al., 
1989). However, adrenalectomy performed 12 to 14 days after induction of EAE did not 
result in the development of disease suggesting that the long-term refractory period found 
in recovered rats does not depend on corticosterone-mediated suppression (MacPhee et 
al., 1989). Mason et al. (1990) have also proposed that the resistance to EAE seen in 
some strains is due to corticosterone-mediated suppression. The PVG strain of rat, which 
has significantly higher basal levels of corticosterone than those in Lewis rats (Mason et 
al., 1990) is not susceptible to EAE. However, this strain develops severe disease after 
adrenalectomy with steroid replacement therapy preventing the fatal progression of 
disease. Griffin and Whitacre ( 1991) found that Lewis rats had low basal levels of 
circulating corticosterone, and high numbers of CD4+ T cells compared with F344 rats 
and they suggested that these factors may play a causative role in the susceptibility of 
Lewis rats to autoimmune diseases such as EAE. In the study reported in this chapter, it 
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was hypothesised that an age-related decline in the production of corticosterone may cause 
the chronicity of disease evident in middle-aged animals. However, it was found that 
middle-aged animals exhibited a substantial increase in corticosterone levels during the 
course of disease. Although a reduction in the concentration of membrane receptors for 
glucocorticoids has been found with advancing age (Roth, 1975), circulating 
corticosterone levels as measured by RIA have previously been found to progressively 
increase with age (Iams and Wexler, 1979). In the study presented in this chapter, an 
increase in corticosterone production was associated with an increase in disease severity 
and the disease recovery followed the peak in corticosterone levels. Whether the elevated 
levels of corticosterone play an immunoregulatory role or are due to the stress caused by 
the clinical symptoms of EAE is unclear and needs further study. 
Elevated levels of RNI were found in young and middle-aged animals 
immediately prior to and during the early stages of symptomatic EAE. RNis have 
vasodilatory effects in the brain and have been implicated in microvascular permeability 
changes (Del Maestro et al., 1981) and may be critical in amplifying the.cellular response 
in localised forms of inflammation (Akira et al., 1990). A critical event in the 
development of encephalomyelitis is the breakdown of the BBB and guinea pigs and 
monkeys immunised with CNS endothelial membrane fractions uncontaminated with 
myelin proteins can cause an EAE-like disease consisting of paralysis and demyelination 
(Tsukada et al., 1987). This result suggests that an immune disturbance of the BBB is 
sufficient to cause EAE and nitric oxide may be involved in permeability of the BBB. In 
the study presented in this chapter, the reduction in RNI to baseline levels occurred in 
conjunction with the increase in corticosterone levels in middle-aged animals though this 
was not evident in young animals. Glucocorticoids have previously been found to inhibit 
the production of nitric oxide in macrophages (Di Rosa et al., 1990) and endothelial cells 
(Radomski et al., 1990; Knowles et al., 1990). Macrophages, which express high 
affinity receptors for glucocorticoids (Werb et al., 1978) play a significant role in the 
inflammatory process in EAE (Panitch and Ciccone, 1981; Brosnan et al., 1981; Killen 
and Swanborg, 1982a). The anti-inflammatory and immunosuppressive effects of 
steroids may be related to the ability to inhibit the production of nitric oxide in 
inflammatory cells (Knowles et al., 1990; di Rosa et al., 1990; Moncada and Palmer, 
1991). Additional time points between days 10 and 20 would have given more 
information on the exact peak of RNI and corticosterone production in relation to clinical 
signs of EAE. 
The results presented in this chapter, are consistent with the hypothesis that nitric 
oxide may play a role in the pathogenesis of disease whereas corticosterone may be 
involved in the immunoregulation of the disease. However, these factors do not explain 
the differences in chronicity of disease evident in middle-aged animals. Possibly, as 
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suggested in Chapter 5, astrocytic hypertrophy may induce prolonged paralysis in aged 
animals. 
6.4 Summary 
In Chapter 4, middle-aged rats were found to develop a more severe and chronic 
form of EAE than younger rats of the same strain. In order to determine whether the 
chronicity results from a modified immune response in middle-aged animals or an 
inability of an ageing CNS to resolve paralysis resulting from localised inflammatory 
lesions, EAE was induced in young and middle-aged naive recipients by the adoptive 
transfer of lymphocytes from actively immunised donors. It was found that middle-aged 
recipients developed more severe disease than young recipients. Based on these 
observations it was concluded that disease chronicity in middle-aged animals is a property 
of the CNS mill fe LJ rather than a property of an ageing immune system. In parallel 
studies the naturally occurring pro-inflammatory mediators TNF and nitric oxide and anti-
inflammatory mediators corticosterone and PGE were examined in young and middle-
aged animals using the actively induced model of EAE. No detectable levels of TNF-a 
were evident in middle-aged and young rats during the course of disease and no 
significant differences in PGE2 levels between young and middle-aged animals or 
between symptomatic and asymptomatic animals were found. By contrast, markedly 
elevated corticosterone levels were found in both young and middle-aged animals with the 
development of clinical signs which returned to baseline levels with the resolution of 
clinical symptoms. Elevated levels of RNI were evident in animals immediately prior to 
and during the early stages of symptomatic EAE. Although, these results suggest that 
nitric oxide may play a role in the pathogenesis of disease, whereas corticosterone may 
play a role in the immunoregulation of the disease, these factors cannot explain 
differences in disease chronicity evident in middle-aged animals. 
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CHAPTER 7: DISCUSSION AND CONCLUDING REMARKS 
EAE, a major applied model for MS research, is also an excellent model for 
studying interactions between the immune system and the CNS. The specific aims of this 
study were to ascertain how T cells, which are normally found in low numbers in the CNS, 
localise during the inflammatory response and as MS and EAE are both age-dependent 
diseases, to establish the clinical, histopathological and immunoregulatory changes which 
occur in aged animals suffering from EAE. 
7 .1 T cell entry into the CNS 
Lymphocytes are normally found in low numbers in the CNS. Migration of T 
cells to the CNS and their cellular distribution in EAE lesions is well documented. How 
their initial entry is achieved during EAE in the absence of gross damage to the vascular 
endothelium is unknown. This study addressed the hypothesis put forward by W ekerle et 
al. (1986) that "activated" lymphocytes of any specificity enter the CNS but only those 
with neuro-antigen specificity persist and cause pathology. Using EAE in the rat as a 
model of CNS inflammation, H33342-labelled activated and quiescent T cells with 
different antigen specificities were tested for their ability to accumulate in different 
regions of the spinal cord and in other organs at varying times post inoculation. The data 
presented in this study strongly supported the Wekerle hypothesis as T cell lines specific 
for MBP, PPD, or OA all entered the spinal cord, if first activated with their specific 
antigen, but only MBP-specific cell lines accumulated. OA- and PPD-specific T cell lines 
were used because the antigen-specificities of these lines are non-specific to the CNS and 
cause no known illness or inflammation in syngeneic rats. 
The state of activation of the MBP-specific cells was also found to be critical for 
the induction of disease. Non-activated MBP-specific T cells failed to accumulate in the 
spinal cord to a substantial degree and did not cause clinical signs of EAE. These results 
are consistent with the earlier finding that quiescent cells do not cause disease (Panitch 
and Ciccone, 1981; Ben-Nun et al., 1981; Holda et al., 1980; Peters and Hinrichs, 1982; 
Naparstek et al., 1983) and lack the elevated levels of heparanases (Naparstek et al., 1984) 
which facilitate penetration of the cells through the CNS endothelium and into the 
inflammatory site (Willenborg and Parish, 1988; Willenborg et al., 1989a, 1989b). 
MBP-specific T cell accumulation was found to be similar throughout the 
different regions of the spinal cord during the first 3 days post inoculation Histologically, 
lesions were also apparent throughout the spinal cord at days 4 and 7 post inoculation and 
there was marked perivascular inflammation evident in all regions of the cord. As EAE is 
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a disease consisting of an ascending paralysis with clinical signs attributed to disturbances 
of the lumbar-sacral areas of the cord, it is possible that either lower spinal cord nerve 
damage is more likely to result in the clinical signs of disease or otherwise due to the 
caudally increasing length of the spinal roots (Waibl, 1973), the probability of lesion 
formation progressively increases in a caudal direction. 
The substantial increase in accumulation of the antigen-activated MBP-specific T 
cells between days one and four was much more than could be accounted for by either 
random entrance of activated cells or by the replication of the cells in situ once they had 
entered the parenchyma. One possible explanation is that the MBP-specific cell line is 
being recruited in a non-specific fashion following the initial entrance of specific cells and 
their subsequent interaction with antigen. If this is the case then one would expect that 
antigen-activated, non-neuroantigen specific T cells could be recruited into the CNS if 
injected along with activated MBP-specific cells. This is indeed what happened. The 
CNS accumulation of an QA-activated, QA-specific T cell line increased 15-20 fold when 
injected simultaneously with a MBP-activated, MBP-specific T cell line. However, there 
was a delay in CNS accumulation of the QA-specific T cells, suggesting the need for the 
MBP-specific T cells to first establish an inflammatory response. 
To examine the host contribution to passively induced EAE, the entrance and 
accumulation of activated MBP-specific T cells was assessed in irradiated recipients. 
Radiation has been reported to have varying effects on the induction of EAE (Levine et 
al., 1969) with variations probably being related to the species studied, the dose, the 
timing and the type of radiation. Sedgewick et al. (1987) reported that regardless of the 
status of the recipient (irradiated or not), clinical signs were induced when animals 
received MBP-reactive T cells although the number of infiltrating leukocytes was reduced 
in irradiated animals. In this study, activated MBP-specific T cells accumulated in the 
spinal cord of irradiated rats but to a lesser extent than in non-irradiated recipients. There 
was also a delay in the kinetics of accumulation by about two days which agrees with the 
altered kinetics of clinical signs. Two possible explanations for these results would be that 
irradiation may directly affect the endothelium in a way that makes it less adhesive or 
alternatively the recruitment of "non-specific" host cells may in tum act as recruiting cells 
in further promotion of the inflammatory response. In this study, the failure of non-
specific T cells to accumulate in the CNS rules out the possibility of extensive radiation-
induced changes in the vasculature allowing non-specific cellular infiltration. 
Differences in the size and distribution of inflammatory lesions between 
irradiated and non-irradiated recipients were observed histologically in spinal cord 
sections. In this study, as in that of Sedgewick et al. (1987), the number of inflammatory 
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cells in the spinal cord of irradiated animals was reduced compared to non-irradiated 
recipient animals. The correlation between the number of lesions in the CNS and flaccid 
paralysis has been found to be poor (Hoffman et al., 1973; Raine, 1980; Simmons et al., 
1982, 1984), and possibly other mechanisms of dysfunction cause clinical symptoms of 
EAE. Considerable hemorrhage and the exposure of collagen, a component of the 
extracellular matrix, was found in irradiated recipients in this study, suggesting that the 
integrity of the vasculature had been affected. Sedgewick et al. ( 1987) also found that 
disease in irradiated recipients was associated with substantial hemorrhagic lesions in the 
spinal cord and brain stem. In addition, a complete absence of hemorrhagic lesions was 
reported in irradiated recipients receiving QA-reactive T cells, suggesting that the vascular 
damage was caused by the MBP-reactive T cells. In support of this hypothesis, the 
clinical.signs of EAE and hemorrhage were preventable by the administration of anti-CD4 
mAbs, leading to the conclusion that the ability to repair damage has been compromised in 
irradiated animals. 
An important observation in the study described in this thesis, was that astrocytic 
proliferation was evident in irradiated and non-irradiated animals exhibiting advanced 
clinical signs of EAE. The astrocytic response to injury of the CNS is a process called 
reactive gliosis (Miller et al., 1986). Scars are formed by astrocytes extending numerous 
processes that become larger and have a substantial increase in glial filaments (Maxwell 
and Kruger, 1965; Eng, 1985). The proliferating astrocytes engage in phagocytosis 
(Noske et al., 1982; Kandel, 1985; Eng, 1985), and consequently astrocytes remove 
debris and help seal-off damaged brain tissue after neuronal death or injury (Kandel, 
1985). This encroachment of astrocytes displaces presynaptic terminals and results in the 
damaged neurones receiving reduced synaptic input, with the evoked excitatory 
presynaptic potentials being smaller in amplitude (Kandel, 1985). These results suggest 
that astrocytes could be important in the development of clinical signs of EAE with the 
loss of nerve transmission which results in paralysis possibly being due to astrocytic 
proliferation slowing the conduction of fibers. 
7.2 Age related changes in EAE 
It is clearly established that EAE is mediated by class II MHC antigen-restricted T cells 
(Pettinelli and McFarlin, 1981; Zamvil et al., 1985). However, the actual mechanisms which 
initiate the CNS entry of T cells and which result in the subsequent CNS damage produced by 
the ensueing inflammatory response remain unclear. In this context, it was of considerable 
interest to determine whether advanced age, which is associated with a decline in T cell-
mediated immunity, protects against EAE, a T cell mediated disease. 
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Although EAE is usually a monophasic self-limiting disease in r
ats, recurrent EAE has 
been previously reported in aged (6 months old, Mc Farlin et al., 1974 and 13 m
onths old, Ben-
Nun et al., 1980) female Lewis rats. Kallen and Logdberg (1982) also reported
 there was an 
age-effect on the susceptibility of Lew/Mol (a nearly EAE resistant Lewis subs
train) rats. In 
contrast, an age related decline in susceptibility to EAE has been
 demonstrated by some 
researchers in mice (Endoh et al., 1990) and F344 rats (Levine and Sowinski, 1
976). Due to the 
array of pathologic lesions found in aged F344 rats (Sass et al., 1975; Levine an
d Sowinski, 
1976), it appears that F344 rats are not a good model for assessing age-related f
actors. In this 
study, the pathogenesis and immunoregulation of EAE was inve
stigated by specifically looking 
at age-related differences in Lewis (JC) rats, a rat strain which does not suffer f
rom a 
multiplicity of age-related illnesses. 
The results showed that aged Lewis (JC) rats develop a more chronic form of E
AE with 
significantly more deaths than younger rats of the same strain. A
lthough there was a slower and 
less vigorous response initially in aged animals, consistent with 
an age-dependent decline in T 
cell-mediated immunity, paradoxically the disease chronicity in 
middle-aged and geriatric rats 
was significantly higher. Young animals exhibited a short mono
phasic episode of disease, had a 
low death rate and only a few animals exhibited a mild second e
pisode of disease. These results 
suggest there is a deficit in the resolution of paralysis resulting f
rom CNS inflammatory lesions 
in older animals. The study also revealed that male rats exhibite
d increased severity and 
chronicity of disease compared with females of the same age. H
owever, sterilisation of females 
did not have a significant effect on disease profiles. 
On the other hand, studies reported in this thesis demonstrated n
o significant 
differences between young and aged animals in the production o
f MBP-specific antibody. 
Furthermore, MBP-specific antibody production did not correlat
e with onset, severity or 
relapse of EAE in both young and middle-aged animals. These 
are similar results to those 
found in previous studies where MBP-specific antibody levels w
ere determined in young 
animals (Lisak et al., 1969; Lennon et al., 1971; Tabira and Endoh, 1985). Fin
ally, when 
EAE was induced in young and middle-aged naive recipients by
 the adoptive transfer of 
lymphocytes from actively immunised donors, the data clearly d
emonstrated increased 
disease severity and/or chronicity of EAE in middle-aged rats w
hen compared with young 
animals. These results suggested that disease chronicity in midd
le-aged animals was a 
property of the CNS mill 1eu rather than a property of an ageing 
immune system. 
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7.3 Astrocytes play a central role in EAE chronicity 
In order to determine whether the age-related differences in the clinical 
manifestation of EAE could be attributed to gross differences in the histopathology of the 
disease in middle-aged animals, the inflammatory lesions were quantified, and the degree of 
fibrin deposition, demyelination and astrocytic hypertrophy was compared. 
It has previously been found in EAE, that the correlation between the number of 
lesions in the CNS and flaccid paralysis is poor (Hoffman et al., 1973; Raine, 1980; 
Simmons et al., 1982, 1984). Similarly, in this study, it was evident that the persistence of 
inflammatory lesions found in young animals at day 22 was not associated with chronicity 
of disease. In addition, the resolution of lesions in middle-aged animals at days 22 and 40 
post inoculation suggests that the persistence of the neurological deficit found in middle-
aged animals at these time points is not due to inflammatory lesions. 
Although fibrin has previously been found to be deposited in lesions of EAE 
(Oldstone and Dixon, 1968; Paterson, 1976; Rauch et al., 1978) and has been suggested as a 
cause of paralysis in EAE (Paterson, 1976), no significant fibrin deposition above 
background was found in this model of EAE in young and middle-aged or symptomatic and 
asymptomatic animals using both light and electron microscopic methods for the detection 
of fibrin. The reason for this discrepancy with earlier studies is unclear. However the 
results clearly indicate that fibrin deposition does not cause the chronicity of the 
neurological deficit found in middle-aged animals using this particular model of EAE. 
In this model of EAE, demyelination was not apparent in young and middle-aged, 
or symptomatic and asymptomatic animals. This finding is consistent with earlier reports 
where demyelination was found to be sparse or absent in acute models of EAE, particularly 
if MBP is the inoculum (Hoffman et al., 1973; Lassman and Wisniewski, 1979; Panitch and 
Ciccone, 1981; Raine et al., 1981; Simmons et al., 1981, 1983; White, 1984; Kerlero de 
Rosbo et al., 1985). It has also been suggested that recovery from EAE occurs too rapidly 
to be attributed to remyelination (McDonald, 197 4a,b; Panitch and Ciccone, 1981; 
Simmons et al., 1981). Demyelination has usually been found in animals with a more 
chronic disease process (Tabira and Sakai, 1987) and it was hypothesised that the more 
chronic form of disease in middle-aged animals may be due to demyelination. However, 
this was clearly not the case. The results presented in this thesis suggest that generalised 
demyelination is not the cause of the persistent neurological deficit found in middle-aged 
animals in this model of EAE, although electron microscopic studies would be necessary to 
discount highly localised demyelination in the spinal cord ventral roots as suggested by 
Pender (1988b). 
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In this study astrocytic hypertrophy was found to increase during the development 
of disease and persist in symptomatic middle-aged animals. Astrocytic proliferation was 
also found in irradiated and non-irradiated animals exhibiting advanced clinical signs of 
EAE. These results suggest that astrocytes may play an important role in the pathogenesis 
of EAE. Fibrillary astrogliosis has previously been found to be one of the preclinical 
changes evident in EAE (Field, 1961; Bubis and Luse, 1964; Lampert, 1967). Gliosis is 
also a prominant feature in the chronic model of EAE in the guinea pig and mouse 
(Linington et al., 1984; Raine, 1983; Smith et al., 1984, 1985). In the studies presented in 
this thesis, the intensity of staining increased with time post inoculation with reactive 
astrocytes being distributed throughout the tissue and decreasing in their intensity of 
staining as clinically evident disease subsided. Similarly, other investigators have also 
shown that in acute EAE in the Lewis rat enhanced immunocytochemical staining of GFAP 
is evident 10 to 12 days post inoculation with staining for GFAP increasing with time 
(Smith et al., 1983; Goldmuntz et al., 1986; Cammer et al., 1990). 
An intriguing question arising from these observations is how astrocytic 
hypertrophy can inhibit nerve conductance. In this context, it is possible that the astrocytic 
hypertrophy evident in middle-aged animals results in chronicity of disease by the long 
astrocytic processes interfering with synaptic input. Astrocytes that surround the synaptic 
region, also have a high affinity for certain neurotransmitters such as gamma aminobutyric 
acid and serotonin (Bowman and Kimelberg, 1984; Kandel and Schwartz, 1985; Kimelberg 
and Katz, 1985). Thus, it is possible that astrocytes, by their ability to bind and internalise 
neurotransmitters, may reduce local concentrations of specific neurotransmitters and 
consequently interfere with the conduction of impulses. Finally, it could be argued that 
astrocytes interfere with neurotransmission via unknown mechanisms, such as secretion of 
inhibitors of neurotransmission. 
7.4 Effect of age on production of inflammatory mediators 
Although EAE chronicity in aged animals is most likely due to astrocytic 
hypertrophy, it was unclear which factors both initiate and suppress the astrocytic response. 
It is known that CD4+ T cells are cytotoxic for MBP-presenting astrocytes in vitro (Sun and 
Wekerle, 1986) and possibly CD4+ T cells in inflammatory lesions cause damage to 
astrocytes within the CNS, resulting in the formation of astrocytic hypertrophy and 
consequently in nerve conduction defects and clinical symptoms of EAE. Another 
possibility is that the naturally occurring pro-inflammatory mediators TNF and nitric oxide 
and anti-inflammatory mediators corticosterone and PGE regulate the astrocytic response. 
No TNF-a was detected in animals with EAE in this study. However, TNF production may 
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possibly be involved in other models of disease where an enhanced immune response is 
evident, eg. in a model where pertussis is added to the inoculum. In addition, there were no 
significant differences in PGE2 levels between young and middle-aged animals or between 
symptomatic and asymptomatic animals at different time intervals during the course of the 
disease. 
Based on earlier studies by others (Levine et al., 1962; MacPhee et al., 1989; 
Mason et al., 1990), it could be hypothesised that an age-related decline in the production of 
corticosterone may cause the chronicity of disease evident in middle-aged animals. 
However, it was found that middle-aged animals exhibited a substantial increase in 
corticosterone levels during the course of disease. This increase in corticosterone 
production was associated with an increase in disease severity and the disease recovery 
followed the peak in corticosterone levels. Whether the elevated levels of corticosterone 
play an immunoregulatory role or are due to the stress caused by the clinical symptoms of 
EAE is unclear and needs further study. Nevertheless, data from this study clearly 
eliminated corticosterone as a regulator of disease chronicity. When RNI levels were 
assessed, the reduction in RNI to baseline levels occurred in conjunction with the increase 
in corticosterone levels in middle-aged animals though this was not evident in young 
animals. Additional data points are required to establish whether this difference is of 
relevance to age-related differences in EAE induction. However, as with corticosterone, it 
seems unlikely that RNI plays any role in disease chronicity. 
Collectively, the data suggests that none of the naturally occurring inflammatory 
mediators examined are associated with prolonged astrocytic hypertrophy. Nevertheless, 
the possibility still remains that the pro-inflammatory mediators TNF and RNI may initiate 
the astrocytic response. 
7.5 Relevance to MS 
In this study, a memory response was evident in aged animals 13 months after 
receiving MBP-specific effector T cells, suggesting that an early etiological event may set up an 
autoimmune carrier state which can persist even into middle-age. These results support the 
hypothesis put forward by many researchers that MS is caused by a viral infection occurring in 
childhood or adolescence which induces prolonged immunological memory to CNS antigens 
(Wege et al., 1984; Tardieu et al., 1984; Waksman, 1988). Coupled with the observation in this 
study that EAE is more severe in aged animals, in MS an early etiological event may set up an 
autoimmune carrier state which can persist even into middle-age and be reactivated with chronic 
disease resulting due to the aged persons inability to resolve inflammation effectively. 
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MS is a disease in which intense fibrous astrogliosis is a prominant feature 
(Raine, 1983, 1984) and it is possible that astrocytes contribute to tissue damage by 
acting as either auxillary or effector cells. Active and replicating astrocytes are 
prominant in the MS lesion (Adams, 1983) where they fill areas formerly occupied by 
myelinated axons (Raine, 1985). The demonstration in this thesis that astrocytic 
hypertrophy is associated with neurological dysfunction, in the absence of demyelination, 
raises the interesting possibility that astrocytic hypertrophy may play a significant role in 
both acute and chronic MS, independent of demyelination. 
7.6 Future Work 
An important unanswered question is the nature of the factor(s) which control 
initial entry of antigen-specific lymphocytes into the CNS. When comparing the studies 
of Naparstek et al. (1983), Hickey et al. (1991), Lightman et al. (1987) and my own (all of 
which used T cell lines in a rat model) it is evident that where accumulation of antigen 
specific T cells is reported, the cell lines were activated with specific antigen, but when 
ConA was used to activate the cell lines antigen specific T cells did not accumulate. In 
addition, both activated non-neurospecific T cell lines (OA- and PPD-specific) enter the 
lower spinal cord and persist at a low level. There was a difference in the absolute 
numbers of cells observed for the two cell lines, with the PPD-specific T cells being more 
numerous. One possible explanation for this difference is that the two cell lines differed in 
their degree of "activation" and hence their ability to enter the CNS parenchyma. This 
brings up the question of what exactly "activation" represents. This is currently unknown 
but it has been suggested that activation translates to the expression of enzymes on the 
lymphocyte surface that facilitate the degradation of the sub-endothelial basement 
membrane and extracellular matrix thus promoting emigration (Willenborg and Parish, 
1988; Willenborg et al., 1989a, 1989b). There are, of course, a number of other 
interpretations of what "activation" represents such as the up-regulation of various 
lymphocyte cell adhesion molecules with resultant increased adhesion to endothelial cells 
(Cannella et al., 1990; Sobel et al., 1990), or the ability of activated but not non-activated 
cells to produce a given range of cytokines (Powell et al., 1990). Comparing specific 
antigen-activated with ConA-activated T cells with respect to their ability to express 
enzymes, adhesion molecules or various cytokines may provide valuable information. 
Studies presented in this thesis suggest that in contrast to a role in healing CNS 
injury, astrogliosis may produce pathological effects by interfering with neuronal 
conduction and regeneration. Therefore, further studies are needed to clarify the causes 
of the astrocytic hypertrophy which possibly results in the neurological deficit found in 
this model of EAE. Of considerable interest is the nature of the factor(s) which initiate 
the astrocytic response. Are certain inflammatory cytokines involved, are critical 
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interactions between lymphocytes and CNS elements required and are particular T cell 
subsets involved? Similarly, electron microscopic studies may possibly reveal the 
encroachment of astrocytic processes on neurones and how this encroachment correlates 
with symptoms of disease. In vitro models also could be used to examine the interaction 
between astrocytes and neurones and to determine whether inhibition of nerve 
conductance by astrocytes is due to simple physical encroachment or to the inhibition of 
neurotransmitter action. Investigation of factors which downregulate astrocytic 
hypertrophy and whether such factors are lacking in the ageing CNS is another important 
area of study. 
In conclusion, this study clearly shows that astrocytes are potential targets for 
therapeutic intervention as they affect neurophysiological function, maintain the BBB and 
participate in the inflammatory process. Possibly the inhibition of GFAP synthesis 
during inflammation may delay astrogliosis, allowing neurones time to regenerate. As 
highly localised forms of inflammation in the CNS have profound and debilitating 
consequences particularly for the aged, it would be of benefit to consider how astrogliosis 
can be modulated to promote healing and functional recovery of neuronal pathways. 
1 1 8 
BIBLIOGRAPHY 
Abalan. F. (1984). Alzheimer's disease and malnutrition. A new etiological hypothesis . Med. Hypotheses 
15 : 385-393. 
Abernethy, D.J. and Hay, J.B. (1988) Lymphocyte migration through skin and skin lesions. In: 
Migration and homing of lymphoid cells (ed. Husband, A.J.) pp. 113. CRC Press, Boca Raton, Florida. 
Abraham, C., Tal, Y. and Gershon, H. (1977) Reduced in vitro response to Concavalin A and 
lipopolysaccharide in senescent mice: a function of reduced number of responding cells. Eur. J. 
Immunol. 7 : 301-304. 
Acha-Orbea, H., Mitchell, D.J., Timmermann, L., Wraith, D.C., Tausch, G.S., Waldor, M.K., Zamvil, 
S.S., McDevitt, H.O. and Steinman, L. (1988) Limited heterogeneity of T cell receptors from 
lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54 : 
263-273. 
Ackerman, H.P., Ulrich, J., Heitz, P.U. (1981) Experimental Allergic Encephalomyelitis. Exudate and 
cellular infiltrates in the spinal cord of Lewis rats. Acta Neuropath., Berlin 54: 149-152. 
Ackerman, K.D., Bellinger, D.L., Felten, S.Y. and Felten, D.L. (1991) Ontogeny and Senescence of 
Noradrenergic innervation of the rodent thymus and spleen. In: Psychoneuroimmunology, 2nd edition 
(ed. Ader, R) Academic Press, San Diego, CA. 
Adachi, K., Kumamoto, T., and Araki, S. (1989) Interleukin-2 receptor levels indicating relapse in MS 
(letter) Lancet 1 : 559-560. 
Adams, C.W.M. (1972) Research on Multiple Sclerosis. Thomas, Springfield, pp35. 
Adams, C.W.M. (1977) Pathology of MS. Progression of the lesion. Br. Med. J. 33 : 15-20. 
Adams, C.W.M. (1983) The general pathology of multiple sclerosis: morphological and chemical aspects 
of the lesions. In: Multiple Sclerosis, Pathology, Diagnosis and Management. (eds. Hallpike, J.F., 
Adams, C.W.M. and Tourtellotte, W.W.) Williams and Wilkins, Baltimore. 
Adams, I., Jones, D.G. (1985). Synaptic remodelling and astrocytic hypertrophy in rat cerebral cortex 
from early to late adulthood. Neurobiol. Aging 3 : 179-186. 
Adams, R.D. (1959) A comparison of the morphology of the human demyelinative diseases and 
experimental "allergic" encephalomyelitis. In: "Allergic" encephalomyelitis (eds. Kies, M.W. and Alvord, 
E.C. Jr.) C.C. Thomas, Springfield, Illinois, pp. 183-209. 
Ader, R. (ed.) (1981) Psychneuroimmunology, Academic Press, Orlando 
Ader, R., Felten, D.L. Cohen, N. (1991) Psychneuroimmunology, 2nd Edition, Academic Press, San 
Diego, CA. 
Agnarsdottir, G. (1977) Subacute sclerosing panencephalitis. Recent Advances in Clin. Virol. 1: 21-49. 
Aldra, S., Hirano, T., Taga, T. and Kishimoto, T. (1990) Biology of multifunctional cytokines: IL-6 and 
related molecules (IL-1 and 1NF). FASEB J. 4: 2860-2867. 
Allen, I. V. (1983) Hydrolytic enzymes in multiple sclerosis. Prog. Neuropath. 5 : 1-17. 
Allen, J.E., Dixon, J.E. and Doherty, P.C. (1987) Nature of the inflammatory process in the central 
nervous system of mice infected with lymphocytic choriomeningitis virus. Current Topics in 
Microbiology and Immunology 134: 131-143. 
Allen, P.M. (1987) Antigen processing at the molecular level. Immunology Today 8 : 270-273. 
Allerand, C.D. and Yahr, M.D. (1964) Gamma globulin affinity for normal human tissue of the nervous 
system. Science 144: 1141-1142. 
Alpert, J.S. (1990) Nitrate therapy in the elderly. Am. J. Cardiol. 65: 23J-27J. 
1 1 9 
Alter, M., Kahana, E. and Loewenson, R. (1978) Migration and risk of multiple sclerosis. Neurology 28 
: 1089-1093. 
Altman, J. (1972) Postnatal development of the cerebellar cortex in the rat. The external germinal layer 
and the transitional molecular layer. J. Comp. Neurol. 145 : 353-397. 
Altmann, J. (1966) Proliferation and migration of undifferentiated precursor cells in the rat during 
postnatal gliosis. Exp. Neurol. 16 : 263-278. 
Altmann, D.M., Hogg, N., Trowsdale, J. and Wilkinson, D. (1989) Cotransfection of ICAM-1 and HLA-
DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 338: 512-514. 
Alvord, E.C. (1988) Experimental Allergic Encephalomyelitis as a model of Multiple Sclerosis. In: 
Myelination and demyelination. Implications for Multiple Sclerosis (ed. S.U. Kim) pp 13-24. 
Alvord, E.C. Jr, Compston, D.A.S. and Kies, M.W. (1988) Is multiple sclerosis already being 
prevented? In: "Trends in European multiple sclerosis research" (eds. C. Confavreux, G. Aimard & M. 
Devic), pp. 61-65,. Elsevier Science Publ. B.V., Amsterdam. 
Alvord, Jr., E.C. (1970) Acute disseminated encephalomyelitis and "allergic" neuroencephalopathies. 
Handb. Clin. Neurol. 9 : 500. 
Antel, J.P., Peeples, D.M., Reder, A.T. and Amason B.F.W. (1984) Analysis of T regulator cell surface 
markers and functional properties in multiple sclerosis. J. Neuroimmunol. 6: 93-103. 
Anver, M.R. and Cohen, BJ. (1979) Lesions associated with aging. In: The laboratory nat. Volume 1 
(eds. H.J. Baker and J. Russell Lindsey, S.H. Weisbroth) Academic Press, N.Y. 
Aranella, L.S. and Herndon, R.M. (1984) Mature oligodendrocytes . Division following experimental 
demyelination in adult animals. Arch. Neurol. 41: 1162-1165. 
Aranson, B.G., Jankovic, B.D., Waksman, B.H. and Wennersten, C. (1962) Role of the thymus in 
immune reactions in rats. II. Suppressive effect of thymectomy at birth on reactions of delayed (cellular) 
hypersensitivity and the circulating small lymphocyte. J. Exp. Med. 116: 177-186. 
Aranson, B.G.W. (1972) lmmunosuppression in experimental demyelinating diseases. In: Multiple 
Sclerosis: lmmnuology, Virology and Ultrastructure (eds. F. Wolfgram, G.W. Ellison, J.G. Stevens and 
J.M. Andrews), Academic Press, New York, pp. 487-509. 
Arezzo, J.C., Brosnan, C.F., Schroeder, C.E., Litwak, M.S. and Bornstein , M.B . (1988) 
Electrophysiological analysis of factors involved in the primary demyelinating diseases: the rabbit eye 
model system. Brain Research, Amsterdam, 462: 286-300. 
Amon, R. (1981) experimental allergic encephalomyelitis-susceptibility and suppression. Immunological 
Reviews 55 : 5-30. 
Arstila, A.U., Riekkinen, P., Rinne, U.K. et al . (1973) Studies on the pathogenesis of multiple 
sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside 
plaques. Eyr. Neurol. 9 : 1-20. 
Astrom, K.E. and Waksman, B.H. (1962) The passive transfer of experimental allergic encephalomyelitis 
and neuritis with living lymphoid cells. J. Pathol. Bacteriol. 83 : 89-106. 
Baldinger, A. and Blumenthal, H.T. (1983) The immunopathology of the aging . In: Handbook of 
diseases of aging (ed. Blumenthal, H.T.) Van Nostrand Reinhold, New York. 
Banks W.A. and Kastin A.J. (1983). Aluminum increases permeability of the blood-brain barrier to 
labelled DSIP and beta-endorphin:Possible implications for senile and dialysis dementia. Lancet ii: 1227-
1229. 
Banks W.A. and Kastin AJ. (1985) Peptides and blood-brain barrier: Lipophilicity as a pedictor of 
permeability. Brain Res Bull 15 : 287-292. 
Banks, W.A., Kastin, A.J., and Michals, E.A. (1985). Transport of thyroxine across the blood-brain 
barrier is directed primarily from brain to blood in the mouse. Life Sci. 37: 2407-2414. 
Arai, K.I., Lee, F., Miyajima, A. et al. (1990) Cytokines: coordinators of immune and inflammatory responses. 
Annu. Rev. Biochem. 59 : 783-836. 
Aronson, S.M., Bauer, H.J., Brown, J.R. et al. (1982) Therapeutic Claims in Multiple Sclerosis. International 
Federation of Multiple Sclerosis Societies. 
120 
Bannister, R. (1985) Brain's Clinical Neurology (5th Edition). Oxford University Press, London, pp 88-
129. 
Barna, B.P., Chose, S.M., Ransohoft, R.M. and Jacobs, B. (1984) Astrocyte interactions with immune 
modifiers: a possible role for astrocytes in the immunopathogenesis of multiple sclerosis. Prog. Cli . 
Biol. Res. 146: 153-158. 
Barr, T.H. (1978) Morphometric evaluation of capillaries in different laminae of rat cerebral cortex by 
automatic image analysis: changes during development and aging. Adv. Neurol. 20: 1-9. 
Bassoe, P. and Grinker, R.R. (1930) Human rabies and rabies vaccine encephalomyelitis. A 
clinicopathologic study. Archives of Neurology and Psychiatry (Chicago) 23 : 1138-1160. 
Bauer, H.J., Poser, S., Ritter, G. (eds.) (1980) Progress in Multiple Sclerosis Research, Springer-Verlag, 
Berlin. 
Baxter, J.D. and Harris, A.W. (1975) Mechanism of glucocorticoid action: general features, with 
reference to steroid mediated immunosuppression. Transplant. Proc. 7 : 55. 
Becker, M.J., Drucker, I., Farkas, R., Steiner, Z. and Klajman, A. (1981) Monocyte mediated regulation 
of cellular immunity in humans: loss of suppressor activity with aging. Clinical and Experimental 
Immunology 45 : 439-446. 
Behan, P.O. and Spreafico, F. (eds.) (1984) Neuroirnmunology, Raven Press, New York. 
Bell, A., Hurst, N. and Nuki, G. (1986) Effect of corticosteroid therapy on blood monocyte superoxide 
generation in rheumatoid arthritis: studies in vitro and in vivo. Br. J. Rheumatol. 25 : 366-371 
Ben-Nun, A. and Cohen, I.R.(1981~ Vaccination against autoimmune encephalomyelitis (EAE): 
attenuated autoimmune T lymphocytes confer resistence to induction of active experimental allergic 
encephalomyelitis but not to experimental allergic encephalomyelitis mediated by the intact T 
lymphocyte line. Eur. J. Immunol. 11 : 949-952 
Ben-Nun, A., Ron, Y. and Cohen, I.R. (1980) Spontaneous remission of autoimmune encephalomyelitis 
is inhibited by splenectomy, thymectomy or aging. Nature 288 : 389-390. 
Ben-Nun, A., Wekerle, H. and Cohen, I.R. (1981~ The rapid isolation of clonable antigen-specific T-
lymphocyte lines capable of mediating experimental allergic encephalomyelitis. European J. Immunol. 
25 : 1-6. 
Ben-Nun, A., Wekerle, H. and I.R. Cohen (1981) The rapid isolation of clonable antigen-specific T 
lymphocyte lines capable of mediating autoimmune encephalomyelitis Eur. J. Immunol. 11: 195-199. 
Benveniste, E.N. (1988) Lymphokines and monokines in the neuroendocrine system. Prog. Allergy 43 : 
84-120. 
Benveniste, E.N., and Merrill J.E. (1986) Stimulation of oligodendroglial proliferation and maturation by 
Interleukin-2 Nature 321 : 610-613. 
Benveniste, E.N., Sparacio, S.M. and Bethea, J.R. (1989) Tumour necrosis factor-a enhances interferon-g 
mediated class II antigen expression on astrocytes. J. Neuroimmunol. 25 : 209-219. 
Benveniste, E.N., Sparacio, S.M. Norris, J.G., Grenett, H.E. and Fuller, G.M. (1990) Induction and 
regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroirnmunol. 30: 201-212. 
Berg L.E., Goldstein L.A., Jutila M.A., Nakache M., Picker L.J., Streeter P.R. , Wu N.W., Zhou D. & 
Butcher E.C. (1989) Homing receptors and vascular addressins: Cell adhesion molecules that direct 
lymphocyte traffic. Immunol. Rev. 108: 5-18. 
Berg, L. and Morris J .G. (1990) Aging and Dementia. In: Neurobiology of Disease (eds. A.L Pearlman 
and RC Collins) Oxford Uni Press, New York. 
Bergman, R.K., Munoz, J.J. and Portis, J.L. (1978) Vascular permeability changes in the central nervous 
system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a 
substance from Bordatella pertussis. Infect. Immunity 21 : 627-637. 
B~raud, E., Lider, 0., ~ahar~v, E. et al. _(1989~ Vaccination against expe1imental autoimmune encephalomyelitis 
usmg a subencephalltogemc dose of autoimmune effector cells (1). Characteristics of vaccination J 
Autoimmunity 2(1) : 75-86. · · 
121 
Bernard, C.C.A. and Carnegie, P.R. (1975) Experimental autoimmune encephalomyelitis in mice -
immunologic response to mouse spinal cord and myelin basic proteins. J. Immunol. 14: 1537-1544. 
Bernard, C.C.A. and Mackay, I.R. (1983) Transfer of murine experimental autoimmune 
encephalomyelitis and cell-mediated immunity to myelin protein is effected by Lyt-1 cells. J. 
Neuroimmunol. 4: 61-65. 
Bernard, C.C.A., Leydon, J. and Mackay, LR. (1976) T cell necessity in the pathogenesis of 
experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. 6 : 655-660. 
Bernard, C.C.A., Mackay, LR., Whittingham, S. and Brous, P. (1976) Durability of immune protection 
against experimental autoimmune encephalomyelitis. Cell. Immunol. 22: 297-310. 
Besedovsky, H., Del Ray, A., Sorkin, E. and Dinarello, C.A. (1986) Immunoregulatory feedback 
between interleukin-I and glucocorticoid hormones. Science, 233 : 652. 
Bevilacqua, M. P., Pober, J.S., Mendrick, D.L., Cotran, R.S., and Gimbrone Jr., M.A. (1987) 
Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84 : 
9238. 
Bevilacqua, M. P., Stengelin, S., Gimbrone Jr., M.A., and Seed, B. (1989) Endothelial leukocyte 
adhesion molecule 1 : An inducible receptor for neutrophils related to complement regulatory proteins and 
lectins. Science 243 : 1160-1165. 
Bevilagua, M.P., Pober, J.S., Wheeler, M.E. et al., (1985) Interleukin-1 acts on cultured human vascular 
endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related cell lines. 
J Clin. Invest. 76 : 2003-2011. 
Bevilagua, M.P., Pober, G, Majeau, W. et al (1986) Recombinant TNF induces procoagulant activity in 
endothelium. Proc. Natl. Acad. Sci. 83 : 4533. 
Bierer, B.A. and Burakoff, S.J. (1988) T cell adhesion molecules. FASEB J. 2: 2584-2590. 
Bignami, A., Eng, L.F., Dahl, D. and Uyeda, C.T. (1972) Localisation of the glial fibrillary acidic 
protein in astrocytes by immunofluorescence. Brain Research 43 : 429-435. 
Bigner, D.D., Pitts, O.H. and Wilkstrand, C.J. (1981) Induction of lethal experimental allergic 
encephalomyelitis in non-human primates and guinea pigs with human glioblastoma multiforme tissue. 
J. Neurosurg. 55 : 32-42. 
Billiau, A., Heremans, H., Vanderkerckhove, F., Dijmans, R., Sobis, H., Meulepas, E. and Carton, H. 
(1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-
gamma. J. Immunol. 140: 1506-1510 
Black, J.A., Waxman, S.G. and Smith, M.E. (1987) Macromolecular structure of ax.anal membrane 
during acute experimental allergic encephalomyelitis in rat and guinea pig spinal cord. Journal of 
Neuropathology and Experimental Neurology 46: 167-184. 
Blakemore, W.F., Summers, B.A. and Sedgewick, J. (1989) Lymphocyte-myelin sheath interactions in 
acute experimental allergic encephalomyelitis. J. Neuroimmol. 23 : 19-24. 
Bleiberg I., MacGregor, I. and Aronson, M. (1983) Heparin receptors on mouse macrophages. Thromb. 
Res. 29 : 53-61. 
Blumenthal, H.T. (1976) Immunological aspects of the aging brain. In: Neurobiology of Aging (ed RD 
Terry and S Gershon), Raven Press, NY. 
Blumenthal, H.T. (1988) Does the brain possess an independent immune compartment? Drug 
Development Research 15 : 207-226. 
Blumenthal, H.T. and Berns, A.W. (1964): Autoimmunity in ageing. In: Advances in Gerontology 
Research, Vol.l, edited by b.l. Strehler, pp 289-342. Academic Press, New York. 
Blumenthal, H.T., and Probstein, J.G. (1968) The pathogenesis of diseases of senescences. In: Surgery of 
the Aged and Debilitated Patient, (ed. J.M. Powers), pp. 44-81, W.B. Saunders, Philadelphia. 
122 
Blumenthal, H.T., Young, D., Wozniak, D. and Finger, S. (1984) Effects of age, brain damage and stress 
on antibody binding to the brain. Journal of Gerontology 39 : 552-560. 
Boese, A. (ed.) (1980) Search for the cause of multiple sclerosis and other diseases on the central nervous 
system. Verlag-Chemie, Weinheim. 
Bolton, C., Turner, A.M., Turk, J.L. (1984) Prostaglandin levels in CSF from MS patients in remission 
and relapse. J. Neuroimmunol. 6: 151-159. 
Booss, J., Esiri, M.M., Tourtelotte, W.W., Mason, D.Y. (1983) Immunohistochemical analysis of T 
lymphocyte subsets in the CNS in chronic progressive MS. J. Neurol. Sci. 62 : 219-232. 
Bornstein, M.B. and Appel, S.H. (1961) The application of tissue culture to the study of experimental 
"allergic" encephalomyelitis. I. Patterns of demyelination. J. Neuropathol. Exp. Neurol. 20: 141-157. 
Bornstein, M.B. and Raine, C.S. (1976) The initial structural lesion in serum induced demyelination in 
vitro. Lab. Invest. 35 : 391-398. 
Bostock, H. and Grafe, P. (1985) Activity-dependent excitability changes in normal and demyelinated rat 
spinal root axons. Journal of Physiology, London, 365 : 239-257. 
Bowe, C.M., Hildebrand, C., Kocsis, J.D. and Waxman, S.G. (1989) Morphological and physiological 
properties of neurones after long-term axonal regeneration: observation on chronic and delayed sequelae of 
peripheral nerve injury. J. Neurol. Sci. 91 : 259-292. 
Bowen, B. R., Nguyen, T., Lasky, L.A. (1989) Characterization of a human homologue of the murine 
peripheral lymph node homing receptor. J. Cell Biol. 109 : 421. 
Bowman, C.L., Kimelberg, H.K. (1984). Excitatory amino acids directly depolarize rat brain astrocytes in 
primary culture. Nature 311 : 656-659. 
Boyd, A. W., Wawryk, S.O., Bums, G.F. and Fecondo, J.V. (1988) Intercellular adhesion molecule 1 
(ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc. Natl. Acad. Sci. 
USA 85 : 3095-3099. 
Boyd, E. (1932) The weight of the thymus gland in health and in disease. American Journal of Diseases 
of Children 43: 1162-1214. 
Bradbury, M. G., and Parish, C.R. (1989) Receptors on lymphocytes for endogenous splenic 
glycosaminoglycans. Immunology 66: 546-553. 
Bradfield, J. W. B., and Born, G.V.R. (1974) Lymphocytosis produced by heparin and other sulphated 
polysaccharides in mice and rats. Cell. Immunol. 14: 22-32. 
Branceni, D. and Amason, B.G. (1966) Thymic involution and recovery: Immune responsiveness and 
immunoglobulins after neonatal prednisolone in rats. Immunology 10: 35. 
Brenan, M. and Parish, C.R. (1984) Intracellular fluorescent labelling of cells for analysis of lymphocyte 
migration. J. Immunol. Methods 74: 31-38. 
Brenan, M. and Parish, C.R. (1986) Modification of lymphocyte migration by sulphated polysaccharides. 
Eur. J. Immunol. 16 : 423-430. 
Brenan, M., Parish, C.R. and Schoefl, G.I. (1985) Topographical studies of lymphocyte localisation 
using an intracellular fluorochrome. Anat. Rec. 213 : 421-428. 
Brinkman, C.J.J., Nillesen, W.M. and Hommes, O.R. (1983) T cell subpopulations in blood and 
cerebrospinal fluid of multiple sclerosis patients: effects of cyclophosphamide. Clin. Immunol. 
Immunopathol. 29 : 341-348. 
Brosnan, C.F., Bornstein, M.B. and Bloom, B.R. (1981) The effects of macrophage depletion on the 
clinical and pathologic expression of experimental autoimmune encephalomyelitis. J .Immunol. 126 : 
614-620. 
123 
Brosnan, C.F., Traugott, U. and Raine, C.S. (1983) Analysis of humoral and cellular events and the role 
of lipid haptens during central nervous system demyelination. Acta Neuropathologica, Berlin, 
Supplement IX : 59-70. 
Brostoff, S.W. and Mason, D.W. (1984) experimental allergic encephalomyelitis: successful treatment in 
vivo with a monoclonal antibody that recognises T helper cells. J. Immunol. 133: 1938-1942. 
Brown, A., McFarlin, D.E. and Raine, C.S. (1982) Chronologic neuropathology of relapsing 
experimental allergic encephalomyelitis in the mouse. Lab. Invest. 46: 171-185. 
Brown, A.M. and McFarlin, D.E. (1981) Relapsing experimental allergic encephalomyelitis in SJL/J 
mouse. Lab. Invest. 145 : 278-284. 
Bubis, J.J. and Luse, S.A. (1964) An electron microscope study of experimental allergic 
encephalom yelitis in the rat. Am. J. Path. 44 : 299-317. 
Bult, H., Boeckxstaens, G.E., Pelckmans, P.A., Jordaens, F.G., Herman, A.G. (1990) Nitric oxide as an 
inhibitory non-adrenergic non-cholinergic transmitter. Nature. 345 : 346-347. 
Bunge, R.P. (1968) Glial cells and the central myelin sheath. Physiol. Rev. 48: 197-251. 
Burger, D.R., Ford, D., Yetto, R.M., Hamblin, A., Goldstein, A., Hubbard, M. and Dumonde, D.C. 
(1981) Endothelial cell presentation of of antigen to human T cells. Human Irnmunol. 3 : 209. 
Bums, E.M., Kruckeberg, T.W., and Gaetano, P.K. (1981) Changes with age in cerebral capillary 
morphology. Neurobiol. Aging 2: 285-291. 
Burns, E.M., Kruckeberg, T.W., Comerford, L.E., and Buschmann, M .B.T. (1979). Thinning of 
capillary walls and declining numbers of endothelial mitochondria in the cerebral cortex of the aging 
primate, Macaca nemestrina. J. Gereontol. 34 : 642-650. 
Busby, D.E. and Burton, A.C. (1965) The effect of age on the elasticity of the major brain arteries. 
Canadian Journal of Pharmacology 43 : 185-202. 
Bussolino, F, Camussi, G, Aglietta, M, Braquet, P, Bosia, A, Pescarmona, GP, Sanavio, F, D'urso, M, 
Marchisio, PC (1987). Human endothelial cells are target for platelet-activating factor: Platelet activating 
factor induces changes in cytoskeleton structures. J. Immunol. 139 : 2439-2446. 
Butcher, E. C. (1986) The regulation of lymphocyte traffic. Curr. Top. Microbiol. Irnmunol. 128 : 852. 
Butcher, E. C., and Ford, W.L. (1986) Following cellular traffic: Methods of labelling lymphocytes and 
other cells to trace their migration in vivo. In: Handbook of Experimental Immunology. (ed. Weir, D.M., 
and Herzenberg, L. A.) pp.57. Blackwell Scientific Publications, Oxford. 
Butcher, E. C., and Weissman, I.L. (1980) Direct fluorescent labelling of cells with fluorescein or 
rhodamine isothiocyanate. I Technical aspects. J. Immunol. Methods 37: 97. 
Butter, C., Healey, D.G., Agha, N., Wilcox, C.E., Antoniou, A.V. and Turk, J.L. (1989) The 
localisation of fibrin, fibronectin and class II major histocompatibility complex antigen in the spinal cord 
in chronic relapsing experimental allergic encephalomyelitis. J. Neuroimrnunol. 22 : 11-27. 
Callard, R.E., de St Groth, B.F., Basten, A. and Mc Kenzie, I.F.C. (1980) Immune function in aged 
mice. V. Role of suppressor cells. J. Immunol. 124: 52-58. 
Cammer, W., Bloom, B.R., Norton, W.T., Gordon, S. (1978) Degradation of basic protein in myelin by 
neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory 
demyelination. Proc. Nat. Acad. Sci. USA 75 : 1554-1558. 
Camussi, G, Bussolino, F, Salvidio, G, Baglioni, C (1977). Tumor necrosis factor/cachetin stimulates 
peritoneal macrophages, poly-morphonuclear neutrophils and vascular endothelial cells to synthesize and 
release platelet-activating factor. J. Exp. Med. 166: 1390-1404. 
Camussi, G, Turello, E, Bussolino, F, Baglioni, C (1991) Tumour necrosis factor alters cytoskeletal 
organisation and barrier function of endothelial cells. Int. Arch. Allergy Appl. Immunol. 96 : 84-91. 
124 
Camussi, G. (1986) Potential role of platelet-activating factor in renal pathophysiology. Kidney Int. 29 : 
469-477. 
Canella, B., Cross, A.H. and Raine, C. (1991) Adhesion related molecules in the central nervous system. 
Lab. Invest. 65(1) : 23-31. 
Cannella, B., Cross, A. and Raine, C.S. (1990) Upregulation and coexpression of adhesion molecules 
correlate with relapsing autoimmune demyelination in the central nervous system. J . Exp. Med. 172 : 
1521-1524 
Carnegie, P.R. (1971) Properties, structure and possible neuroreceptor role of the encephalitogenic 
protein of human brain. Nature, London, 229 : 25-28. 
Carnegie, P.R.and Lumsden, C.E. (1966) Encephalitogenic petides from spinal cord. Nature 209 : 1354-
1355. 
Carnegie, P.R.and Lumsden, C.E. (1967) Fractionisation of encephalitogenic polypetides from bovine 
spinal cord by gel filtration in phenolacetic acid-water. Immunology 12 : 133-145. 
Caspary, E.A., Prineas, J., Miller, H. and Field, E.J . (1965) Platelet stickiness in multiple sclerosis. 
Lancet ii : 1108-9. 
Chase, M. W. (1959) A critique of attempts at passive transfer of sensitivity to nervous tissue. In: 
Allergic Encephalomyelitis (eds. Kies, M.W. and Alvord, E.C.) pp.348, Charles C. Thomas, Springfield 
Ill. 
Chelmicka-Schorr, E. and Amason, B.G.W. (1972) Partial suppression of experimental allergic 
encephalomyelitis with heparin. Arch. Neurol . 27 : 153-158. 
Chelmicka-Schorr, E., Checinski, M.E. and B.G.W. Amason (1987) Sympathetic nervous system 
trophism for neuroblastoma and its age dependence in rats. J. Neuroirnmunol. 16: 31. 
Chiapppa K.H. (1980) Pattern shift visual, brainstem auditory and short latency somatosensory evoked 
potentials in multiple sclerosis. Neurology 30 : 110. 
Chong, A.S.F. and Parish, C.R. (1986) Cell surface receptors for sulphated polysaccharides: A potential 
marker for macrophage subsets. Immunology 58: 277-284. 
Chung, LY. and Benveniste, E.N. (1990) Tumour necrosis factor-alpha production by astrocytes: 
induction by lipopolysaccharide, interferon-gamma and interleukin-I. J. Irnrnunol. 144: 2999-3007. 
Chung, LY., Norris, J.G., Benveniste, E.N. (1991) Differential Tumour necrosis factor expression by 
astrocytes from experimental allergic encephalomyelitis-susceptible and resistant rat strains. J. Exp. Med. 
173 : 801-811. 
Claman, H.N. (1972) Corticosteroids and lymphoid cells. N. Engl. J. Med. 287 : 388. 
Claman, H.N. (1983) Glucocorticords I: Anti-inflammatory mechanisms. Hosp Pract 18(7) : 123. 
Claman, H.N., Moorhead, J.W. and Benner, W.H. (1971) Corticosteroids and lymphoid cells in vitro. I. 
Hvdrocortisone lysis of human, guinea pig and mouse thmus cells. J. Lab. Clin. Med. 18: 499. 
Clark, G. (1981) Staining Procedures. 4th Edition, Williams and Wilkins, Baltimore. 
Clark, I.A., Macmicking, J .D., Gray, K.M. et al (1992) Malaria mimicry with tumour necrosis factor. 
Arn. J. Path. 140 (2) : 325-336. 
Clark, I.A., Chaudhri, G. and Cowden, W.B. (1989) Roles of tumour necrosis factor in the illness and 
pathology of malaria. Trans. R. Soc. Trop. Med. Hyg. 83 : 436-440. 
Clark, R.A.F., Dvorak, H.F. and Colvin, R.B. (1981) Fibronectin in delayed-type hypersensitivity skin 
reactions: associations with vessel permeability and endothelial cell activation. J . Imrnunol. 126 : 787-
793. 
Clark, R.B., Dore-Duffy, P., Donaldson, J.O., Pollard, M.K. and Muirhead, S.P. (1984) Generation of 
phenotypic helper/inducer and suppressor/cytotoxic T cell lines from cerebrospinal fluid in multiple 
sclerosis. Cell. Irnrnunol. 84 : 409-416. 
125 
Claudio, L, ., Brosnan, C.F. (1990) Increased vesicular transport and decreased mitochondrial content in 
BBB endothelial cells during EAE. Am. J. Path. 135(6) : 1157-68. 
Cohen S.R. Brooks, B.R. Herndon, R.M. and Khann, G.M. (1980) A Diagnostic index of active 
demyelination:Myelin basic protein in cerebrospinal fluid. Ann. Neurol. 8 : 25. 
Cohen, I.R. (1986) Regulation of autoimmune disease : Physiological and therapeutic. Immunol. Rev. 
94 : 5-21. 
Cohen, J. and Crnic, L. (1984) Glucocorticoids, stress and the immune response. In:D.R. Webb (Ed.), 
Immunopharmacology and the Regulation of Leukocyte Function, Dekker New York pp 61-91. 
Cole, G.J., Loewy, A. and Glaser, L. (1986) Neuronal cell-cell adhesion depends on interactions of N-
CAM with heparin-like molecules. Nature 320: 445-447. 
Collins, T., Lapierre, L.A., Fiers, W. et al (1986) Recombinant 1NF increases mRNA levels and surface 
expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. 
Acad. Sci. 83 : 446. 
Colvin, R.B. and Dvorak, H.F. (1975) Role of the clotting system in cell-mediated hypersensitivity. II. 
Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous 
basophil hypersensitivity reactions. J. Immunol. 114 : 377-387. 
Compstom, A.(1986) Genetic factors in the aetiology of multiple sclerosis, in "Multiple sclerosis" (eds. 
W.I. MacDonald & Silberberg, D.D.) (pp 56-73). Butterworths, London. 
Compston, D.A.S., Morgan, B.P., Obesky, D et al., (1986) CSF in demyelinating disease. Neurology 
36: 1503-6. 
Compston, D.A.S., Vakarelis, B.N., Paul, E. et al. Brain 109 : 325-344. 
Cooper, D.A., Petts, V., Luckhurst, E. and Penny, R. (1977) The effect of acute and prolonged 
administration of prednisolone and ACTH on lymphocyte subpopulations. Clin. Exp. Immunol. 28 : 
267. 
Cornford, E.M. and Oldendorf, W.H. (1975). Independent blood-brain barrier transport systems for nucleic 
acid precursors. Biochim. Biophys. Acta. 394: 211-219. 
Cornford, E.M., and Cornford, M.E.(1986) Nutrient transport and the blood-brain barrier in developing 
animals. Fed. Proc. 45 : 2065-2072. 
Cornford, E.M., Braun, L.D. and Oldendorf, W.H.(1978). Carrier mediated blood-brain barrier transport of 
choline and certain choline analogs. J. Neurochem. 30: 299-308. 
Coutinho, G.C., Durieu-Trautmann, D., Strosberg, A.D. and Couraud, P.O. (1991) Catecholamines 
stimulate the IFN-g-induced class II MHC expression on bovine brain capillary endothelial cells. J. 
Immunol. 147(8) : 2525-2529. 
Craddock, C.G. (1978) Corticosteroid-induced lymphophenia, immunosuppression and body defense. 
Ann. Intern. Med. 88 :564. 
Cragg, B.G. and Thomas, P.K. (1964) The conduction velocity of regenerated peripheral nerve fibres. 
Journal of Physiology, London, 171 : 164-175. 
Craggs, R.I. and Webster, H. def. (1985) Ia antigens in the normal rat nervous system and in lesions of 
experimental allergic encephalomyelitis. Acta Neuropathology 68: 263-272. 
Crapper, D.R., Quittkat, S., Krishnan, S.S., Dalton, A.J. and DeBoni, V.(1982) lntranuclear aluminium 
content in Alzheimer's disease, dialysis encephalopathy and experimental aluminium encephalopathy. 
Acta. Neuropathol. (Berl) 50: 19-24. 
Critchlow, V., Liebelt, R., Bar-Sela, M., Mountcastle, W. and Lipscomb, H. (1963) Sex differences in 
resting pituitary-adrenal function in the rat. Am J. Physiol. 205(5): 807-815. 
Crone, C. (1965) Facilitated transfer of glucose from blood into brain tissue. J. Physiol. (Lond) 181 : 
103-113. 
Currier, R.D., Jackson, J.F. and Meydrech, E.F. (1982) Progression rate and age at onset are related in 
autosomal dominant neurologic diseases. Neurology 32(8): 907-9. 
Cross, A.H., Cannella, B., Brosnan, C.F. and Raine, C. (1990) Homing to the central nervous system 
vasculature by antigen-specific lymphocytes. Lab. Invest. 63(2) : 162-170 
Cruzner, M.L., Hayes, G.M., Newcombe, J. and Woodroofe, M.N. (1988) The nature of inflammatory 
components during demyelination in multiple sclerosis. J. Neuroimmunol. 20 : 203-209. 
Cupps, T. and Fauci, A. (1982) Corticosteroid-mediated immunoregulation in man. Imrnunol. Rev. 65 : 
133-155. 
Dailey, M. 0., Gallatin, W.M., and Weissman, I.L. (1985) The in vivo behaviour of T cell clones : 
Altered migration due to the loss of the lymphocyte surface homing receptor. J. Mol. Cell. Imrnunol. 2 : 
27-36. 
Dal Canto, M.C. and Lipton, H.L. (1975) Primary demyelination in Theiler's virus infection. An 
ultrastructural study. Lab. Invest. 33 : 626-637. 
Daniel, P.M., Lam, D.K. and Pratt, O.E. (1981) Changes in the effectiveness of the blood-brain and 
blood-spinal cord barriers in experimental allergic encephalomyelitis J. Neurol. Sci. 52: 211-219. 
Daniel, P.M., Lam, D.K. and Pratt, O.E. (1983) Relation between the increase in the diffusional 
permeability of the blood-central nervous system barrier and other changes during the development of 
experimental allergic encephalomyelitis in the Lewis rat. J. Neurol. Sci. 60: 367-376. 
Dau P.C. Petajan, J.H., Johnson, K.P., Panitch, H.S. and Bornstein, M.B. (1980) Plasmapheresis in 
multiple sclerosis: Preliminary findings, Neurology 30 : 1023. 
Davidson, W. and Woof, C. (1978) Comparison of different forms of falciparum as reducing agents for 
the batch determination of nitrate. Analyst 102 : 403-406. 
Davidson, W. F., and Parish, C.R. (1975) A procedure for removing red cells and dead cells from 
lymphoid cell suspensions. J. Immunol. Methods 7 : 291-300. 
Day, E.D., Varitek, V.A., Fujinami, R.S. and Paterson P.Y. (1978) MBP-SF, a prominent serum factor 
in suckling Lewis rats that additively inhibits the primary binding of myelin basic protein (MBP) to 
syngeneic anti-MBP antibodies. Immunochem. 15 : 1-9. 
De Sousa, M. (1981) Lymphocyte Circulation: Experimental and Clinical Aspects. p. 259. John Wiley 
and Sons, Chichester. pp. 1-13. 
De Vellis, J., Wu, D.K., Kumar, S.(1986). Enzyme induction and regulation of protein synthesis. In: 
Astrocytes, vol. 2.(Fedoroff, S.: Vemadakis, A., eds.), Orlando, FL: Academic Press Inc. : 209-235. 
Deibler, G.E., Martenson, R.E. and Kies, M.W. (1972) Large scale preparation of myelin basic protein 
from central nervous tissue of several mammalian species. Prep. Biochem. 2: 139-165. 
Del Maestro, R., Bjork, J. and Arfors, K.E. (1981) Increase in microvascular permeability induced by 
enzymatically generated free radicals. Microvasc. Res. 22: 255-270. 
di Rosa, M., Radomski, M., Camuccio, R., and Moncada, S. (1990) Glucocorticoids inhibit the 
induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172 : 1246-1252. 
Ding, A., Nathan, C. and Stuehr, D. (1988) Release of reactive nitrogen intermediates and reactive 
oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141 : 2407-2412. 
Doherty, P.C. (1984) Clearance of experimental viral infections of the central nervous system In: 
Neuroimmunology (eds. Behan, P. and Spreafico, F.) pp. 301-310, Raven Press, New York. 
Doherty, P.C., Solter, D. and Knowles, B.B. (1977) H-2 gene expression is required for T cell-mediated 
lysis of virus-infected target cells. Nature (London) 266: 361-362. 
Donahue, S. and Pappas, G.D.(1961). The fine structure of capillaries in the cerebral cortex of the rat at 
various stages of development. Am. J. Anat. 108: 331-347. 
Dresser, D.W., Taub, R.N. and Krantz, A.R. (1970) The effect of localised injection of adjuvant material 
on the draining lymph node. Immunol. 18 : 663-670 
127 
Driscoll, B.F., Kies, M.W. and Alvord, E.C. (1974) Successful treatment of experimental allergic 
encephalomyelitis (EAE) in guinea-pigs with homologous myelin basic protein. J. Immunol. 112 : 392-
397. 
Duijvestijn, A., and Hamann, A. (1989) Mechanisms and regulation of lymphocyte migration. Immunol. 
Today 10 : 23-28. 
Duijvestijn, A.M., Schreiber, A.B. and Butcher, E.C. (1986) Interferon-gamma regulates an antigen 
specific for endothelial cells involved in lymphocyte traffic. Proc. Natl. Acad. Sci. USA 83 : 9114. 
Dunkley, P.R. and Carnegie, P.R. (1974) Amino acid sequence of the smaller basic protein from rat 
brain myelin. Biochem. J. 141 : 243-255. 
Dustin M.L., Staunton D.E. & Springer T.A. (1988) Supergene families meet in the immune system. 
lmmunol. Today 9 : 213-215. 
Dustin, M. L., and Springer, T.A. (1988) Lymphocyte function-associated antigen-I (LFA-1) interaction 
with intercellular adhesion molecule-I (ICAM-1) is one of at least three mechanisms for lymphocyte 
adhesion to cultured endothelial cells. J. Cell Biol. 107: 321-331. 
Dustin, M. L., Singer, K.H., Tuck, D.T., and Springer, T.A. (1988) Adhesion of T lymphoblasts to 
epidermal keratinocytes is regulated by interferon g and is mediated by intercellular adhesion molecule 1 
(ICAM-1). J. Exp. Med. 167: 1323. 
Einstein, E.R. and Czejtey, J. (1968) Degradation of encephalitogen by purified brain acid proteinase. 
FEBS Lett. 1 : 191-195. 
Einstein, E.R., Chao, L.P. and Czejtey, J. (1972) Suppression of experimental allergic 
encephalomyelitis by chemically modified encephalitogen. Immunochem. 9: 1013-1019. 
Ellerman, K.E., Powers, J.M. and Brostoff, S.W. (1988) A suppressor T-lymphocyte cell line for 
autoimmune encephalomyelitis. Nature 331 : 265-267. 
Ellison, G.W. and Myers C.N., (1980) Immunosuppresive drugs in multiple sclerosis: Pro and con. 
Neurology 30 : 28. 
Endoh, M. and Tabira, T. (1990) Effect of thymic hormones on induction of experimental allergic 
encephalomyelitis in old mice. Tokoku J. Exp. Med 161(4) : 303-9. 
Endoh, M., Rapoport, SJ., Tabira, T. (1990). Studies of experimental allergic encephalomyelitis in old 
mice. J. Neuroimmunol. 29(1-3): 21-31. 
Eng, L.F. (1980) Astrocytes (eds. Bradshaw, R.A. and Schneider, D.M.), Raven Press, NY, pp 85-117. 
Eng, L.F. (1985) Glial Fibrillary Acid Protein (GF AP): the major protein of glial intermediate filaments 
in differentiated astrocytes. J. Neuroimmunol. 8 : 203-214. 
Eng, L.F., Vanderhaegen, T.J., Bignami, A. and Gerstl, B. (1971) An acidic protein isolated from fibrous 
astrocytes. Brain Res. 28 : 351-254. 
Engelhardt, B. Diamanstein, T. and Wekerle, H. (1989) Immunotherapy of experimental autoimmune 
encephalomyelitis (EAE): differential effect of anti-IL2 receptor antibody therapy on actively induced and 
T-line mediated experimental allergic encephalomyelitis of the Lewis rat. J. Autoimmunity 2: 61-73 . 
Espevik, T. and Nissen-Meyer, J. (1986) A highly sensitive cell line WEHI 164 clone 13 for measuring 
cytotoxic factorrINF from human monocytes. J.Immunol. Methods 95: 99-105. 
Eylar, E.H., Brostoff, S., Hashim, G., Caccam, J. and Burnett, P. (1971) Basic Al protein of the myelin 
membrane. The complete amino acid sequence. J. Biol. Chem. 246 : 5770-5784. 
Eylar, E.H., Jackson, J., Rothenberg, B. and Brostoff, S.W. (1972) Suppression of the immune response 
reversal of the disease state with antigen in allergic encephalomyelitis. Nature (London) 236 : 74. 
Fabris, N. (1982) Neuroendocrine-immune network in aging. In: Developmental Immunology: clinical 
problems and aging (ed ET Bloom) Academic Press Inc. 
128 
Fauci, A.S. (1975) Corticosteroids and circulating lymphocytes. Transplant. Proc. 7 : 3 7. 
Fauci, A.S. and Dale, D.C. (1974) The effect of in vivo hydrocortisone on subpopulations of human 
lymphocytes. J. Clio. Invest. 53 : 240. 
Fauci, A.S. and Dale, D.C. (1975a) Alternate-day prednisone therapy and human lymphocyte 
subpopulations. J. Clio. Invest. 55 : 22. 
Fauci, A.S. and Dale, D.C. (1975b) Effect of hydrocortisone on the kinetics of normal human 
lymphocytes. Blood 46: 235. 
Fauci, A.S., Dale, D.C. and Balow, J.E. (1976) Glucocorticosteroid therapy: mechanisms of actions and 
clinical considerations. Ann. Intern. Med. 84: 304. 
Feasby, T.E., Bostock, H. and Sears, T.A. (1981) Conduction in regenerating dorsal root fibres. J. 
Neurol. Sci. 49 : 439-454. 
Feden, G., Baldinger, A., Miller-Soule, D. and Blumenthal, H.T. (1979) An in vivo and in vitro study of 
an aging-related neuron cytoplasmic binding antibody in male Fisher rats. Journal of Gerontology 34 : 
651-660. 
Feldman, S., Tal, C. and Behar, A.J. (1969) Electrical changes in the brain in the course of experimental 
allergic encephalomyelitis in rabbits. J. Neurol. Sci. 8 : 413-424. 
Felten, D.L., Ackerman, K.D., Wiegand, S.J. and Felten, S.Y. (1987) Noradrenergic sympathetic 
innervation of the spleen: I. Nerve fibers aasociate with lymphocytes and macrophages in specific 
compartments of the splenic white pulp. Journal of Neuroscience Research 18: 28-36. 
Felten, S.Y. and Felten, D.L. (1991) Innervation of lymphoid tissue. In: Psychoneuroimmunology 2nd 
edition (ed. Ader, R.) Academic press, San Diego, CA. 
Ferguson, M.A.J. and Williams, A.F. (1988) Cell-surface anchoring of proteins via 
glycosylphosphatidylinositol structures. Annu. Rev. Biochem. 57 : 285-320. 
Ferraro, A. and Cazzulo, C.L. (1949) Prevention of experimental encephalomyelitis in guinea-pigs. J. 
Neuropathol. Exp. Neurol. 8 : 61-69. 
Ferraro, A. and Jervis, G.A. (1940) Experimental disseminated encephalopathy in the monkey. Archives 
of Neurology and Psychiatry (Chicago) 43 : 195-209. 
Ferraro, A. and Roizin, L. (1954) Neuropathologic variations in experimental allergic encephalomyelitis. 
Hemorrhagic encephalomyelitis, perivenous encephalomyelitis, diffuse encephalomyelitis, patchy gliosis. 
J. Neuropathol. Exp. Neurol. 13 : 60-89. 
Ffrench-Constant, C. and Raff, M.C. (1986) The oligodendrocyte-type-2 astrocyte cell lineage is 
specialised for myelination. Nature, London, 307 : 273-276. 
Field, E.J. (1961) The early lesion of experimental "allergic" encephalomyelitis. Exp. Neurol. 4: 233-
240. 
Field, E.J. (1967) Experimental allergic demyelination and multiple sclerosis. J.R. Coll. Physicians 
Lond. 1 : 56-67. 
Fierz, W., Endler, B., Reske, K., Wekerle, H. and Fontan~ A. (1985) Astrocytes as antigen presenting 
cells: Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on 
antigen presentation. J. Immunol. 134: 3785-3793. 
Finch, C.E. Morgan, D.G.(1990). RNA and protein metabolism in the aging brain. Annu. Rev. 
Neurosci. 13 : 75-87. 
Fishman, R.A. (1975) Brain edema. New England Journal of Medicine 293 : 706-711. 
Fleury, H.J., Sheppard, R.D., Bornstein, M.B. et al. (1980) Further ultrastructural observations of virus 
morphogenesis and myelin pathology in JHM virus encephalomyelitis. Neuropath. App. Neurobiol. 6 : 
165. 
129 
Flower, R.J. (1984) In: Textbook of Immunopharmacology (eds. Dale, M.M. and Foreman, J.C .), 
Blackwell, Oxford. 
Fog, T., Kristensen, I. and Helwig-Larsen, H.F. (1955) Blood platelets in disseminated sclerosis. Arch. 
Neurol. Psychiatry 73 : 267-285. 
Fontana, A., and Fierz, W. (1985) The endothelium-astrocyte immune control system of the brain. 
Springle Seminars in Immunopathology 8: 57-70. 
Fontana, A., Dubs, R., Merchant, R., Balsiger, S. and Grob, P.J. (1981a) Glia cell stimulating factor 
(GSF): a new lymphokine. Part 1. Cellular sources and partial purification of murine GSF, role of 
cytoskeleton and protein synthesis in its production. J. Neuroimmunol. 2: 55-71. 
Fontana, A., Erb, P., Pircher, H., Zinkemagel, R., Weber, E. and Fierz, W. (1986) Astrocytes as antigen 
presenting cells. Part II unlike H-2k-dependent cytotoxic T cells, H-21a - restricted T cells are only 
stimulated in the presence of gamma interferon. J. Neuroimmunol. 12: 15-28. 
Fontana, A., F. Kristensen, R. Dubs, D. Gemsa, and E. Weber (1982) Production of Prostaglandin E and 
an interleukin-1 like factor by cultured astrocytes and C6 gliomia cells. J. Immunol. 129(6): 2413-2419. 
Fontana, A., Fierz, W. and Wekerle, H. (1984) Astrocytes present myelin basic protein to 
encephalitogenic T-cell lines. Nature, London, 307 : 273-276. 
Fontana, A., Fierz, W. and Wekerle, H. (1984) Astrocytes present myelin basic protein to encephalogenic 
T-cell lines. Nature (London) 307 : 273-276. 
Fontana, A., Frei, K., Bodmer, S. and Hofer, E. (1987) Immune mediated encephalitis: On the role of 
antigen presenting cells in the brain. Immunological Reviews 100 : 185-201. 
Fontana, A., Kristensen, F., Dubs, R., Gemsa, D. and Weber, E. (1982) Production of prostaglandin E 
and IL-1 like factors by cultured astrocytes and C6 glioma cells. J. Immunol. 129: 2419-2431. 
Fontana, A., Otz, U., de Weck, A.L. and Grob, P.J. (1981b) Glia cell stimulating factor (GSF): a new 
lymphokine. Part 2. Cellular sources and partial purification of human GSF. J. Neuroimmunol. 2 : 73-
81. 
Forster, M.J. and Lal, H (1991) Neurobehavioural biomarkers of ageing: influence of genotype and 
dietary restriction. Biomed. Environ. Sci. 4(1-2): 144-165. 
Frei, K., Bodmer, S. Schwerdel, C. and Fontana, A. (1985) Astrocytes of the brain synthesize 
interleukin-3 like factors. J. Immunol. 135(6) : 4044-4047. 
Frei, K., Malipiero, U.V., Leist, T.P., Zinkemagel, R.M., Schwab, M.E. and Fontana, A. (1989) On 
the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. 
Eur. J. Immunol. 19 : 689-694. 
Frei, K., Siepl, C., Groscurth, P., Bodmer, S. and Fontana, A. (1988) Immunobiology of microglial 
cells. Ann. N.Y. Acad. Sci. 540: 218-227. 
Frei, K., Siepl, C., Groscurth, P., Bodmer, S., Schwerdel, C. and Fontana, A. (1987) Antigen 
presentation and tumor cytotoxicity by interferon g treated microglial cells. European J. Immunol. 17 : 
1271-1278. 
Freund, J. Mc Dermott, K. (1942) Sensization to horse serum by means of adjuvants. Proc. Soc. Exp. 
Biol. Med. 49 : 548-553. 
Freund, J ., Stem, E.R. and Pisani, T.M. (1947) Isoallergic encephalomyelitis and radiculitis in guinea 
pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J. Immunol. 57 : 179-194. 
Freund, M. and Pick, E. (1985) The mechanism of action of lymphokines VIII. Lymphokine-enhanced 
spontaneous hydrogen peroxide production by macrophages. Immunology 54 : 35-45. 
Fritz, R.B., Skeen, M.J ., Jen-Chou, C.H., Garcia, J. and Egorov, I.K. (1985) Major histocompatibility 
complex-linked control of the murine response to myelin basic protein. J. Immunol. 134: 2328-2332. 
130 
Fujinami, R.S. and Oldstone, M.B.A. (1985) Amino acid homology between the encepbalitogenic site of 
MBP and virus. Mechanisms for autoimmunity. Science 230: 1043-1045. 
Funke, I., Hahn, A., Reiber, E.P., Weiss, E., reithmiller, G. (1987) The cellular receptor (CD4) of the 
human immunodeficiency virus is expressed on neurones and glial cells in human brain. J . Exp. Med. 
165 : 1230-1235. 
Furukawa, S., Furukawa, Y., Satoyoshi, E., Hayashi, K. (1986). Synthesis and secretion of nerve 
growth factor by mouse astroglial cells in culture. Biochem. Biophys. Res. Commun. 136 : 57-63. 
Gahwiler, B.H. and Honeggar, G.C. (1979) Myelin basic protein depolarizes neuronal membranes . 
Neurosci. Lett. 11 : 317-321. 
Gardner, I.D. (1980) The effect of ageing on the susceptibility to infection. Rev. Infect. Dis. 2: 801. 
Gardner, I.D. and Remington, J.S. (1978) Aging and the immune response II. Lymphocyte 
responsiveness and macrophage activation in Toxoplasma gondi-infected mice. J. Immunol. 120 : 944-
949. 
Garthwaite, J., Charles, S.L., Chess-Williams, R. (1988) Endothelium-derived relaxing factor release on 
activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 : 385-
388. 
Gasser, D.L., Newlin, C.M., Palm J. and Gonatas, N.K. (1973) Genetic control of susceptibility to 
experimental allergic encephalomyelitis in rats. Science 181 : 872-873. 
G~sser, D.L., Palm, J. and Gonatas, N.K. (1975) Genetic control of susceptibility to experimental 
allergic encephalomyelitis and the Ag-B locus of rats. J. Immunol. 115 : 431-433 . 
Gavin J.R. III (1977) Polypeptide hormone receptor on lymphoid cells. Compr. Immunol. 3 : 357. 
Geinisman, Y., Bondareff, W., Dodge, J.T. (1978) Hypertrophy of astroglial processes in the dentate 
gyrus of the senescent rat. Am. J. Anat. 153 : 537-543. 
Gijbels, K., Van Damme, J., Proost, P., Put, W., Carton, H. and Billiau, A. (1990) Interleukin 6 
production in the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. 
Immunol. 20 : 233-235 
Gillespie, J.S., Liu, X., Martin, W. (1989). The effects of L-arginine and N-monomethyl-L-arginine on 
the response of the rat annococcygeus muscle to NANC nerve stimulation. Br J Pharmacol. 98 : 1080-
1082. 
Giotta, G.J., and Cohn, M. (1982) Derivation of neural cell lines with Rous Sarcoma virus In: 
Neuroscience Approached Through Cell Culture (ed.S.E. Pfeiffer) pp203-225. 
Giulian, D., Baker, T.L., Shih, L. and Lachman, L.B. (1986) Interleukin-I of the central nervous system 
is produced by ameboid microglia. J. Exp. Med. 164: 594-604. 
Glabe C.G., Yednock T. and Rosen S.D. (1983) Reversible disruption of cultured endothelial monolayers 
by sulphated fucans. J. Cell. Sci. 61 : 475-490. 
Glimelius, B., Busch, C., and Hook, M. (1978) Binding of heparin on the surface of cultured human 
endothelial cells. Thromb. Res. 12 : 773-782. 
Goidl, E.A., Choy, J.W., Gibbons, J.J., Weksler, M.E., Thorbecke, G.J. and Siskind, G.W. (1983) 
Production of auto-anti-idiotypic antibody during normal immune response. VII. Analysis of the cellular 
basis for the increased auto-anti-idiotypic antibody production by aged mice. J. Exp. Med. 157 : 1635-
1645. 
Goldstein, G.W. and Betz, A.L. (1986) The blood-brain barrier. Sci. Am. 255 : 70. 
Gonatas, N.K. and Howard, J.C. (1979) Inhibition of EAE in rats severly depleted of T cells. Science 186 
: 839-841. 
1 3 1 
Gonatas, N.K., Gonatas, J.O., Stieber, A., Lisak, R., Suzuki, K. and Martensen, R.E. (1974) The 
significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis. Am. J. 
Path. 76 : 529-547. 
Goodwin, J.S. and Webb, D.R. (1980) Regulation of the immune response by protaglandins. Clin. 
Immunol. Immunopathol. 15 : 106-122. 
Goodwin, J.S., Goodwin, J.M. and Garry, P.J. (1983). Association between nutritional status and 
cognitive functioning in a healthy elderly population. J. Am. Med. Assoc. 249: 2917-2921. 
Gorczynski, R.M., Kennedy, M. and Mac Rae, S. (1984) Altered lymphocyte recognition repertoire 
during ageing. II Changes in MHC restriction patterns in parental T lymphocytes and diminution in T 
suppressor function . Imnmnol. 52: 611-620. 
Goss, J.R., Finch, C.E. and Morgan, D.E. (1991) Age-related changes in glial fibrillary acidic protein 
mRNA in the mouse brain. Neurobiology of Aging 12: 165-170. 
Goto, K. and Ishii, N. and Fukasawa, H. (1981) Diffuse white-matter disease in the geriatric population: 
a clinical, neuropathological and CT study. Radiology 141 : 687-695. 
Gottesman, S.R.S. and Walford, R.L. (1982) Autoimmunity and aging. In: Methods in Aging Research 
XIV (R.C. Adelman and G.S. Roth, eds.) CRC Press. West Palm Beach, Florida. 
Gowans, J. L. (1957) The effect of continuous re-infusion of lymph and lymphocytes on the output of 
lymphocytes from the thoracic duct of unanaesthetized rats. Br. J. Exp. Pathol. 38 : 67-78. 
Gowans, J. L. (1959a) The recirculation of lymphocytes from blood to lymph in the rat. J. Physiol. 146 
: 54. 
Gowans, J. L. (1959b) The life-history of lymphocytes. Br. Med. Bull. 15 : 50. 
Gowans, J.L. and Knight, E.J. (1964) The route of recirculation of lymphocytes in the rat. Proc. R. Soc. 
Lond. B Biol. Sci. 159 : 257-282. 
Graebar, J.E. and Stuart, M.J. (1978) Spinal fluid procoagulant activity: a sensitive indicator of central 
nervous system damage. Lancet ii: 285-288. 
Graeber, M.B., Streit, W.J. and Kreutzberg, G.W. (1988) Axotomy of rat facial nerve leads to increased 
CR3 complement receptor expression by activated microglia. Journal of Neuroscience Research 21 : 18-
24. 
Graeber, M.B., Streit, W.J. and Kreutzberg, G.W. (1989) Identity of ED-2 positive perivascular cells in 
rat brain. Journal of Neuroscience Research 22: 103-106. 
Graham, D.I., Thomas, D.G.T. and Brown, I. (1983) Nervous system antigens. Histopathology 7 : 1-21. 
Granelli-Piperno, A. , Keane, M. , Steinman, R.M.(1988) Evidence that cyclosporine inhibits cell-
mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. 
Transplantation 46 (Suppl) 535-605. 
Grant, L. (1973) The inflammatory process (eds. B.W. Zweifach, L.Grant and R.T. McCluskey), 
Academic Press, N.Y., p 205. 
Green, SJ., Mellock, S.L., Hoffman, M.S. et al., (1990) Cellular mechanisms of non-specific immunity 
to intracellular infection: cytokine-induced synthesis of toxin nitrogen oxides from L-arginine by 
macrophages and hepatocytes. Immunol. Lett. 25 : 15-20. 
Griffin, A.C. and Whitacre, C.C. (1991) Sex and strain differences in the circadian rhythm fluctuation of 
endocrine and immune function in the rat: implications for rodent models of autoimmune disease. J. 
Neuroimmunol. 35 : 53-64. 
Guilian, D. (1987) Ameboid microglia as effectors of inflammation in the central nervous system. 
Journal of Neuroscience Research 18 : 155-171. 
Guilian, D. and Baker, T.J. (1985) Peptides released by ameboid microglia regulate astrocyte 
proliferation. Journal of Cell Biology 101 : 2411-2415. 
132 
Guilian, D. and Ingeman, J.E. (1988) Colony stimulating factors as promoters as ameboid microglia. 
Journal of Neuroscience 8 : 4707-4717. 
Guilian, D., Balcer, T.J ., Shih, L.-C.N. and Lachman, l.B. (1986) Interleukin-I of the central nervous 
system is produced by ameboid microglia. J. Exp. Med. 164 : 594-604. 
Gunther, E., Odenthal, H. and Weschler, W. (1978) Association between susceptibility to experimental 
allergic encephalomyelitis and the major histocompatibility system in congenic rat strains. Clin. Exp. 
lmmunol. 32 : 429-434. 
Guy, J, Ellis, E.A>, Hope, G.M. and Emerson, S. (1991) Maintenance of myelinated fibre-g ratio in 
acute EAE. Brain 114(1a): 281-94. 
Hafter, D.A. and Weiner, H.L. (1989) MS: a CNS and systemic autoimmune disease. Immunol. Today 
10(3) : 104-7. 
Halliwell, B. and Gutteridge, J.M.C. (1985) Oxygen radicals and the nervous sytem. Trends in 
Neurosciences & : 22-26 
Hallpike, J.F. (1983) Clinical aspects of MS. In : MS pathology, diagnosis and management (eds. J.F. 
Hallpike, W.M. Adams, W.W. Tourtellotte) Chapman and Hall, London, pp 12-15. 
Hamann, A., and Thiele, H.G. (1989) Molecules and regulation in lymphocyte migration. Immunol. 
Rev. 108 : 19-44. 
Hamann, A., Jablonski-Westrich, D., Duijvestijn, A., Butcher, E.C., Baisch, H., Harder, R., and Thiele, 
H.G. (1988a) Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during 
homing. J. Immunol. 140 : 693-699. 
Hamann, A., Jablonski-Westrich, D., Scholz, K.-U., Duijvestijn, A., Butcher, E.C., and Thiele, H.G. 
(1988b) Regulation of lymphocyte homing I. Alterations in homing receptor expression and organ-
specific high endothelial venule binding of lymphocytes upon activation. J. Immunol. 140: 737. 
Hansen, L.A. and Pender, M.P. (1989) Hypothermia due to an ascending impairment of shivering in 
hperacute experimental allergic encephalomyelitis in the Lewis rat. J. Neurol. Sci. 94 : 231-240. 
Happ, M.P., Wettstein, P., Dietzschold, B. and Heber-Katz, E. (1988) Genetic control of the 
development of experimental allergic encephalomyelitis in rats. J. Immunol. 141 : 1489-1494. 
Hartung, H-P., Schafer, B., van der Meide, P.et al., (1990) The role of interferon-gamma in the 
pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann. Neurol. 27 : 
247-257. 
Harvey, W.F. and Acton, H.W. (1923) An examination into the degree of efficacy of anti-rabic treatment. 
Indian J. Med. Res. 10 : 1020-1077 
Hashim, G.A., Carvalho, E.F. and Sharpe, R.D. (1978) Definition and synthesis of the essential amino 
acid sequence of experimental allergic encephalomyelitis in Lewis rats. J. Immunol. 121 : 665-670 
Hashim, G.A., Wood, D.D. and Moscarello, M.A. (1980) Myelin lipophilin-induced demyelinating 
disease of the central nervous system. Neurochemical Research 5 : 1137-1145. 
Hatzinikolaou, P., Brecher, P., and Gavras, H. (1981) Chronic hypertension increases tyrosine transport 
across the blood-brain barrier in the rat. Life Sci. 29 : 1657-1660. 
Hauser, S., Dawson, D., Lehrich, J., Beal, M., Kevy, S., Propper, R., Mills, J. and Weiner, H. (1983) 
Intensive immunosuppression in progressive multiple sclerosis - a randomised, three-arm study of high 
dose intravenous cyclophosphamide, plasma exchange, and ACTI-1. N. Engl. J. Med. 308 : 173-180 
Hauser, S.L., Bahn, A.K., Che, M., Gilles, F., Weiner, H.L. (1984) Redistribution of Lyt-bearing T 
cells in acute murine experimental allergic encephalomyelitis: selective migration of Lyt-! cells to to the 
CNS is associated with a transient depletion of Lyt-1 cells in peripheral blood. J. Immunol. 133: 3037-
3042. 
133 
Hauser, S.L., Bhan, A.K., Gilles, F.H., Hoban, C.J., Reinherz , E.L. and Weiner, H.L. (1983) 
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, 
monocytes and the Ia antigen. J. Neuroimmunol. 5 : 197-205. 
Hawkins, C.P., McKenzie, F., Tofts, P. et al., (1991) Patterns of BBB breakdown in inflammatory 
demyelination. Brain 114(2) 801-10. 
Hayes, G.M., Woodroofe, M.N. and Cruzner, M.L. (1987) Microglia are the major cell type expressing 
MHC class II antigens in human white matter. J. Neurol. Sci. 80 : 25-37. 
Hazzard WR (1989) Atherosclerosis and aging: a scenario in flux. Am. J. Cardiol. 63 : 20H-24H. 
Heidrick, M.L. and Makinodan, T. (1972) Nature of cellular deficiencies in age-related decline of the 
immune system. Gerontologia 18 : 305-320. 
Hendrich, D., Roberts, C. and Waxman, F. (1981) Regulation of paralytic experimental allergic 
encephalomyelitis in rats: Susceptibility to active and passive disease reinduction. J. Immunol. 126 : 
1857-1862. 
Hertz, L., Juurlink, B.H.J., Fosmark, H. and Schorsboe, A. (1982) Methodological appendix: Astrocytes 
in primary cultures. In: Neuroscience Approached Through Cell Culture, (ed. Pfeiffer, S.E.) pp. 175-187. 
Hibbs, J.B., Taintor, R.R. and Vavrin, Z. (1987) Macrophage cytotoxicity: role for L-arginine deiminase 
and nitrogen oxidation to nitrite. Science 240 : 473. 
Hickey, W.F. and Gonatas, N.K. (1984) Suppressor T lymphocytes in the spinal cord of Lewis rats 
recovered from acute experimental allergic encephalomyelitis. Cell. Immunol. 85 : 284-288. 
Hickey, W.F. and Kimura, H. (1987) Graft-versus-host disease elicits expression of class I and class II 
histocompatibility antigens and the presence of scattered T-cells in rat central nervous system. 
Proceedings of the National Academy of Sciences of the United States of America 84: 2082-2087. 
Hickey, W.F. and Kimura, H. (1988) Perivascular microglial cells of the CNS are bone marrow derived 
and present antigen in vivo. Science 239 : 290-292. 
Hickey, W.F., Cohen, J.A. and Burns, J.B. (1987) A quantitative immunohistochemical comparison of 
actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat. Cell. 
Immunol. 109 : 272-328. 
Hickey, W.F., Gonatas, N.K., Kimura, H. and Wilson, D.B. (1983) Identification and quantification of T 
lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic 
encephalomyelitis J Immunol. 131 : 2805-2809. 
Hickey, W.F., Gonatas, N.K., Kimura, H. and Wilson, D.B. (1983) Identification and quantitation of T-
lymphocyte subsets found in the spinal cord of Lewis rats during acute experimental allergic 
encephalomyelitis. J. Immunol. 131 : 2805-2809. 
Hickey, W.F., Hsu, B.L. and Kimura, H. (1989) T-cell entry into the rat central nervous system. 
FASEB Journal 3 (Suppl. 1) A482 (abstract). 
Hickey, W.F., Hsu, B.L. and Kimura, H. (1991) T-lymphocyte entry into the central nervous system. J. 
Neurosci. Res. 28 : 254-260 
Hickey, W.F., Osborn, J.P. and Kirby, W.M. (1985) Expression of Ia molecules by astrocytes during 
acute experimental allergic encephalomyelitis in the Lewis rat. Cell. Immunol. 91 : 528-533. 
Hicks, P., Rolsten, C., Brizzee, D., and Samorajski, T. (1983) Age related changes in rat brain 
capillaries. Neurobiol. Aging 4 : 69-75. 
Hildebrand, C., Kocsis, J.D., Berglund, S. and Waxman, S.G. (1985) Myelin sheath remodelling in 
regenerated rat sciatic nerve. Brain Research, Amsterdam, 358: 163-170. 
Hinrichs, DJ. (1984) Requirements for the regulation of adoptively transferred paralytic experimental 
allergic encepbalomyelitis. In: Immunoregulatory processes in experimental allergic encephalomyelitis 
and Multiple Sclerosis (eds. AA Vanderbark and JCM Raus) Elsevier Science Publishers BV, Amsterdam. 
134 
Hinrichs, D.J., Roberts, C.M. and Waxman, F.J. (1981) Regulation of paralytic experimental allergic 
encephalomyelitis in rats: Susceptibility to active and passive disease reinduction. J. Immunol. 128 : 
1857-1862. 
Hinrichs, D.J., Wegmann, K.W. and Dietsch, G.N. (1987) Transfer of experimental allergic 
encephalomyelitis to bone marrow chimeras. Endothelial cells are not a restricting element. J. Exp. Med. 
166: 1906-1911 
Hirsch, M.R., Wietzerbin, J., Pierres, M. and Goridis, C. (1983) Expression of la antigens by cultured 
astrocytes treated with gamma-Interferon. Neuroscience Letters 41 : 499-504. 
Hoffman, P.M., Gaston, D.D. and Spitler, L.E. (1973) Comparison of experimental allergic 
encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide. Clin. 
Immunol. Immunopathol. 1 : 364-371. 
Hofman, F, Von Hanwher, R., Dinarello, C., Mizel, S. Hinton, D. Merill, J.E. (1986) 
Immunoregulatory molecules and IL-2 receptors identified in Ms brain. J. Immunol. 136: 3239-3245. 
Hofman, F.M., Hinton, D.R., Johnson, K. and Merrill, J.E. (1989) Tumour Necrosis Factor identified in 
Multiple Sclerosis brain. J. Exp. Med. 170 : 607-612. 
Holda, J.A., Welch, A.M. and Swanborg, R.H. (1980) Autoimmune effector cells 1. Transfer of 
experimental allergic encephalomyelitis with lymphoid cells cultured with antigen. Eur. J. Immunol. 10: 
657-659. 
a 
Holda, J.H. and Swanborg, R.H. (1982) Autoimmune effector cells. II Transfer of experimental allergic 
encephalomyelitis with a subset of T lymphocytes. Eur. J. Immunol. 12 : 453-455. 
Holda, J.H. and Swanborg, R.H. (1982f Autoimmune effector cells. II. Transfer of experimental allergic 
encephalomyelitis with a subset of T-cells. European J. Immunol. 12: 657-661. 
Holda, J.H., Welch, A.M. and Swanborg, R.H. (1980) Utoimmune effector cells. I. Transfer of 
experimental allergic encepbalomyelitis with lymphoid cells cultured with antigen. European J. 
Immunol. 10 : 657 -659. 
Honeggar, C.G. and Isler, H. (1984) Neurotransmitters, precursors and metabolites in spinal cord and 
brain of Lewis rats with experimental allergic encepbalomyelitis. Prog. Clin. Biol. Res. 146: 131-138. 
Honeggar, C.G., Gahwiler, B.H. and Isler, H. (1977) The effect of myelin basic protein (MBP) on the 
bioelectric activity of spinal cord and cerebellar neurones. Neurosci. Lett. 4: 303-307. 
Horley, K.J., Carpenito, C., Baker, B. and Takei, F. (1989) Molecular cloning of murine intercellular 
adhesion molecule (ICAM-1). Eur. Mol. Biol. Organ. J. 8: 2880. 
Hughes, R.A.C. (1974) Protection of rats from experimental allergic encephalomyelitis with antiserum 
to guinea-pig spinal cord. Immunology 26 : 703-711. 
Hurst, E.W. (1932) The effects of the injection of normal brain emulsion into rabbits. Journal of 
Hygiene 32 : 33-44. 
Hynes, R. 0. (1987) lntegrins a family of cell surface receptors. Cell 48 : 549-554. 
Hynes, R.O. and Yamada, K.M. (1982) Fibronectins: multifunctional modular glycoproteins. J. Cell. 
Biol. 95 : 369-377. 
lames, S.G. and Wexler, B.C. (1979) Inhibition of the development of spontaneous hypertension in SH 
rats by gonadectomy and estradiol. J. Lab. Clin. Med. 94: 608-616 
Ignarro, L.J., Byrns, R.E., Buga, G.M., Wood, K.S. (1987) Endothelium-derived relaxing factor from 
pulmonary artery and vein to those of nitric oxide radical. Circ. Res. 61 : 866-879. 
Isler, H. and Honeggar, C.G. (1983) The effects of human myelin basic protein (HMBP) on the 
bioelectric activity of the frog spinal cord. J. Neurol. Sci. 58: 387-397 
135 
Jablons, D.M., Mule, CJ., McIntosh, J.K., Sehgal, P.B., May, L.T., Huang, C.M., Rosenberg S.A. 
and Lotze M.T. (1989). IL-6/IFN beta-2 as a circulating hormone. Induction by cytokine administration 
in humans. J. Immunol. 142(5) : 1542-7 
Jacobson, M. (1978) Developmental Neurobiology. 2nd ed., Plenum, New York. 
Jacobson, S.G., Eames, R.A. and McDonald, W.I. (1979) Optic nerve fibre lesions in adult cats: pattern 
of recovery of spatial vision. Exp. Brain Res. 36: 491-508. 
Jalkanen, S.T., Reichert, R.A., Gallatin, W.M., Bargatze, R.F., Weissman, I.L. and Butcher, E.C. 
(1986) Homing receptors and the control of lymphocyte migration. Immunol. Rev. 91 : 39-60. 
Jankovic, B.D. (1985) From imrnunoneurology to imrnunopsychiatry: neuromodulating activities of 
anti-brain antibodies. In: International review of neurobiology (eds. Smythies, J.R. and Bradley, R.J. ) 
Vol. 26, pp.249-314, Academic Press, New York. 
Jankovic, B.D., Draskoci, M. and Janjic, M. (1965) Passive transfer of 'allergic' encephalomyelitis with 
antibrain serum injected into the lateral ventricle of the brain. Nature 207 : 428-429. 
Jankovic, B.D., Markovic, B.M. and Spector, N.H. (Eds.) (1987) Neuroimmune interactions: 
Proceedings of the second international workshop on neuroimrnunomodulation [special issue]. Ann. 
N.Y. Acad. Sci. 496. 
Jansen, C. R., Cronkite, E.P., Mather, G.C., Nielsen, N.O., Rai, K., Adamik, E.R., and Sipe, C.R. 
(1962) Studies on lymphocytes. II. The production of lymphocytosis by intravenous heparin in calves. 
Blood 20: 443-452. 
Jelinek, D.F. and P.E. Lipsky (1987) Enhancement of human B cell proliferation and differentiation by 
TNF-a and IL-1. J. Imrnunol. 139: 2970-6 
Jersild, C., Dupont, B., Fog, T., Platz, P.J. and Svesgaard, A. (1975) Histocompatibility determinants in 
multiple sclerosis. Transplant. Rev. 22 : 148-163. 
Johansson, B., Li, C.L., Olsson, Y., and Klatzo, I. (1970). The effect of acute arterial hypertension on 
the blood-brain barrier permeability to protein tracers. Acta. Neuropathol. (Berl) 16 : 117-124. 
Johnson, J. P., Stade, B.G., Holzmann, B., Schwable, W., and Riethmuller, G. (1989) De novo 
expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. 
Proc. Natl. Acad. Sci. USA 86: 641. 
Johnson, R.T. (1980) Selective vulnerability of neural cells to viral infections. Brain 103 : 447-472. 
Johnson, R.T. (1982) Viral infections of the nervous system. Raven Press: New York. 
Johnson, R.T. (1984) Relapsing and remitting viral diseases of the nervous system. Trends in 
Neurosciences 7(8): 268-269. 
Johnson, R.T., Hirsch, R.L., Griffin, D.E., Wolinsky, J.S., Roedenbeck, S., Lindo de Soriano, I. and 
Vaisberg, A. (1981). Trans Amer. Neurol. Assoc. 106: 42-45. 
Jones, R.E., Offner, H., Dietsch, G., Hinrichs, D. and Vandenbark, A.A. (1989) PHA activation of 
encephalitogenic T cells: in vitro line selection overcomes splenic suppression. Cell. Imrnunol. 123 : 
60-69. 
Jonker, M., van Lambalgen, R., Mitchell, D.J., Durham, S.K. and Steinman, L. (1988) Successful 
traetment of experimental allergic encephalomyelitis in rhesus monkeys with MHC-class II (HLA-DQ) 
specific monoclonal antibodies. J. Autoimmunity 1 : 399-414. 
Jordan, F.L. and Thomas, W.E. (1988) Brain macrophages: Questions of origin and interrelationship. 
Brain Research Reviews 13 : 165-178. 
Kabat, E.A., Freedman, D.A., Murray, J.P. and Knab, V. (1950) A study of the crystalline albumin, 
gamma globulin and total protein in the cerebrospinal fluid of one hundred cases of multiple sclerosis and 
in other diseases. Am. J. Med. Sci. 219 : 55 . 
136 
Kabat, E.A., Wolf, A. and Bezer, A.E. (1947) The rapid production of acute disseminated 
encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with 
adjuvants. J. Exp. Med. 85 : 117-130. 
Kabat, E.A., Wolf, A. and Bezer, A.E. (1952) Studies on acute disseminated encephalomyelitis produced 
experimentally in rhesus monkeys. VII. The effect of cortison. J. Immunol. 68: 265. 
Kaji, R., Suzumura, A. and Sumner, A.J. (1988) Physiological consequences of antiserum-mediated 
experimental demyelination in CNS. Brain 111 : 675-694. 
Kallen, B. and Logdberg, L. (1982) Low susceptibility to the induction of Experimental Autoimmune 
Encephalomyelitis in a substrain of the otherwise susceptible Lewis rat. Eur. J. Immunol. 12: 596-599. 
Kalpaktsoglou, P.K., Yunis, E.J. and Good, R.A. (1969) Changes produced by pertussis antigen on the 
blood cells and lympho-haemapoietic tissues after early and late thymectomy or splenectomy. Clin. exp. 
Immunol. 5 : 91. 
Kandel, E.R. (1985) Nerve cells and behaviour. In: Principles of Neural Science 2nd Edition (eds. Kandel, 
E.R., and Schwartz, J.H.) Elsevier, New York. 
Kandel, E.R., and Schwartz, J.H. (1985) Principles of Neural Science 2nd Edition, Elsevier, New York. 
Kasid, A., Director, E.P., and Rosenberg, S.A. (1989). J. Immunol. 143,736-739. 
Kassabova, T., Staykova, M., Balevska, P. et al. (1990) Anti-oxidant capacity of spinal cord and 
erythrocytes of guinea pigs in case of EAE and after disease. Acta Neurol. Scand. 82(2): 116-20. 
Kay, M.M.B. (1980) Immunological aspects of aging. In: Aging immunity and arthritic disease (eds. 
Kay, M.M.B., Galpin, J. and Makinodan, T.). Raven, New York: 33-78. 
Kay, M.M.B. and Makinodan, T. (1981) Relationship between aging and the immune system. Progress 
in Allergy 29: 134-181. 
Keirstead, S.A., Rasminsky, M., Fukuda, Y., Carter, D.A., Aguayo, A.J. and Vidal-Sanz, M. (1989) 
Electophysiological responses in Hamster superior colliculus evoked by regenerating retinal axons. 
Science 246: 255-257. 
Keith, A.B. (1978a) Sex difference in Lewis rats in the incidence of recurrent experimental allergic 
encephalomyelitis. Nature 272: 824-825 
Keith, A.B. (1978b) Effect of pregnancy on experimental allergic encephalomyelitis in guinea-pigs and 
rats. J. Neurol. Sci. 38(3): 317-326 
Kelly, J.P. (1985) Reactions of neurones to injury. In: Principles of Neural Science 2nd Edition (eds. 
Kandel, E.R., and Schwartz, J.H.) Elsevier, New York. 
Kerlero de Rosbo, N., Bernard, C.C.A., Simmons, R.D. and Carnegie, P.R. (1985) Concomitant 
detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute 
experimental autoimmune encephalomyelitis by electroimmunoblotting. J. Neuroimmunol. 9 : 349-361. 
Kety, S.S. (1979) Disorders of the human brain. Scientific American: The Brain. 
Khoury, S.J., Lider, 0., al Sabbagh, A. and Weiner, H.L. (1990) Suppression of EAE by oral 
transmission of MBP. Cell. Immunol. 131(2): 302-10. 
Kieran, M. W., Blank, V., le Bail, 0., and Israel, A. (1989) Lymphocyte homing. Res. Immunol. 140 : 
399-450. 
Kies, M.W., Driscoll, B.F., Lisak, R.P. and Alvord, E.C., Jr. (1975) Immunologic activity of myelin 
basic protein in strain 2 and strain 13 guinea pigs. J. Immunol. 115 : 7 5-79. 
Killen, J.A. and Swanborg, R.H. (1982) Autoimmune effector cells. III. Role of adjuvant and accessory 
cells in the in vitro induction of autoimmune encephalomyelitis. J. Immunol. 129 : 759-763. 
Kimelberg, H.K., Katz, D.M. (1985) High affinity uptake of serotonin into immunocytochemically 
identified astrocytes. Science 228 : 889-891. 
137 
Kishimoto, T. K., Larson, R.S., Corbi, A.L., Dustin, M.L., Staunton, D.E. , and Springer, T.A. (1989) 
The leukocyte integrins. Adv. I.mmunol. 46 : 149. 
Kitay, J. (1961) Sex differences in adrenocortical secretion in the rat. Endocrinology 68: 818-824. 
Kjaer, M. (1980). Visual evoked potentials in normal subjects and patients with multiple sclerosis. Acta 
Neurol. Scand. 62 : 1. 
Klatzo, I. (1983). Disturbances of the blood-brain barrier in cerebrovascular disorders. Acta. Neuropathol. 
(Berl) Suppl 111 : 81-88. 
Klebanoff, S. (1988) Phagocytic cells: products of oxygen metabolism. In: Inflammation: basic priciples 
and clinical correlates. Raven Press, Ltd., New York, pp. 391-444. 
Knowles, R.G., Salter, M., Brooks, S.L., and Moncada, S. (1990). Anti-inflammatory glucocorticoids 
inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat Biochem. 
Biophys. Res. Commun. 172: 1042-1048. 
Kocsis, J.D., Ruiz, J.A. and Waxman, S.G. (1983) Maturation of mammaliam myelinated fibres: 
changes· in action-potential characteristics following 4-aminopyridine application. Journal of 
Neurophysiology 50 : 449-463. 
Kocsis, J.D., Waxman, S.G., Hildebrand, C. and Ruiz, J.A. (1982) Regenerating mammalian nerve 
fibres: changes in action potential waveform and firing characteristics following blockage of potassium 
conductance. Proceedings of the Royal Society of London B 217 : 77-87. 
Koles, Z.J. and Rasminsky, M. (1972) A computer simulation of conduction in demyelinated nerve 
fibres. Journal of Physiology, London 227: 351-364. 
Komarek, A. and Dietrich, F.M. (1971) Chemical prevention of experimental allergic encephalomyelitis 
in rats: A quantitative evaluation of steroids and various non-steroid drugs. Arch. Int. Pharmacodyn. 193 
: 249. 
Koritschoner, R. and Schweinburg, F. (1925) Klinische und experimentelle Beobachtungen uber 
Lahmungen nach Wutschutzimpfung. Zeitschrift fur Immunitatsforschung und experimentelle Therapie 
42 : 217-283. 
Kornblum, J. (1968) The application of the irradiated hamster test to the study of experimental allergic 
encephalomyelitis. J. Immunol. 101 : 702. 
Kosunen, T.U., Waksman, B.H. and Samuelsson, I.K. (1963) Radioautographic study of cellular 
mechanisms in delayed hypersensitivity. II. Experimental allergic encephalomyelitis in the rat. J. 
Neuropath. Exp. Neurol. 22 : 367-380. 
Kreiger, D. (1979) Rhythms in CRF, ACTH and cortico-steroids. In:L. Martini (Ed.), Comprehensive 
Endocrinology Series, Endocrine Rhythms, Raven Press, New York, pp. 123-142. 
Krenger, W., Honegger, C.G., Feurer, C. and Cammisuli, S. (1986) Changes of neurotransmitter 
systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord. Journal 
of Neurochemistry 47 : 1247-1254. 
Kristensen, K. and Norrby, E. (1986) Persistence of RNA viruses in the CNS. Ann. Rev . Microbiol. 40 
: 159-84. 
Kristensson, K and Wisniewski (1977) Chronic relapsing experimental allergic encephalomyelitis. 
Studies in vascular permeability changes. Acta. Neuropath. 38 : 189-194. 
Kroemer, G., Brezinschek, H-P., Faessler, R., Schauenstein, K. and Wick, G. (1988) Physiology and 
pathology of an immunoendocrine feedback loop. Immunology Today 9 : 163-165. 
Kronke, M., Leonard, W.J., Depper, J.M ., Arya, J.M., Wong-Staal, F., Gallo, R.C., Waldmann, T.A. 
and Greene, W.C. (1984). Proc. Natl. Acad. Sci. U.S.A. 81 : 5214-5218. 
Kuffler, S.W., and Potter, D.D. (1964) Glia in the leech CNS: physiological properties and neuron-glia 
relationship. Journal of Neurophysiology 27 : 290-320. 
Kro~mer, G._, Gastinel, L.N., Neu, N., Auffray, C. and Wick, G. (1990) How many genes code for organ-
pecific autounmunity? Autoimmunity 6 : 215-233. 
1 1 R 
Kurtzke, J.F. and Hyllested, K. (1986) Multiple sclerosis in the Faroe Islands. II. Clinical update transmission 
and the nature of MS. Neurology 36(3) : 307-28. ' ' 
Kurland, L.T. (1952) Epidemiologic characteristics of multiple sclerosis. Am. J. Meo. 1.L : :,01 -:,, 1. 
Kurtzke, J.F., Beebe, G.W., Nagler, B. et al., (1977) Studies on the natural history of MS. Early 
prognostic features of the later course of the illness. J. Chronic Dis. 30: 819-30. 
Kurtzke, J.F. (1988) Multiple Sclerosis. What's in a name? neurology 38: 309-316. 
Kurtzke, J.F. (1970). In: Handbook of clinical neurology (eds. Vinken, P.T. and Bruyn, G.W.), 
American Elsevier, New York, Vol. 9: 161-216. 
Kurtzke, J.F., Dean, G. and Bot.ha, D.P.J. (1970) A met.hod of estimating the age at immigration of 
white immigrants to South Africa, with an example of its importance. S. Afr. Med. J. 44 : 663-669. 
Kuwert, E. (1977) Histocompatibility determinants. In: The Histocompatibility system in Multiple 
Sclerosis. Munksgaard, Copenhagen, pp 23-42. 
Lampert, P. (1967) Electron microscopic studies in in ordinary and hyperacute experimental allergic 
encephalomyelitis. Acta Neuropat.hologica 9 : 99-126. 
Lampert, P. (1978) Autoimmune and virus induced demyelinating disease. Am. J. Pat.ho!. 91 : 175-208. 
Lampert, P., Sims, J.K. and Kniazeff, A.J. (1973) Mechanism of demyelination in JHM virus 
encephalomyelitis: Electron microscopic studies. Acta Neuropathologica 24: 76-85 . 
Lampert, P.W. (1965) Demyelination and remyelination in experimental allergic encephalomyelitis. J. 
Neuropat.h. Exp. Neurol. 24: 371-385. 
Lampert, P.W. (1968) Autoimmune and virus-induced demyelinating disease. A review. Am. J. Pathol. 
91 : 175-208. 
Lampert, P.W. and Carpenter, S. (1965) Electron microscopic studies on the vascular permeability and 
the mechanisms of demyelination in experimental allergic encephalomyelitis. J. Neuropat.h. Exp. Neurol. 
24 : 11-24. 
Lampert, P.W. and Kies, M.W. (1967) Mechanism of demyelination in allergic encephalomyelitis of 
guinea pigs. An electron microscopic study. Experimental Neurology 18 : 210-223. 
Lampson, L.A. and Hickey, W.F. (1986) Monoclonal antibody analysis of MHC expression in human 
brain biopsies. J. Immunol. 136 : 4054-4062. 
Landfield, P.W., Rose, G., Sandles, L., Wohstadter, T.C., Lynch, G. (1977). Patterns of astroglial 
hypertrophy and neuronal degeneration in the hippocampus of aged memory-deficient rats. J. Gerontol. 32 
: 3-12. 
Lassman, H. and Wisniewski, H.M. (1979b) Chronic relapsing experimental allergic encephalomyelitis. 
Clinicopat.hological comparison with multiple sclerosis. Arch. Neurol. 36 : 490-497. 
Lassman, H., Kitz, K. and Wisniewski, H.M. (1980) Chronic relapsing experimental allergic 
encephalomyelitis in rats and guinea pigs - a comparison. In: Search for the cause of Multiple Sclerosis 
and othe chronic diseases of the central nervous system (ed. Boese, A.) Verlag Chemie, Weinheim, pp.96-
104. 
Lassman, H., Schwerer, B. Kitz, K. et al., (1983) Pat.hogenetic aspects of demyelinating lesions in 
chronic relapsing experimental allergic encephalomyelitis: possible interaction of cellular and humoral 
immune mechanisms. Prog. Brain Res. 59 : 305-315. 
Lassman, H., Vass, K., Brunner, C. and Seitelberger, F. (1986) Characterisation of inflammatory 
infiltrates in experimental allergic encephalomyelitis. Progress in Neuropathology 6 : 33-62. 
Lassmann, H. and Wisniewski, H.M. (1979a) Chronic relapsing experimental allergic encephalomyelitis: 
effect of age at the time of sensitisation on clinical course and pathology. Acta Neuropat.hologia, Berlin 
47: 111-116. 
139 
Lassmann, H., Kitz, K. and Wisniewski, B. (1980) Structural vatriability of demyelinating lesions in 
different models of subacute and chronic experimental allergic encephalomyelitis. Acta Neuropathologica, 
Berlin, 51 : 191-201. 
Lee, J.M. and Schneider, H.A. (1962) Critical relationships between constituents of the antigen-adj uvant 
emulsion affecting experimental allergic encephalomyelitis in a completely susceptible mouse genotype. 
J. Exp. Med. 115 : 157-168. 
Leibowitz, S. and Hughes, R.A.C. (1983) Immunology of the Nervous System, Edward Arnold, London. 
Leibowitz, S. and Kennedy, L. (1972) Cerebral vascular permeability and cellular infiltration in 
experimental allergic encephalomyelitis. Immunology 22 : 859-869. 
Lennon, V.A. and Byrd, W.J. (1973) Role of T lymphocytes in the pathogenesis of experimental 
autoimmune encephalomyelitis. Eur. J. Immunol. 3 : 243-245. 
Lennon, V.A. and Carnegie, P.R. (1971) Immunopharmacological disease: a break in tolerance to 
receptor sites. Lancet i : 630-633 . 
Lennon, V.A., Deldman, M. and Crawford, M. (1972) the detection of autoanti-body-forming cells. II. 
Cells in lymph nodes and central nervous system containing antibody to myelin basic protein. Int. Arch. 
Allergy Appl. Immunol. 43 : 749-758. 
Lennon, V.A., Westall, F.C., Thompson, M . and Ward, E. (1976) Antigen, host and adjuvant 
requirements for induction of hyperacute experimental allergic encephalomyelitis. Eur. J. Immunol. 6 : 
810-816. 
Levine, S., Hoenig, E.M. and Kies, M.W. (1970) Allergic Encephalomyelitis - Immunologically specific 
inhibition of cellular passive transfer by encephalitogenic basic protein. Clin. Exp. Immunol. 6 : 503-
517. 
Levine, S., Saltzman, A., Deibler, G .. (1990) Encephalitogenicity for rats of MBP without the aid of 
water-in-oil emulsions. J. Neuropathol. Exp. Neurol. 49(5) : 480-5. 
Levine, S. (1971) Relationship of experimental allergic encephalomyelitis to human disease. In: 
Immunological disorders of the Nervous System (Res. Publ. Assoc. Res. Nerv. Ment. Dis. Vol. XLIX) 
(ed. Rowland, L.P.) Williams and Wilkins, Baltimore, pp.33-49. 
Levine, S. (1974) Hyperacute, neutrophilic and localised forms of experimental allergic 
encephalomyelitis: a review. Acta Neuropath. 28: 179-189. 
Levine, S. and Sowinski, R. (1973) Experimental allergic encephalomyelitis in inbred and outbred mice. 
J. Immunol. 110 : 139-143. 
Levine, S. and Sowinski, R. (1976) Experimental allergic encephalomyelitis in aged F344 rats. Journal 
of Gerontology 31(3): 271-274. 
Levine, S. and Wenk, E. (1963) Encephalitogenic potencies of nervous system tissues. Proc. Soc. Exp. 
Biol. Med. 114 : 220. 
Levine, S. and Wenk, E. (1964) Allergic encephalomyelitis: A hyperacute form. Science 146 : 1681-
1682. 
Levine, S. and Wenk, E. (1965) A hyperacute form of allergic encephalomyelitis. Am. J. Pathol. 47 : 
61-88. 
Levine, S. Simon, J. and Wenk, E.J. (1966) Edema of the spinal cord in experimental allergic 
encephalomyelitis. Proc. Soc. Exp. Biol. Med. 123 : 539-541. 
Levine, S., Prinaes, J. and Schein berg, L.C. (1969) Allergic encephalomyelitis inhibition of cellular 
transfer by x-irradiation. Proc. Soc. Exp. Biol. Med. 131 : 986-990. 
Levine, S., Sowinski, R. and Kies, M.W. (1972) Treatment of experimental allergic encephalomyelitis. 
Proc. Soc. Exp. Biol. Med. 135 : 569. 
140 
Levine, S.R., Strebel, R., Wenk, E.J. and Harman, P.J. (1962) Suppression of experimental
 allergic 
encephalomyelitis by stress. Proceedings of the Society for Experimental Bio
logy and Medicine, USA, 
109 : 294-298. 
Lider, 0., Baharav, E., Mekori, Y., Miller, T., Naparstek, Y., Vladovsky, I.
 and Cohen, I.R. (1989) 
Suppression of experimental allergic encephalomyelitis and prolongation
 of allograft survival by 
treatment of animals with low dose heparin. Journal of Clinical Investigation 
83 : 752-756. 
Lieberman, A.P., Pitha, P.M., Shin, H.S. and Shin, M.L. (1989) Production of tumour necro
sis factor 
and other cytokines by astrocytes stimulated with lipopolysaccharide or a ne
urotropic virus. Proc. Natl. 
Acad. Sci. USA 86 : 6348-6352. 
Lightman, S.L., Caspi, R.R., Nussenblatt, R.B. and Palestine, A.G. (1987) Antigen-directed ret
ention of 
an autoimmune T-cell line. Cell. Immunol. 110: 28-34. 
Lindholm, D., Heumann, R., Meyer, M., Thoenen, H. (1987) Interleukin-I regulates synthesis
 of nerve 
growth factor in nonneuronal cells of rat sciatic nerve. Nature 330: 658-659. 
Linington, C., Suckling, A.J. and Cuzner, M.L. (1983) Increased astrocyte metabolism durin
g chronic 
relapsing encephalomyelitis is coincident with the invasion of the CNS by
 immunocompetent cells. 
Proceedings of the British Society for Immunology. p. 54 (Abstract). 
Linthicum, D.S., Munoz, J.J. and Blaskett, A. (1982) Acute aoutoimmune encephalomyelitis i
n mice. I. 
Adjuvant action of Bordatella pertussis is due to vasoactive amine sensitization and increased vasc
ular 
permeability of the central nervous sytem. Cell. lmmunol. 73 : 299-310. 
Lipton, H.L. and Dal Canto, M.C. (1979) Susceptibility of inbred mice to chronic centra
l nervous 
system infection by Theilers murine encephalomyelitis virus. Infect. lmmun.
 26 : 369-374. 
Lipton, M.M. and Freund, J. (1953) Allergic encephalomyelitis in the rat induced by the intrac
utaneous 
injection of central nervous sytem tissue and adjuvants. J. Immunol. 71 : 98-109. 
Lisak, R.P., Behan, P.O., Zweiman, B. and Shetty, T. (1974) Cell-mediated immunity to my
elin basic 
protein in acute disseminated encephalomyelitis. Neurology 24: 560-564 
Lisak, R.P., Heinze, R.G., Kies, M.W. et al. (1969) Antibodies to encephalitogenic basic p
rotein in 
experimental allergic encephalomyelitis. Proc. Exp. Biol. Med. 130: 814-818
. 
Lisak, R.P., Zweiman, B and Norman, M. (1975) Antimyelin antibodies in neurologic disease
s: 
lmmunofluorescent demonstration. Arch. Neurol. 32: 163-167. 
Lisak, R.P., Zweiman, R., Kies, M.W. and Driscoll, B. (1975) Experimental allergic encephal
omyelitis 
in resistant and susceptible guinea pigs: In vivo and in vitro correlates. J. Immuno
l. 114 : 546-549. 
Liuzzi, F.J. and Lasek, R.J. (1987) Astrocytes block axonal regeneration in mammals by activ
ating the 
physiological stop pathway. Science 237 : 642-645. 
Lublin, F.D., Maurer, P.H., Berry, R.G. et al., (1981) Delayed, relapsing experimenta
l allergic 
encephalomyelitis in mice. J. Immunol. 126: 819-822. 
Ludwin, S.K. (1984) Proliferation of mature oligodendroctes after trauma to the nervous system
. Nature, 
London 308 : 274-275. 
Lumsden, C.E. (1951) Fundamental problems in the pathology of MS and allied demyelinating
 diseases. 
Br. Med. J. 1: 1035-1043. 
Lumsden, C.E. (1971) The immunogenesis of the multiple sclerosis plaque. Brain Res. 28 : 36
5-390. 
Lycke, E and Roos, B.E. (1973) Brain monoamines in guinea pigs with experimenta
l allergic 
encephalomyelitis. Int. Arch. Allergy 45 : 341-351. 
Mackay, R. and Myrianthopoulos, N. (1966) Multiple sclerosis in twins and their relatives. Fin
al report. 
Arch. Neurol. 15 : 449-462. 
141 
MacPhee, I.A.M., Antoni, F.A. and D.W. Mason (1989) Spontaneous recovery of rats from experimental 
allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adr
enal 
corticosteroids. J. Exp. Med. 169: 431-445. 
Madrid, R.E. and Wisniewski , H.M. (1978) Peripheral nervous system pathology in relapsing 
experimental allergic encephalomyelitis. J. Neurocytol. 7 : 265-282. 
Maillard, J. and Bloom, B.R. (1972) Immunological adjuvants and the mechanism of cell cooperation. J. 
Exp. Med. 136 : 185. 
Maio, M., Tessitori, G ., Pinto, A., Temponi, M. , Colombatti , A. and Ferone, S. (1989) Differential 
role of distinct determinants of intercellular adhesion molecule- I in immunologic phenomen
a. J. 
Immunol. 143 : 181-188. 
Male, D. and Pryce, G. (1988) Synergy between interferons and monokines in MHC induction on brain 
endothelium. Immunology Letters 17 : 267-272. 
Male, D. and Pryce, G. (1989) Induction of Ia molecules on brain endothelium is related to susceptibility 
to experimental allergic encephalomyelitis. J. Neuroimmunol. 21 : 87-90. 
Male, D., Pryce, G. and Hughes , C.C.W. (1987) Antigen presentation in brain: MHC expression on 
brain endothelium and astrocytes compared. Immunology 60 : 453-459. 
Marble, A., Selenkow, H.A. et al., (1980). In Drug Treatment: principles and practice of clinical 
pharmacology and therapeutics. (ed. G.S. Avery) pp. 493-553. ADIS Press, Sydney 
Marlin, S.D. and Springer, T.A. (1987) Purified intercellular adhesion molecule-I (ICAM-1 ) is a ligand 
for lymphocyte function-associated antigen 1 (LFA-1). Cell 51 : 813-819 . 
Martenson, R.E., Deibler, G.E. , Kies, M.W. , McKneally, S.S., Shapira, R. and Kibler , R .F. (1972) 
Differences between the two myelin basic proteins of the rat central nervous sys tems. A deletion i
n the 
smaller protein. Biochem. Biophys. Acta. 263 : 193-203. 
Martenson, R.E. , Levine, S., Deibler, G.D . and Kramer, A.J. (1974) 
5 : 164-
Trans. Amer. Soc. Neurochem. 
Mason, D., MacPhee, I. and Antoni, F. (1990) The role of the neuroendocrine system in determining 
genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunol. 70: 1-5. 
Massa, P.T., Dorries, R. and ter Meulen, V. (1986) Viral particles induce Ia antigen expression on 
astrocytes. Nature 320 : 543-546. 
Massa, P.T., Ter Meulen (1987) Analysis of Ia induction on Lewis rat astrocytes in vi tro by virus 
particles and bacterial adjuvants. J. Neuroimmunol. 13 : 259-271. 
Mastaglia, F.L. and Cala L.A. (1980) Computed tomography of the brain in multiple sclerosis. Trends 
Neurosci. 3 : 16. 
I 
Mathewson, A.J., Berry, M. (1985). Observations on the astrocyte response to a cerebral stab wound in 
adult rats. Brain Res. 327 : 61-69. 
Matsumoto, Y. and Fujiwara, M. (1986) In situ detection of class I and II major histocompatibility 
complex antigens in the rat central nervous system during experimental allergic encephalomyeliti
s. J. 
Neuroimmunol. 12: 265-267. 
Matsumoto, Y. and Fujiwara, M. (1988) Adoptively transferred experimental allergic encepbalomyelitis 
in chimeric rats: Identification of transferred cells in lesions of the central nervous system
. J. 
Neuroimmunol. 65 : 23-29. 
Matsumoto, Y ., Hara, N. , Tanaka, R. and Fujiwara, M. (1986) Immunohistochemical analysi of of rat 
central nervous system during experimental allergic encepbalomyelitis with pecial reference t
o Ia-
positive cells with dendritic morphology. J . Immunol. 136 : 3668-3675. 
Maxwell, D.S., and Kruger, L. (1965) The fine structure of astrocytes in the cerebral cortex and their 
response to focal injury produced by heavy ionizing particles. J . Cell Biol. 25 : 141-15 7. 
142 
Mc Carron, R.M., Kempski, 0., Spatz, M. and Mcfarlin, D.E. (1985) Presentation of myelin basic 
protein by murine cerebral vascular endothelial cells. J. Immunol. 134 : 3100-3103. 
McAlpine, D., Lumsden, C.E. and Acheson, E.D. (1972) Multiple sclerosis: a reappraisal. 2nd edition, 
Churchill-Livingstone, Edinburgh. 
McCall, T., Boughton-Smith, N., Palmer, R., Whittle, B. and Moncada, S. (1989) Synthesis of nitric 
oxide from L-arginine by neutrophils. Biochem. J. 261 : 293-296. 
McCarthy, K., Prime, J., Harmon, T. and Pollenz, R.S. (1985) Receptor mediated phosphorylation of 
astroglial intermediate filament proteins in culture. J. Neurochem. 44 : 723-730. 
McClusky, R.T., Benacerral, B. and McClusky, J.W. (1963) Studies on the specificity of the cellular 
infiltrate in delayed hypersensitivity reactions. 
McDonald, W.I. (1974) Pathophysiology in multiple sclerosis. Brain 97: 179-196. 
McDonald, W.I. and Sears, T.A. (1970) The effects of experimental demyelination on conduction in the 
central nervous system. Brain 93 : 583-598. 
McFarland, H.F. (1988) Immunology of multiple sclerosis. Ann. N.Y. Acad. Sci. 540: 99-105. 
Mcfarlin, D.E., Blank, S.E. and Kibler, R.F. (1974) Recurrent experimental allergic encehalomyelitis in 
the Lewis. J. Immunol. 113(2): 712-715. 
Mcfarlin, D.E., Blank, S.E. Kibler, R.F. McNeally, S. and Shapira, R.(1973) Experimental allergic 
encehalomyelitis in the rat. Response to encephalogenic proteins and peptides. Science 179: 478-480. 
McGeer, P.L., Itagaki, S., Boyes, B.E. and McGeer, E.G. (1988) Reactive microglia are positive for 
HLA-DR in substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 28 : 1285-1291. 
McGeer, P.L., Itagaki, S., Tago, H. and McGeer, E. (1987) Reactive microglia in patients with semi 
dementia of Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neuroscience 
Letters 79 : 195-200. 
McKay, I.R., Carnegie, P.R. and Coates, A.B. (1973) Immunopathological comparisons between 
experimental allergic encephalomyelitis and MS: a review. Clin. Exp. Immunol. 15 : 471-482. 
Meade, CJ., Mertin, J., Sheena, J. and Hunt, R. (1978) Reduction of linoleic acid of the severity of 
experimental allergic encephalomyelitis in the guinea pig. J. Neurol. Sci. 35 : 291-308. 
Melmon, K.L. Wenstein, J., Poon, T.C., Bourne, M.R., Shearer, G.M. , Coffino, P., and lnsel, P.A. 
(1977) Receptors for low-molecular-weight hormones on lymphocytes. Compr. Immunol., 3 : 331-356. 
Meredith, P. and Walford, P.L. (1977) Effect of age on response to T- and B-cell mitogens in mice 
congenic at the H-2 locus. Immunogenetics 5 : 109-128. 
Merrill, J., Ellison, G. and Myers, L. (1989) In vitro study of mediators of inflammation in MS. J. Clin. 
Immunol. 9 : 84-96. 
Merrill, J.E., Kutsunai, S., Mohstrom, C. et al (1983) Proliferation of astroglia and oligodendroglia in 
response to human T cell derived factors. Science 224: 1428-1430. 
Mertin, J. (1985) Drug treatment of patients with Multiple Sclerosis. In: Handbook of clinical 
neurology. Vol. 47 (eds. Vinken, P.J., Bruyn, G.W. and Klawans, H.L.) Elsevier Science Publishing 
Co., Inc., Amsterdam, 187-212. 
Meyermann, R., Korr, J. and Wekerle, H. (1986) Specific target retrieval by encephalitogenic T-line 
cells. Clinical Neuropathology 5 : 101 (abstract). 
Michaelson, I.A.and Bradbury, M. (1982) Effect of early inorganic lead exposure on rat blood-brain barrier 
permeability to tyrosine or choline. Biocherri. Pharmacol. 31 : 1881-1885. 
Millar, J .H.D., Merrett, J .D. and Dalby, A.M. (1966) Platelet stickiness in multiple sclerosis. J. 
Neurol. Neurosurg. Psychiatry 29: 187-189. 
143 
Miller, R.A. and Stutman, 0. (1981) Decline, in aging mice, of the anti-2,4,6-trinitrophenyl (TNP) 
cytotoxic T cell response attributable to loss of Lyt-2-, interleukin 2-producing helper cell function. 
European J. Immunol. 11 : 751-756. 
Miller, R.H., Abney, E.R., David, S., Ffrench-Constant, C., Lindsay, R. , Patel, R., Stone, J. and Raff, 
M.C. (1986) Is reactive gliosis a property of a distinct subpopulation of astrocytes? J. Neurosc. 6 : 22-
29. 
Miller, R.H., Abney, E.R., David, S., French-Constant, C., Lindsay, R., Patel, R., Stone, J. and Raff, 
M.C. (1986) Is reactive gliosis a property of a distinct subpopulation of astrocytes. J. Neurosc. 6(1) : 22-
29. 
Miyazaki, C., Nakamura, T., Kaneko, K. et al., (1985) Reinduction of experimental allergic 
encephalomyelitis in convalescent Lewis rats with cyclophosphamide. J. Neurol. Sci. 67: 277-284. 
Moncada, S., and Palmer, R.M.J. (1991). Inhibition of the induction of nitric oxide synthase by 
glucocorticoids:yet another explanation for their anti-inflammatory effects? Trends in Pharmacological 
Science 12 : 130-131. 
Mooradian, A.D. (1988) Effect of aging on the blood brain barrier. Neurobiol. Aging 9(1) 31-39. 
Moore, K.L., Esmon, C.T. and Esmon, N.L. (1989) 1NF leads to the internalisation and degradation of 
thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73 : 159. 
Moore, G.R., Traugott, U., Farooq, M., Norton, N.T. and Raine, C.S. (1984) Experimental allergic 
encehalomyelitis. Augmentation of demyelination by different myelin lipids. Lab. Invest. 51 : 416-424. 
Morgan, I.M. (1947) Allergic encephalomyelitis in monkeys in response to injection of normal monkey 
nervous tissue. J. Exp. Med. 85 : 131-140. 
Mori, S. and Leblond, C.P. (1970) Electron microscopic identification of three classes of 
oligodendrocytes and a preliminary study of their proliferative activity in the corpus callosum of young 
rats. Journal of Comparative Neurology 139: 1-28. 
Morrell, P. and Norton, W.T. (1980) Myelin. Scient. Am. 242: 88-118. 
Morris, A.G., Lin, Y.L. and Askonas, B.A. (1982) Immune interferon release when a cloned cytotoxic T-
cell line meets its correct influenza-infected target cell Nature (London) 295 : 150-152. 
Morrison, L.R. (1947) Disseminated encephalomyelitis experimentally produced by the use of 
homologous antigen. Archives of Neurology and Psychiatry (Chicago) 58 : 391-416. 
Morrison, R.S., Saneto, R.P. and de Vellis, J. (1982) Developmental expression of rat brain mitogens 
for cultured astrocytes. Journal of Neuroscience Research 8 : 435-442. 
Munck A., Guyre P.M. & Holbrook N.H (1984) Physiological functions of glucocorticoids in stress and 
their relation to pharmacological actions. Endocr. Rev. 5 : 25. 
Munck, A. and Brinck-Johnson, T. (1968) Specific and non-specific physiochemical interactions of 
glucocorticoids and related steroids with rat thymus cells in vitro. J. Biol. Chem. 243 : 5556. 
Munoz, G.R., Traugott, U., Farooq, M., Norton, N.T. and Raine, C.S. (1984) Experimental allergic 
encehalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant. J. 
Neuroimmunol. 7 : 91-96. 
Nagasawa, S., Handa, H. and Naruo, Y. (1982) Biomechanical study on aging changes and vasospasm of 
human cerebral arteries. Biorheology 19: 481-489. 
Nagel, J.E. (1983) Immunology. Review of Biological Research in Aging 1 : 103-160. 
Nandy, K. (1972a) Brain-reactive antibodies in mouse serum as a function of age. J. Gerontol. 27 : 173-
177. 
Nandy, K. (1972b) Neuronal degeneration in aging and after experimental injury. Exp. Gerontol. 7: 303-
311. 
144 
Nandy, K. (1975) Significance of brain-reactive antibodies in serum of aged mice . J . Gerontol. 30: 412-
416. 
Naparstek, Y., Ben-Nun, A., Holoshitz, J., Resef, T., Frenkel, A., Rosenberg, M . and Cohen, I.R. 
(1983) T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE) . 
Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of 
line cells. Eur. J. Immunol. 13 : 418-423 
Naparstek, Y., Cohen, I.R., Fuchs, Z. and Vlodavsky, I. (1984) Activated T-lymphocytes produce a 
matrix degrading heparan sulphate endoglycosidase. Nature, London, 310: 241-244. 
Nathan, C., Murray, H., Weibe, M. and Rubin, B. (1983) Identification of interferon-gamma as the 
lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. 
Med. 158 : 670-689. 
Nathanson, M. and Savitsky, J.P. (1952) Platelet adhesive index studies in multiple sclerosis and other 
neurologic disorders. Bull. NY Acad. Med. 28: 462-468. 
Naworth, P.P. and Stem D.M. (1986) Modulation of endothelial cell hemostatic properties by TNF. J. 
Exp. Med. 163 : 740. 
Noma, T. and Dorf, M. (1985) Modulation of suppressor T cell induction with gamma-interferon. J. 
Immunol. 135 : 3655-3660. 
Norrby, E (1978) Viral antibodies in MS. Prog. Med. Virol. 24 : 1. 
Northoff, H., Bauer, J., Schobert, A., Flegel, W.A. and Gebicke-Haertrer, P.J. (1989) Lipopolysaccharide 
free conditions allow growth and purification of post-natal brain macrophages (microglia). Journal of 
Immunological Methods 116: 147. 
Noske, W., Lentzen, H., Lange, K. and Keller, K. (1982) Phagocytotic activity of glial cells in culture. 
Experimental Cell Research 142: 437-445. 
Nowell, P.C. (1960) PHA: An initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 
20: 562. 
O'Callaghan, J.P. and Miller, D.M. (1991) The concentration of glial fibrillary acidic protein increases 
with age in the mouse and rat brain. Neurobiology of Aging 12 : 171-174. 
Oehmichen, M., Domasch, D. and Wietholter, H. (1982) Origin, proliferation and fate of cerebrospinal 
fluid cells. J. Neurol. 227 : 145-150. 
Okumura, K. and Tada, T (1971) Regulation of homocytotrophic antibody formation in the rat. J . 
Immunol. 106(4): 1019-1025 
Old, L.J. (1986) Tumor Necrosis Factor. Science 230: 630-632. 
Old, L.J. (1988) Tumor Necrosis Factor. Sc. Am. 
Oldstone, M.B.A. and Dixon, F.J. (1968) Immunohistochemical study of allergic encehalomyelitis. 
Amer. J. Path. 52 : 251-257. 
Oldstone, M.B.A., Rodriguez, M., Daugbaday, W.H. and Lampert, P.W. (1984) Viral pertubation of 
endocrine function: disordered cell function leads to disturbed homeostasis and disease. Nature 307 : 278-
281. 
Oosbima, A. and Yamori, Y. (1980) Hypertension, vasculature and aging. Adv . Exp. Med. Biol. 129 : 
99-110. 
Oropeza, R .L ., Wekerle, H. and Z. Werb (1987) Expression of apolipoprotein E by mouse brain 
astrocytes and its modulation by IFN-g. Brain Res. 410 : 45-51. 
Ortiz-Ortiz, L. and Weigle, W.O. (1976) Cellular events in the induction of experimental allergic 
encephalomyelitis in rats. J. Exp. Med. 144: 604-616. 
145 
Palmer, F.B. and Dawson, R.M.C. (1969) The isolation and properties of experimental allergic 
encephalotigenic protein. B iochem. J. 111 : 629. 
Pals, S. T., Horst, E., Scheper, R.J., and Meijer, C.J.L.M. (1989) Mechanisms of human lymphocyte 
migration and their role in the pathogenesis of disease. Immunol. Rev. 108 : 110-133. 
Panitch, H. and Ciccone, C. (1981) Induction of recurrent experimental allergic encephalomyelitis with 
myelin basic protein. Annals of Neurology 9 : 433-438. 
Panitch, H., Hirsch, R., Schindler, J. and Johnson, K. (1987) Treatment of Multiple Sclerosis with 
gamma-interferon: exacerbations associated with activation of the immune system. Neurol. 37 : 1097-
1102. 
Panitch, H.S. (1980) Adoptive transfer of experimental allergic encephalomyelitis with activated spleen 
cells: Comparison of in vitro activation by concanavalin A and myelin basic protein. Cell. Immunol. 
56 : 163-171. 
Panitch, H.S. and Ciccone, C. (1981) Adoptive transfer of experimental allergic encephalomyelitis: 
requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic 
protein. Cell. Immunol. 60 : 24-33. 
Panitch, H.S. and Mcfarlin, D.E. (1977) Experimental allergic encephalomyelitis: enhancement of cell 
mediated transfer by concanavalin A. J. Immunol. 119: 1134-1139. 
Parish, C.R. and Snowden, J.M. (1985) Lymphocytes express a diverse array of specific receptors for 
sulfated polysaccharides. Cell. Immunol. 91 : 201-214. 
Parish, C.R., Hogarth, P.M. and McKenzie, I.F.C. (1988a) Evidence that Thy-1 and Ly-5 (T-200) 
antigens interact with sulphated carbohydrates. Immunol. Cell Biol. 66: 221-230. 
Parish, C.R., McPhun, V. and Warren, H.S. (1988b) Is a natural ligand of the T lymphocyte CO2 
molecule a sulfated carbohydrate? J. Immunol. 141: 3498-3504. 
Parish, C.R., Rylatt, D.B. and Snowden, J.M. (1984) Demonstration of lymphocyte surface lectins that 
recognize sulphated polysaccharides. J. Cell. Sci. 67 : 145-158 
Patarroyo, M., Prieto, J., Rincon, J., Timonen, T., Lundberg, C., Lindbom, L., Asjo, B. and Gahmberg, 
C.G. (1990) Leukocyte cell adhesion : A molecular process fundamental in leukocyte physiology. 
Immunol. Rev. 114 : 67. 
Paterson, P.Y., Richardson, W.P. and Drobish, D.G. (1975) Cellular transfer of EAE: altered disease 
pattern in irradiated recipient Lewis rats. Cell. Immunol. 16: 48-59. 
Paterson, P. and Swanborg, R. (1988) Demyelinating diseases of the central and peripheral nervous 
systems. In: Immunological diseases, (eds. Samter, M., Talmage, D.W., Frank, M.M., Austen, K.F. and 
Claman, H.N.) 4th Edition, Little Brown and Co., Boston, 1877-1916. 
Paterson, P.Y. (1958) Studies of immunological tolerance to nervous tissue in rats. Ann. N.Y. Acad. 
Sci. 73 : 811. 
Paterson, P.Y. (1959) Organ-specific tissue damage induced by mammalian tissue-adjuvant emulsions. 
In: Cellular and Humoral Aspects of the Hypersensitive States (ed. Lawrence, H.S.). Harper & Row, 
NY, pp. 469. 
Paterson, P.Y. (1960) Transfer of allergic encephalomyelitis in rats by means of lymphoid cells. J. Exp. 
Med. 111: 119-136. 
Paterson, P.Y. (1966) Experimental allergic encephalomyelitis and autoimmune disease. Adv. Immunol. 
5 : 131. 
Paterson, P.Y. (1971) The demyelinating diseases: clinical and experimental correlates. In: 
Immunological Diseases Vol. 2 (ed. Samter, M.), Little, Brown and Company, Boston, pp.1269-1299. 
Paterson, P. Y. (1976) Experimental allergic encehalomyelitis: role of fibrin deposition in 
immunopathogenesis of inflammation in rats. Fed. Proc. 35 : 2428-2434. 
146 
Paterson, P.Y. and Beisaw, N.E. (1963) Effect of wholebody x-irradiation on induction of allergic 
encephalomyelitis in rats. J. Immunol. 90 : 532. 
Paterson, P.Y. and Bell, E. (1962) Studies in the induction of allergic encehalomyelitis in rats and guinea 
pigs without the use of mycobacteria. J. Immunol. 89 : 72-79. 
Paterson, P.Y. and Harwin, S.M. (1963) Suppression of allergic encehalomyelitis in rats by means of 
antibrain serum. J. Exp. Med. 117 : 755-774. 
Paterson, P.Y., Day, E.D., Whitacre, C.C., Berenberg, R.A. and Harter, D.H. (1981) Endogenous 
myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera 
of clinically well subjects and patients with multiple sclerosis. J. Neurol. Sci. 52: 37. 
Paterson, P.Y., Drobish, D.G., Hanson, M.A. and Jacobs, A.F. (1970) Induction of experimental allergic 
encephalomyelitis in Lewis rats. International Archives of Allergy & Applied Immunology 37 : 26-40. 
Paterson, P.Y., Day, E.D. Whitaker, C.C. (1981) Neuroimmunologic disease - effector cell responses and 
immunoregulatory mechanisms. Imm. Rev. 55: 317-348. 
Pender, M.P. (1986a) Ascending impairment of nociception in rats with experimental allergic 
encephalomyelitis. J. Neurol. Sci. 75 : 317-328. 
Pender, M.P. (1986b) Conduction block due to demyelination at the ventral root exit zone rn 
experimental allergic encephalomyelitis. Brain research, Amsterdam 367: 398-401. 
Pender, M.P. (1987) Demyelination and Neurological signs in experimental allergic encephalomyelitis. J. 
Neuroimmunol. 15 : 11-24. 
Pender, M.P. (1988) The pathophysiology of myelin basic protein-induced acute experimental allergic 
encephalomyelitis in the Lewis rat. J. Neurol. Sci. 86: 277-289. 
Pender, M.P. (1989) Recovery from acute experimental allergic encephalomyelitis in the Lewis rat. 
Early restoration of nerve conduction and repair by Schwann cells and oligodendrocytes. Brain 112: 393-
416. 
Pender, M.P. and Sears, T.A. (1982) Conduction block in the peripheral nervous system in experimental 
allergic encephalomyelitis. Nature, London 296 : 860-862. 
Pender, M.P. and Sears, T.A. (1984) The pathophysiology of experimental allergic encephalomyelitis in 
the rabbit. Brain 107 : 699-726. 
Pender, M.P. and Sears, T.A. (1986) Involvement of the dorsal root ganglion in acute experimental 
allergic encephalomyelitis in the Lewis rat: a histological and electrophysiological study. J. Neurol. 
Sci. 72: 231-242. 
Pender, M.P., Stanley, G.P., Yoong, G. and Nguyen, K.B. (1990) The neuropathology of chronic 
relapsing experimental allergic encephalomyelitis in the Lewis rat by inoculation with whole spinal cord 
and treatment with cyclosporin A. Acta Neuropathologica, Berlin, 80 : 172-183. 
Perry, V.H. and Gordon, S. ( 1987) Modulation of CD4 antigen on macrophages and microglia in the rat 
brain. J. Exp. Med. 166: 1138-1143. 
Perry, V.H. and Gordon, S. ( 1988) Macrophages and microglia in the nervous system. Trends in 
Neuroscience 11 : 273-277. 
Peters, A. and Vaughn, J.E. (1970) Morphology and development of the myelin sheath. In: Myelination. 
(eds. Davison, A.N. and Peters, A.) C.C. Thomas. 
Peters, A., Palay S.L. and Webster, H.deF. (1970) The Fine Structure of the Nervous System: The Cells 
and their Processes. Harper & Row Publishers USA. 
Peters, A., Palay, S.L. and Webster, H.deF. (1976) The Fine Structure of the Nervous System: The 
Neurons and Supporting Cells Saunders Philadelphia. Pfeiffer, S.E. (ed) (1982) Neuroscience approached 
through cell culture. 
147 
Peters, B.A. and Hinrichs, DJ. (1982) Passive transfer of experimental allergic encephalomyelitis in the 
Lewis rat with activated spleen cells: Differential activation with mitogens. Cell. Immunol. 69 : 175-
185. 
Pettinelli, C.B. and Mcfarlin, D.E. (1981) Adoptive transfer of experimental allergic encehalomyelitis in 
SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 
1+2- T lymphocytes. J. Immunol. 127 : 1420-1423. 
Pinkston, P., Saltini, C., Muller-Quembeim, J. and Crystal, R. (1987) Corticosteroid therapy suppresses 
spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with 
active pulmonary sarcoidosis. J. Immunol. 139: 755-760. 
Pober, J. S. (1988) TNF as an activator of vascular endothelium. Ann. Inst. Pasteur Immunol. 139 : 
317. 
Pober, J.S., Gimbrone, M.A., Cotran, R.S., Reis, C.S., Burak.off, SJ., Fiers, W . and Ault, K.A. 
(1983) Ia expression by vascular endothelium is inducible by activated T-cells and by human interferon. 
J. Exp. Med. 157 : 1339-1349. 
Polman, C.H., Matthaei, I., de Groot, CJ.A., Koetsier, J.C., Sminia, T. and Dijkstra, C.D. (1988) 
Low-dose cyclosporin A induces relapsing remitting experimental allergic encepbalomyelitis in the Lewis 
rat. J. Neuroimmunol. 17 : 209-216. 
Powell, H.C. and Lampert, P.W. (1983) Symposium on MS pg. 631, Saunders, Philadelphia. 
Powell, M., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S., Graham, M. and Ruddle, N. (1990) 
Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones 
correlates with encephalitogenicity. Int. Immunol. 2: 439-544. 
Prineas, J. (1975) Pathology of the early lesion in MS. Human Pathol. 6: 531-554. 
Prineas, J ., Raine, C.S. and Wisniewski, H. (1969) An ultrastructural study of experimental 
demyelination and remyelination. III. Chronic experimental allergic encephalomyelitis in the central 
nervous system. Laboratory Investigation 21 : 472-483. 
Prineas, J.W. (1985) in Handbook of Clinical Neurology (Vol. 3) (ed. Koetsier,J.C.), pp. 213-257, 
Elsevier Science Publishers. 
Putnam, T.J. (1935) Studies in multiple sclerosis. IV. Encephalitis and sclero plaques produced by 
venular obstruction. Arch. Neurol. Psychiatry 33 : 929-940. 
Putnam, T.J. (1937) Evidence of vascular occlusion in multiple sclerosis and 'encephalomyelitis'. Arch. 
Neurol. Psychiatry 37 : 1298-1321. 
Radomski, M.W., Palmer, R.M.J. and Moncada, S. (1987) Endogenous nitric oxide inhibits human 
platelet adhesion to vascular endothelium. Lancet 2: 1057-1058. 
Radomski, M.W., Palmer, R.M.J. and Moncada, S. (1990). Glucocorticords inhibit the expression of an 
inducible but not the constitutine, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. 
Sci. USA 87 : 10043-10047. 
Raff, M. (1989) Glial cell diversification in the rat optic nerve. Science 243 : 1450-1455. 
Raine, C.S., Canella, B., Dujvestijn, A.M., Cross, A.H. (1990) Homing to CNS vasculature by 
antigen-specific lymphocytes. Lab. Invest. 63(4): 476-89 . 
Raine, C.S. (1976b) Immune-mediated demyelination in the rabbit retina after intraocular injection of 
antigen. Brain Res. 102 : 355. 
Raine, C.S. (1976) Experimental allergic encepbalomyelitis and related conditions . In: Progress in 
Neuropathology Vol. 3 (ed. Zimmerman, H.M.), Grune & Stratton, New York, pp. 225-251. 
Raine, C.S. (1978) Membrane specialisation between demyelinated axons and astroglia in chronic 
experimental allergic encephalomyelitis lesions and multiple sclerosis plaques. Nature 275 : 326-327. 
148 
Raine, C.S . (1980) Neuropathology of experimental allergic encehalomyelitis in inbred strains of mice. 
Lab. Invest. 43 : 150-157. 
Raine, C.S. (1984) Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. 
Invest. 50 : 608-635. 
Raine, C.S. (1984) Biology of disease: analysis of autoimmune demyelination: its impact upon 
multiple sclerosis. Laboratory Investigation 50 : 608-635. 
Raine, C.S. (1985) Neurons, astrocytes and ependyma. In: Textbook of Neuropathology, pp468-547, 
Williams and Wilkins, Baltimore. 
Raine, C.S. and Traugott, U. (1983) Chronic relapsing experimental autoimmune encephalomyelitis. 
Ultrastructure of the central nervous system of animals treated with combinations of myelin components. 
Laboratory Investigation 48 : 275-284. 
Raine, C.S., Barnett, L.B., Brown, A., Behar, T. and Mcfarlin, D.E. (1980) Neuropathology of 
experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43: 150-157. 
Raine, C.S., Bornstein, M.B. (1970) experimental allergic encephalomyelitis: and ultrastructural study of 
experimental demyelination in vitro. J. Neuropath. Exp. Neurol. 29 : 177-191. 
Raine, C.S., Diaz, M., Pakingan, M. and Bornstein, M.B. (1978) Antiserum induced dissociation of 
myelinogenesis in vitro: An ultrastructural study. Lab. Invest. 38 : 397-403. 
Raine, C.S., Johnson, A.B. Marcus, D.M. et al., (1981) Demyelination in vitro: absorption studies 
demonstrate that galactocerebroside ids a major target. J. Neurol. Sci. 52 : 117-131. 
Raine, C.S., Snyder, D .. H., Stone, S.H. and Bornstein, M.B. (1977) Suppression of acute and chronic 
experimental allergic encephalomyelitis in Strain 13 guinea-pigs. J. Neurol. Sci. 31 : 355-367. 
Rappaport, S.I. (1976) Blood-brain barrier in physiology and medicine. Raven Press, New York. 
Ravens, J.R. (1978). Vascular changes in the human senile brain. Adv. Neurol. 20: 487-501. 
Reinhardt, W.O. and Li, C.H. (1945) Depression of lymphocyte content of thoracic duct lymph by 
adrenocorticotrophic hormone. Science (Wash. DC) 101 : 360. 
Reinherz, E.L., Weiner, H.L., Hauser, S.L. et al. (1980) Loss of suppressor T cells in active multiple 
sclerosis. Analysis with monoclonal antibodies. New Eng. J. Med. 303: 125-129. 
Richert, J.R., Driscoll, B.F., Kies, M.W. and Alvord, E.C., Jr. (1979) Adoptive transfer of experimental 
allergic encephalomyelitis: Incubation of rat spleen cells with specific antigen. J. Immunol. 122: 494-
496. 
Richert, J.R., Driscoll, B.F., Kies, M.W. and Alvord, Jr. E.C. (1981) Experimental allergic 
encephalomyelitis: activation of myelin basic protein-sensitized spleen cells by specific antigen in 
culture. Cell. Immunol. 59 : 42. 
Richert, J.R., Namikawa, T., Kies, M.W. and Alvord, E.C. (1982) Failure of serum from recovered rats 
to prevent enhanced adoptive transfer of experimental allergic encehalomyelitis. J. Neurol. Sci. 53 : 225-
232. 
Rivers, T.M. and Schwentker, F.F. (1935) Encephalomyelitis accompanied by myelin destruction 
experimentally produced in monkeys. J. Exp. Med. 61 : 689-702. 
Rivers, T.M., Sprunt, D.M. and Berry, G.P. (1933) Observations on attempts to produce acute 
disseminated encephalomyelitis in monkeys. J. Exp. Med. 58 : 39-53. 
Rivnay, B., Globerson, A. and Shinitzky, M. (1973) Viscosity of lymphocyte plasma membrane in 
aging mice and its possible relation to serum cholesterol. Mechanisms of Aging and Development 10 : 
71-79. 
Robbins, D.S., Shirazi, Y. , Drysdale, B.E., Lieberman, A., Shin, H.S. and Shin, M.L. (1987) 
Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139 : 2593-
2597. 
149 
Roberts-Thomson, I.C., Whittingham, S., Youngchaiyud, U. and Mackay, I.R. (1974) Aging, immune 
response and mortality. Lancet ii: 368-370. 
Rockett, K.A., Awburn, M.M., Aggarwal, B.B., Cowden, W.B. and Clark, I.A. (1992) In vivo induction 
of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-!: Possible rol
es in malaria. 
Infection and Immunity (in press). 
Rodriguez, M., Oleszak, E. and Leibowitz, J. (1987) Theiler's murine encephalomyelitis: A model of 
demyelination and persistence of virus. CRC Critical Reviews in Immunology 7 : 325-365. 
Rose, M.L. and Parrott, D.M.V. (1977) Vascular permeability and lymphoblast extravasation into 
inflammed skin are not related. Cell. Immunol. 33 : 62-71. 
Rosenberg, S.A., Spiess, P.J. and Schwartz, S. (1978) In vitro growth of murine T cells 1. Production 
of factors necessary for T cell growth. J. Immunol. 121 : 1946-1950. 
Ross, L.L. and Bornstein, M.B. (1969) An electron microscopic study of synaptic alterations in cultured 
mamalian central nervous tissues exposed to serum from animals with experime
ntal allergic 
encehalomyelitis. Lab. Invest. 20 : 26-35. 
Roth G.S. (1979) Hormone action during ageing: Alteration and mechanisms. Mech. Ageing Dev. 9 : 
497-514. 
Roth, G.S. (1975) Age related change in glucocorticoid binding by rat spenic leukocytes. Possible cause 
of altered adaptive responsiveness. Fed. Proc., Fed. Am. Soc. Exp. Biol., 34 : 183-187. 
Rothlein, R., Czajkowski, M., O'Neill, M.M., Marlin, S.D., Mainolfi, E., Merluzzi, V.J. (1988) 
Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-
inflammatory 
cytokines: Regulation by pharmacologic agents and neutralizing antibodies. J. Immunol. 1
41 : 1665. 
Rothlein, R., Dustin, M.L., Marlin, S.D., and Springer, T.A. (1986) A human intercellular adhesion 
molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137: 1270-1274. 
Rowland, L.P. (1985) Blood-brain barrier, cerebrospinal fluid, brain edema, and hydrocephalus In: 
Principles of Neuroscience 2nd edition (eds. Kandel, E.R. and Schwartz, J .H.) pp. 838-844, Els vier, New 
York. 
Rowland, L.P. (1985) Diseases of the motor unit: the motor neuron, peripheral nerve, and muscle. In: 
Principles of Neural Science 2nd Edition (eds. Kandel, E.R., and J.H. Schwartz) pp. 196-208, Elsevier, 
New York. 
Rozemuller, J.M., Eikelenboom, P., Pals, S.T. and Stam, F.C. (1989) Microglial cells around amyloid 
plaques in Alzheimer's disease express leukocyte adhesion molecules of the LFA-1 family. 
Neuroscience 
Letters 101 : 288-292. 
Ruddle, N., Bergman, C., McGrath, K., Lingenheld, E., Grunnet, M., Padula, S. and Clar
ke, R. (1990) 
An antibody to lymphotoxin and tumour necrosis factor prevents transfer to experim
ental allergic 
encephalomyelitis. J. Exp. Med. 172 : 1193-1200. 
Sage, J.I., Van Uitert, R.L. and Duffy, T.E. (1984). Early changes in blood-brain barrier permeability to 
small molecules after transient cerebral ischemia. Stroke 15 : 46-50. 
Sakaguchi, S. and Sakaguchi, N. (1989) Organ-specific autoimmune disease induced in mice by 
elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoim
mune disease. 
J. Immunol. 142 : 471-480. 
Sakai, K., Namakawa, T., Kunishita, T., Yoshimura, T. and Tabira, T. (1985) Ia restriction of murine 
encephalitogenic T-cells in vitro and in vivo. J. Neuroimmunol. 9: 281-291. 
Salpolsky R., Rivier C., Yamamoto G, Plotsky P. & Vale W. (1987) Interleukin-I stimulates the 
secretion of hypothalamic corticotropin releasing factor. Science 238 : 522. 
Samuelson, B. Granstrom, E., Green, et al., (1975) Prostaglandins. 
150 
Saragea, M., Rotaru, N., Negru, T. and Vladutiu, A. (1965) Monoamine oxidase and ac
etylcholinestera e 
activity in animals with experimental allergic encehalomyelitis. Natur
e 206 : 306-307 
Sasaki, S., and Suchi, T. (1967) Mobilization of lymphocytes from lymph nod
es and spleen by 
polysaccharide polysulphate. Nature 216: 1013-1014. 
Sass, B., Rabstein, L.S., Madison, R., Nims, R .. M., Peters, R.L. and
 Kelloff, G.J. (1975) Incidence of 
spontaneous neoplasms in F344 rats throughout the natural life-sp
an. Journal of National Cancer 
Institute 54 : 1449-1456. 
Scarpati, E.M. and Sadler, J.E. (1989) Equilibrium binding of thrombin to rec
ombinant human 
thrombomodulin, effect of hirudin, factor va and peptide analogues. Bio
chemistry 29 10602-12. 
Schacher, S (1986) Determination and Differentiation in the development of the ne
rvous system. In: 
Principles of Neuroscience, 2nd Ed (eds E.R. Kandel and J .H. Schwartz) Elsevier, New 
York. 
Schachner, M. and Sidman, R. (1973) Distribution of H-2 alloantigen in developing m
ouse brain. Brain 
Research 60: 191-198. 
Schauer, R. (1985) Sialic acids and their role as biological masks. TIBS (Trends Bioch
em. Sci.) 10: 357-
360 
Schlesinger, M. and Israel, E. (1974) The effect of lectins on the migration of lympho
cytes in vivo. Cell. 
Immunol. 14 : 66-79 
Schmidley, JW and Maas E.F.(1990) Cerebrospinal fluid, blood-brain barrier and
 brain edema. In: 
Neurobiology of Disease (ed AL Pearlman and RC Collins) Oxford Uni. Press, New Y
ork. 
Schocken, D.D. and Roth G.S. (1977) Reduced beta adrenergic receptor concentratio
ns in ageing man. 
Nature (London) 267 : 856-857. 
Schumacher, G.A., Beebe, G., Kibler, R.E., Kurland, L.T., Kurtzke
, J.F., McDowell, F., Nagler, B., 
Sibley, W.A., Tourtellotte, W.W. and Willmon, T.L. (1965) Problems of experiment
al trials of therapy 
in multiple sclerosis: report by the panel on evaluation of experim
ental trials of therapy in multiple 
sclerosis. Ann. N.Y. Acad. Sci. 122 : 552-568. 
Schwartz, A., Askenase, P.W. and Gershon, R.K. (1977) The effect of locally injected vaso
active amines 
on the elicitation of delayed-type hypersensitivity. J. Immunol. 1 : 1
59-165 
Schwartz, R. H. (1989) Acquisition of immunologic self tolerance. Cell 57 : 1073. 
Schwartz, R.H. (1985) T-lymphocyte recognition of antigen in association with ge
ne products of the 
major histocompatibility complex. Ann. Rev. Immunol. 3 : 237-261. 
Sears E.S. Tindall R.S.A. and Zarnow H (1978) Active multiple sclerosis:Enhan
ced computerized 
tomographic imaging of lesions and the effect of cortcosteroids. Arch. 
Neurol. 35 : 126. 
Sedgewick, J.D. and Mason, D.W. (1986) The mechanism of inhibition of EAE in the
 rat by monoclonal 
antibody against CD4. J. Neuroimmunol. 13: 217. 
Sedgwick, J., Brostoff, S. and Mason, D. (1987) Experimental allergic encephalomye
litis in the absence 
of a classical delayed-type hypersensitivity reaction: severe paralytic d
isease correlates with the presence 
of interleukin 2 receptor-positive ceHs infiltrating the central nervou
s system. J. Exp. Med. 165 : 1058-
1075. 
Seil, F.J., Falk, G.A., Kies, M.W. and Alvord, E.C. (1968) In vitro demyelinating ac
tivity of serum of 
guinea pigs sensitised with whole CNS tissue and purified encephalito
gen. Exp. Neurol. 22 : 545-555. 
Selmaj, K, Raine, CS, Cross, AH (1991). Anti-Tumour necrosis factor therapy alerogates
 autoimmune 
demyelination. Annals of Neurology 30(5) : 694-700. 
Selmaj, K.W. and Raine, C.S. (1988) Tumour necrosis factor mediates myelin and oli
godendrocyte 
damage in vitro. Ann. Neurol. 23(4) : 339-346. 
1 5 1 
Sethi, K.K., Omata, Y., Schnoewis, K.E. (1983) Protection of mice from fatal herpes simplex virus type 
1 infection by adoptive transfer of cloned virus-specific and H-2 restricted cytotoxic T lymphocytes. J. 
Gen. Virol. 64 : 443-447. 
Shaw, S. and Luce, G.E. (1987) The LFA-1 and CD2/LFA-3 pathways of antigen independent human T 
cell adhesion. J. Immunol. 139(4) : 1037-45. 
Shaw, C., Alvord, Jr., E.C., Fahlberg, W.J. and Kies, M.W. (1962) Adjuvant-antigen relationships in 
the production of experimental "allergic" encephalomyelitis in the guinea pig. J. Exp. Med. 115 : 169. 
Shaw, C.M., Alvord, E.C. and Hruby, S. (1988) Chronic remitting-relapsing experimental allergic 
encephalomyelitis induced in monkeys with homologous myelin basic protein. Ann. Neurol. 24 : 738-
748. 
Shaw, S., Luce, G.E.G., Quinones, R., Gress, R.E., Springer, T.A. and Sanders, M.E. (1986) Two 
antigen-independent pathways used by human cytotoxic T cell clones. Nature 323 : 262. 
Shaw, S., Makgoba, M.W. and Shimizu, Y. (1990) Antigen-independent adhesion: a critical process in 
human cytotoxic T cell recognition. In: Leukocyte adhesion molecules. (ed. Springer, T.A., Anderson, 
D.C., Rosenthal, A.S., and Rothlein, R.R.) p. 236. Springer-Verlag, New York. 
Sheehan, K., Ruddle, N. and Schreiber, R. (1989) Generation and characterisation of hamster monoclonal 
antibodies that neutralize murine tumour necrosis factor. J. lmmunol. 142 : 3884-3893. 
Shimizu, Y ., and Shaw, S. (1990) T lymphocyte adhesion molecules. In: The Year in Immunology 
1989-90. Molecules and Cells of Immunity, 6. (eds. Cruse, J.M. and Lewis Jr., R.E.) p. 69. Karger, 
Basel. 
Sbrager, P. (1988) Ionic channels and signal conduction in single remyelinating frog nerve fibres. 
Journal of Physiology, London, 404: 695-712. 
Simeonovic, CJ., Mackie, P.J., Wilson, J .D. (1990) Functional proerties of proislet isografts in diabetic 
mice. Diabetes Res. Clin. Pract. 8(3) 275-81. 
Simmons, D., Makgoba, W.M. and Seed, B. (1988) ICAM-1, an adhesion ligand of LFA-1, is 
homologous to the neural cell adhesion molecule NCAM. Nature 331 : 624-627. 
Simmons, R.D. , Bernard, C.C.A., Singer, S. and Carnegie, P.R. (1982) Experimental allergic 
encehalomyelitis: an anatomically based explanation of clinical progression in rodents. J. Neuroimmunol. 
3: 307-318. 
Simmons, R.D. and Willenborg, D. (1990) Direct injection of cytokines into the spinal cord causes 
autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 140: 2210-2214. 
Simmons, R.D., Bernard, C.C.A. and Carnegie P.R. (1983) Factors underlying ascending paralysis in 
rodents during experimental autoimmune encephalomyelitis (EAE). In: Molecular Pathology of Nerve 
and Muscle: Noxious Agents and Genetic Lesions (eds. Kidman, A.D., Tomkins, J .K., Morris, C.A. and 
Cooper, N.A.). The Humana Press, Clifton NJ, pp 99-111. 
Simmons, R.D., Bernard, C.C.A., Kerlero de Rosbo, N. and Carnegie, P.R. (1984) Criteria for an 
adequate explanation of typical clinical signs in experimental allergic encephalomyelitis in rodents. Prog. 
Clin. Biol. Res. 146 : 23-29. 
Simmons, R.D., Bernard, C.C.A., Ng, K.T. and Carnegie, P.R. (1981) Hind-limb motor ability in 
Lewis rats during the onset and recovery phases of experimental autoimmune encephalomyelitis. Brain 
Research, Amsterdam, 215 : 103-114. 
Simmons, R.D., Buzbee, T.M., Linthicum, D.S., Mandy, W.J., Chen, G. and Wang, C. (1987) 
Simultaneous visualisation of vascular permeability change and leukocyte egress in the central nervous 
system during experimental autoimmune encephalomyelitis. Acta. Neuropathhol. 74: 191-193. 
Simon, J. and Anzil, A.P. (1974) Immunohistochemical evidence of perivascular localisation of basic 
protein in early development of experimental allergic encehalomyelitis. Acta neuropath . 27 : 33-42. 
152 
Singer, D.E., Moore, M.J. and Williams, R.M. (1981) experimental allergic encephalomyelitis in rat 
bone marrow chimeras: Analysis of cellular mechanism of BN resistance. J. Immunol. 126 : 1553-
1557. 
Smith, K.J., Blakemore, W.F. and McDonald, W.I. (1979) Central remyelination restores secure 
conducttion. Nature, London 280 : 395-396. 
Smith, k.J., Blakemore, W.F. and McDonald, W.I. (1981) The restoration of conduction by central 
remyelination. Brain 104 : 383-404. 
Smith, S.B. and Waksman, B.H. (1969) Passive transfer and labelling studies on the cell infiltrate in 
experimental allergic encephalomyelitis. J. Pathol. 99 : 237-244. 
Sobel, H., Hatler, D., Castro, E., Morimoto, C. and Weiner, H. (1988) The 2H4(CD45R) antigen is 
selectively decreased in multiple sclerosis lesions. J. Immunol. 140: 2210-2214. 
Sobel, R.A. and Colvin, R.B. (1985) The immunopathology of experimental allergic encephalomyelitis: 
III. Differential expression of strain 13 Ia on endothelial and inflammatory cells of (strain 2 x strain 
13)F1 guinea pigs with experimental allergic encephalomyelitis. J. Immunol. 134: 2333-2337. 
a., 
Sobel, R:A., Blanchette, B.W. and Colvin, R.B. (1984) Pre-inflammatory expression of fibronectin (Fn) 
and Ia in acute experimental allergic encehalomyelitis (EAE): Modulation of endothelial cells (EC) in the 
immune response detected by quantitative immunoperoxidase studies using monoclonal antibodies. Prog. 
Clin. Biol. Res. 146 : 81-86. 
Sobel, R.A., Blanchette, B.W., Bhan, A.K. and Colvin, R.B. (1984f The immunopathology of 
experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell 
infiltration. J. Immunol. 132: 2402-2409. 
Sobel, R.A., Mitchell, M.E. and Fondren, G. (1990) Intercellular adhesion molecule-I (ICAM-1) in 
cellular immune reactions in the human central nervous system. Am. J. Pathol. 136(6): 1309-1316 .. 
Soffer, D. and Raine C.S. (1980) Morphologic analysis of axo-glial membrane specialisations in the 
demyelinated central nervous system. Brain Res. 186: 301-313. 
Springer, T.A., Dustin, M.L., Kishimoto, T.K. and Marlin, S.D. (1987) The lymphocyte function-
associated LFA-1, CD-2 and LFA-3 molecules: Cell adhesion receptors of the immune system. Annual 
Review of Immunology 5 : 223-252. 
Sriram, S. and Steinnman, L. (1983) Anti I-A antibody suppresses active encephalomyelitis treannent 
model for disease linked to IR genes. Journal of Experimental Medicine 158: 1362-1367. 
Sriram, S., Solomon, D., Rouse, R.V. and Steinman, L. (1982) Identification of T cell subsets and B 
lymphocytes in mouse brain experimental allergic encephalomyelitis patients. J. Immunol. 129 : 1649-
1651. 
Stanley, G.P. and Pender, M.P. (1991) The pathophysiology of CREAE in the Lewis rat. Brain 114(4) : 
1827-53. 
Steiniger, B. and van der Meide, P.H. (1988) Rat ependyma and microglia cells express class II MHC 
antigens after intervenous infusion of recombinant g interferon. J. Neuroimmunol. 19 : 111-118. 
Steinman, L., Rosenbaum, J.T., Sriram, S. and McDevitt, H.O. (1981) In vivo effects of antibodies to 
immune response gene products: Prevention of experimental allergic encephalitis. Proceedings of the 
National Academy of Sciences USA 78 7111-7114. 
Steinmetz, M. and Hood, L. (1983) Genes of the major histocompatibility complex in mouse and man. 
Science 222: 727-733. 
Stem, D.M. and P.P.Nawortb (1986) J.Exp. Med. 163 : 740. 
I 
153 
Stevens, J.G. (1978) Latent characteristics of selected herpes viruses. Advances in cancer research 26 : 
227-256. 
Stevens, S. K., Weissman, I.L., and Butcher, E.C. (1982) Differences in the migration of B and T 
lymphocytes : Organ-selective localization in vivo and the role of lymphocyte-endothelial cell 
recognition. J. Immunol. 128 : 844-851. 
Stewart P.A., Magliocco, M., Hayakawa, K., Farrell, C.L., Del Maestro, R.F. Girvin, J., Kaufmann, 
J.C.E., Vinters, H.V. and Gilbert, J. (1987) A quantitative analysis of blood-brain barrier ultrastructure in 
the aging human. Microvasc. Res. 33 : 270-282. 
Stohl, W. and Gonatas, N.K. (1978) Chronic permeability of the central nervous system to mononuclear 
cells in experimental allergic encehalomyelitis in the Lewis rats. J. Imrnunol. 120: 844-849. 
Stone, S.H. (1961) transfer of experimental allergic encehalomyelitis by lymph node cells in inbred 
guinea pigs. Science 134 : 169. 
Stone, S.H. and Lerner, E.M. (1965) Chronic disseminated allergic encephalomyelitis in guinea pigs. 
Ann. N. Y. Acad. Sci. USA 122 : 227-241. 
Stoolman, L.M. (1989) Adhesion molecules controlling lymphocyte migration. Cell 56 : 907-910. 
Stoolman, L.M. and Rosen, S.D. (1983) A possible role for cell surface carbohydrate-binding molecules 
in lymphocyte recirculation. J. Cell. Biol. 96 : 722-729. 
Stoolman, L.M., Yednock, T.A. and Rosen, S.D. (1987) Homing receptors on human and rodent 
lymphocytes - Evidence for a conserved carbohydrate-binding specificity. Blood 70: 1842-1850. 
Streit, W.J., Graeber, M.B. and Kreutzberg, G.W. (1988) Functional plasticity of microglia: A review. 
Olia 1 : 301-307. 
Suckling, A.J., Reiber, H., Kirby, J.A., Rumsby, M.G. (1983) Chronic relapsing experimental allergic 
encehalomyelitis: immunological and blood-cerebrospinal fluid barrier dependent changes in the 
cerebrospinal fluid. J. Neuroimmunol. 4 : 35-45. 
Suckling, A.J., Reiber, H., Kirby, J.A., Rumsby, M.G. (1984) Blood-cerebrospinal fluid barrier 
permeability changes in guinea pigs inoculated for chronic relapsing experimental allergic 
encehalomyelitis or with adjuvant alone. Prog. Clin. Biol. Res. 146 : 75-80. 
Sullivan, C.B., Visscher, B.R. and Detels, R. (1984) Neurology 34: 1144-1148. 
Sun, D. and Wekerle, H. (1986) Ia-restricted encephalitogenic T lymphocytes mediating experimental 
allergic encephalomyelitis lyse autoantigen-presenting astrocytes. Nature (London) 320 : 70-71. 
Suzimura, A., Lavi, E., Weis, S.R. and Silberberg, D.H. (1986) Coronavirus infection induces H-2 
antigen expression on oligodendrogliocytes and astrocytes. Science 232: 991-993. 
Suzimura, A., Metzitis, S.G.E., Gonatas, N.K. and Silberberg, D.H. (1987) MHC antigen expression on 
bulk isolated macrophage-microglia from newborn mouse brain: Induction of Ia antigen by g interferon. 
J. Neuroimmunol. 15 : 262-278. 
Swanborg, R.H. (1983) Autoimmune effector cells V, a monoclonal antibody specific for rat helper T-
cells inhibits adoptive transfer of autoimmune encephalomyelitis. J. Imrnunol. 130: 1503-1505. 
Swierkosz, J.E. and Swanborg, R.H. (1975) Suppressor cell control of unresponsiveness to experimental 
allergic encehalomyelitis. J. Immunol. 115: 631-633 
Tabira, T. and Endoh, M. (1985) Humoral immune response to myelin basic protein, cerebroside and 
ganglioside in chronic relapsing experimental allergic encehalomyelitis of the guinea pig. J. Neurol. Sci. 
67 : 201-212 
Tabira, T. and Sakai, K. (1987) Demyelination induced by T cell lines and clones specific for myelin 
basic protein in mice. Laboratory Investigation 56 : 518-525. 
Taguchi and Nishizuka (1987) J. Exp. Med. 165: 146-156. 
r 
154 
Taguchi, 0., Takahashi, T. and Nishizuka, Y. (1990) Self tolerance and localised immunity. Current 
opinion in Immunology 2: 576-581. 
Takei, F. (1985) Inhibition of mixed lymphocyte response by rat monoclonal antibody to a novel murine 
lymphocyte activation antigen (MALA-2). J. Immunol. 134 : 1403-9. 
Takenaka, A., Minegawa, H., Kaneka, K., Mori, R. and Itoyama, Y. (1986) Adoptive transfer of 
experimental allergic encephalomyelitis with lectin activated spleen cells, part 2. Studies on T-cell 
subsets and interleukin production. J. Neurol. Sci. 72: 337-345. 
Takiguchi, M., and Frelinger, J.A. (1986) Induction of antigen presentation ability in purified cultures of 
astroglia by gamma interferon. J. Mol. Cell Immunol. 2 : 269-280. 
Talor, B. and Rose, N.R. (1991) Hypothesis: The aging paradox and autoimmune disease. Autoimmunity 
8: 245-249. 
Tardieu, M., Powers, M.L., Hafler, D.A., Hauser, S.L. and Weiner, H.L. (1984) Autoimmunity 
following viral infection: demonstration of monoclonal antibodies against normal tissue following 
injection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes. 
Eur. J. Immunol. 14 : 561-565. 
Tasaki, I. (1953) Nervous transmission. Thomas, Springfield. 
Teuscher, C., Hickey, W. and Komgold, R. (1990) An analysis of the role of tumour necrosis factor in 
the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic 
encephalomyelitis. Clin. Immunol. Immunopathol. 54 : 442-453. 
Thoman, M.L. and Weigle, W.O. (1981) Lymphokines and aging: lnterleukin-2 production and activity 
in aged animals. J. Immunol. 127 : 2102-2106. 
Thoman, M.L. and Weigle, W.O. (1982) Cell-mediated immunity in aged mice: An underlying lesion in 
IL 2 synthesis. J. Immunol. 128 : 2358-2361. 
Ting, J.P.-Y., Shigekawa, B.L.,Linthicum, D.S., Weiner, L.P. and Frelinger, J.A. (1981) Expression 
and synthesis of murine immune response associated (Ia) antigens by brain cells. Proceedings of the 
National Academy of Sciences of the united States of America 78 : 3170-3174. 
Ting, J.P.Y., Shigekawa, B.L., Linthicum, D.S. et al (1981) Expression and synthesis of murine 
immune response-associated Ia antigens of brain cells. Proceedings of the National Academy of Sciences 
USA 78: 3170-3174. 
Tokuchi, F., Nishizawa, M., Nihei, J., Motoyama, K., Nagashima, K. and Tabira, T. (1990) 
Lymphokine production by encephalitogenic and non-encephalitogenic T cell clones reactive to the same 
antigenic determinant. J. Neuroimmunol. 30: 71-79. 
Tourtellotte, W.W. (1971) Cerebrospinal fluid immunoglobulins and the central nervous system as an 
immunological organ particularly in multiple sclerosis and subacute sclerosing panencephalitis. Res. 
Pub. Assoc. Nerv. Mental Dis. XLIX : 112. 
Traugott , U. Scheinberg, L.C. and Raine, C.S. (1985) On the presence of la-positive endothelial cells 
and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J. Neuroimmunol. 8 
: 1-14. 
Traugott U and Raine CS (1984) The neurology of myelin diseases. In: Myelin 2nd edition (ed. P. 
Morell), Plenum Press New York. 
Traugott, U. (1989) Detailed analysis of early immunopathologic events during lesion formation in acute 
experimental autoimmune encephalomyelitis. Cell. Immunol. 119: 114-129. 
Traugott, U., Mc Farlin, D.E. and Raine, C.S. (1986) lmmunopathology of the lesion in chronic 
relapsing experimental autoimmune encephalomyelitis in the mouse. Cell. Immunol. 99: 395-410. 
Traugott, U., Raine, C.S. and Mcfarlin, D.E. (1985) Acute experimental allergic encephalomyelitis in 
the mouse: Immunopathology of the developing lesion. Cell. Immunol. 91 : 240-254. 
155 
Traugott, U., Reinberz, E.L. and Raine, C.S. (1983a) Multiple sclerosis: Distribution of T cell subsets 
within active chronic lesions. Science 219 : 308-310. 
Traugott, U., Reinherz, E.L. and Raine, C.S. (1983b) Multiple sclerosis. Distribution of T cells, T cell 
subsets and Ia positive macrophages in lesions of different ages. J. Neuroimmunol. 4 : 201-221. 
Traugott, U., Scheinberg, L.C. and Raine, C.S. ( 1985) On the presence of Ia positive endothelial cells 
and astrocytes in multiple sclerosis and its relevance to antigen presentation. J. Neuroimmunol. 8 : 1-9. 
Traugott, U., Shevach, E., Chiba, J., Stone, J.H. (1981) Autoimmune encephalomyelitis: simultaneous 
identification of T and B cells in the target organ. Science 214: 1251-1253. 
Traugott, U., Shevach, E., Chiba, J., Stone, S.H. and Raine, C.S. (1982a) Chronic relapsing 
experimental allergic encephalomyelitis: identification and dynamics of T and B cells within the central 
nervous system. Cell. Immunol. 68 : 261-275. 
Traugott, U., Shevach, E., Chiba, J., Stone, S.H. and Raine, C.S. (1982b) Acute experimental 
autoimmune encephalomyelitis: T and B cell distribution within the target organ. Cell. Immunol. 70 : 
345-356. 
Traugott, U., Stone, S.H. and Raine, C.S. (1978) Experimental allergic encephalomyelitis: migration of 
early T cells from the circulation into the central nervous system. J. Neurol. Sci. 36: 55-61. 
Trotter, J. Flesch, I, Schmidt, B. and Ferber, E. (1982) Acetyltransferase-catalysed cleavage of arachidonic 
acid from phospholipids and transfer to lysophosphatatides in lymphocytes and macrophages. J. Biol. 
Chem. 257 : 1816-1823. 
Trotter, J.L., Clifford, D.B., Anderson, C.B. van der Veen, R.C., Hicks, B.C. and Banks, G. (1988). 
N. Engl. J. Med. 318: 1206. 
Urban, J.L., Horvath, SJ. and Hood, L. (1989) Autoimmune T cells: immune recognition of normal 
and variant peptide epitopes and peptide-based therapy. Cell 59: 257-271. 
Van Swieten, J.C., Van den Hout, J.H., Van Ketel, Hijdra, A., Wokke, J.H.J. and Van Gijn, J. (1991) 
Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. Brain 114 : 
761-774. 
Vandenbark A. A. D. R. Burger and Yetto, R. M. (1975) Cell mediated immunity in experimental 
allergic encephalopmyelitis: Cross reactivity between myelin basic protein and Mycobacterial antigens. 
Proc. Soc. Exp. Biol. Med. 148: 1233-1236. 
Vandenbark, A.A. and Hinrichs, DJ. (1974) Experimental allergic encephalomyelitis and cellular 
immunity in the Lewis rat. Cell. Immunol. 12 : 85. 
Vandenbark, A.A., Gill, T. and Offner, H. (1985) A myelin basic protein specific T-cell line that 
mediates experimental allergic encephalomyelitis. J. Immunol. 135 : 223-228. 
Vandvi.k, B. and Norrby, E. (1973) Oligoclonal IgG antibody response in the CNS to different measles 
virus antigens in SSPE. Proc. Nat. Acad. Sci. USA 70: 1060-1063. 
Vass, K., Lassman, H., Wekerle, H. and Wisniewski, H.M. (1986) The distribution of Ia antigen in the 
lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathology 70: 149-160. 
Vel~ L., Merino, A.G, Fernandez-Gallard, S. et al., (1991) Platelet-activating factor antagonists do not 
protect against the development of EAE. J. Neuroimmunol. 33: 81-86. 
Vidovic, M., Hill, C.E., Hendry, I.A. and Parish, C.R. (1986) Binding sites for glycosaminoglycans on 
developing sympathetic neurones. J. Neurosci. Res. 15 : 503-511. 
Vidovic, M., Sparacio, S.M., Elovitz, M. and Benveniste, E.N. (1990) Induction and regulation of class 
II major histocompatibility complex mRNA expression in astrocytes by interferon-g and tumour necrosis 
factor-a. J. Neuroimmunol. 30: 189-200. 
Vijayan, V.K., Cotman, C.W. (1987). Hydrocortisone administration alters glial reaction to entorhinal 
lesion in the rat dent.ate gyrus. Exp. Neurol. 96 : 307-320. 
I 
156 
Vitale, B., Allegretti , N. and Matosic, M. (1966) Influence of x-irradiation on experimental allergic 
encephalomyelitis in rats. Radiation Res. 28 : 727 . 
Voorthuis, J ., Uidtdehaag, B., DeGroot, C. , Goede, P., Van Der Meide, P. and Dijkstra, C. (1990) 
Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-
gamma in Lewis rats. Clin. Exp. Immunol. 81 : 183-188 
Wagner, C.R., Yetto, R.M. and Burger, D.R. (1985) Subcultured human endothelial cells can function 
independently as fully competent antigen presenting cells. Human Immunology 13 : 33-41. 
Waibl, H. (1973) Zur Topographie der Medulla spinalis der Albinoratte (Rattus norvegicus). Advances in 
Anatomy, Embryology and Cell Biology 47 : 5-42. 
Waksman, B.H. (1959) Experimental allergic encephalomyelitis and the "auto-allergic" diseases. Int. 
Arch. Allergy Appl. Immunol. 14 (Suppl.) : 1-87. 
Waksman, B.H. (1988) Autoimmunity in demyelinating diseases. Ann. N.Y. Acad. Sci. 540: 13-24. 
Waksman, B.H. and Adams, R.D. (1955) Allergic neuritis: anexperimental disease of rabbits induced by 
the injection of peripheral nervous tissue and adjuvants. J. Exp. Med. 102 : 213-236. 
Waksman, B.H. and Adams, R.D. (1956) A comparative study of experimental allergic neuritis in the 
rabbit, guinea pig and mouse. J. Neuropathol. Exp. Neurol. 15 : 293-333. 
Waksman, B.H. and Adams, R.D. (1962) A histologic study of the early lesions in experimental allergic 
encephalomyelitis in the guinea pig and rabbit. Am. J. Pathol. 41 : 135-162. 
Waksman, B.H. and Reingold, S.C. (1986) Viral etiology of multiple sclerosis: where does the truth lie? 
Trends in Neuroscience 9: 388-391. 
Walford, R.L. (1969) The immunologic theory of aging. Williams & Wilkins, Baltimore. 
Watanabe, R., Wege, H. and Ter Meulen, V. (1983) Adoptive transfer of experimental allergic 
encephalomyelitis-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. 
Nature 305 : 150-153. 
Wawryk, S.O., Novotny, J.R., Wicks, I.P., Wilkinson, D., Maher, D ., Salvaris , E., Welch, K., 
Fecondo, J. and Boyd, A.W. (1989) The role of the LFA-1/ICAM-1 interaction in human leukocyte 
homing and adhesion. Immunol. Rev. 108 : 135-161. 
Waxman, F.J., Fritz, R.B. and Hinrichs, D.J. (1980) The presence of specific antigen-reactive cells 
during the induction, recovery, and resistence phases of experimental allergic encephalomyelitis. Cell. 
Immunol. 49 : 34-42. 
Waxman, S.G. (1982) Membranes, myelin and the pathophysiology of multiple sclerosis. New Eng. J. 
Med. 306: 1529-1533. 
Webb, C., Teitelbaum, D., Amon, R. and Sela, M. (1973) In vivo and in vitro immunological cross-
reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing 
experimental allergic encephalomyelitis. European J . Immunol. 3 : 279-286. 
Wege, H. Watanabe, R. and ter Meulen, V. (1984) Coronavirus JHM infection in rats as a model for 
virus induced demyelinating encephalomyelitis. Prog. Clin. Biol. Res. 146 : 13-22. 
Wei, E., Christman, C., Kontos, H. and Povlishock, J . (1985) Effects of oxygen radicals on cerebral 
arterioles. Am. J. Physiol. 248: H157-162 
Weigel, W. (1980) Analysis of autoimmunity through experimental models of thyroiditis and allergic 
encephalomyelitis. Advances in Immunology 30: 159-273. 
Weiner, H.L. and Hauser, S.L. (1983) Immunoregulation in multiple sclerosis. Prog. Brain Res. 59 : 
339-343. 
1/.1 
.:, 
I 
! 
it 157 
Weinstock, M., Shoham-Moshonov, S., Teitelbaum, D. and Amon, R. (1977) Inactivation of neurogenic 
5-hydroxytryptamine receptors in guinea pigs with experimental allergic encephalomyelitis (EAE) induced 
paralysis. Brain Res. 125: 192-195 
Wekerle, H. (1986) Cellular basis of physiological and autoaggressive immune reactivity within the 
central nervous system. Clin. Neuropathol. 5 : 100 (abstract). 
Wekerle, H. and Fierz, W. (1985) T-cell approach to demyelinating diseases. Springer Seminars in 
Immunopathology 8: 97-110. 
Wekerle, H., Linington, C., Lassman, H. and Meyerman, R. (1986) Cellular immune reactivity within 
the central nervous system. TINS 9 : 271-277 
Wekerle, H., Linnington C., Lassman, H. and Meyermann, R. (1987) Cellular immune reactivity within 
the CNS. TINS 9 : 271-277. 
Wekerle, H., Sun, D., Oropeza-Wekerle, R.L. and Meyermann, R. (1987) Immune reactivity in the 
nervous system: Modulation of T-lymphocyte activation by glial cells . J. Exp. Biol. 132: 43-57. 
Welch, A.M., Holda, J.H. and Swanborg, R.H. (1980) Regulation of experimental allergic 
encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease. J. 
Immunol. 125 : 186-189. 
Werdelin, 0. and McCluskey, R. (1971) The nature and specificity of mononuclear cells in experimental 
autoimmune inflammations and the mechanisms leading to their accumulation. J . Exp. Med. 133 : 1242-
1263. 
Werdelin, 0., Wick, G. and McCluskey, R. (1971) The fate of newly formed lymphocytes migrating 
from an antigen-stimulated lymph node in rats with allergic adrenalitis. Lab. Invest. 25(3) : 279-286. 
Westergaard, E., Deurs, D., and Bronsted, H.E. (1977). Increased vesicular transfer of horseradish 
peroxidase across cerebral endothelium evoked by acute hypertension. Acta. Neuropathol. (Berl) 37: 141-
152. 
Weston, S. A., and Parish, C.R. (1990) New fluorescent dyes for lymphocyte migration studies : 
Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133 : 87-97. 
Weston, S. A., and Parish, C.R. (1991) Modification of lymphocyte migration by mannans and 
phosphomannans : Different carbohydrate structures control entry into spleen and lymph nodes. J. 
Immunol. 146 : 4180. 
Wettstein, P.J., Frelinger, J.G. and Hood L. (1981) Serological and biochemical characterisation of rat 
(RTl) class II molecules with restricted mouse anti-Ia sera. Immunogenetics 13: 93-107 . 
White, F.P., and Hertz, L. (1981) Protein synthesis by astrocytes in primary cultures. Neurochemical 
Research 6(4): 353-364. 
White, S.R. (1984) experimental allergic encephalomyelitis: Effects on monoaminergic 
neurotransmission. In: Brainstem Control of Spinal Cord Function (ed. Barnes, C.D.). Academic Press, 
Orlando, Florida, pp 257 -281. 
White, S.R. and Bowker, R.M. (1988) Retrograde transport of horseradish peroxidase is specifically 
impaired in bulbospinal serotonin axons during experimental allergic encephalomyelitis. J . 
Neuroimmunol. 18 : 75-86. 
White, S.R., Vyas, D. and Bieger, D. (1985) Serotonin immunoreactivity in spinal cord axons and 
terminals of rodents with experimental allergic encephalomyelitis. Neuroscience 16 : 701-7(1). 
White, S.R., Vyas, D., Bieger, D. and Samathanam, G. (1989) Monoamine-containing fibre plexuses in 
the spinal cord of guinea pigs during paralysis, recovery and relapse stages of chronic relapsing 
experimental allergic encephalomyelitis. J. Neuroimmunol. 22: 211-221. 
Willenborg, D.O. (1981) Mechanisms of recovery and acquired resistance in Lewis rat Experimental 
Allergic Encephalomyelitis. AJEBAK 59(2): 125-134. 
Wilkinson (1988) Mims Annual, 12tJ1 Edition (Ed. L.L. Wilkinson), Singapore. 
1 
I 
I 
I 
I 
158 
Willenborg, D., Sjollema, P. and Danta, G. (1986) The fate of neonatally infected effector cells of 
allergic encephalomyelitis. Scand. J. Immunol. 23 : 75-80. 
Willenborg, D.O. (1979) Experimental allergic encephalomyelitis in the Lewis rat: studies on the 
mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 123 : 1145. 
Willenborg, D.O. (1980) Mechanisms of recovery and acquired resistance in Lewis rat experimental 
allergic encephalomyelitis. Aust. J. Exp. Biol. Med. 59: 125-134. 
Willenborg, D.O. (1982) Total body irradiation allows reinduction of experimental allergic 
encephalomyelitis in convalescent Lewis rats. Int. Arch. Allergy Appl. Immunol. 68: 247-251. 
Willenborg, D.O. and Parish, C.R. (1979) Experimental allergic encephalomyelitis in the Lewis rat: 
studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 
123: 1145-1150 
Willenborg, D.O. and Parish, C.R. (1988) Inhibition of allergic encephalomyelitis in rats by treatment 
with sulfated polysaccharides. J. Immunol. 140: 3401-3405. 
Willenborg, D.O. and Prowse, S.J. (1983) Immunogloobulin-deficient rats fail to develop experimental 
allergic encephalomyelitis. J. Neuroimmunol. 5: 99-109. 
Willenborg, D.O., Parish, C.R. and Cowden, W.B. (1989a) Inhibition of experimental allergic 
encephalomyelitis by the alpha-glucosidase inhibitor castanospermine. J. of Neural. Sciences 90: 77-85. 
Willenborg, D.O., Parish, C.R. and Cowden, W.B. (1989b) Phosphosugars are potent inhibitors of 
central nervous system inflammation. FASEB J. 3 : 1968-1971. 
Williams Pelton, E., Kimelberg, H.K., Shipherd, S.V. and Bourke, R.S. (1981) Dopamine and 
Norepinephrine uptake and metabolism by astroglial cells in culture. Life Sciences 28 : 1655-1663. 
Williams, K., Hart, D., Fabre, J. and Morris, P. (1980) Distribution and quantitation of HLA-A,B,C and 
DR(Ia) antigens on human kidney and other tissues. Transplantation 29 : 274-280. 
Williams, R.M. and Moore, M.J. (1973) Linkage of susceptibility to experimental allergic 
encephalomyelitis to the major histocompatibility locus in the rat. J. Exp. Med. 138 : 775-783. 
Williams, R.M. and Moore, M.J. (1973) Linkage susceptibility to experimental allergic 
encephalomyelitis to the major histocompatibility locus in the rat. J. Exp. Med. 138 : 775-783. 
Wisniewski, H. and Raine, C.S. (1971) An ultrastructural study of experimental demyelination and 
remyelination. V. Central and peripheral nervous system lesions caused by diphtheria toxin. Laboratory 
Investigation 25 : 73-80. 
Wisniewski, H., Prineas, J. and Raine, C.S. (1969) An ultrastructural study of experimental 
demyelination and remyelination. I. Acute experimental allergic encephalomyelitis in the peripheral 
nervous system. Laboratory Investigation 21 : 105-118. 
Wisniewski, H.M. (1977) Immunopathology of demyelination in autoimmune diseases and virus 
infections. Br. Med. Bull. 33 : 54-59. 
Wisniewski, H.M. and Keith, A.B. (1977) Chronic relapsing experimental allergic encephalomyelitis: an 
experimental model of MS. Ann. Neural. 1 : 144-148. 
W odruff, J J ., Clarke, L.M. and Chin, Y .H. (1987) Specific cell adhesion mechanisms determining 
migration pathways of recirculating lymphocytes. Annual Review of Immunology 5 : 201-222. 
Wolinsky, J.S., and Johnson, R.T. (1980) Role of viruses in chronic neurological diseases In: 
Comprehensive Virology, Vol 17, (eds. Fraenkel-Conrat, H. and Wagner, R.R.) pp. 257-296 Plenum 
Press, New York. 
Wong, G.H.W., Bartlett, P., Clark-Lewis, I., Battye, F. and Schrader, J.W. (1984) Inducible expression 
of H-2 and Ia antigens on brain cells. Nature, London, 310: 688-691. 
11 
I 
Ir 
1i 
II 
\1 
I 
I 
II 
l 
I 
I 
I 
159 
Wong, G.H.W., Bartlett, P.F., Clark-Lewis, I., McKimm-Breschkin, J.L. and Schrader, J.W. (1985) 
Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells . Journal of 
Neuroimmunology 7 : 255-278. 
Wong, G.H.W., Clark-Lewis, I., Harris, A.W. and Schrader, J.W. (1984) Effect of cloned interferon-g on 
expression of H2 and Ia antigens on cells of hematopoetic, lymphoid, epithelial, fibroblastic, and 
neuronal origin. European J. Immunol. 14 : 52-56. 
Woodroofe, M. , Hayes, G., and Cuzner, M. (1989) Fe receptor density, MHC antigen expression and 
superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain. 
lmmunol. 68 : 421-426. 
Woodroofe, M.N., Bellamy, A.S ., Feldmann, M., Davidson, A.N. and Cruzner, M.L. (1986) 
lmmunocytochemical characterisations of immune reactions in the central nervous system in multiple 
sclerosis: Possible role for microglia in lesion growth. J. Neurol. Sci. 74: 135-152. 
Woodruff, J.J. and Clarke, L.M. (1987) Specific cell-adhesion mechanisms determining migration 
pathways of recirculating lymphocytes. Annu. Rev. Immunol. 5 : 201-222. 
Wraith, D.C., Smilek, D.E., Mitchell, D.J., Steinman, L. and McDevitt, H.O. (1989) Antigen 
recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. 
Cell 59 : 247-255. 
Wright, H.P., Thompson, R.H.S. and Zilk.ha, K.J. (1963) Platelet adhesiveness in multiple sclerosis. 
Lancet ii : 1109-1110. 
Yednock, T. A., and Rosen, S.D. (1989) Lymphocyte homing. Adv. Immunol. 44: 313-378. 
Zamvil, S.S., Mitchell, D.J., Moore, A.C. et al (1986) T cell epitope of the autoantigen MBP that 
induces encephalomyelitis. Nature 324: 258-260. 
Zamvil, S. and Steinman, L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. 
Annu. Rev. lmmunol. 8 : 579-621. 
Zamvil, S., Nelson, P., Mitchell, D., Knobler, R., Fritz, R. and Steinman, L. (1985) Encephalogenic T 
cell clones specific for myelin basic protein: an unusual bias in antigen presentation. J. Exp. Med. 162: 
2107-2124. 
Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R. and Steinman, L. (1985) T cell 
clones specific for myelin basic protein in duce chronic relapsing experimental allergic encephalomyelitis 
and demyelination. Nature 317 : 355-358. 
Zamvil, S.S. , Mitchell, D.J., Powell, M.B., Sakai, K., Rothbard, J.B. and Steinman, L. (1988) 
Multiple discrete encephalitogenic epitopes of autoantigen myelin basic protein include a determinant for 
I-E class II-restricted T cells. J. Exp. Med. 168: 1181-1186. 
Ziegler M.G., Lake C.R. and Kopin I.J. (1976) Plasma noradrenaline increases with age. Nature 
(London). 261 : 333-334. 
Zinkernagel, R.M. (1978) Thymus and lymphohemopoietic cell: Their role in T cell maturation in 
selection of T cells' H-2-restriction-specificity in H-2 linked Ir gene control. Immunological Reviews 42 
: 224-270. 
Zucker-Franklin, D., Warfel, A., Grusky, G., Frangione, B. and Teitel, D. (1987) Novel monocyte-like 
properties of microglial astroglial cells. Laboratory Investigation 57 : 176-185. 
• 
